data_2nnz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nnz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 111.588 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -102.35 145.06 30.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 111.76 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 164.17 19.3 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.004 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.32 102.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.085 0.469 . . . . 0.0 109.779 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -99.82 156.23 17.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.376 0.608 . . . . 0.0 111.893 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.7 m-85 -135.88 138.87 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.495 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.6 p -125.98 21.83 7.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -176.53 153.32 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.91 146.58 37.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 149.01 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.168 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.29 155.66 24.74 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.81 142.06 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.223 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 7.4 mt-10 -100.58 -178.8 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.062 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD11 HG12 ' A' ' 107' ' ' ILE . 3.8 tp -150.92 149.36 29.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.067 0.46 . . . . 0.0 111.368 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -126.36 148.01 49.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.732 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.18 -8.88 1.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.65 -27.73 0.85 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.621 0.248 . . . . 0.0 111.593 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.502 ' CH2' ' CD2' ' A' ' 77' ' ' TYR . 8.9 t90 -81.61 -56.27 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 154.89 114.87 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.452 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -46.41 -35.23 15.73 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.555 2.17 . . . . 0.0 112.335 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.78 -53.5 57.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.539 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.483 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.51 -45.06 92.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.521 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 61.4 t -47.43 -28.42 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.33 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt-85 -61.21 -38.64 87.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.464 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.94 79.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.671 0.272 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.09 -51.29 55.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.03 -27.8 69.66 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 120.948 0.404 . . . . 0.0 110.369 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.93 -25.31 61.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 0.0 110.599 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.23 49.6 1.13 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.047 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.89 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.1 mt -61.91 -160.21 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.58 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.89 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 32.3 Cg_exo -29.2 107.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.04 150.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.627 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -85.77 136.61 33.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.111 0.481 . . . . 0.0 111.745 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.594 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.33 149.1 33.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.497 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 125.59 48.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB1' ' CG2' ' A' ' 126' ' ' VAL . . . -83.85 136.01 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -108.26 125.8 52.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.073 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -85.39 135.37 33.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -150.91 148.97 29.08 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.902 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . -32.88 102.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.505 -0.379 . . . . 0.0 113.729 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.22 30.87 0.49 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.02 142.91 30.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.351 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.584 HD13 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -139.92 124.83 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.299 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 34.9 p90 -133.83 127.84 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.477 ' CE2' HG12 ' A' ' 126' ' ' VAL . 4.0 p90 -133.58 146.5 51.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.049 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.01 145.19 24.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER 82.95 -8.14 1.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.34 115.78 26.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.33 94.56 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 112.053 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -123.21 106.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.081 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.41 136.39 46.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.041 0.448 . . . . 0.0 111.665 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -160.32 161.7 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.987 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -96.33 96.28 8.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.0 tt0 -170.37 149.87 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.884 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.411 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 57.4 t-20 63.33 -81.74 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.727 0.299 . . . . 0.0 111.108 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m 29.97 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.676 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -99.54 157.06 16.71 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.145 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -120.98 -4.16 9.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.5 p -127.56 141.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.403 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 35.9 m -158.75 157.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.599 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.62 150.77 19.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.401 0.619 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -44.85 126.49 5.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.98 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.41 -26.96 10.44 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 120.256 -0.973 . . . . 0.0 114.614 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -82.53 156.21 24.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.844 0.822 . . . . 0.0 111.894 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -113.48 151.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.393 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.06 153.34 33.78 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CD2' ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -103.98 131.69 50.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.308 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.44 ' CD1' HG11 ' A' ' 104' ' ' VAL . 4.0 t90 -74.37 109.12 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.669 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -65.32 -69.17 0.61 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.311 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 39.0 Cg_exo -58.85 80.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.886 1.724 . . . . 0.0 111.518 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.46 -9.33 3.19 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.291 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 50.05 39.62 19.52 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.907 0.354 . . . . 0.0 111.121 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.02 136.38 54.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.53 147.05 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.5 m -143.12 135.89 27.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.07 160.82 19.18 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 57.1 m-85 -136.32 114.71 11.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 111.984 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.673 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -150.23 31.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.082 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.54 -153.07 24.1 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.663 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.6 -173.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.522 0.677 . . . . 0.0 112.203 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.538 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -159.31 -175.85 0.55 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.118 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 74.3 Cg_exo -42.6 -25.22 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.032 1.821 . . . . 0.0 112.888 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 mp -142.02 72.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -109.32 99.26 35.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.959 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 60.0 Cg_endo -70.66 -31.27 16.83 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.151 . . . . 0.0 112.719 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.411 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 178.69 -162.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.22 -5.37 14.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.613 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.27 70.06 0.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 12.7 m -119.01 141.4 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.024 0.44 . . . . 0.0 111.805 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 2.1 m120 -84.43 151.39 24.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.419 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.7 96.89 6.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.573 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.27 20.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.74 -149.75 18.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.55 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 74' ' ' ASP . 30.6 mtp180 -156.75 168.03 28.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.19 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.84 112.72 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.531 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.547 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.421 ' HG ' HG12 ' A' ' 120' ' ' VAL . 6.7 tt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.78 -21.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.404 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -93.43 34.35 4.65 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.427 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.615 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 7.1 m -71.58 154.83 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 122.161 0.184 . . . . 0.0 111.088 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.406 ' C ' ' HD3' ' A' ' 47' ' ' ARG . . . -81.22 147.92 29.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.594 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.1 p-10 -56.16 118.0 4.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.177 0.513 . . . . 0.0 112.328 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.63 101.15 0.02 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.008 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.8 155.55 40.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 110.48 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 t -55.56 164.98 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.681 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.594 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 44.5 t -157.96 127.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.562 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.39 108.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.314 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.405 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.68 128.89 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.407 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.7 pt-20 -153.41 129.18 10.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.66 0.267 . . . . 0.0 111.379 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.479 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.24 89.54 3.12 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.682 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -108.38 145.43 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.356 0.598 . . . . 0.0 112.319 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 163.92 18.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.62 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 144.87 31.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 12' ' ' ILE . 1.7 mt -148.04 99.31 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -104.98 156.06 18.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.877 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 45' ' ' ALA . 2.7 m-85 -129.63 139.11 51.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.277 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -28.53 0.43 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -121.34 22.97 10.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.76 151.46 1.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.37 138.35 54.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.791 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 149.2 11.32 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.639 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.33 158.26 31.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.115 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.24 141.13 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.374 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mt-10 -96.86 -178.46 4.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.979 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.533 HD11 HG12 ' A' ' 107' ' ' ILE . 8.1 tp -154.15 144.57 22.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.148 0.499 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.14 146.73 50.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.638 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -57.07 -9.29 0.83 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -45.49 -28.29 0.89 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.265 -0.272 . . . . 0.0 111.33 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.56 ' CZ2' ' CE1' ' A' ' 77' ' ' TYR . 7.8 t90 -81.12 -56.18 4.26 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.41 115.47 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.597 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -46.17 -35.47 15.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.517 2.145 . . . . 0.0 112.341 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.15 -52.7 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.446 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.513 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.39 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 65.0 t -47.91 -30.04 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.307 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -60.66 -38.31 84.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.399 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.19 75.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.34 -52.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.9 -29.01 69.92 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.977 0.417 . . . . 0.0 110.445 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.92 -25.44 62.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.42 50.82 1.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.968 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.883 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.92 -160.05 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.45 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.4 Cg_exo -29.59 105.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.106 1.871 . . . . 0.0 113.953 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.7 mt -147.94 149.29 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.566 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.89 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.09 0.471 . . . . 0.0 111.766 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.7 p -146.08 149.01 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.463 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.92 129.38 48.17 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 14' ' ' PHE . . . -89.46 134.45 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -106.06 122.02 45.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.045 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.61 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.79 136.73 35.4 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -154.45 148.34 25.59 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.47 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.83 86.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.497 0 O-C-N 123.278 0.361 . . . . 0.0 113.838 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.4 t70 76.15 -36.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 138.49 37.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 111.376 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -136.26 110.01 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.991 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 39.7 p90 -119.87 128.74 53.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.475 ' CE2' HG13 ' A' ' 126' ' ' VAL . 5.3 p90 -136.64 144.46 44.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.393 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.64 147.07 23.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.423 HG23 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.89 7.56 10.42 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' HG3' ' C ' ' A' ' 56' ' ' THR . 36.1 mt-30 81.02 -6.82 1.59 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.819 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.54 115.76 28.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.39 94.9 5.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.045 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 2.9 p -125.33 106.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.961 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 138.17 53.88 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.053 0.454 . . . . 0.0 111.623 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -152.99 164.5 37.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.335 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.12 87.2 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.78 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.0 tt0 -170.11 153.56 4.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.467 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 49.7 t-20 69.42 -80.27 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.277 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 65' ' ' ASN . 5.3 m 25.28 82.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.473 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.77 157.02 17.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.536 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -118.97 -8.13 10.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 5.0 p -124.89 143.04 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.296 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.428 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 26.9 m -159.08 157.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.78 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.49 151.59 21.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.406 0.622 . . . . 0.0 111.483 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.38 125.36 10.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.805 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.59 -32.18 6.0 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.268 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.489 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 1.9 p30 -73.61 156.49 37.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.578 0.689 . . . . 0.0 111.942 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 110' ' ' ILE . 19.0 t -112.93 152.35 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.497 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.4 148.94 31.83 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.262 0.483 . . . . 0.0 112.294 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.56 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -103.91 123.08 46.49 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.501 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.0 t90 -64.62 119.98 11.53 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.809 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.733 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -70.64 -68.03 0.55 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.753 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.07 78.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.846 1.697 . . . . 0.0 111.696 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 141.19 -9.24 2.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.737 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.02 36.23 14.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.0 0.4 . . . . 0.0 111.059 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.85 134.75 54.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.723 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.8 mt -84.3 141.16 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.451 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.5 m -135.65 130.36 34.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.58 156.3 19.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 4.8 m-85 -136.79 129.67 30.76 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.626 0.25 . . . . 0.0 110.989 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.444 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -165.79 42.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.304 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.47 -84.09 0.1 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.327 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.57 -166.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.259 0.552 . . . . 0.0 111.902 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.456 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -159.56 -176.65 0.63 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 87.7 Cg_exo -47.32 -24.62 4.05 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.793 1.662 . . . . 0.0 111.786 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -142.57 66.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.1 mt . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.84 0.352 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -103.47 99.21 14.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 52.4 Cg_endo -68.33 -31.39 28.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.482 2.121 . . . . 0.0 112.537 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.423 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 175.41 -158.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -6.93 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.697 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.01 73.12 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 16.7 m -122.74 142.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 111.826 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 2.5 m120 -83.58 152.0 25.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.854 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.73 99.84 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.533 HG12 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.66 21.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.79 -133.22 10.55 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.245 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HB3' ' HA ' ' A' ' 74' ' ' ASP . 9.5 ptt85 -170.47 168.12 7.92 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.045 0.45 . . . . 0.0 111.484 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.417 ' CD1' HG23 ' A' ' 75' ' ' VAL . 3.0 mt -98.16 115.27 37.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.575 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.504 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.531 ' HG ' HG12 ' A' ' 120' ' ' VAL . 6.2 tt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.783 0.325 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.95 -24.38 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.173 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.431 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.92 31.29 4.72 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.531 HG12 ' HG ' ' A' ' 117' ' ' LEU . 10.6 m -75.09 153.98 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.562 0.22 . . . . 0.0 111.299 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.26 146.61 32.91 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.61 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -57.28 111.64 1.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.99 98.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.401 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 pt-20 -152.41 149.71 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.68 166.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.281 0.562 . . . . 0.0 112.257 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.614 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 48.8 t -157.98 128.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.137 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.46 109.14 17.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 111.589 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 HG23 HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.89 129.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.243 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.445 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 11.8 pt-20 -154.31 128.04 8.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.622 0.249 . . . . 0.0 111.293 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.472 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.81 87.59 1.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 110.786 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.751 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -108.54 145.32 34.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.2 0.524 . . . . 0.0 112.329 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.48 163.96 17.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.682 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 145.68 38.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.796 0.332 . . . . 0.0 110.948 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.2 100.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -102.63 155.5 18.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.615 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.2 138.05 49.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.441 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.53 -29.07 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -126.08 23.12 7.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.06 152.44 3.49 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.78 143.5 49.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.676 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 148.6 13.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.75 0.31 . . . . 0.0 111.769 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -136.31 157.83 45.86 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.054 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.15 146.57 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.446 . . . . 0.0 111.648 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 6.6 mt-10 -98.16 -178.29 4.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.871 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.52 HD12 HG12 ' A' ' 107' ' ' ILE . 7.9 tp -153.71 144.2 22.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -123.97 146.8 48.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.45 -9.27 0.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.61 -27.26 0.74 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.939 0.336 . . . . 0.0 111.443 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 7.5 t90 -81.28 -56.37 4.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 154.23 113.62 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.665 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.72 -29.62 8.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.35 -46.46 80.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.283 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.49 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.32 -46.2 70.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 30.2 t -45.87 -29.82 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.339 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -33.44 72.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.477 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.53 55.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -49.08 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.12 -28.62 69.89 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.319 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -71.4 -25.38 62.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.376 . . . . 0.0 110.543 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.01 51.11 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.988 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.887 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -62.21 -159.93 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.594 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.887 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.4 Cg_exo -29.08 107.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.186 1.924 . . . . 0.0 114.059 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.9 mt -150.04 149.78 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.642 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -85.84 136.85 33.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.919 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -146.05 149.19 33.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.45 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 124.44 47.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -84.93 133.58 34.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -103.4 124.98 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.931 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -88.52 135.88 33.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.6 t-105 -156.71 148.34 22.58 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.957 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.81 84.89 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.649 -0.31 . . . . 0.0 113.764 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' TRP . 30.5 t70 74.22 -36.64 0.34 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 49' ' ' GLY . 6.3 tt0 -74.71 128.22 35.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.399 . . . . 0.0 111.346 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -132.29 119.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.849 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 53.4 p90 -131.47 125.03 31.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.319 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.463 ' CE2' HG12 ' A' ' 126' ' ' VAL . 3.0 p90 -129.87 145.8 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.05 144.12 25.76 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -118.89 6.4 11.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.6 mm-40 82.23 -7.44 1.33 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.98 116.87 29.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.159 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.87 94.56 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.703 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.414 ' CG2' HG21 ' A' ' 31' ' ' THR . 6.0 p -126.08 106.74 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.3 133.93 43.21 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 161.14 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.083 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.73 93.97 7.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.51 148.39 3.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 35.5 t-20 70.44 -76.87 0.06 Allowed 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.606 0.241 . . . . 0.0 111.165 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' ASN . 11.0 t 21.41 83.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.58 161.51 13.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.361 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.28 1.04 8.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 49.6 t -138.41 142.33 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.442 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.6 m -157.99 157.55 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.887 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.79 152.2 19.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.495 0.664 . . . . 0.0 111.62 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -48.29 125.91 10.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.933 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.07 6.08 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.505 -0.855 . . . . 0.0 114.083 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -75.37 156.37 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.458 0.629 . . . . 0.0 111.984 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -113.05 152.25 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.497 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.08 149.39 29.47 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.151 0.432 . . . . 0.0 111.874 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -104.51 137.66 42.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.341 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.432 ' CD1' ' HG2' ' A' ' 80' ' ' PRO . 1.6 t90 -78.72 108.26 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.445 HG13 ' ND2' ' A' ' 105' ' ' ASN . 0.3 OUTLIER -63.94 -66.42 1.5 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.634 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 21.1 Cg_endo -60.72 77.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.255 1.97 . . . . 0.0 111.6 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 142.91 -9.99 2.31 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.324 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 54.47 33.6 19.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.965 0.382 . . . . 0.0 110.913 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.96 134.8 54.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.049 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.1 mt -87.37 150.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 24.8 t -143.52 156.09 44.52 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.66 157.76 21.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.943 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 5.5 m-85 -136.71 138.21 40.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.492 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -175.46 44.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.957 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.36 -91.14 0.1 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.973 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -133.36 -167.76 1.98 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.424 0.63 . . . . 0.0 111.724 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.488 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -163.61 -173.94 0.38 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.01 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 90.4 Cg_exo -45.48 -22.2 0.97 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 121.81 1.673 . . . . 0.0 112.736 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -142.06 73.1 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 91' ' ' THR . 34.6 mmm-85 -98.76 99.11 7.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.4 Cg_endo -68.87 -31.09 25.5 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.483 2.122 . . . . 0.0 112.561 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 175.77 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.76 -0.43 14.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.599 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.42 68.25 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 18.6 m -121.45 141.63 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.132 0.492 . . . . 0.0 112.09 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.445 ' ND2' HG13 ' A' ' 79' ' ' ILE . 2.2 m120 -82.32 152.04 26.45 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.815 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.1 97.43 6.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.52 HG12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -82.95 22.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.43 -144.65 17.9 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.079 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -156.79 168.1 28.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 111.33 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.9 mp -91.41 116.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.076 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' HG12 ' A' ' 120' ' ' VAL . 1.2 tp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.782 0.325 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.51 -26.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.94 -179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.54 31.34 4.22 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.47 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 3.1 m -79.84 154.19 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.641 0.258 . . . . 0.0 111.202 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.96 146.55 32.01 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.571 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 16.0 p-10 -54.57 112.01 0.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.997 0.427 . . . . 0.0 111.593 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.61 100.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.179 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.82 148.88 28.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.371 . . . . 0.0 110.982 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.1 t -46.63 163.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.327 0.584 . . . . 0.0 112.233 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 42.4 t -158.1 128.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.326 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.51 108.42 19.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.901 0.382 . . . . 0.0 111.547 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.05 128.53 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.289 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.4 pt-20 -154.0 130.26 10.45 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.43 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.463 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.19 89.53 3.09 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.801 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.719 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.692 0.282 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -111.27 145.32 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 112.099 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 164.57 14.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.796 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.35 143.82 36.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 0.0 111.159 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.45 100.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -102.48 156.26 17.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.597 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.452 ' CD2' HG12 ' A' ' 120' ' ' VAL . 4.1 m-85 -136.27 137.91 41.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.524 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.5 -29.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -123.88 22.81 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.86 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -126.68 141.5 51.83 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.83 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 148.94 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.717 0.294 . . . . 0.0 111.498 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.5 160.11 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.308 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.86 144.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.122 0.487 . . . . 0.0 111.571 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.3 mt-10 -96.21 -178.52 4.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.13 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.623 HD12 HG12 ' A' ' 107' ' ' ILE . 6.0 tp -151.02 147.02 26.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.029 0.442 . . . . 0.0 111.15 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.5 146.88 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -59.06 -9.03 1.7 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.4 -29.56 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.501 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -79.9 -56.38 4.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 158.24 117.2 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -45.99 -35.36 14.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.523 2.149 . . . . 0.0 112.208 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.63 76.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.708 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.459 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.91 -44.22 93.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.859 0.362 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 63.7 t -47.68 -34.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.204 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -60.07 -36.98 78.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.39 70.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.76 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.42 -28.7 69.98 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.028 0.442 . . . . 0.0 110.399 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.74 -26.16 63.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.452 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.0 51.48 1.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.778 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.891 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.7 -159.71 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.591 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.891 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.6 Cg_exo -28.92 105.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.996 1.798 . . . . 0.0 113.989 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 39' ' ' LEU . 21.0 mt -146.64 150.71 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.63 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.036 0.446 . . . . 0.0 111.82 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -144.05 148.97 35.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.453 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 126.95 48.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 110.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -88.84 132.75 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -102.63 122.3 44.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.712 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -89.66 136.18 33.18 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -155.74 148.26 23.9 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.81 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -32.07 85.47 0.01 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.178 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.1 t70 76.0 -39.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.09 120.26 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 0.0 111.504 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -128.36 121.54 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.742 178.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -135.23 127.91 30.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.844 0.354 . . . . 0.0 111.296 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.7 p90 -133.4 145.76 50.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.013 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.15 146.19 24.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -120.63 6.31 10.53 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER 83.07 -8.08 1.16 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.76 115.02 26.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.38 94.7 5.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.975 0.417 . . . . 0.0 112.052 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 HG21 ' CG2' ' A' ' 31' ' ' THR . 4.8 p -129.66 106.78 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.124 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.64 134.75 54.49 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 121.027 0.441 . . . . 0.0 111.641 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.26 167.26 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.065 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.03 88.78 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.972 0.415 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.33 160.79 7.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.757 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.8 t-20 63.42 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 65' ' ' ASN . 3.3 m 28.5 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.368 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.19 155.45 17.75 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.398 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -120.41 2.11 10.74 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 51.0 t -137.28 141.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG1' ' HD3' ' A' ' 67' ' ' LYS . 35.3 m -158.12 157.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.715 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -98.26 148.73 23.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.389 0.614 . . . . 0.0 111.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.61 129.42 4.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.948 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.51 -32.06 6.08 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.134 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 2.5 p30 -81.15 157.93 25.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.327 0.564 . . . . 0.0 111.929 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 38.4 t -116.21 152.53 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.48 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.603 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 151.32 32.54 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.305 0.502 . . . . 0.0 112.341 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -107.36 137.28 45.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.436 ' CD1' HG13 ' A' ' 104' ' ' VAL . 2.3 t90 -76.22 111.95 12.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -64.04 -67.37 1.08 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 32.2 Cg_endo -63.5 76.28 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.23 1.954 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.83 -10.84 1.65 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.545 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.38 28.72 11.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.147 0.474 . . . . 0.0 110.944 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.12 130.9 55.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.676 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.74 147.66 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.197 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.1 t -141.06 156.83 45.94 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.482 0.658 . . . . 0.0 112.769 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.75 161.76 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.069 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 10.5 m-85 -136.55 138.94 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -177.68 49.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.418 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.71 -78.54 0.19 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.619 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -141.47 -161.51 1.23 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.976 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.561 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -166.33 177.87 1.41 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.009 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -41.79 -23.67 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.473 2.115 . . . . 0.0 112.921 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.475 HD13 HG21 ' A' ' 93' ' ' ILE . 10.0 pt -141.19 64.59 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 121.115 0.483 . . . . 0.0 110.662 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 99.06 8.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 46.9 Cg_endo -68.16 -29.68 32.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.215 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 104' ' ' VAL . . . 176.39 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.661 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.8 -2.97 15.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.654 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -172.16 70.1 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 17.4 m -120.03 141.64 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.956 0.408 . . . . 0.0 111.8 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 1.8 m120 -83.83 153.1 24.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.285 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.84 89.66 3.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.121 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.87 23.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 114.71 -150.46 18.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.424 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 27.2 mtp180 -156.94 168.16 28.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.407 ' CD1' HG23 ' A' ' 75' ' ' VAL . 3.2 mt -98.05 114.59 35.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.568 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.737 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.49 ' HG ' HG13 ' A' ' 120' ' ' VAL . 1.5 tp . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.41 -26.43 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.282 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.03 29.83 4.54 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.39 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.49 HG13 ' HG ' ' A' ' 117' ' ' LEU . 12.3 m -84.32 153.89 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.832 0.316 . . . . 0.0 111.381 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.67 147.18 32.08 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 5.2 p-10 -56.31 117.72 4.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.52 100.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.108 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.29 149.63 27.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.137 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.2 t -48.6 164.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 112.061 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.599 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 48.0 t -158.02 128.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 108.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.453 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.0 128.79 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.225 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.479 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -154.43 131.66 11.1 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.799 0.333 . . . . 0.0 111.542 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.432 ' HB2' HD23 ' A' ' 39' ' ' LEU . 3.1 tmm_? -74.25 92.85 2.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.867 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -109.15 145.42 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 112.156 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 163.27 17.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.7 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 144.86 32.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.885 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.89 101.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 109.749 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -100.09 156.12 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.71 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.8 m-85 -134.67 138.03 44.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.431 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.43 -28.91 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -125.56 22.37 7.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.14 150.26 1.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.415 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -131.92 139.23 48.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.188 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 149.2 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.7 0.286 . . . . 0.0 111.339 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -116.41 156.92 25.95 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.41 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.79 138.04 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.3 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.436 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 3.2 mt-10 -92.96 -178.3 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.325 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.4 tp -155.43 145.87 21.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -126.65 146.71 50.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 29.6 mt-10 -56.59 -9.13 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.67 -27.4 0.79 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.212 -0.305 . . . . 0.0 111.383 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.518 ' CZ2' ' CG2' ' A' ' 31' ' ' THR . 6.6 t90 -80.56 -55.96 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 157.49 109.7 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.48 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.738 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 88.4 Cg_exo -40.9 -29.71 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.789 2.326 . . . . 0.0 112.967 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.97 -42.04 81.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.321 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.518 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.74 -45.03 72.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.784 0.326 . . . . 0.0 110.477 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 35.5 t -48.85 -33.64 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.244 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -58.03 -37.25 74.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.5 -48.44 69.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -51.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.04 -29.03 70.01 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.331 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.7 -24.76 61.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.62 51.47 0.93 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.886 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.522 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.6 Cg_exo -29.49 105.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.071 1.848 . . . . 0.0 113.969 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.8 mt -147.23 150.79 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.569 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.9 136.85 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.602 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.0 p -145.23 148.88 34.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.504 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 123.65 46.09 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.068 0.461 . . . . 0.0 110.263 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -83.49 135.04 34.81 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -107.26 126.43 52.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.679 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -89.43 137.4 32.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 14.4 t-105 -149.47 148.37 29.34 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.431 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.17 92.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.053 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 27.9 t70 78.87 -41.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.724 0.41 . . . . 0.0 111.649 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 152.55 24.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 111.425 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -153.0 117.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.627 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.2 p90 -124.06 141.68 51.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.345 0.593 . . . . 0.0 112.226 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CD2' HG13 ' A' ' 126' ' ' VAL . 3.7 p90 -140.45 145.39 36.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.33 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.57 149.5 21.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.429 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.89 5.23 8.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.2 mm-40 83.32 -8.08 1.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.764 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 p -85.02 116.7 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.33 94.95 5.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 0.0 112.187 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.0 p -124.55 106.62 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.874 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.71 136.44 50.6 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.026 0.441 . . . . 0.0 111.708 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -156.86 164.62 37.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.233 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.79 91.02 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.7 tt0 -170.12 152.04 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.45 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.7 t-20 68.5 -79.96 0.04 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.4 m 23.8 80.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.47 158.67 16.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.558 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -120.64 -5.88 9.71 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.9 p -128.83 142.87 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.392 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.438 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 29.5 m -158.68 157.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -88.23 151.45 22.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.343 0.592 . . . . 0.0 111.412 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -50.43 126.2 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.143 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.53 -32.22 6.19 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.939 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.4 p-10 -68.98 162.49 26.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.074 0.464 . . . . 0.0 112.101 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 110' ' ' ILE . 21.6 t -121.73 152.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.948 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.739 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.61 146.24 25.68 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.495 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.99 130.98 44.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.817 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.431 ' CD1' HG13 ' A' ' 104' ' ' VAL . 3.9 t90 -71.03 122.66 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.99 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.487 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -68.09 -67.84 0.75 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.903 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 47.1 Cg_endo -68.05 80.56 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.246 1.964 . . . . 0.0 112.181 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.46 -11.94 2.48 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 53.76 30.56 11.41 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.11 0.455 . . . . 0.0 110.749 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -109.65 135.07 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.63 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.5 mt -85.96 144.24 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.66 130.7 30.39 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.36 156.86 19.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.09 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.7 m-85 -136.5 130.13 32.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 2.6 m-85 -152.51 28.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 151.07 -151.78 23.7 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.518 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -40.73 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.484 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -151.2 -174.62 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 79.6 Cg_exo -46.18 -24.19 2.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.748 1.632 . . . . 0.0 112.297 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.94 55.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.8 mt . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.7 mtt85 -136.33 99.2 10.93 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.556 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 54.0 Cg_endo -68.21 -31.66 28.67 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.44 2.093 . . . . 0.0 112.331 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 177.0 -161.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.748 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.16 -7.68 15.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.53 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.39 71.24 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 14.5 m -118.36 141.92 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.472 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 31.7 m-20 -82.15 150.94 27.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.51 92.61 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.739 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -79.17 19.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.423 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.11 -148.24 18.21 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.087 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -155.93 167.87 29.03 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.964 0.411 . . . . 0.0 111.518 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.413 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -94.15 114.8 31.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' HG12 ' A' ' 120' ' ' VAL . 7.4 tt . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.421 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.9 -24.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.727 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.455 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.34 32.54 4.11 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.452 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.1 m -74.94 154.54 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.272 0.229 . . . . 0.0 110.825 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.45 144.53 46.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 12.2 p-10 -58.02 112.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.423 . . . . 0.0 111.866 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.2 103.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.522 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -158.16 151.49 23.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.934 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.11 164.54 0.11 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.307 0.575 . . . . 0.0 112.196 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.602 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 58.6 t -158.07 128.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.37 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.51 108.39 18.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 111.356 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.429 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.01 128.84 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.7 pt-20 -153.26 129.64 10.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.672 0.273 . . . . 0.0 111.274 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.462 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.81 89.96 2.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.798 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -106.66 145.32 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.205 0.526 . . . . 0.0 112.29 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.97 164.72 15.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.66 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 147.29 36.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.787 0.327 . . . . 0.0 111.11 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -142.88 102.92 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -102.37 156.24 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.481 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CE1' HG22 ' A' ' 126' ' ' VAL . 43.9 m-85 -139.01 138.59 37.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.104 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -125.7 22.97 7.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.38 154.67 1.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.46 147.04 50.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 149.79 14.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.19 156.94 47.46 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.142 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.33 149.87 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 111.631 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 13.5 mt-10 -102.23 -178.64 3.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.974 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD11 HG12 ' A' ' 107' ' ' ILE . 4.1 tp -153.29 149.52 27.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.11 0.481 . . . . 0.0 111.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -127.24 148.87 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.2 -8.97 0.55 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -45.61 -27.49 0.79 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.967 0.349 . . . . 0.0 111.533 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.505 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -82.42 -56.53 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 157.42 116.16 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.416 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -45.89 -34.41 12.34 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.478 2.119 . . . . 0.0 112.383 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -61.63 -49.99 74.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.484 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.38 -44.85 93.57 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.606 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 24.9 t -49.15 -31.48 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -61.97 -38.16 87.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.63 80.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -51.31 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.02 -28.09 69.34 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.087 0.47 . . . . 0.0 110.445 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.85 -23.5 59.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.62 51.37 0.84 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.661 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.907 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.5 mt -61.95 -159.9 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.692 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.907 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.0 Cg_exo -27.66 105.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.167 1.911 . . . . 0.0 114.156 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.8 mt -147.18 150.71 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.395 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 135.42 33.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 0.0 111.748 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.5 p -146.06 149.13 33.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.391 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 132.03 47.69 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 47' ' ' ARG . . . -90.11 136.07 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -100.79 117.55 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.914 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' NH1' ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.11 133.0 33.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.4 t-105 -154.21 148.81 26.33 Favored 'General case' 0 C--O 1.229 0.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -30.72 85.61 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.282 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.0 t70 73.31 -37.8 0.39 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.542 0.337 . . . . 0.0 111.521 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' GLY . 6.1 tt0 -72.08 129.29 38.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.855 0.359 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -133.26 124.63 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.129 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.41 ' CE1' ' ND2' ' A' ' 46' ' ' ASN . 55.0 p90 -135.7 133.15 37.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.944 0.402 . . . . 0.0 111.644 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 126' ' ' VAL . 6.3 p90 -138.83 145.44 40.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.6 148.52 22.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.162 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.436 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.99 5.87 9.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 83.38 -8.18 1.11 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.89 114.15 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.124 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.31 98.47 8.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 112.055 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.1 p -134.42 106.81 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -126.64 133.93 50.87 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.054 0.454 . . . . 0.0 111.555 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 31.8 tttt -140.07 164.77 29.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.292 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -99.23 86.94 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.778 0.323 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.7 tt0 -170.18 160.61 8.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.4 t-20 63.31 -82.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' ASN . 5.4 m 26.48 81.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.65 161.08 13.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.349 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -122.62 -7.44 8.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.3 p -126.7 141.6 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 27.4 m -159.27 146.9 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.14 152.76 21.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 0.0 110.953 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -41.23 124.01 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.348 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -32.31 6.04 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.058 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 127.05 31.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.818 0.309 . . . . 0.0 111.505 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 t -94.8 150.62 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -145.65 153.04 40.58 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.516 0.598 . . . . 0.0 112.474 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 122.63 48.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.091 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.3 t90 -61.84 127.22 30.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.087 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.461 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -75.13 -64.19 0.63 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.893 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 46.3 Cg_endo -67.8 85.55 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.283 1.988 . . . . 0.0 112.025 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.43 -6.75 5.3 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.38 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.16 36.88 13.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.95 134.19 51.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.37 149.42 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.504 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 34.7 t -143.16 156.53 44.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.265 0.555 . . . . 0.0 112.492 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.99 158.59 18.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.415 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 12.9 m-85 -136.67 127.11 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.515 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -168.62 51.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.677 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.74 -80.78 0.13 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.44 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -155.89 176.92 12.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.036 0.446 . . . . 0.0 111.926 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.488 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.52 -174.32 0.4 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 97.0 Cg_exo -45.02 -22.81 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.131 1.887 . . . . 0.0 112.934 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 99' ' ' ARG . 1.6 mp -132.44 76.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.872 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.4 mt . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.68 0.276 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 27.9 mmm-85 -99.89 99.35 8.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.482 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 64.1 Cg_endo -71.24 -32.14 13.31 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.513 2.142 . . . . 0.0 112.579 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.62 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.816 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.69 -5.38 13.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.96 71.65 0.07 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 16.6 m -121.34 142.04 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.696 0.284 . . . . 0.0 111.222 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 1.7 m-20 -85.86 153.0 22.55 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.14 101.99 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.541 HG12 HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -87.51 22.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.4 -148.6 18.74 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.196 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -154.84 163.0 40.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.12 113.8 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.292 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.432 ' CD1' ' CD2' ' A' ' 14' ' ' PHE . 5.2 tp . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.78 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.062 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.27 34.98 3.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.423 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.525 ' HB ' ' NH1' ' A' ' 47' ' ' ARG . 3.3 m -81.5 153.75 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.7 147.31 43.73 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.379 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.481 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 2.4 p30 -53.35 135.86 38.28 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.433 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 55.32 99.4 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.243 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.01 153.29 41.32 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.92 157.74 24.05 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.482 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.614 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 47.5 t -148.54 129.05 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.023 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.401 ' CG2' ' CG ' ' A' ' 13' ' ' ARG . 24.9 m -124.27 107.13 17.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.37 128.97 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.739 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -150.96 128.23 11.27 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.714 0.292 . . . . 0.0 111.147 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.44 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 90.91 3.05 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.688 179.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.79 145.22 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 112.346 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 163.67 19.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.507 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 144.62 31.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.89 100.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -108.77 156.21 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.832 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CG ' HD11 ' A' ' 117' ' ' LEU . 2.9 m-85 -126.49 143.7 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.154 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -28.67 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.0 t -121.69 23.07 10.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.76 154.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.631 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -127.53 142.79 51.29 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.16 149.49 12.2 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.676 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -121.9 158.16 29.59 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.349 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.59 142.84 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.78 -178.27 4.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.498 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.5 tp -152.72 140.39 19.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.963 0.411 . . . . 0.0 110.95 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.13 143.14 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -8.49 2.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.02 -29.63 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.521 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -76.77 -54.14 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . . . 162.59 116.24 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.804 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.4 Cg_endo -47.4 -34.61 19.52 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.578 2.185 . . . . 0.0 112.504 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.51 -37.51 80.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.353 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 HG23 ' CE2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.72 -43.95 74.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 110.28 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 65.3 t -50.04 -38.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.716 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -56.87 -35.13 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.72 -47.06 70.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.799 0.333 . . . . 0.0 111.011 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -49.24 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.601 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.1 -29.63 70.95 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.144 0.497 . . . . 0.0 110.284 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -70.43 -25.76 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.554 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.39 52.79 0.94 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.849 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.918 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.68 -159.91 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.692 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.918 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 27.9 Cg_exo -28.04 106.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.18 1.92 . . . . 0.0 114.099 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.6 mt -148.18 150.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.514 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -85.87 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 111.759 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.602 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -146.05 149.12 33.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.361 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.72 130.42 48.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.912 0.387 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -91.88 133.12 35.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -103.39 128.38 50.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.004 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -88.6 138.21 31.63 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.3 t-105 -155.1 148.98 25.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -37.31 97.16 0.01 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.492 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 88' ' ' PHE . 1.6 t0 53.27 24.6 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 111.356 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 136.93 39.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.489 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -138.4 129.42 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 52.6 p90 -137.92 122.11 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.371 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' VAL . 2.9 p90 -131.29 146.36 52.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 148.9 21.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.423 HG22 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.73 6.33 8.8 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER 82.89 -8.01 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.05 114.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.258 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.48 96.04 6.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 111.855 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 5.9 p -133.14 106.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.253 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -130.87 133.5 45.96 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.535 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 40.5 tttm -145.08 165.55 27.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.372 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.09 90.06 4.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.5 tt0 -170.21 158.49 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.454 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 35.8 t-20 63.21 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.85 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 19.9 m 25.63 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.326 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -104.13 162.03 13.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.852 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -120.94 -12.16 8.82 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.4 p -121.27 143.25 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.439 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.51 HG21 ' CZ ' ' A' ' 87' ' ' PHE . 36.0 m -158.31 157.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.71 150.15 24.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.338 0.59 . . . . 0.0 111.053 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.63 125.01 15.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.939 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.98 -31.43 6.53 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.223 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.2 p-10 -69.24 165.72 19.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 117.16 0.48 . . . . 0.0 111.825 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 76' ' ' ALA . 24.9 t -119.99 152.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.44 148.92 30.01 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.442 0.565 . . . . 0.0 112.381 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -104.57 135.42 46.02 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.161 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.454 ' O ' ' CE1' ' A' ' 77' ' ' TYR . 2.0 t90 -76.6 108.7 9.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.52 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -56.73 -70.65 0.32 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.145 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.52 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -58.64 87.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.266 1.977 . . . . 0.0 112.347 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.39 -6.03 5.61 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.774 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.8 32.42 9.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.959 0.38 . . . . 0.0 110.582 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.66 131.68 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.764 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 84' ' ' ILE . 11.4 mt -87.76 150.6 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.087 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 18.6 t -143.34 156.35 44.67 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.37 137.8 54.54 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.144 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 14.9 p90 -136.65 139.76 42.26 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.029 -0.419 . . . . 0.0 111.491 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.404 ' N ' ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -149.55 53.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.048 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.22 -135.03 5.47 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -57.35 -173.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.676 0.738 . . . . 0.0 111.2 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -167.93 -174.14 0.33 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.932 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 88.2 Cg_exo -45.83 -21.4 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.816 1.677 . . . . 0.0 112.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.2 mt -143.36 60.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 110.761 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.965 0.412 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.64 99.42 52.81 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.998 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.61 -29.69 78.24 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.472 2.115 . . . . 0.0 112.604 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 173.37 -162.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.798 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.59 -5.92 22.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.536 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -176.31 77.54 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.413 HG13 ' CB ' ' A' ' 101' ' ' ALA . 24.5 m -125.35 141.5 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 111.611 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' A' ' 77' ' ' TYR . 1.4 m-20 -81.88 153.91 26.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.261 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -84.23 81.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.609 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -64.86 19.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 117.51 -138.07 13.81 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.849 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 74' ' ' ASP . 4.2 ptt180 -170.51 162.19 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.49 115.75 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.217 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 14' ' ' PHE . 3.8 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.688 0.28 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.19 -25.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.04 30.21 6.01 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.559 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.455 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 2.7 m -71.02 154.47 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 122.334 0.254 . . . . 0.0 111.56 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.18 148.57 32.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.7 p-10 -57.0 109.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.462 . . . . 0.0 111.947 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.04 101.54 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.93 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.02 154.46 33.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.969 0.414 . . . . 0.0 110.845 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.66 167.24 0.77 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.964 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.602 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 58.6 t -158.01 129.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.78 108.05 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.311 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.31 128.79 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.457 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 5.2 pt-20 -153.75 131.62 11.64 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 111.29 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.11 89.89 3.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.85 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.748 179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -116.9 145.39 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.173 0.511 . . . . 0.0 112.125 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.35 163.6 15.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.621 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 147.24 31.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.4 OUTLIER -143.93 102.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -100.5 156.36 17.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.446 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 126' ' ' VAL . 6.8 m-85 -139.71 134.9 32.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.72 -29.14 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -125.02 22.45 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.7 153.09 1.37 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.377 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.87 142.79 50.85 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.866 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.81 149.32 12.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.767 0.318 . . . . 0.0 111.475 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -128.77 158.9 37.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.056 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.1 144.16 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.657 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.0 mt-10 -97.47 -178.5 4.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.906 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.57 HD11 HG12 ' A' ' 107' ' ' ILE . 6.1 tp -153.52 148.1 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -125.37 148.14 48.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.692 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -57.54 -8.97 0.96 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.37 -28.3 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.259 -0.276 . . . . 0.0 111.512 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.506 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.77 -56.5 3.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.66 117.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.58 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.77 -34.76 12.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.449 2.1 . . . . 0.0 112.223 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -60.52 -52.0 67.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.476 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.01 -45.44 94.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.833 0.349 . . . . 0.0 110.349 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.4 t -49.83 -30.41 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.207 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -28.72 70.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.52 39.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.715 0.293 . . . . 0.0 110.979 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -51.46 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.08 -28.64 69.75 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.362 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.44 -24.6 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 51.49 0.93 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.918 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -61.71 -160.09 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.622 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.918 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 24.6 Cg_exo -27.66 107.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.297 1.998 . . . . 0.0 114.085 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.0 mt -149.62 151.06 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.513 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 136.37 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.05 148.99 33.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.483 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 129.5 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.199 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB1' ' CG2' ' A' ' 126' ' ' VAL . . . -92.79 130.76 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -97.81 133.12 42.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.506 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.579 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -100.05 133.02 45.05 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ASP . 1.9 t90 -157.22 148.32 21.77 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -25.6 87.29 0.01 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.203 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' TRP . 13.0 t70 69.12 -40.94 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 49' ' ' GLY . 15.6 tt0 -62.72 118.99 8.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -129.01 114.68 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.763 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -126.37 126.96 44.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.445 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.31 145.99 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 149.75 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.056 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -123.71 4.48 8.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.5 OUTLIER 83.2 -8.09 1.14 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.798 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.13 114.97 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.08 94.78 5.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 111.94 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 6.6 p -127.62 106.71 15.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.901 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' HG2' HG22 ' A' ' 79' ' ' ILE . 1.8 mt-10 -127.92 134.37 49.33 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.966 0.412 . . . . 0.0 111.898 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 13.8 tttp -142.14 165.74 26.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -103.63 88.65 3.12 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.058 0.456 . . . . 0.0 111.33 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.1 tt0 -170.2 161.38 8.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.2 t-20 63.9 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.469 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 13.2 m 30.8 81.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.732 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -99.58 157.41 16.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.209 178.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.29 -7.24 10.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.2 144.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.67 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.3 m -157.86 156.84 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -99.65 149.03 23.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.03 126.87 2.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.094 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.01 6.1 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.197 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.86 157.38 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.457 0.629 . . . . 0.0 111.945 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.32 152.61 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.252 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.69 150.94 34.06 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -110.62 132.43 54.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.687 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.667 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.3 t90 -73.62 143.71 46.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.189 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.644 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -94.13 -54.26 0.24 Allowed Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 8.6 Cg_exo -72.3 72.36 2.87 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.529 2.153 . . . . 0.0 111.649 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 143.05 -7.65 2.13 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.513 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 52.57 34.64 16.07 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.977 0.388 . . . . 0.0 110.867 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.84 131.13 55.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mt -89.3 150.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.278 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -141.28 155.73 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.27 0.557 . . . . 0.0 112.259 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.01 161.59 15.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.482 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 28.2 m-85 -136.48 141.12 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 175.34 43.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.9 -82.81 0.11 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.154 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -144.37 -168.75 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.469 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -162.45 -177.96 0.78 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.712 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 80.8 Cg_exo -42.5 -27.53 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.324 2.016 . . . . 0.0 112.81 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 99' ' ' ARG . 3.3 mp -131.31 75.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.179 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.8 mt . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.67 0.272 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 12.9 mmm-85 -100.15 99.15 8.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.497 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.3 Cg_endo -69.63 -31.69 20.59 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.565 2.177 . . . . 0.0 112.655 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.29 -162.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.93 -9.4 15.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.537 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.31 72.76 0.19 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 19.7 m -121.36 141.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.815 0.341 . . . . 0.0 111.406 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 66' ' ' SER . 30.4 m-20 -85.35 151.47 24.0 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.67 98.17 7.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.57 HG12 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.43 23.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.53 -159.94 13.74 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.663 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -143.26 168.19 20.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 111.717 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.94 115.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.601 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.466 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HG ' HG13 ' A' ' 120' ' ' VAL . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.12 -27.2 0.12 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.917 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.99 30.01 4.06 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.4 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.499 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 3.9 m -81.81 154.33 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.943 0.371 . . . . 0.0 111.246 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.33 147.21 34.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.579 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 11.2 p-10 -55.35 116.46 2.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.072 0.463 . . . . 0.0 112.14 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.59 103.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.626 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -154.95 149.57 26.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 165.68 0.07 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.189 0.519 . . . . 0.0 112.173 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.597 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 43.9 t -158.09 128.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.61 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.54 107.89 19.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 111.233 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.99 128.6 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.521 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.469 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.3 pt-20 -152.12 130.46 12.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.667 0.27 . . . . 0.0 111.261 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.444 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -77.46 95.16 4.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.785 179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 40.7 tpp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.04 145.36 27.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.09 156.69 25.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.965 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.51 141.63 36.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.066 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.73 100.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.02 156.11 17.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.028 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.17 138.58 46.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.322 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.08 -28.83 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 p -123.49 23.0 9.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 150.48 1.29 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.63 140.64 47.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.207 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.53 149.38 9.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.626 0.251 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.46 157.23 25.5 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.514 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.2 141.1 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 111.132 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.435 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 12.6 mt-10 -98.75 -178.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.057 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.431 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.5 tp -151.89 144.43 24.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.09 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -120.76 146.46 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.553 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.44 -9.46 0.71 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -45.93 -27.58 0.93 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.197 -0.315 . . . . 0.0 111.363 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.525 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 6.6 t90 -80.23 -56.35 4.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 152.48 115.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.665 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -45.55 -36.19 13.53 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.05 -52.85 63.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -60.76 -45.66 93.49 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.356 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 23.8 t -48.9 -29.55 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.31 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -59.58 -38.54 81.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.63 73.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.671 0.272 . . . . 0.0 111.204 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.66 -51.78 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.29 -28.67 69.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.31 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -71.65 -25.02 61.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.373 . . . . 0.0 110.641 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.54 50.96 0.99 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.977 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.887 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 mt -62.42 -160.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.528 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.887 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 34.0 Cg_exo -29.35 106.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.191 1.927 . . . . 0.0 113.934 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.5 mt -149.99 149.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.635 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.82 136.78 33.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.097 0.475 . . . . 0.0 111.86 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.581 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.5 p -145.79 149.1 33.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.439 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 122.43 43.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.053 0.454 . . . . 0.0 110.285 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -81.14 132.44 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -104.33 123.84 48.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.597 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.93 137.33 32.46 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.4 t-105 -149.54 148.54 29.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.348 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.445 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.18 91.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.241 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 48' ' ' TRP . 35.7 t70 78.64 -42.0 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.536 0.334 . . . . 0.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HG3' ' CG2' ' A' ' 91' ' ' THR . 4.6 mt-10 -80.5 150.87 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.2 OUTLIER -149.73 115.88 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.574 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.7 p90 -123.4 136.45 54.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 111.969 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 126' ' ' VAL . 5.1 p90 -136.46 145.34 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.522 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.32 146.73 23.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -121.92 6.96 9.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.8 mt-30 82.07 -7.36 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.722 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 p -86.21 115.6 27.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.066 0 CA-C-O 120.79 0.328 . . . . 0.0 110.289 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.68 96.06 6.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.8 p -123.85 106.66 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.133 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.51 133.36 52.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.959 0.409 . . . . 0.0 111.515 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -147.61 164.48 33.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.261 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -100.54 83.46 2.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 110.757 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.21 154.71 5.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 21.2 t-20 71.67 -78.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 65' ' ' ASN . 9.0 t 18.69 81.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.82 164.06 11.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.813 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -125.61 -5.6 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 39.6 t -131.8 141.92 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.9 m -158.31 157.97 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.59 152.06 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.308 0.575 . . . . 0.0 111.39 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.36 127.1 16.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.124 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.62 -32.33 6.11 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.819 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.43 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.7 p-10 -69.64 162.06 28.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.114 0.483 . . . . 0.0 111.927 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -122.54 152.45 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.911 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.15 147.14 26.68 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -97.7 121.57 39.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.954 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.511 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.5 t90 -64.21 117.77 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.037 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.641 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -69.07 -69.5 0.44 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 42.6 Cg_exo -54.73 85.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.796 1.664 . . . . 0.0 111.968 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 128.8 -6.74 6.51 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.647 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.99 37.68 14.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.035 0.417 . . . . 0.0 110.959 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . -113.11 137.0 52.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.678 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.6 mt -86.29 148.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.39 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.7 t -143.15 155.33 44.54 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.31 0.576 . . . . 0.0 112.444 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.89 156.21 22.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.949 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.446 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 3.9 m-85 -136.91 127.42 26.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.546 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.7 m-85 -147.57 29.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.343 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 150.47 -150.29 22.29 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.64 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -38.67 170.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.41 -176.44 0.61 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 94.3 Cg_exo -43.82 -25.86 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.989 1.792 . . . . 0.0 112.283 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.31 54.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.234 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -107.58 99.48 29.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.917 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.427 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 37.5 Cg_endo -64.57 -29.6 61.19 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.491 2.127 . . . . 0.0 112.6 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 78' ' ' TRP . . . 177.71 -164.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.09 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -6.16 23.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.06 80.38 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.446 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 7.1 m -125.96 142.39 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.521 ' HB3' ' ND2' ' A' ' 65' ' ' ASN . 15.1 m-20 -83.19 151.85 25.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.485 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.04 87.68 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.737 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -72.76 16.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.366 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.01 -149.68 18.76 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 7.3 mtp-105 -156.84 168.08 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.42 HG13 ' CG2' ' A' ' 75' ' ' VAL . 6.1 mt -100.28 114.82 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.357 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.626 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' A' ' 120' ' ' VAL . 7.2 tt . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.69 -27.22 0.16 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.0 32.31 3.53 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.983 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.536 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 5.6 m -73.11 154.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.91 147.47 38.96 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -58.55 108.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.072 0.463 . . . . 0.0 111.684 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.49 103.45 0.17 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.464 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.46 154.59 33.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.743 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t -53.26 164.16 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 111.748 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.581 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 46.9 t -158.02 128.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.577 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.66 108.11 18.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.94 128.74 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.337 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.459 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.7 pt-20 -153.54 130.73 11.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.672 0.272 . . . . 0.0 111.532 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.453 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.09 88.24 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.655 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.48 145.44 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.541 . . . . 0.0 112.219 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.18 164.16 15.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.559 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.54 35.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -144.22 103.35 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -102.21 156.36 17.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.501 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 126' ' ' VAL . 13.7 m-85 -138.18 137.71 37.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.763 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.44 -28.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.06 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 p -125.96 22.66 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.43 154.38 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.43 144.44 51.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.851 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.22 149.2 11.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.543 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.62 157.11 39.77 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.159 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.06 138.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mp0 -92.45 -178.53 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.296 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.538 HD12 HG12 ' A' ' 107' ' ' ILE . 7.0 tp -152.74 146.63 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -123.33 146.53 47.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -57.17 -9.16 0.84 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -45.81 -25.79 0.57 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 122.259 -0.276 . . . . 0.0 111.551 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 6.9 t90 -81.14 -56.17 4.26 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 153.19 116.03 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.77 -27.78 5.98 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.488 2.126 . . . . 0.0 112.467 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.05 -43.35 78.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.306 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.514 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -70.25 -46.04 65.22 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.65 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.407 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 24.4 t -47.53 -29.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -60.36 -38.59 84.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.44 75.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.723 0.296 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -50.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.48 -27.23 69.13 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.39 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.838 0.351 . . . . 0.0 110.721 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.06 49.46 1.01 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.892 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.893 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.8 mt -61.82 -159.94 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.592 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.893 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.3 Cg_exo -28.52 106.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.158 1.905 . . . . 0.0 114.081 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.8 mt -149.28 149.66 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.507 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -85.91 134.09 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.965 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.604 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -145.32 149.57 35.06 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.61 132.7 47.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 47' ' ' ARG . . . -90.66 137.32 32.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -106.8 120.11 41.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.277 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NH2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -84.69 127.25 34.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.7 t-105 -146.71 148.43 31.99 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.41 93.02 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.196 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 25.3 t70 72.03 -38.29 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.306 0.242 . . . . 0.0 111.585 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -78.94 139.38 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 110.875 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.556 HG12 ' NH2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -144.64 112.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.668 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 40.6 p90 -123.78 139.68 53.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.5 p90 -141.3 142.85 33.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.447 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.38 145.94 24.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.409 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.92 4.96 10.92 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 82.63 -7.38 1.27 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.56 116.08 28.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.209 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.59 94.87 6.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 111.707 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 31' ' ' THR . 6.3 p -124.88 106.58 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.327 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -133.57 132.33 40.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.962 0.41 . . . . 0.0 111.442 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 163.76 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.47 88.15 5.82 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.878 0.37 . . . . 0.0 110.753 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.14 148.01 3.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 28.9 t-20 72.04 -83.18 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.463 0.173 . . . . 0.0 110.981 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.1 m 23.16 82.11 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -99.68 162.66 12.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.282 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -122.5 -0.09 9.3 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 47.2 t -138.53 145.36 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.101 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.421 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 26.8 m -158.75 158.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -94.05 150.81 20.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.16 124.96 7.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.35 -29.73 7.44 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.364 -0.922 . . . . 0.0 114.703 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -78.57 156.98 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.593 0.697 . . . . 0.0 111.921 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.416 HG11 ' N ' ' A' ' 76' ' ' ALA . 21.6 t -111.06 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 105' ' ' ASN . . . -149.3 150.34 32.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.977 0.417 . . . . 0.0 111.658 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.506 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -105.46 131.65 52.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.404 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.451 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.8 t90 -71.99 113.07 8.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -68.25 -66.16 1.17 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.621 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.39 80.28 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.932 1.755 . . . . 0.0 111.663 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.48 -8.13 3.13 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.596 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.18 37.2 17.72 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.857 0.361 . . . . 0.0 111.126 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.45 137.51 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.79 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 3.7 mt -87.58 147.64 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.43 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.3 m -142.86 131.53 22.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 HD11 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.99 159.78 18.87 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.373 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 35.0 m-85 -136.63 132.51 35.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.21 0.529 . . . . 0.0 111.878 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.446 ' CB ' ' HG2' ' A' ' 118' ' ' LYS . 1.4 m-85 -165.21 33.32 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.057 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.22 -150.53 21.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.388 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.19 -172.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.458 0.647 . . . . 0.0 112.131 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -159.83 -176.11 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.522 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 66.2 Cg_exo -41.81 -25.29 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.273 1.982 . . . . 0.0 113.042 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -146.65 67.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 111.678 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.166 0.508 . . . . 0.0 110.483 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.2 mt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.874 0.368 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HB2' HG12 ' A' ' 93' ' ' ILE . 1.8 mtt85 -117.74 99.54 52.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 58.7 Cg_endo -69.73 -31.31 20.89 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.6 2.2 . . . . 0.0 112.564 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.11 -160.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.807 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -5.23 14.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.565 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.43 73.98 0.11 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 21.2 m -124.02 140.46 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 111.477 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.0 m-20 -84.66 150.37 25.18 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.59 100.35 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.538 HG12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.02 21.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.2 -129.46 8.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.192 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' A' ' 74' ' ' ASP . 6.5 ptt180 -170.4 167.19 8.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.04 0.448 . . . . 0.0 111.484 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.8 mp -93.06 116.37 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.667 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.038 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' CD2' HD11 ' A' ' 86' ' ' LEU . 4.5 tp . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.492 0.186 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HG2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.6 -21.32 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.408 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -89.92 30.68 5.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.705 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.412 HG21 ' NH1' ' A' ' 47' ' ' ARG . 3.6 m -81.28 153.65 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 122.232 0.213 . . . . 0.0 111.34 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.491 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.63 143.47 46.3 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 4.6 p-10 -51.07 131.98 27.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.07 100.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.347 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -148.1 154.25 39.96 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 t -63.13 168.34 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.436 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.604 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 48.3 t -157.97 128.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.955 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.27 106.59 16.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 110.718 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.409 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.85 129.07 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.822 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.5 pt-20 -151.41 126.94 10.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.663 0.268 . . . . 0.0 111.327 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.458 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.36 92.16 2.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.817 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.743 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.229 0.024 0 CA-C-O 121.007 0.432 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -84.09 145.47 28.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.754 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 164.05 15.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.104 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 144.09 33.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 mt -145.11 100.39 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 109.963 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 156.04 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.965 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.0 m-85 -134.6 142.64 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.025 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.3 -29.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.7 m -126.2 20.89 7.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -179.13 155.92 0.75 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.37 148.89 30.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.9 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.65 150.05 11.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.46 156.54 18.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.759 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.22 140.19 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.7 mt-10 -90.91 -178.48 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.657 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 7.2 tp -147.73 136.26 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.077 0.465 . . . . 0.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.84 141.0 49.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.619 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.6 -8.95 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -45.38 -29.0 0.96 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.295 -0.253 . . . . 0.0 111.31 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.515 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -78.3 -56.69 4.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.57 118.54 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.775 178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.42 -33.31 12.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.436 2.091 . . . . 0.0 112.338 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.38 -52.27 66.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.848 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.425 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -66.31 -44.12 84.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.82 0.343 . . . . 0.0 110.419 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.425 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 75.8 t -44.62 -31.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.347 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -64.45 -38.32 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.65 79.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -52.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.15 -27.48 69.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.43 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.26 -25.39 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.57 50.71 1.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.797 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.895 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -61.73 -160.04 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.612 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.895 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.5 Cg_exo -28.95 103.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.116 1.877 . . . . 0.0 113.887 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 39' ' ' LEU . 18.5 mt -145.74 151.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.567 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 136.69 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.089 0.471 . . . . 0.0 111.604 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -145.1 148.91 34.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.94 127.19 48.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.037 0.446 . . . . 0.0 110.313 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -87.03 136.13 33.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -108.34 122.97 48.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.686 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.39 138.27 35.62 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 10.9 t-105 -153.87 148.95 26.83 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.862 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.03 94.51 0.01 OUTLIER Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.524 -0.37 . . . . 0.0 113.781 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 3.7 m-20 51.85 25.42 2.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.896 0.379 . . . . 0.0 111.578 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.2 138.91 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.149 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -137.29 119.93 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.225 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.2 p90 -128.5 126.94 41.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.492 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.8 p90 -135.49 145.93 47.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.94 149.65 21.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.455 HG22 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.22 7.9 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.41 -8.77 1.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.722 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -86.31 114.0 25.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.19 94.99 5.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 31' ' ' THR . 3.2 p -122.79 106.78 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.879 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.95 125.26 54.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -140.83 165.32 27.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.3 pm0 -113.84 91.34 3.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.043 0.449 . . . . 0.0 111.023 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.5 tt0 -170.38 157.07 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.45 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 34.8 t-20 64.21 -81.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.081 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 m 31.88 82.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.212 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.43 154.9 18.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.589 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -119.78 -4.75 10.19 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.2 p -126.32 140.45 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.528 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 32.8 m -158.39 157.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.594 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -96.03 149.7 21.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.485 0.66 . . . . 0.0 111.732 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.26 126.76 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.002 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.19 -30.08 7.27 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.366 -0.921 . . . . 0.0 114.636 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.43 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -80.64 156.64 26.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.533 0.666 . . . . 0.0 112.032 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -116.34 152.4 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.283 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.616 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.01 151.1 30.72 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.971 -0.455 . . . . 0.0 111.696 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.9 132.58 52.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.449 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -68.49 120.81 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.648 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.486 HD11 ' OD1' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.07 -68.44 0.53 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.049 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 33.9 Cg_endo -63.62 75.8 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.165 1.91 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.67 -9.98 1.88 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.71 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.0 32.23 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.061 0.43 . . . . 0.0 111.161 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.97 131.04 55.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.221 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 10.0 mt -88.16 144.24 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.98 134.53 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.43 158.8 19.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.896 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 36.1 m-85 -136.62 117.11 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.507 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER -163.7 52.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.18 -78.72 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.721 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -147.26 -169.47 3.32 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.479 0.657 . . . . 0.0 111.93 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.526 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -154.44 174.89 3.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.035 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.5 Cg_exo -39.1 -25.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.696 2.264 . . . . 0.0 113.129 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . 2.1 mp -137.69 62.71 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.162 0.506 . . . . 0.0 110.375 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 99.22 8.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.022 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 55.4 Cg_endo -69.33 -31.12 23.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.515 2.144 . . . . 0.0 112.584 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 176.33 -161.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -6.99 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.83 71.11 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 17.6 m -117.69 141.49 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.555 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.486 ' OD1' HD11 ' A' ' 79' ' ' ILE . 2.9 m120 -81.88 150.29 27.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.278 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -83.97 82.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.616 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.7 18.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 119.12 -153.21 16.98 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.944 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 33.3 mtp180 -156.23 167.17 31.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.422 HG13 ' CG2' ' A' ' 75' ' ' VAL . 5.0 mt -98.83 114.96 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.36 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.398 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.446 ' HG ' ' CG1' ' A' ' 120' ' ' VAL . 5.7 tt . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.88 -22.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -92.24 36.1 3.79 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.495 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 6.4 m -69.19 154.87 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 122.513 0.325 . . . . 0.0 111.535 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.95 145.93 44.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.686 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.3 p-10 -57.88 121.24 10.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.122 0.487 . . . . 0.0 111.921 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.93 101.46 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.46 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 3.9 pt-20 -154.35 150.78 28.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.14 165.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.222 0.535 . . . . 0.0 111.904 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.615 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 46.5 t -157.74 128.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.312 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.3 108.49 18.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.978 0.418 . . . . 0.0 111.46 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.455 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.9 129.17 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.356 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.0 pt-20 -153.82 129.06 9.73 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.576 0.227 . . . . 0.0 111.344 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.42 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.5 89.45 1.68 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 110.785 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.649 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.718 0.294 . . . . 0.0 111.043 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 145.43 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.131 0.491 . . . . 0.0 112.135 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.8 163.5 17.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.851 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 146.47 29.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.739 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.32 100.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 109.787 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -104.79 156.0 18.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.635 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 126' ' ' VAL . 3.0 m-85 -130.76 138.55 50.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.448 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.77 -29.01 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -124.22 23.04 8.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.42 154.18 1.63 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -114.81 151.86 33.13 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.68 151.14 16.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.866 0.365 . . . . 0.0 111.779 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -137.53 150.4 47.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.87 143.76 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.138 0.494 . . . . 0.0 112.012 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -95.48 -178.38 4.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.199 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.46 HD11 HG12 ' A' ' 107' ' ' ILE . 7.6 tp -150.07 134.73 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.973 0.416 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.73 139.25 50.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.566 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -8.46 3.02 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -44.66 -29.49 0.76 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.07 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.494 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -76.54 -56.01 5.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 163.2 116.05 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.739 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -46.58 -36.99 19.6 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.375 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -49.59 76.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.458 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.2 -44.5 97.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.757 0.313 . . . . 0.0 110.27 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 90.9 t -46.74 -37.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.693 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -33.35 71.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.009 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.41 -47.43 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -50.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.75 -29.39 70.65 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.261 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -70.55 -25.74 63.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.12 51.96 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.914 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.25 -159.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.62 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.914 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.4 Cg_exo -27.8 105.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.083 1.855 . . . . 0.0 114.085 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.7 mt -145.16 149.11 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.366 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -85.9 133.64 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 111.887 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.631 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.9 p -142.33 149.02 38.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.299 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 131.33 48.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.354 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -92.05 135.54 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -106.92 122.88 47.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.061 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -83.18 137.04 34.21 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 12.7 t-105 -152.26 149.13 28.36 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.866 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.54 92.82 0.01 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.666 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER 53.27 25.98 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 48' ' ' TRP . 8.5 tp10 -136.77 139.36 41.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.952 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -139.18 122.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.593 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 50.8 p90 -130.04 123.37 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -133.15 145.38 50.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 146.48 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.415 HG22 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -117.85 5.61 12.22 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.3 mt-30 82.34 -8.2 1.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -87.23 115.43 27.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.61 94.79 5.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 111.911 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.431 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 3.5 p -131.53 106.73 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.299 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -130.16 133.18 46.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 53.4 tttt -140.8 164.77 29.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.291 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -99.14 90.87 4.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 0.0 110.966 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 5.9 tt0 -170.16 157.88 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.599 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 24.7 t-20 62.74 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.906 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 31.99 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.297 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -101.95 158.06 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.282 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -124.11 0.38 8.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 3.3 p -126.71 138.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.616 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 27.6 m -160.56 164.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.784 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.84 158.8 31.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.086 0.47 . . . . 0.0 110.769 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -38.56 129.67 1.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.24 -31.31 6.52 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.059 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.436 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.2 p30 -88.73 156.36 19.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 112.327 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 110' ' ' ILE . 25.7 t -119.13 152.55 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.078 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.663 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.06 150.14 34.47 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.807 -0.558 . . . . 0.0 112.472 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.58 126.78 53.96 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.168 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.6 t90 -67.2 112.65 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.563 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -67.19 -61.1 5.06 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.786 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 14.8 Cg_exo -67.98 66.27 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.232 1.955 . . . . 0.0 111.807 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.68 -11.45 0.3 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.034 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.62 27.49 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.306 0.553 . . . . 0.0 110.957 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.92 55.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.522 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 84' ' ' ILE . 7.8 mt -88.05 143.38 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.331 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.7 132.39 36.85 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.89 161.07 18.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.168 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 20.8 m-85 -136.25 125.78 25.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -163.88 54.54 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.209 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -75.1 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.372 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -158.83 174.02 15.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.796 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.487 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -134.77 -175.11 0.45 Allowed Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 84.4 Cg_exo -47.93 -22.46 3.42 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.017 1.811 . . . . 0.0 112.724 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.69 68.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.862 0.363 . . . . 0.0 111.722 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.915 0.388 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -98.44 99.86 8.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.523 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 69.1 Cg_endo -70.57 -32.48 15.13 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.668 2.245 . . . . 0.0 112.969 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.421 ' CB ' HG12 ' A' ' 104' ' ' VAL . . . 179.05 -154.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.697 0.284 . . . . 0.0 110.879 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 -5.04 10.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.552 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.96 67.06 0.08 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 14.9 m -118.14 142.42 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.777 0.322 . . . . 0.0 111.552 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -84.28 152.99 23.81 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 86.56 2.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.663 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.55 23.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.97 -149.57 18.51 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.996 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.31 166.42 33.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.072 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.412 ' CD1' HG21 ' A' ' 75' ' ' VAL . 4.2 mt -99.85 114.43 38.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.475 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 120' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.797 0.332 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -42.4 -25.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -85.88 28.97 4.76 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.492 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 117' ' ' LEU . 12.5 m -83.16 154.26 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.937 0.368 . . . . 0.0 111.534 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.53 148.76 30.26 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.604 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.1 p-10 -58.06 112.02 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.994 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.76 100.89 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.728 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 153.84 31.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.6 t -56.96 168.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.535 . . . . 0.0 111.894 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.631 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 47.0 t -157.88 128.84 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.06 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.59 108.63 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 111.473 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.21 129.04 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.4 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -152.92 130.16 11.24 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.709 0.29 . . . . 0.0 111.204 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.462 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.41 88.99 2.1 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.689 179.906 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -108.68 145.3 35.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 163.75 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.703 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 144.89 34.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.401 HG13 HG12 ' A' ' 128' ' ' VAL . 1.3 mt -145.89 100.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -100.8 156.13 17.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.122 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 45' ' ' ALA . 2.7 m-85 -131.83 141.28 49.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.204 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.47 -28.89 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -126.05 22.96 7.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -173.23 151.3 2.03 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 142.12 45.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.26 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.74 149.24 9.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -115.28 157.82 23.22 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.87 137.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.044 0.449 . . . . 0.0 111.439 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 14.6 mt-10 -92.51 -178.65 4.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.268 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 107' ' ' ILE . 3.3 tp -153.22 150.42 28.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -129.23 147.95 51.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.027 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -58.21 -8.63 1.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.35 -29.2 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.85 0.296 . . . . 0.0 111.355 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.504 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -80.92 -56.32 4.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 160.3 117.09 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.474 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.76 -35.86 18.37 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.6 -47.7 82.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.468 HG22 ' CE2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.95 -44.37 96.25 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.78 0.324 . . . . 0.0 110.397 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 46.3 t -50.05 -34.64 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -59.44 -37.01 77.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.79 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.04 -51.54 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.46 -28.71 70.0 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.65 -25.37 62.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 51.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.784 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.915 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.4 mt -61.58 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.539 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.915 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 25.6 Cg_exo -27.8 104.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.275 1.983 . . . . 0.0 114.033 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 39' ' ' LEU . 19.5 mt -145.57 151.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.309 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -85.72 136.57 33.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.064 0.459 . . . . 0.0 111.871 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.629 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -146.0 148.86 33.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.41 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.02 130.48 48.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.44 135.84 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -108.12 125.2 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.182 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.45 138.42 34.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 14.8 t-105 -154.17 148.95 26.53 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.069 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.13 99.86 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.768 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 45.62 30.15 0.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.382 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.35 33.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.118 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.477 HD13 ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -139.49 123.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 23.4 p90 -130.64 132.36 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.482 ' CE2' HG12 ' A' ' 126' ' ' VAL . 4.6 p90 -140.87 146.11 37.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.986 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.69 149.45 22.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.158 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.431 HG23 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.18 5.92 9.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 56' ' ' THR . 12.1 mt-30 80.94 -7.07 1.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.716 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.22 114.95 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.76 94.89 5.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.7 p -127.06 106.69 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.724 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 79' ' ' ILE . 2.5 mt-10 -125.28 134.98 52.07 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.082 0.467 . . . . 0.0 111.929 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 6.9 ttmt -144.55 165.62 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.165 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.68 90.74 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.021 0.438 . . . . 0.0 110.947 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.4 160.22 7.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.77 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 31.7 t-20 64.03 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.096 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 2.1 m 30.49 81.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.646 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -100.47 156.71 17.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.73 -7.81 10.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.38 142.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.386 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.9 m -157.74 156.23 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.108 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.36 151.04 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.354 0.597 . . . . 0.0 111.368 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -48.16 126.39 10.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.214 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -31.99 6.21 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.093 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p-10 -70.04 163.17 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 112.085 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 110' ' ' ILE . 16.0 t -121.41 152.02 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.074 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -149.58 152.36 35.36 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.463 0.574 . . . . 0.0 112.125 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -111.04 131.28 55.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.449 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.616 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t90 -73.03 146.62 45.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -96.3 -53.14 0.22 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.522 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 6.9 Cg_exo -73.86 70.74 4.3 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.696 2.264 . . . . 0.0 111.623 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 144.38 -8.33 1.86 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.556 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 53.1 34.1 16.52 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.857 0.361 . . . . 0.0 110.827 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.76 130.85 55.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.167 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 6.4 mt -85.83 151.51 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.0 135.15 32.42 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.25 161.74 18.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.029 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 54.1 m-85 -136.25 118.61 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.499 . . . . 0.0 111.782 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.6 m-85 -157.43 30.35 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.851 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.55 -152.74 23.53 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.36 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -54.0 -173.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.507 0.67 . . . . 0.0 112.086 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -157.47 -173.54 0.38 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.81 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 72.9 Cg_exo -42.15 -23.63 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.976 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -146.38 87.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.817 179.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.391 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.2 mt . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.424 ' CB ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -101.73 99.21 11.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.475 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 57.9 Cg_endo -70.44 -31.22 17.87 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.508 2.139 . . . . 0.0 112.645 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 179.2 -163.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -10.5 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.407 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -164.81 72.1 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 22.2 m -119.13 140.15 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.337 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.603 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 37.2 m-20 -84.91 148.14 26.4 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.41 ' CG1' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.18 97.82 5.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.064 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.558 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.96 21.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.31 -149.18 18.71 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.206 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -152.92 167.67 28.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.061 0.458 . . . . 0.0 111.362 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.7 mp -100.44 114.3 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.342 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.593 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.433 ' HG ' ' CG1' ' A' ' 120' ' ' VAL . 8.2 tt . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.34 -26.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.28 38.35 3.23 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.566 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.472 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 8.6 m -74.4 154.74 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 122.393 0.277 . . . . 0.0 111.465 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.98 146.09 44.11 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.687 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 6.1 p-10 -59.59 115.35 3.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 111.901 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.32 100.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.65 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 4.0 pt-20 -154.27 150.75 28.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.881 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 166.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.629 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 52.4 t -157.81 129.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.433 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.14 108.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.355 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.62 128.93 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.27 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.447 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.5 pt-20 -152.9 130.88 11.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.636 0.255 . . . . 0.0 111.339 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.431 ' CB ' HD21 ' A' ' 39' ' ' LEU . 5.9 tmm_? -75.22 92.91 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.686 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.832 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.784 0.325 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -110.1 145.47 37.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.0 112.314 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 164.78 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 145.96 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -145.03 100.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -102.29 156.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.511 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.413 ' CE1' HG11 ' A' ' 126' ' ' VAL . 3.6 m-85 -134.71 137.79 43.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.384 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.44 -29.05 0.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.95 23.07 7.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.77 151.45 2.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -125.65 141.34 52.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.963 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 149.13 11.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.53 159.27 36.02 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.146 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.83 140.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 111.747 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mt-10 -94.28 -178.61 4.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.537 HD11 HG12 ' A' ' 107' ' ' ILE . 5.3 tp -153.98 148.27 25.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.087 0.47 . . . . 0.0 111.284 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.06 148.45 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.635 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.27 -9.01 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.61 -27.68 0.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.249 -0.282 . . . . 0.0 111.533 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.512 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.07 -56.62 3.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 155.07 110.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -40.48 -30.0 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.817 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.78 -49.84 73.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.447 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.495 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -65.42 -45.66 83.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.39 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -47.87 -29.01 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.32 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -65.35 -38.64 90.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.09 74.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -51.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.598 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.54 -29.53 70.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.16 -25.48 62.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.976 0.417 . . . . 0.0 110.611 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 51.92 1.0 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.917 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.22 -159.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.312 -0.852 . . . . 0.0 109.682 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.917 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.4 Cg_exo -27.58 105.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.216 1.944 . . . . 0.0 114.006 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.5 mt -146.5 150.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.498 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -86.27 134.12 33.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.596 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.7 p -142.06 149.1 39.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.75 128.24 48.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.398 . . . . 0.0 110.319 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' ' CG2' ' A' ' 126' ' ' VAL . . . -91.0 131.94 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -100.86 122.63 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.725 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -86.81 136.53 32.95 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.6 t-105 -155.01 148.62 25.36 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.833 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -33.22 86.92 0.01 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.294 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' TRP . 18.1 t0 72.68 -35.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.47 0.308 . . . . 0.0 111.512 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 49' ' ' GLY . 6.0 tm-20 -73.86 133.57 43.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.6 OUTLIER -138.87 125.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.203 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -137.14 128.79 28.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.374 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.51 145.97 47.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.59 147.89 22.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.403 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.63 7.91 10.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.3 mt-30 80.07 -6.34 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.654 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -88.53 115.13 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.708 0.29 . . . . 0.0 110.317 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.7 94.91 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.761 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 7.1 p -129.98 106.55 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.202 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.88 133.93 48.1 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.014 0.435 . . . . 0.0 111.667 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 159.22 42.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.149 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -92.81 88.8 6.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.386 0.612 . . . . 0.0 111.127 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.33 159.66 7.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.3 t-20 64.07 -82.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.3 t 27.82 82.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.325 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HD3' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -100.72 156.65 17.22 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.37 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -117.33 -6.53 11.26 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 27.3 t -131.99 144.91 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.204 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.454 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.9 m -158.06 157.85 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.814 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -94.72 151.12 19.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.357 0.599 . . . . 0.0 111.638 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -45.95 125.75 6.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.979 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.4 -31.41 6.43 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.487 -0.863 . . . . 0.0 114.525 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p30 -75.91 156.56 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.464 0.632 . . . . 0.0 112.188 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 t -114.23 152.59 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.187 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.97 149.69 31.6 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.44 129.02 50.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.993 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.414 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 2.0 t90 -69.5 117.89 11.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.986 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.543 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -65.66 -72.07 0.3 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 34.1 Cg_endo -63.43 80.45 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.081 1.854 . . . . 0.0 112.12 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.82 -11.17 2.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.732 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.98 31.46 11.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.066 0.433 . . . . 0.0 110.902 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.92 133.56 52.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.462 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.59 145.94 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.434 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 17.4 t -139.12 156.27 47.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.258 0.551 . . . . 0.0 112.389 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.47 156.03 20.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.263 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.6 m-85 -136.69 127.24 26.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 111.23 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.483 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.98 49.72 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.18 -82.35 0.11 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -154.14 176.39 12.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.119 0.485 . . . . 0.0 111.69 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -144.15 -174.26 0.4 Allowed Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.238 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 99.6 Cg_exo -45.17 -22.74 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.012 1.808 . . . . 0.0 112.598 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 77.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.042 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.7 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.859 0.361 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.32 99.36 8.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.476 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.8 Cg_endo -69.3 -31.14 23.18 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.467 2.112 . . . . 0.0 112.638 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.01 -163.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -3.4 20.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.58 77.4 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 19.3 m -127.52 142.04 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.722 0.296 . . . . 0.0 111.68 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.6 m-20 -86.31 153.66 21.81 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.62 99.48 7.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.573 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -85.47 22.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.36 -147.77 18.9 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.07 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -156.52 168.13 28.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 111.416 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mt -100.4 114.94 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.165 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.593 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.45 -22.8 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -88.21 27.78 6.63 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.451 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 3.4 m -79.18 153.95 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.765 0.283 . . . . 0.0 111.247 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.64 146.99 29.77 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.527 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.2 p-10 -53.75 117.81 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.34 98.64 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.007 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -150.61 146.4 26.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.993 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.2 164.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 112.268 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.596 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 44.9 t -158.14 128.45 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.34 108.35 19.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 0.0 111.402 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.04 128.7 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.407 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.468 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.3 pt-20 -152.86 130.74 11.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.459 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.38 91.43 3.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.858 0.361 . . . . 0.0 110.809 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.743 179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.892 0.377 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.71 145.31 40.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.153 0.501 . . . . 0.0 111.926 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.9 163.9 15.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.932 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 143.63 38.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.825 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.72 100.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -99.98 156.32 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.78 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.8 m-85 -136.82 137.99 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.697 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.79 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 22.19 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.79 151.37 1.41 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.63 143.43 48.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.179 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.84 149.01 10.68 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.308 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -119.25 156.05 30.63 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.437 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.71 144.41 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 111.083 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 5.9 mt-10 -99.18 -178.27 3.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD13 HG12 ' A' ' 107' ' ' ILE . 6.6 tp -151.37 144.4 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.078 0.466 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -125.24 145.99 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.594 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.32 -9.04 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -45.66 -28.08 0.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.588 ' CZ2' ' CE1' ' A' ' 77' ' ' TYR . 7.2 t90 -80.03 -56.08 4.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 157.14 115.88 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.675 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.76 -34.82 16.42 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 112.49 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.78 -50.85 71.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.394 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.541 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.02 -45.42 92.42 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 84.2 t -46.65 -32.66 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.429 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -58.99 -38.7 79.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.482 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.9 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -51.55 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.11 -27.92 69.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 110.211 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -71.74 -25.57 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.562 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.25 49.95 1.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.063 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.887 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -62.42 -160.08 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.312 -0.851 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.887 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 38.9 Cg_exo -29.85 107.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.125 1.883 . . . . 0.0 113.85 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.5 mt -150.02 148.54 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.638 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.92 136.07 33.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.101 0.477 . . . . 0.0 111.953 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.576 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.2 p -146.03 148.65 32.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 125.82 49.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.162 0.506 . . . . 0.0 110.376 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 124' ' ' GLU . . . -85.55 132.46 34.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.042 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -100.39 128.19 46.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.56 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.621 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -90.26 135.15 33.85 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 50' ' ' ASP . 10.1 t-105 -154.5 148.43 25.64 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.888 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.47 85.75 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.632 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 48' ' ' TRP . 36.6 t70 74.09 -38.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.882 0.326 . . . . 0.0 111.882 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 49' ' ' GLY . 44.3 tt0 -72.4 124.19 24.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 111.114 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 HD11 ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -126.74 111.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 110.179 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 43.7 p90 -122.48 134.06 54.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.068 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.452 ' CE2' HG13 ' A' ' 126' ' ' VAL . 5.2 p90 -140.15 145.61 37.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.599 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 147.58 22.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -122.38 6.48 9.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 83.45 -8.13 1.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.1 115.43 26.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.136 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.01 94.82 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.064 0.459 . . . . 0.0 112.029 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.4 p -120.66 106.68 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.139 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -120.2 136.43 54.64 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.25 163.4 39.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.205 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -104.62 87.02 2.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -170.13 149.69 3.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.4 t-20 72.03 -82.66 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.523 0.202 . . . . 0.0 111.273 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.7 m 27.46 82.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.77 156.18 17.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.457 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -121.25 -3.25 9.49 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.1 p -127.65 140.01 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.513 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 33.1 m -158.7 157.55 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.544 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.2 150.67 19.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.49 0.662 . . . . 0.0 111.719 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -45.0 126.09 5.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.964 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -30.77 6.82 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.599 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.434 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.01 157.06 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.528 0.664 . . . . 0.0 111.978 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.96 152.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.624 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.52 151.23 31.31 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 121.86 -0.525 . . . . 0.0 112.41 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.588 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -102.19 123.99 47.0 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.075 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.468 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 4.1 t90 -66.57 119.02 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.901 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.708 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -69.53 -71.01 0.3 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.601 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.48 83.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.628 1.552 . . . . 0.0 111.705 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 133.6 -8.35 4.95 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.416 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.66 39.79 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.841 0.353 . . . . 0.0 111.24 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.15 135.17 54.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.77 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 36.8 mt -84.35 145.3 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.42 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 m -140.69 132.42 27.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 158.0 19.57 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.1 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 23.7 m-85 -136.67 115.17 11.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 111.369 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.54 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -156.53 39.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.07 -89.16 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.934 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.47 -169.08 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 111.499 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -152.29 -177.68 0.74 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.558 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 87.9 Cg_exo -47.49 -16.9 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 121.968 1.779 . . . . 0.0 112.896 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 93' ' ' ILE . 6.0 pt -145.75 62.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.6 mt . . . . . 0 CA--C 1.523 -0.096 0 CA-C-O 120.802 0.334 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.35 99.16 7.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.6 Cg_endo -69.16 -31.21 23.68 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.473 2.115 . . . . 0.0 112.491 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' CB ' HG12 ' A' ' 104' ' ' VAL . . . 175.66 -158.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.776 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -6.96 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.779 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.48 69.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 6.2 m -116.8 142.83 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.827 0.346 . . . . 0.0 111.65 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 3.0 m120 -83.18 151.31 25.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.595 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -87.08 86.95 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.624 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.03 18.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.509 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.94 -150.91 18.52 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.678 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -156.37 168.19 28.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.187 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.9 mt -95.27 113.61 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.463 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.418 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.591 ' HG ' HG12 ' A' ' 120' ' ' VAL . 8.4 tt . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.617 0.246 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.53 -24.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.457 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -94.59 37.69 3.34 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.841 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.591 HG12 ' HG ' ' A' ' 117' ' ' LEU . 3.5 m -79.01 154.47 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.728 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.74 148.48 33.01 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.307 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.2 p-10 -50.72 110.84 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.37 111.62 0.04 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.314 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -155.46 139.05 15.98 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.561 0.219 . . . . 0.0 110.701 178.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.9 t -40.75 161.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.111 0.482 . . . . 0.0 112.0 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.576 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 41.8 t -154.17 128.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.4 m -126.57 108.09 18.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 120.86 0.362 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.8 128.76 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.453 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 pt-20 -153.28 129.64 10.57 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.49 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.64 88.75 2.21 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.695 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.703 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.827 0.346 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.87 145.42 38.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.851 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 162.31 18.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.828 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 142.95 34.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.824 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.26 101.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 109.824 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -102.03 156.77 17.33 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.778 0.799 . . . . 0.0 112.501 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.2 m-85 -134.56 137.45 43.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.499 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -28.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 p -124.79 22.24 8.19 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.09 150.76 1.22 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.28 144.05 48.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.127 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.57 148.31 7.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.56 155.96 26.63 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.675 0.274 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.2 138.57 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.972 0.415 . . . . 0.0 111.258 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 1.3 mt-10 -95.1 -178.39 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.3 tp -154.34 146.37 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -126.76 147.71 49.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.853 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -56.28 -9.27 0.63 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.55 -28.78 1.01 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.857 0.298 . . . . 0.0 111.296 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.595 ' CZ2' ' CE2' ' A' ' 77' ' ' TYR . 7.9 t90 -80.81 -56.27 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 155.6 113.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.688 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -46.65 -35.9 17.97 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.456 2.104 . . . . 0.0 112.577 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.96 -51.94 67.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.528 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.18 -45.81 90.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.835 0.35 . . . . 0.0 110.503 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.427 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 59.3 t -46.16 -30.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.226 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -60.14 -38.95 84.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.101 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.15 84.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -49.29 78.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.27 -27.17 68.86 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.249 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.13 -24.49 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.631 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.19 49.39 1.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.0 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.878 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.16 -159.97 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.356 -0.831 . . . . 0.0 109.592 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.878 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 39.0 Cg_exo -29.87 106.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.132 1.888 . . . . 0.0 114.085 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.11 149.44 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.621 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -85.92 134.95 33.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.003 0.43 . . . . 0.0 111.669 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.567 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 6.0 p -143.6 149.27 37.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.696 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.76 121.27 41.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 110.212 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -80.42 131.26 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -102.68 123.83 47.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.593 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.512 ' HD2' ' O ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.19 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -151.5 148.51 28.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.236 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -35.08 91.67 0.01 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.029 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 29.3 t70 75.94 -41.15 0.42 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.683 0.393 . . . . 0.0 111.309 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' HG3' ' CG2' ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.06 143.1 41.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.438 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.2 OUTLIER -146.81 114.9 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.529 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -126.27 133.34 51.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.144 0.497 . . . . 0.0 112.038 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CD2' HG12 ' A' ' 126' ' ' VAL . 4.5 p90 -131.63 143.84 50.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.369 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 142.91 26.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -119.82 8.48 11.14 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.7 mt-30 80.74 -6.33 1.66 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.94 115.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.4 106.59 17.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.747 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.08 106.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.395 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.73 133.65 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.91 0.386 . . . . 0.0 111.254 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -153.92 165.09 37.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.335 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.16 88.35 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -170.08 149.13 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.0 t-20 69.24 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.522 0.201 . . . . 0.0 111.162 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.3 m 24.73 82.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.72 156.53 17.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.518 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -120.72 -3.6 9.76 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.2 p -127.83 140.11 50.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.494 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 30.5 m -159.02 157.89 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.759 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -93.84 152.06 19.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.424 0.63 . . . . 0.0 111.684 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.64 126.49 10.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -28.86 8.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.131 -1.033 . . . . 0.0 114.63 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.407 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.0 p30 -80.14 156.11 27.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.641 0.72 . . . . 0.0 111.988 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 110' ' ' ILE . 22.3 t -114.03 152.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.29 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.25 145.4 24.61 Favored 'General case' 0 C--N 1.342 0.249 0 O-C-N 121.9 -0.5 . . . . 0.0 112.169 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.84 137.26 36.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.167 179.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.45 ' HA ' HG13 ' A' ' 104' ' ' VAL . 1.8 t90 -79.47 121.97 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.622 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.516 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -72.89 -70.19 0.28 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 79.3 Cg_exo -33.14 -62.96 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.155 2.57 . . . . 0.0 113.845 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.68 -1.46 90.01 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.262 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.77 26.97 8.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.983 0.42 . . . . 0.0 110.485 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.99 137.76 46.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.638 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.63 148.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.604 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -143.26 155.24 44.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.285 0.564 . . . . 0.0 112.486 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.07 158.76 16.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.98 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.468 ' HE2' ' HB1' ' A' ' 76' ' ' ALA . 35.5 m-85 -136.53 115.39 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.676 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.536 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -139.33 25.46 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 152.63 -153.7 25.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.051 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -39.43 171.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.539 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -153.21 176.99 2.12 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.8 Cg_exo -39.01 -27.66 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.568 2.179 . . . . 0.0 112.714 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.44 52.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.675 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.99 0.424 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -121.53 99.46 45.24 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.998 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 61.4 Cg_endo -70.66 -31.6 16.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.466 2.111 . . . . 0.0 112.587 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.432 ' HB1' ' CZ2' ' A' ' 78' ' ' TRP . . . -178.39 -160.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -6.39 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.404 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.72 69.35 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 11.9 m -116.02 141.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.047 0.451 . . . . 0.0 111.783 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 3.0 m120 -82.49 150.96 26.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.618 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -84.02 86.53 2.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.736 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -71.77 16.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.527 -178.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.41 -147.79 18.6 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.749 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 11.5 mtp-105 -155.94 167.61 29.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.357 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.425 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.77 114.85 30.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.646 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HG ' HG12 ' A' ' 120' ' ' VAL . 7.2 tt . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 120.626 0.25 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -25.35 0.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.411 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.82 34.29 4.12 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.91 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.8 m -74.73 154.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 111.302 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.8 38.06 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.508 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -56.54 110.16 0.74 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.058 0.456 . . . . 0.0 111.593 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.31 102.7 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.305 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.63 150.03 28.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.71 162.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 112.154 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.567 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 51.7 t -158.06 128.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.483 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.2 107.43 17.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.46 128.68 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.472 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.447 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.48 127.9 9.25 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.597 0.237 . . . . 0.0 111.319 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.46 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.6 89.97 2.77 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.766 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.858 0.361 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 145.3 46.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.071 0.462 . . . . 0.0 111.949 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 163.68 15.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.92 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.92 145.58 38.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.3 OUTLIER -142.25 102.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 14.7 ptm180 -102.4 156.22 17.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.582 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE2' ' CG2' ' A' ' 126' ' ' VAL . 32.3 m-85 -140.69 139.54 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.915 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -28.84 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.064 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -125.79 22.44 7.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.9 154.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.389 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 144.29 47.32 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.877 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 150.09 12.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.5 158.6 34.08 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.339 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.02 143.56 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 111.212 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -90.96 -178.29 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.305 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' CD1' HG12 ' A' ' 107' ' ' ILE . 2.6 tp -151.04 130.43 12.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 111.525 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -113.54 136.46 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.42 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -57.84 -8.83 1.05 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -45.0 -28.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.652 0.263 . . . . 0.0 111.009 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.498 ' CZ2' ' CG2' ' A' ' 31' ' ' THR . 6.4 t90 -75.94 -53.16 8.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 159.72 114.05 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.806 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 3.3 Cg_exo -47.2 -37.76 24.34 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.567 2.178 . . . . 0.0 112.547 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -62.43 -46.76 87.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.498 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -64.05 -44.7 91.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.261 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 58.5 t -47.02 -36.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.005 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.47 -39.0 72.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.528 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.73 80.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -49.98 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.66 -26.83 68.85 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.6 -24.1 60.01 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.96 49.19 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.967 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.883 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mt -62.04 -159.78 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.697 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 36.2 Cg_exo -29.46 107.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.063 1.842 . . . . 0.0 114.049 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' LEU . 33.5 mt -150.13 149.87 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.6 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -85.94 133.88 33.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 111.866 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.59 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.8 p -145.91 149.5 34.34 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.517 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.53 133.39 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . . . -91.96 136.59 33.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.04 120.15 39.96 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.755 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -87.88 133.39 33.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' A' ' 50' ' ' ASP . 9.3 t-105 -155.65 148.7 24.5 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.369 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.69 89.76 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.415 -0.422 . . . . 0.0 113.391 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.9 t70 72.99 -36.82 0.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -75.87 132.08 40.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 111.092 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -138.86 121.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.768 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -134.01 131.59 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.613 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 6.2 p90 -136.61 145.13 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.66 144.28 25.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.175 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -119.7 5.79 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.26 -7.77 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.5 p -84.1 115.52 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.207 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.37 94.8 7.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.001 0.429 . . . . 0.0 111.716 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 31' ' ' THR . 6.7 p -129.17 106.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.493 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.94 132.7 30.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.872 0.368 . . . . 0.0 111.328 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -148.74 164.33 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.426 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -94.32 87.91 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.455 0.645 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -170.23 148.79 3.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 43.2 t-20 71.85 -83.21 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.578 0.228 . . . . 0.0 111.165 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' ASN . 8.1 m 27.4 81.4 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.41 156.03 17.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.225 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.83 -6.75 11.02 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 5.9 p -127.48 143.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.631 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 33.3 m -158.56 157.6 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -94.56 150.51 20.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.373 0.606 . . . . 0.0 111.576 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.28 126.67 8.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.956 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.37 -30.64 6.87 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.385 -0.912 . . . . 0.0 114.535 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB3' ' NE ' ' A' ' 109' ' ' ARG . 2.4 p30 -79.21 156.39 28.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 111.957 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 19.7 t -111.16 152.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.257 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.11 150.22 30.42 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.086 0.403 . . . . 0.0 111.882 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.473 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -106.32 137.91 43.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.443 ' O ' ' CE1' ' A' ' 77' ' ' TYR . 4.3 t90 -79.1 108.46 12.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.588 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -63.94 -65.84 1.82 Allowed Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.82 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.99 81.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.823 1.682 . . . . 0.0 111.714 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 136.56 -6.89 3.91 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.651 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 52.36 36.82 20.83 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.002 0.401 . . . . 0.0 110.931 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.84 54.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.044 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -88.38 151.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.401 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 16.9 t -143.47 157.06 44.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.2 159.68 17.17 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.353 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 33.7 m-85 -136.78 134.56 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 111.792 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.526 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -169.47 35.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.853 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.14 -153.53 24.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.323 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.4 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 112.097 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -163.79 -174.34 0.4 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.934 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 93.9 Cg_exo -44.89 -24.32 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.877 1.718 . . . . 0.0 112.519 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mp -142.25 69.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 110.365 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.818 0.342 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -103.55 99.25 14.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 59.7 Cg_endo -70.39 -31.51 17.61 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.505 2.137 . . . . 0.0 112.69 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 178.42 -161.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.62 -8.76 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.665 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -166.56 71.83 0.13 Allowed 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 18.4 m -119.08 141.24 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.004 0.431 . . . . 0.0 111.872 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 1.9 m120 -83.88 150.24 25.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.713 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.28 94.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.566 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -80.28 24.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.81 -149.98 17.38 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.41 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.424 ' NE ' ' HB3' ' A' ' 74' ' ' ASP . 26.2 mtp180 -157.01 168.06 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.454 . . . . 0.0 111.216 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.15 113.86 30.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 14' ' ' PHE . 2.0 tt . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.586 0.232 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.43 -26.85 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.31 33.94 3.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.928 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.489 ' HB ' ' NH1' ' A' ' 47' ' ' ARG . 2.4 m -80.39 154.03 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.627 0.251 . . . . 0.0 111.473 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.53 146.81 44.53 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.439 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 12.8 p-10 -53.6 134.61 41.23 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.454 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 56.86 99.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.282 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -144.61 153.34 41.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 110.98 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 126' ' ' VAL . 14.3 t -65.09 158.17 26.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.542 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.59 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 40.8 t -148.06 129.18 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.087 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.402 ' CG2' ' CG ' ' A' ' 13' ' ' ARG . 28.0 m -124.55 106.1 16.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.595 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.17 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.813 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.456 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.3 pt-20 -153.2 125.04 7.82 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.665 0.269 . . . . 0.0 111.25 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.445 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.14 94.74 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.813 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.8 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.809 0.337 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -114.77 145.29 42.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.483 . . . . 0.0 112.113 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.26 163.61 16.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.951 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 147.37 33.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.6 OUTLIER -144.33 101.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.404 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.12 156.17 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.555 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.7 m-85 -138.25 136.47 36.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.1 -29.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 22.49 7.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.35 152.96 1.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.39 145.6 50.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.871 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 148.46 11.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.658 0.266 . . . . 0.0 111.607 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 158.88 41.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.163 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.23 148.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.107 0.48 . . . . 0.0 111.644 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.2 mt-10 -94.57 -178.29 4.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.021 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.0 tp -147.46 133.19 18.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.148 0.499 . . . . 0.0 111.4 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.12 139.49 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.436 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -57.11 -8.92 0.76 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.29 -27.98 0.74 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.62 0.248 . . . . 0.0 111.427 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.494 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -79.26 -56.61 4.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.9 115.98 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.784 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.5 -34.67 11.2 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.396 2.064 . . . . 0.0 112.246 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -59.32 -52.74 64.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.78 -45.65 92.98 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 23' ' ' LEU . 87.4 t -46.72 -31.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.71 86.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.267 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.57 67.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -52.05 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.85 -29.25 70.05 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.911 0.386 . . . . 0.0 110.395 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.01 -25.58 62.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.528 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.02 51.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.767 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.922 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -61.56 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.828 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.922 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.3 Cg_exo -26.83 108.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.275 1.983 . . . . 0.0 113.992 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 41' ' ' ILE . 14.5 mt -147.9 153.91 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.628 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -89.28 131.98 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.78 40.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.94 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 128.25 48.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -91.55 132.74 36.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -100.7 130.02 46.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.593 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -94.1 134.79 36.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' ASP . 7.5 t-105 -154.87 148.36 25.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.044 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -29.34 84.32 0.0 OUTLIER Glycine 0 C--N 1.336 0.557 0 O-C-N 123.375 0.422 . . . . 0.0 113.781 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' TRP . 27.8 t70 73.93 -37.23 0.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.406 0.282 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' GLY . 1.3 tm-20 -73.44 128.04 34.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.992 0.425 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -131.1 125.0 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.786 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -136.49 127.43 27.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.355 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 4.3 p90 -133.28 145.39 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.61 146.62 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.412 HG21 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.82 6.79 10.42 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 82.57 -7.89 1.24 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.66 114.42 24.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.94 94.87 5.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' A' ' 31' ' ' THR . 6.1 p -132.47 106.74 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.143 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -124.12 134.64 53.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.027 0.441 . . . . 0.0 111.621 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -146.86 165.34 30.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.267 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 3.7 pm0 -102.02 92.4 4.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.048 0.451 . . . . 0.0 111.245 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.13 156.16 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.5 t-20 63.19 -81.48 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.706 0.289 . . . . 0.0 111.094 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.1 m 28.15 82.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.55 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.99 155.9 17.88 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.318 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -117.45 -7.01 11.18 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 5.7 p -127.03 144.43 37.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.623 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 27.5 m -158.47 163.19 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -108.65 143.22 38.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.036 0.446 . . . . 0.0 110.935 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -37.71 131.83 0.95 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.01 -31.52 6.47 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.711 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -83.25 156.83 22.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.247 0.546 . . . . 0.0 112.215 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 152.43 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.637 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.94 149.33 32.0 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.313 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.47 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -106.73 123.78 48.64 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.268 179.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.444 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.1 t90 -65.67 111.07 3.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -66.3 -68.31 0.76 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.69 80.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 121.914 1.743 . . . . 0.0 111.752 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.12 -9.41 3.29 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.607 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.04 32.29 17.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.096 0.448 . . . . 0.0 110.863 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.16 133.9 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.881 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 84' ' ' ILE . 16.2 mt -90.78 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.236 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 35.3 t -143.14 157.26 44.67 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 156.41 22.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.941 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 4.9 m-85 -136.76 130.86 32.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 111.515 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.77 49.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.71 -82.22 0.12 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.268 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -138.94 -167.85 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.265 0.555 . . . . 0.0 111.748 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.4 -176.51 0.62 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.822 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 97.1 Cg_exo -45.18 -21.69 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.187 1.925 . . . . 0.0 112.997 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -147.51 65.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.575 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 99.41 9.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.065 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.6 Cg_endo -68.95 -31.15 24.85 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.538 2.159 . . . . 0.0 112.564 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 175.99 -162.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -7.3 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.645 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.97 73.74 0.07 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 HG12 ' CD1' ' A' ' 78' ' ' TRP . 17.5 m -122.16 142.3 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.005 0.431 . . . . 0.0 111.774 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.468 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m120 -83.15 152.19 25.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.43 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -83.96 82.02 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.637 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -65.9 20.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 114.27 -149.51 18.74 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.871 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -156.23 163.6 39.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.07 116.3 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.242 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.42 ' HG ' HG11 ' A' ' 120' ' ' VAL . 4.1 tp . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.583 0.23 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -20.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 117' ' ' LEU . . . -91.31 30.34 6.45 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.644 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.522 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 2.8 m -77.52 154.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.483 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 147.21 30.2 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 13.6 p-10 -53.81 112.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 112.01 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.25 100.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.565 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' HB ' ' A' ' 120' ' ' VAL . 5.5 pt-20 -152.82 148.37 27.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.68 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.324 0.583 . . . . 0.0 112.456 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 40.1 t -158.13 127.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.258 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 29.8 m -125.22 107.29 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.0 111.228 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.412 HG22 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.21 128.72 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.573 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 pt-20 -152.45 129.07 10.77 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.751 0.31 . . . . 0.0 111.235 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.449 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.86 92.73 3.1 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.874 0.369 . . . . 0.0 110.735 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.724 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' MET . . . . . 0.445 ' O ' ' HG2' ' A' ' 8' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.07 0.462 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 145.45 51.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.12 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.37 162.44 15.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.649 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.46 142.79 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -138.91 102.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 109.704 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.34 156.15 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.589 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.443 ' CD2' HG11 ' A' ' 120' ' ' VAL . 3.2 m-85 -137.64 138.34 39.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -29.14 0.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -126.22 22.1 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.87 153.34 1.35 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.66 145.06 48.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.085 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.36 148.85 11.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.561 0.22 . . . . 0.0 111.432 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -117.93 156.68 28.05 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.22 135.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.047 0.451 . . . . 0.0 111.338 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -178.39 5.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.409 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tp -149.76 146.68 27.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -121.56 146.14 47.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.858 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.73 -9.03 2.39 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -45.52 -28.25 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.603 0.24 . . . . 0.0 111.423 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -80.07 -56.24 4.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 116.23 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.824 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.89 -29.77 8.69 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.521 2.147 . . . . 0.0 112.505 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.31 -43.56 81.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.183 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.466 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -67.18 -46.26 74.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.416 HG12 ' CE ' ' A' ' 8' ' ' MET . 31.0 t -45.98 -35.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -56.62 -37.76 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.01 -47.56 74.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.99 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -49.78 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.46 -28.79 70.21 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.247 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -71.19 -25.65 62.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 110.481 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.88 51.29 1.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.962 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.897 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.06 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.434 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.897 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 29.9 Cg_exo -28.64 103.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.058 1.839 . . . . 0.0 114.086 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.8 mt -145.62 150.62 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.395 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -85.88 135.62 33.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.164 0.506 . . . . 0.0 111.914 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.579 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.06 148.6 32.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.232 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.008 0.432 . . . . 0.0 110.374 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 124' ' ' GLU . . . -83.98 132.55 34.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -104.13 119.01 38.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.802 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.43 136.88 34.84 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 16.0 t-105 -148.44 148.56 30.43 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.588 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.177 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 26.4 t70 79.44 -41.31 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.712 0.405 . . . . 0.0 111.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.56 152.08 24.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.2 OUTLIER -150.13 117.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.726 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.1 p90 -125.15 140.17 53.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.243 0.545 . . . . 0.0 112.169 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 4.3 p90 -140.25 145.33 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.581 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 145.58 24.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.17 6.6 11.25 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.7 mt-30 81.75 -7.78 1.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.14 115.63 27.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.25 94.74 6.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.002 0.429 . . . . 0.0 111.706 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.436 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 7.6 p -130.13 106.75 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.511 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.94 131.77 33.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.939 0.399 . . . . 0.0 111.412 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 52.1 tttm -141.07 165.65 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.354 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -99.56 89.27 4.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 111.374 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.8 tt0 -170.14 157.82 6.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.67 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.0 t-20 63.5 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m 29.95 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.534 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.47 156.29 17.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.327 179.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.92 -7.01 10.96 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.63 142.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.537 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.433 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.6 m -157.81 157.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.26 151.08 19.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.357 0.599 . . . . 0.0 111.57 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -46.42 125.84 7.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.171 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.41 -31.72 6.27 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.369 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -75.66 155.81 35.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.619 0.709 . . . . 0.0 112.078 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 76' ' ' ALA . 21.5 t -113.09 152.54 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.027 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.707 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.03 145.92 28.68 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.343 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -101.54 121.37 41.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 179.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.474 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -64.83 114.48 4.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.821 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -70.74 -67.34 0.63 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.735 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 27.8 Cg_exo -61.23 75.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.856 1.704 . . . . 0.0 111.633 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 147.11 -10.94 1.37 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 30.61 12.38 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.234 0.517 . . . . 0.0 110.973 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.72 136.64 52.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 9.5 mt -88.53 147.81 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.8 m -142.77 132.1 23.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.55 157.73 17.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.025 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 7.7 m-85 -136.49 134.67 37.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 111.536 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -153.58 28.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.708 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 148.53 -149.59 21.64 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.584 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.45 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -39.75 169.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.79 -176.58 0.63 Allowed Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 79.2 Cg_exo -42.64 -25.49 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.087 1.858 . . . . 0.0 112.571 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.49 52.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.511 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.45 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.1 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.41 99.32 49.1 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.24 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.25 -30.6 30.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 112.494 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.408 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 179.2 -162.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.838 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -4.84 17.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.727 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.42 74.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 78' ' ' TRP . 20.8 m -122.7 141.98 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.3 m120 -82.15 152.77 26.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.624 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.6 90.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.707 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.93 19.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.263 -177.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.59 -149.24 18.65 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.572 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -151.52 164.18 37.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.003 0.43 . . . . 0.0 111.472 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.411 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.7 mp -93.83 115.78 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.291 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HG ' HG12 ' A' ' 120' ' ' VAL . 1.2 tp . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.63 -19.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.417 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -91.52 27.35 9.75 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.051 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.462 HG12 ' HG ' ' A' ' 117' ' ' LEU . 5.3 m -81.62 153.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.763 0.281 . . . . 0.0 111.527 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.57 148.59 35.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -53.8 105.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 0.0 112.047 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.06 109.94 0.12 Allowed Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.989 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -156.18 138.72 14.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.639 0.257 . . . . 0.0 110.794 178.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.8 152.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 111.901 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.579 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 61.5 t -144.62 128.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.402 ' CG2' ' CG ' ' A' ' 13' ' ' ARG . 26.3 m -124.69 107.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.82 128.38 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.462 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.6 pt-20 -152.46 130.29 11.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 111.216 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.446 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.76 93.79 2.64 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.901 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.948 179.831 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpp . . . . . 0 CA--C 1.524 -0.039 0 CA-C-O 120.859 0.362 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.64 145.26 38.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 112.03 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.54 163.6 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.719 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.45 145.06 33.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -147.35 102.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -108.58 155.99 20.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.854 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CG ' HD13 ' A' ' 117' ' ' LEU . 2.7 m-85 -128.82 140.31 51.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.159 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.07 -28.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -122.24 23.19 9.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 155.05 1.43 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -117.1 152.66 34.24 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.229 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.08 151.47 17.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.92 0.39 . . . . 0.0 111.926 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -137.45 149.96 47.26 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.235 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.13 141.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.131 0.491 . . . . 0.0 111.842 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 2.0 mp0 -95.03 -178.1 4.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.234 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.4 tp -154.79 142.33 19.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.05 146.92 48.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.32 -9.41 0.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.61 -28.59 1.0 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.186 -0.321 . . . . 0.0 111.219 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.52 ' CZ2' ' CG2' ' A' ' 31' ' ' THR . 6.2 t90 -79.78 -55.87 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 115.97 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.648 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -46.22 -36.7 17.37 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -62.12 -48.54 79.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.365 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.52 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.38 -44.96 95.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.888 0.375 . . . . 0.0 110.353 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 43.7 t -51.31 -31.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -59.73 -36.06 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.48 -47.31 67.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -51.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.68 -28.69 69.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.983 0.42 . . . . 0.0 110.42 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.03 -23.83 60.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.44 50.81 0.89 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.877 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.89 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.506 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.89 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 30.7 Cg_exo -28.88 106.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.164 1.909 . . . . 0.0 113.979 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.2 mt -147.63 149.3 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.403 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 136.59 33.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.602 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.09 149.25 33.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.35 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.82 127.89 48.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 14' ' ' PHE . . . -87.16 136.27 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -108.83 123.56 49.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.235 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.693 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -80.85 138.17 36.19 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.414 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.5 t-105 -150.1 148.88 29.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.58 95.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.513 -0.375 . . . . 0.0 113.72 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.68 30.5 11.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.266 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HG3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -145.63 146.03 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.326 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -140.51 121.45 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 19.3 p90 -129.61 129.78 44.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.112 0.482 . . . . 0.0 110.98 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' VAL . 6.7 p90 -139.11 145.53 39.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.815 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 149.34 21.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.34 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.16 6.28 9.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.4 ' HG3' ' C ' ' A' ' 56' ' ' THR . 34.1 mt-30 80.41 -6.21 1.71 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.799 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.54 116.01 28.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.834 0.35 . . . . 0.0 110.2 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.32 94.79 5.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.0 0.429 . . . . 0.0 111.769 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' CG2' HG22 ' A' ' 31' ' ' THR . 7.5 p -124.07 106.59 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.016 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.34 136.56 51.13 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 111.587 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 63' ' ' GLU . 8.9 ttmt -141.51 164.79 29.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.242 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -101.24 76.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.051 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -170.11 160.78 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 28.3 t-20 72.78 -82.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 22.43 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.97 160.55 14.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.639 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.38 -4.3 8.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 40.7 t -131.87 143.66 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.103 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.476 HG22 ' CZ ' ' A' ' 87' ' ' PHE . 26.8 m -158.77 158.21 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.029 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.33 150.54 24.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.362 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp -52.08 124.79 13.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.963 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -32.19 6.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.017 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -67.55 166.05 15.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.104 0.452 . . . . 0.0 111.883 -179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' CG2' ' CD1' ' A' ' 110' ' ' ILE . 22.0 t -122.72 152.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.646 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 146.17 26.47 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.697 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.518 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -98.24 126.97 43.94 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.962 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.5 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.2 t90 -68.38 122.59 18.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.215 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -72.25 -68.53 0.41 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.453 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 38.8 Cg_exo -59.44 82.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.915 1.743 . . . . 0.0 111.837 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.53 -7.18 4.95 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.642 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.62 39.43 13.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 0.0 111.176 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -115.19 135.5 54.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.55 145.57 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.5 m -142.49 131.27 22.79 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -98.07 139.19 34.26 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' A' ' 70' ' ' VAL . 14.3 p90 -136.52 138.05 40.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.075 0.464 . . . . 0.0 110.967 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.9 50.68 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.491 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.03 -81.14 0.13 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -123.49 -170.26 2.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.387 0.613 . . . . 0.0 111.553 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.555 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -166.16 178.09 1.37 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.807 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.6 Cg_exo -36.25 -30.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.659 2.239 . . . . 0.0 112.657 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -142.11 69.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.348 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 111.205 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.83 99.29 52.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 91' ' ' THR . 40.0 Cg_endo -65.73 -31.43 49.02 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.552 2.168 . . . . 0.0 112.446 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.43 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 173.57 -159.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.62 -4.12 17.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.85 73.21 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 15.6 m -120.69 141.96 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.757 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.457 ' HB3' ' ND2' ' A' ' 65' ' ' ASN . 41.1 m-20 -80.71 151.03 29.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.687 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -84.44 85.48 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.646 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -68.17 19.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.945 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 113.33 -146.74 18.52 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.933 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -154.98 168.09 28.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.515 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.403 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 3.6 mt -93.58 118.85 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.451 HD13 ' CG ' ' A' ' 14' ' ' PHE . 5.8 tp . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 120.638 0.256 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.1 OUTLIER -42.3 -24.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -91.32 35.04 4.05 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.057 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.477 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 3.7 m -70.91 154.79 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 122.61 0.364 . . . . 0.0 111.853 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.79 146.66 44.09 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.693 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 p30 -58.1 116.35 3.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.089 0.471 . . . . 0.0 112.238 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.93 102.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.973 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 pt-20 -156.37 150.98 25.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.792 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.4 t -52.1 167.45 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 112.229 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.602 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 89.2 t -157.7 128.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.21 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.84 108.23 17.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.425 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.02 129.01 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.7 pt-20 -152.05 128.22 10.48 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.607 0.242 . . . . 0.0 111.229 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.451 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.79 85.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.175 -0.916 . . . . 0.0 111.634 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.37 38.88 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.448 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -114.19 25.85 10.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.415 ' HD3' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -147.33 -152.15 0.42 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.325 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.73 -50.22 0.05 OUTLIER Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.554 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.457 ' CG2' ' CD1' ' A' ' 24' ' ' TYR . 13.7 p -90.05 53.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.551 . . . . 0.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -157.8 48.79 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.64 90.2 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -102.35 145.06 30.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 111.76 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 164.17 19.3 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.004 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -145.32 102.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.085 0.469 . . . . 0.0 109.779 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -99.82 156.23 17.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.376 0.608 . . . . 0.0 111.893 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.7 m-85 -135.88 138.87 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.495 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.6 p -125.98 21.83 7.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -176.53 153.32 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.91 146.58 37.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 149.01 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.168 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.29 155.66 24.74 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.81 142.06 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.223 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 7.4 mt-10 -100.58 -178.8 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.062 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 HD11 HG12 ' A' ' 107' ' ' ILE . 3.8 tp -150.92 149.36 29.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.067 0.46 . . . . 0.0 111.368 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.457 ' CD1' ' CG2' ' A' ' 6' ' ' VAL . 19.3 m-85 -126.36 148.01 49.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.732 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.18 -8.88 1.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.65 -27.73 0.85 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.621 0.248 . . . . 0.0 111.593 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.502 ' CH2' ' CD2' ' A' ' 77' ' ' TYR . 8.9 t90 -81.61 -56.27 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 154.89 114.87 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.452 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -46.41 -35.23 15.73 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.555 2.17 . . . . 0.0 112.335 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.78 -53.5 57.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.539 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.483 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.51 -45.06 92.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.521 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 61.4 t -47.43 -28.42 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.33 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt-85 -61.21 -38.64 87.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.464 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.94 79.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.671 0.272 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.09 -51.29 55.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.03 -27.8 69.66 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 120.948 0.404 . . . . 0.0 110.369 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.93 -25.31 61.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 0.0 110.599 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.23 49.6 1.13 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.047 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.89 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.1 mt -61.91 -160.21 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.58 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.89 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 32.3 Cg_exo -29.2 107.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.04 150.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.627 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -85.77 136.61 33.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.111 0.481 . . . . 0.0 111.745 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.594 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.33 149.1 33.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.497 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 125.59 48.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB1' ' CG2' ' A' ' 126' ' ' VAL . . . -83.85 136.01 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -108.26 125.8 52.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.073 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.615 ' HD3' ' O ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -85.39 135.37 33.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -150.91 148.97 29.08 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.902 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . -32.88 102.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.505 -0.379 . . . . 0.0 113.729 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.22 30.87 0.49 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.02 142.91 30.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.351 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.584 HD13 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -139.92 124.83 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.299 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 34.9 p90 -133.83 127.84 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.477 ' CE2' HG12 ' A' ' 126' ' ' VAL . 4.0 p90 -133.58 146.5 51.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.049 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.01 145.19 24.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER 82.95 -8.14 1.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.8 p -84.34 115.78 26.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.33 94.56 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 112.053 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.3 p -123.21 106.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.081 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.41 136.39 46.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.041 0.448 . . . . 0.0 111.665 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -160.32 161.7 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.987 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -96.33 96.28 8.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.0 tt0 -170.37 149.87 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.884 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.411 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 57.4 t-20 63.33 -81.74 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.727 0.299 . . . . 0.0 111.108 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 m 29.97 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.676 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -99.54 157.06 16.71 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.145 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -120.98 -4.16 9.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.5 p -127.56 141.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.403 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 35.9 m -158.75 157.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.599 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.62 150.77 19.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.401 0.619 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -44.85 126.49 5.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.98 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.41 -26.96 10.44 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 120.256 -0.973 . . . . 0.0 114.614 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -82.53 156.21 24.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.844 0.822 . . . . 0.0 111.894 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -113.48 151.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.393 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.06 153.34 33.78 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CD2' ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -103.98 131.69 50.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.308 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.44 ' CD1' HG11 ' A' ' 104' ' ' VAL . 4.0 t90 -74.37 109.12 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.669 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -65.32 -69.17 0.61 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.311 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.669 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 39.0 Cg_exo -58.85 80.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.886 1.724 . . . . 0.0 111.518 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.46 -9.33 3.19 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.291 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 50.05 39.62 19.52 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.907 0.354 . . . . 0.0 111.121 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.02 136.38 54.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.53 147.05 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.5 m -143.12 135.89 27.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.07 160.82 19.18 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 57.1 m-85 -136.32 114.71 11.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 111.984 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.673 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -150.23 31.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.082 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.54 -153.07 24.1 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.663 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.471 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.6 -173.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.522 0.677 . . . . 0.0 112.203 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.538 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -159.31 -175.85 0.55 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.118 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 74.3 Cg_exo -42.6 -25.22 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.032 1.821 . . . . 0.0 112.888 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 mp -142.02 72.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -60.6 -75.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.26 -91.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -119.51 -30.69 4.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -125.56 -161.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.319 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.7 mt -118.69 110.3 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.1 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -109.32 99.26 35.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.959 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 60.0 Cg_endo -70.66 -31.27 16.83 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.151 . . . . 0.0 112.719 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.411 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 178.69 -162.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.22 -5.37 14.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.613 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.27 70.06 0.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.494 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 12.7 m -119.01 141.4 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.024 0.44 . . . . 0.0 111.805 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 2.1 m120 -84.43 151.39 24.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.419 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.7 96.89 6.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.573 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.27 20.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.74 -149.75 18.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.55 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HG2' ' HA ' ' A' ' 74' ' ' ASP . 30.6 mtp180 -156.75 168.03 28.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.19 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.84 112.72 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.531 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.35 -86.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.547 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -67.57 74.35 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.81 -70.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 ttm 54.77 35.48 24.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.01 152.31 29.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.97 45.71 2.1 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.393 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.421 ' HG ' HG12 ' A' ' 120' ' ' VAL . 6.7 tt -42.45 -35.59 1.08 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 111.5 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.673 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.78 -21.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.404 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -93.43 34.35 4.65 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.427 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.615 ' O ' ' HD3' ' A' ' 47' ' ' ARG . 7.1 m -71.58 154.83 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 122.161 0.184 . . . . 0.0 111.088 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.406 ' C ' ' HD3' ' A' ' 47' ' ' ARG . . . -81.22 147.92 29.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.594 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.1 p-10 -56.16 118.0 4.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.177 0.513 . . . . 0.0 112.328 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.63 101.15 0.02 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.008 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.8 155.55 40.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 110.48 178.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 t -55.56 164.98 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.681 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.594 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 44.5 t -157.96 127.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.562 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.39 108.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.314 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.405 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.68 128.89 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.407 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.7 pt-20 -153.41 129.18 10.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.66 0.267 . . . . 0.0 111.379 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.479 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.24 89.54 3.12 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.682 179.934 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.825 0.345 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.52 137.46 5.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.61 21.13 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.229 . . . . 0.0 111.077 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 58.69 -84.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.979 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -164.66 27.85 0.2 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.452 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.446 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 32.8 m -115.68 63.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.086 0.47 . . . . 0.0 111.348 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 38.92 0.18 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.95 110.47 22.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -108.38 145.43 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.356 0.598 . . . . 0.0 112.319 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 163.92 18.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.62 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 144.87 31.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 12' ' ' ILE . 1.7 mt -148.04 99.31 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -104.98 156.06 18.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.877 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.455 ' CZ ' ' HB1' ' A' ' 45' ' ' ALA . 2.7 m-85 -129.63 139.11 51.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.277 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -28.53 0.43 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -121.34 22.97 10.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.76 151.46 1.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.37 138.35 54.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.791 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 149.2 11.32 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.639 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.33 158.26 31.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.115 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.24 141.13 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.374 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 4.2 mt-10 -96.86 -178.46 4.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.979 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.533 HD11 HG12 ' A' ' 107' ' ' ILE . 8.1 tp -154.15 144.57 22.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.148 0.499 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.446 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 16.7 m-85 -127.14 146.73 50.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.638 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -57.07 -9.29 0.83 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -45.49 -28.29 0.89 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.265 -0.272 . . . . 0.0 111.33 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.56 ' CZ2' ' CE1' ' A' ' 77' ' ' TYR . 7.8 t90 -81.12 -56.18 4.26 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.41 115.47 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.597 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -46.17 -35.47 15.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.517 2.145 . . . . 0.0 112.341 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.15 -52.7 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.446 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.513 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.39 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 65.0 t -47.91 -30.04 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.307 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -60.66 -38.31 84.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.399 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.19 75.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.34 -52.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.9 -29.01 69.92 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.977 0.417 . . . . 0.0 110.445 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.92 -25.44 62.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.42 50.82 1.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.968 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.883 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.92 -160.05 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.45 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.4 Cg_exo -29.59 105.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.106 1.871 . . . . 0.0 113.953 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.7 mt -147.94 149.29 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.566 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.89 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.09 0.471 . . . . 0.0 111.766 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.7 p -146.08 149.01 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.463 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.92 129.38 48.17 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB1' ' CZ ' ' A' ' 14' ' ' PHE . . . -89.46 134.45 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -106.06 122.02 45.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.045 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.61 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.79 136.73 35.4 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -154.45 148.34 25.59 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.47 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.83 86.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.497 0 O-C-N 123.278 0.361 . . . . 0.0 113.838 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.4 t70 76.15 -36.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 138.49 37.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 111.376 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -136.26 110.01 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.991 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.506 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 39.7 p90 -119.87 128.74 53.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.475 ' CE2' HG13 ' A' ' 126' ' ' VAL . 5.3 p90 -136.64 144.46 44.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.393 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.64 147.07 23.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.423 HG23 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.89 7.56 10.42 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' HG3' ' C ' ' A' ' 56' ' ' THR . 36.1 mt-30 81.02 -6.82 1.59 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.819 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -86.54 115.76 28.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.39 94.9 5.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.045 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 2.9 p -125.33 106.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.961 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 138.17 53.88 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.053 0.454 . . . . 0.0 111.623 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -152.99 164.5 37.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.335 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.12 87.2 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.78 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.0 tt0 -170.11 153.56 4.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.467 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 49.7 t-20 69.42 -80.27 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.277 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 65' ' ' ASN . 5.3 m 25.28 82.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.473 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.77 157.02 17.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.536 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -118.97 -8.13 10.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 5.0 p -124.89 143.04 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.296 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.428 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 26.9 m -159.08 157.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.78 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.49 151.59 21.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.406 0.622 . . . . 0.0 111.483 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.38 125.36 10.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.805 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.59 -32.18 6.0 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.268 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.489 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 1.9 p30 -73.61 156.49 37.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.578 0.689 . . . . 0.0 111.942 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG23 ' CD1' ' A' ' 110' ' ' ILE . 19.0 t -112.93 152.35 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.497 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.4 148.94 31.83 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.262 0.483 . . . . 0.0 112.294 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.56 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -103.91 123.08 46.49 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.501 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.0 t90 -64.62 119.98 11.53 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.809 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.733 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -70.64 -68.03 0.55 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.753 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.733 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.07 78.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.846 1.697 . . . . 0.0 111.696 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 141.19 -9.24 2.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.737 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.02 36.23 14.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.0 0.4 . . . . 0.0 111.059 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.85 134.75 54.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.723 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.8 mt -84.3 141.16 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.451 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.5 m -135.65 130.36 34.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.58 156.3 19.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 4.8 m-85 -136.79 129.67 30.76 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.626 0.25 . . . . 0.0 110.989 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.444 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -165.79 42.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.304 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.47 -84.09 0.1 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.327 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.57 -166.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.259 0.552 . . . . 0.0 111.902 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.456 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -159.56 -176.65 0.63 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.456 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 87.7 Cg_exo -47.32 -24.62 4.05 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.793 1.662 . . . . 0.0 111.786 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 1.9 mp -142.57 66.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -44.55 -33.33 1.72 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.83 146.57 8.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 9.8 m-20 60.63 52.24 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.483 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 66.08 163.32 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.612 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.1 mt -60.37 108.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.102 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -103.47 99.21 14.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 52.4 Cg_endo -68.33 -31.39 28.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.482 2.121 . . . . 0.0 112.537 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.423 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 175.41 -158.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -6.93 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.697 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.01 73.12 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 16.7 m -122.74 142.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 111.826 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 2.5 m120 -83.58 152.0 25.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.854 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.73 99.84 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.533 HG12 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.66 21.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.79 -133.22 10.55 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.245 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HB3' ' HA ' ' A' ' 74' ' ' ASP . 9.5 ptt85 -170.47 168.12 7.92 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.045 0.45 . . . . 0.0 111.484 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.417 ' CD1' HG23 ' A' ' 75' ' ' VAL . 3.0 mt -98.16 115.27 37.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.575 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.74 -85.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -75.73 -176.34 3.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.074 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 57.9 m 62.06 162.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.3 tpp -57.88 129.43 41.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mp0 -104.66 25.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.003 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.84 32.67 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.392 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.531 ' HG ' HG12 ' A' ' 120' ' ' VAL . 6.2 tt -49.94 -31.87 13.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.444 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.95 -24.38 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.173 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.431 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.92 31.29 4.72 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.531 HG12 ' HG ' ' A' ' 117' ' ' LEU . 10.6 m -75.09 153.98 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.562 0.22 . . . . 0.0 111.299 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.26 146.61 32.91 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -57.28 111.64 1.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.99 98.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.401 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 pt-20 -152.41 149.71 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.68 166.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.281 0.562 . . . . 0.0 112.257 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.614 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 48.8 t -157.98 128.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.137 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.46 109.14 17.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 111.589 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 HG23 HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.89 129.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.243 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.445 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 11.8 pt-20 -154.31 128.04 8.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.622 0.249 . . . . 0.0 111.293 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.472 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.81 87.59 1.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 110.786 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.751 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.26 123.28 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.65 -41.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.62 0.247 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.33 -63.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.44 28.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.464 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 32.3 m -113.53 63.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -157.26 38.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.09 110.58 22.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -108.54 145.32 34.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.2 0.524 . . . . 0.0 112.329 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.48 163.96 17.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.682 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 145.68 38.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.796 0.332 . . . . 0.0 110.948 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.2 100.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -102.63 155.5 18.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.615 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -131.2 138.05 49.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.441 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.53 -29.07 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -126.08 23.12 7.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.06 152.44 3.49 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.78 143.5 49.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.676 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 148.6 13.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.75 0.31 . . . . 0.0 111.769 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -136.31 157.83 45.86 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.054 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.15 146.57 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.446 . . . . 0.0 111.648 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 6.6 mt-10 -98.16 -178.29 4.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.871 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.52 HD12 HG12 ' A' ' 107' ' ' ILE . 7.9 tp -153.71 144.2 22.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.464 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 16.0 m-85 -123.97 146.8 48.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.45 -9.27 0.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.61 -27.26 0.74 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.939 0.336 . . . . 0.0 111.443 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.51 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 7.5 t90 -81.28 -56.37 4.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 154.23 113.62 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.665 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.72 -29.62 8.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.35 -46.46 80.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.283 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.49 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.32 -46.2 70.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 30.2 t -45.87 -29.82 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.339 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -33.44 72.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.477 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.53 55.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.3 -49.08 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.12 -28.62 69.89 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.319 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -71.4 -25.38 62.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.376 . . . . 0.0 110.543 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.01 51.11 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.988 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.887 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -62.21 -159.93 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.594 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.887 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.4 Cg_exo -29.08 107.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.186 1.924 . . . . 0.0 114.059 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.9 mt -150.04 149.78 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.642 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -85.84 136.85 33.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.919 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.572 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -146.05 149.19 33.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.45 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 124.44 47.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -84.93 133.58 34.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -103.4 124.98 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.931 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -88.52 135.88 33.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.6 t-105 -156.71 148.34 22.58 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.957 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.81 84.89 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.649 -0.31 . . . . 0.0 113.764 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' TRP . 30.5 t70 74.22 -36.64 0.34 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 49' ' ' GLY . 6.3 tt0 -74.71 128.22 35.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.399 . . . . 0.0 111.346 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.596 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -132.29 119.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.849 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 53.4 p90 -131.47 125.03 31.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.319 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.463 ' CE2' HG12 ' A' ' 126' ' ' VAL . 3.0 p90 -129.87 145.8 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.05 144.12 25.76 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -118.89 6.4 11.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.6 mm-40 82.23 -7.44 1.33 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.98 116.87 29.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.159 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.87 94.56 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.703 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.414 ' CG2' HG21 ' A' ' 31' ' ' THR . 6.0 p -126.08 106.74 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.3 133.93 43.21 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 161.14 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.083 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.73 93.97 7.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.51 148.39 3.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 35.5 t-20 70.44 -76.87 0.06 Allowed 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.606 0.241 . . . . 0.0 111.165 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' ASN . 11.0 t 21.41 83.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.58 161.51 13.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.361 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.28 1.04 8.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 49.6 t -138.41 142.33 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.442 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.6 m -157.99 157.55 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.887 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.79 152.2 19.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.495 0.664 . . . . 0.0 111.62 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -48.29 125.91 10.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.933 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.07 6.08 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.505 -0.855 . . . . 0.0 114.083 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -75.37 156.37 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.458 0.629 . . . . 0.0 111.984 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.9 t -113.05 152.25 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.497 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.08 149.39 29.47 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.151 0.432 . . . . 0.0 111.874 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -104.51 137.66 42.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.341 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.432 ' CD1' ' HG2' ' A' ' 80' ' ' PRO . 1.6 t90 -78.72 108.26 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.445 HG13 ' ND2' ' A' ' 105' ' ' ASN . 0.3 OUTLIER -63.94 -66.42 1.5 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.634 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 21.1 Cg_endo -60.72 77.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.255 1.97 . . . . 0.0 111.6 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 142.91 -9.99 2.31 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.324 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 54.47 33.6 19.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.965 0.382 . . . . 0.0 110.913 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.96 134.8 54.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.049 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.1 mt -87.37 150.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 24.8 t -143.52 156.09 44.52 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.66 157.76 21.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.943 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 5.5 m-85 -136.71 138.21 40.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.492 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.426 ' CZ ' ' O ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -175.46 44.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.957 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.36 -91.14 0.1 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.973 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -133.36 -167.76 1.98 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.424 0.63 . . . . 0.0 111.724 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.488 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -163.61 -173.94 0.38 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.01 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 90.4 Cg_exo -45.48 -22.2 0.97 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 121.81 1.673 . . . . 0.0 112.736 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.7 mp -142.06 73.1 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.49 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -63.75 -13.2 41.54 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.7 t0 -26.1 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 41.47 31.94 0.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.058 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.39 163.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.804 0.335 . . . . 0.0 110.758 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.27 102.32 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' O ' ' HB ' ' A' ' 91' ' ' THR . 34.6 mmm-85 -98.76 99.11 7.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.4 Cg_endo -68.87 -31.09 25.5 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.483 2.122 . . . . 0.0 112.561 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 175.77 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.833 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.76 -0.43 14.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.599 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.42 68.25 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 18.6 m -121.45 141.63 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.132 0.492 . . . . 0.0 112.09 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.445 ' ND2' HG13 ' A' ' 79' ' ' ILE . 2.2 m120 -82.32 152.04 26.45 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.815 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.1 97.43 6.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.52 HG12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -82.95 22.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.116 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.43 -144.65 17.9 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.079 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -156.79 168.1 28.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 111.33 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.409 ' CG2' ' CG ' ' A' ' 115' ' ' GLU . 2.9 mp -91.41 116.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.076 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.46 -87.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.15 126.0 49.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.395 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.59 -67.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.633 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -169.17 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.699 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 22.2 mt-10 57.48 35.32 25.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.024 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.07 28.19 2.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.877 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' HG12 ' A' ' 120' ' ' VAL . 1.2 tp -52.17 -34.06 43.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.995 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.51 -26.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.94 -179.463 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.54 31.34 4.22 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.47 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 3.1 m -79.84 154.19 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.641 0.258 . . . . 0.0 111.202 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.96 146.55 32.01 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.571 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 16.0 p-10 -54.57 112.01 0.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.997 0.427 . . . . 0.0 111.593 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.61 100.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.179 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.82 148.88 28.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.371 . . . . 0.0 110.982 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.1 t -46.63 163.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.327 0.584 . . . . 0.0 112.233 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.572 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 42.4 t -158.1 128.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.326 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.51 108.42 19.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.901 0.382 . . . . 0.0 111.547 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.05 128.53 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.289 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.4 pt-20 -154.0 130.26 10.45 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.43 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.463 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.19 89.53 3.09 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.801 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.719 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HE1' ' CE2' ' A' ' 24' ' ' TYR . 43.0 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.775 0.322 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.09 -27.87 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.501 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 60.91 -160.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.473 0.178 . . . . 0.0 110.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 60.26 19.26 8.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.09 -32.01 0.12 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 26.5 m -112.11 61.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 111.274 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -158.51 36.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 114.5 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -111.27 145.32 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 112.099 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 164.57 14.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.796 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.35 143.82 36.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 0.0 111.159 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.45 100.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -102.48 156.26 17.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.597 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.452 ' CD2' HG12 ' A' ' 120' ' ' VAL . 4.1 m-85 -136.27 137.91 41.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.524 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.5 -29.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -123.88 22.81 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.86 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -126.68 141.5 51.83 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.83 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 148.94 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.717 0.294 . . . . 0.0 111.498 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.5 160.11 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.308 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.86 144.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.122 0.487 . . . . 0.0 111.571 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.3 mt-10 -96.21 -178.52 4.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.13 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.623 HD12 HG12 ' A' ' 107' ' ' ILE . 6.0 tp -151.02 147.02 26.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.029 0.442 . . . . 0.0 111.15 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 19.4 m-85 -128.5 146.88 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -59.06 -9.03 1.7 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.4 -29.56 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.501 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -79.9 -56.38 4.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 158.24 117.2 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -45.99 -35.36 14.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.523 2.149 . . . . 0.0 112.208 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.63 76.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.708 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.459 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.91 -44.22 93.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.859 0.362 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 63.7 t -47.68 -34.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.204 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -60.07 -36.98 78.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.39 70.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.95 -51.76 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.42 -28.7 69.98 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.028 0.442 . . . . 0.0 110.399 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.74 -26.16 63.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.452 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.0 51.48 1.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.778 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.891 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.7 -159.71 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.591 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.891 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.6 Cg_exo -28.92 105.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.996 1.798 . . . . 0.0 113.989 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 39' ' ' LEU . 21.0 mt -146.64 150.71 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.63 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.036 0.446 . . . . 0.0 111.82 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -144.05 148.97 35.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.453 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 126.95 48.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 110.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -88.84 132.75 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -102.63 122.3 44.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.712 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -89.66 136.18 33.18 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -155.74 148.26 23.9 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.81 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -32.07 85.47 0.01 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.178 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.1 t70 76.0 -39.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.09 120.26 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 0.0 111.504 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.1 OUTLIER -128.36 121.54 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.742 178.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -135.23 127.91 30.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.844 0.354 . . . . 0.0 111.296 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.7 p90 -133.4 145.76 50.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.013 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.15 146.19 24.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -120.63 6.31 10.53 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER 83.07 -8.08 1.16 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -85.76 115.02 26.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.38 94.7 5.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.975 0.417 . . . . 0.0 112.052 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG21 ' CG2' ' A' ' 31' ' ' THR . 4.8 p -129.66 106.78 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.124 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.64 134.75 54.49 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 121.027 0.441 . . . . 0.0 111.641 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.26 167.26 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.065 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.03 88.78 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.972 0.415 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.33 160.79 7.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.757 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.8 t-20 63.42 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 65' ' ' ASN . 3.3 m 28.5 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.368 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.19 155.45 17.75 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.398 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -120.41 2.11 10.74 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 51.0 t -137.28 141.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG1' ' HD3' ' A' ' 67' ' ' LYS . 35.3 m -158.12 157.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.715 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -98.26 148.73 23.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.389 0.614 . . . . 0.0 111.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.61 129.42 4.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.948 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.51 -32.06 6.08 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.134 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.42 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 2.5 p30 -81.15 157.93 25.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.327 0.564 . . . . 0.0 111.929 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 38.4 t -116.21 152.53 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.48 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.603 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 151.32 32.54 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.305 0.502 . . . . 0.0 112.341 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.427 ' CZ ' ' HA ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -107.36 137.28 45.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.436 ' CD1' HG13 ' A' ' 104' ' ' VAL . 2.3 t90 -76.22 111.95 12.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.472 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -64.04 -67.37 1.08 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 32.2 Cg_endo -63.5 76.28 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.23 1.954 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.83 -10.84 1.65 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.545 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.38 28.72 11.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.147 0.474 . . . . 0.0 110.944 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.12 130.9 55.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.676 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.74 147.66 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.197 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.1 t -141.06 156.83 45.94 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.482 0.658 . . . . 0.0 112.769 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.75 161.76 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.069 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 10.5 m-85 -136.55 138.94 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' CE1' ' O ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -177.68 49.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.418 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.71 -78.54 0.19 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.619 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -141.47 -161.51 1.23 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.976 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.561 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -166.33 177.87 1.41 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.009 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -41.79 -23.67 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.473 2.115 . . . . 0.0 112.921 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.475 HD13 HG21 ' A' ' 93' ' ' ILE . 10.0 pt -141.19 64.59 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -54.53 -71.12 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.115 0.483 . . . . 0.0 110.662 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 64.0 -102.69 0.1 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.7 -12.17 10.9 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.908 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.97 -159.7 0.98 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.019 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.1 100.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 110.948 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.09 99.06 8.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.444 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 46.9 Cg_endo -68.16 -29.68 32.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.215 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 104' ' ' VAL . . . 176.39 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.661 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.8 -2.97 15.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.654 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -172.16 70.1 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.453 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 17.4 m -120.03 141.64 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.956 0.408 . . . . 0.0 111.8 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 1.8 m120 -83.83 153.1 24.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.285 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.84 89.66 3.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.121 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.87 23.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 114.71 -150.46 18.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.424 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 27.2 mtp180 -156.94 168.16 28.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.407 ' CD1' HG23 ' A' ' 75' ' ' VAL . 3.2 mt -98.05 114.59 35.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.568 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.99 -86.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.737 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -66.98 170.28 6.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.1 p 59.66 168.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 36.4 mmm -58.28 149.64 23.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 3.5 pm0 -131.29 36.17 3.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.89 45.31 1.3 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.755 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.49 ' HG ' HG13 ' A' ' 120' ' ' VAL . 1.5 tp -49.58 -34.7 18.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.41 -26.43 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.282 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.03 29.83 4.54 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.39 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.49 HG13 ' HG ' ' A' ' 117' ' ' LEU . 12.3 m -84.32 153.89 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.832 0.316 . . . . 0.0 111.381 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.67 147.18 32.08 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 5.2 p-10 -56.31 117.72 4.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.52 100.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.108 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.29 149.63 27.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.137 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.2 t -48.6 164.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 112.061 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.599 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 48.0 t -158.02 128.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.83 108.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.453 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.404 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.0 128.79 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.225 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -154.43 131.66 11.1 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.799 0.333 . . . . 0.0 111.542 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.432 ' HB2' HD23 ' A' ' 39' ' ' LEU . 3.1 tmm_? -74.25 92.85 2.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.867 179.771 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.795 0.331 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.2 170.24 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.525 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -147.27 -160.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.582 0.229 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 60.63 19.11 9.08 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.4 -28.12 0.16 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.61 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 27.0 m -112.94 62.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.419 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -156.59 43.47 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 112.11 24.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -109.15 145.42 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 112.156 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 163.27 17.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.7 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 144.86 32.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.885 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.89 101.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 109.749 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -100.09 156.12 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.71 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.8 m-85 -134.67 138.03 44.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.431 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.43 -28.91 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -125.56 22.37 7.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.14 150.26 1.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.415 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -131.92 139.23 48.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.188 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 149.2 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.7 0.286 . . . . 0.0 111.339 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -116.41 156.92 25.95 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.41 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.79 138.04 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.3 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 3.2 mt-10 -92.96 -178.3 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.325 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.4 tp -155.43 145.87 21.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.424 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 20.6 m-85 -126.65 146.71 50.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 29.6 mt-10 -56.59 -9.13 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.67 -27.4 0.79 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.212 -0.305 . . . . 0.0 111.383 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.518 ' CZ2' ' CG2' ' A' ' 31' ' ' THR . 6.6 t90 -80.56 -55.96 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 157.49 109.7 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.48 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.738 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 88.4 Cg_exo -40.9 -29.71 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.789 2.326 . . . . 0.0 112.967 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.97 -42.04 81.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.321 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.518 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.74 -45.03 72.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.784 0.326 . . . . 0.0 110.477 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 35.5 t -48.85 -33.64 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.244 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -58.03 -37.25 74.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.5 -48.44 69.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -51.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.04 -29.03 70.01 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.331 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.7 -24.76 61.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.62 51.47 0.93 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.886 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.522 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.886 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.6 Cg_exo -29.49 105.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.071 1.848 . . . . 0.0 113.969 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.8 mt -147.23 150.79 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.569 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.9 136.85 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.602 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.0 p -145.23 148.88 34.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.504 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 123.65 46.09 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.068 0.461 . . . . 0.0 110.263 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -83.49 135.04 34.81 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -107.26 126.43 52.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.679 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.529 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -89.43 137.4 32.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 14.4 t-105 -149.47 148.37 29.34 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.431 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.17 92.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.053 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 27.9 t70 78.87 -41.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.724 0.41 . . . . 0.0 111.649 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 152.55 24.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 111.425 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -153.0 117.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.627 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.2 p90 -124.06 141.68 51.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.345 0.593 . . . . 0.0 112.226 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.445 ' CD2' HG13 ' A' ' 126' ' ' VAL . 3.7 p90 -140.45 145.39 36.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.33 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.57 149.5 21.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.429 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.89 5.23 8.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.2 mm-40 83.32 -8.08 1.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.764 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.2 p -85.02 116.7 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.33 94.95 5.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 0.0 112.187 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.0 p -124.55 106.62 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.874 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.71 136.44 50.6 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.026 0.441 . . . . 0.0 111.708 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -156.86 164.62 37.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.233 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.79 91.02 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.7 tt0 -170.12 152.04 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.45 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.7 t-20 68.5 -79.96 0.04 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.4 m 23.8 80.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.47 158.67 16.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.558 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -120.64 -5.88 9.71 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.426 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.9 p -128.83 142.87 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.392 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.438 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 29.5 m -158.68 157.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -88.23 151.45 22.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.343 0.592 . . . . 0.0 111.412 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -50.43 126.2 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.143 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.53 -32.22 6.19 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.939 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.4 p-10 -68.98 162.49 26.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.074 0.464 . . . . 0.0 112.101 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' CD1' ' A' ' 110' ' ' ILE . 21.6 t -121.73 152.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.948 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.739 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.61 146.24 25.68 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.495 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.99 130.98 44.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.817 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.431 ' CD1' HG13 ' A' ' 104' ' ' VAL . 3.9 t90 -71.03 122.66 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.99 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.487 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -68.09 -67.84 0.75 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.903 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.487 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 47.1 Cg_endo -68.05 80.56 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.246 1.964 . . . . 0.0 112.181 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.46 -11.94 2.48 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 53.76 30.56 11.41 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.11 0.455 . . . . 0.0 110.749 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -109.65 135.07 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.63 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.5 mt -85.96 144.24 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.66 130.7 30.39 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.36 156.86 19.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.09 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.7 m-85 -136.5 130.13 32.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 2.6 m-85 -152.51 28.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 151.07 -151.78 23.7 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.518 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -40.73 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.484 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -151.2 -174.62 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 79.6 Cg_exo -46.18 -24.19 2.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.748 1.632 . . . . 0.0 112.297 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.94 55.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -48.99 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 49.25 58.46 5.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.702 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.2 11.41 4.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 94' ' ' SER . 2.7 mmpt? -149.02 177.68 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 67.8 mt -123.53 129.11 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.7 mtt85 -136.33 99.2 10.93 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.556 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 54.0 Cg_endo -68.21 -31.66 28.67 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.44 2.093 . . . . 0.0 112.331 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 177.0 -161.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.748 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.16 -7.68 15.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.53 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.39 71.24 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 14.5 m -118.36 141.92 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.472 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 31.7 m-20 -82.15 150.94 27.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.51 92.61 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.739 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -79.17 19.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.423 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.11 -148.24 18.21 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.087 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -155.93 167.87 29.03 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.964 0.411 . . . . 0.0 111.518 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.413 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -94.15 114.8 31.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -54.09 -77.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -75.67 75.84 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -73.07 64.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -147.5 30.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -120.35 7.28 10.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.418 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 115' ' ' GLU . . . 21.3 46.39 0.01 OUTLIER Glycine 0 C--N 1.339 0.723 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' GLU . 7.4 tt -42.5 -35.2 0.99 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.421 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.9 -24.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.727 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.455 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.34 32.54 4.11 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.452 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 12.1 m -74.94 154.54 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.272 0.229 . . . . 0.0 110.825 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.45 144.53 46.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 12.2 p-10 -58.02 112.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.423 . . . . 0.0 111.866 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.2 103.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.522 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -158.16 151.49 23.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.934 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.11 164.54 0.11 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.307 0.575 . . . . 0.0 112.196 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.602 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 58.6 t -158.07 128.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.37 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.4 m -126.51 108.39 18.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 111.356 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.429 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.01 128.84 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.461 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.7 pt-20 -153.26 129.64 10.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.672 0.273 . . . . 0.0 111.274 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.462 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.81 89.96 2.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.798 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.8 0.333 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.57 43.69 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.533 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.65 -158.7 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.571 0.224 . . . . 0.0 110.725 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.39 -82.52 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.616 0.246 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.09 -41.55 0.19 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.586 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.414 ' O ' HG21 ' A' ' 6' ' ' VAL . 32.6 m -120.19 65.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 111.372 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -159.89 44.22 0.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.956 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.59 109.33 21.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.833 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -106.66 145.32 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.205 0.526 . . . . 0.0 112.29 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.97 164.72 15.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.66 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 147.29 36.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.787 0.327 . . . . 0.0 111.11 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -142.88 102.92 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -102.37 156.24 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.481 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' CE1' HG22 ' A' ' 126' ' ' VAL . 43.9 m-85 -139.01 138.59 37.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.104 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -125.7 22.97 7.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.38 154.67 1.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.46 147.04 50.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 149.79 14.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.19 156.94 47.46 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.142 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.33 149.87 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 111.631 -179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 13.5 mt-10 -102.23 -178.64 3.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.974 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.541 HD11 HG12 ' A' ' 107' ' ' ILE . 4.1 tp -153.29 149.52 27.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.11 0.481 . . . . 0.0 111.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -127.24 148.87 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.2 -8.97 0.55 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -45.61 -27.49 0.79 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.967 0.349 . . . . 0.0 111.533 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.505 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -82.42 -56.53 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 157.42 116.16 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.416 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -45.89 -34.41 12.34 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.478 2.119 . . . . 0.0 112.383 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -61.63 -49.99 74.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.484 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.38 -44.85 93.57 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.606 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 24.9 t -49.15 -31.48 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -61.97 -38.16 87.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.63 80.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.23 -51.31 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.02 -28.09 69.34 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.087 0.47 . . . . 0.0 110.445 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.85 -23.5 59.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.62 51.37 0.84 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.661 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.907 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.5 mt -61.95 -159.9 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.692 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.907 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.0 Cg_exo -27.66 105.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.167 1.911 . . . . 0.0 114.156 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.8 mt -147.18 150.71 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.395 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 135.42 33.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 0.0 111.748 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.5 p -146.06 149.13 33.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.391 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 132.03 47.69 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB1' ' CZ ' ' A' ' 47' ' ' ARG . . . -90.11 136.07 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -100.79 117.55 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.914 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' NH1' ' HB ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.11 133.0 33.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.4 t-105 -154.21 148.81 26.33 Favored 'General case' 0 C--O 1.229 0.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -30.72 85.61 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.282 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.0 t70 73.31 -37.8 0.39 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.542 0.337 . . . . 0.0 111.521 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' GLY . 6.1 tt0 -72.08 129.29 38.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.855 0.359 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -133.26 124.63 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.129 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.41 ' CE1' ' ND2' ' A' ' 46' ' ' ASN . 55.0 p90 -135.7 133.15 37.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.944 0.402 . . . . 0.0 111.644 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.422 ' CE2' HG12 ' A' ' 126' ' ' VAL . 6.3 p90 -138.83 145.44 40.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.6 148.52 22.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.162 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.436 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.99 5.87 9.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 83.38 -8.18 1.11 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.89 114.15 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.124 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.31 98.47 8.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 112.055 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.43 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.1 p -134.42 106.81 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -126.64 133.93 50.87 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.054 0.454 . . . . 0.0 111.555 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 31.8 tttt -140.07 164.77 29.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.292 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -99.23 86.94 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.778 0.323 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.7 tt0 -170.18 160.61 8.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.4 t-20 63.31 -82.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 65' ' ' ASN . 5.4 m 26.48 81.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.65 161.08 13.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.349 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -122.62 -7.44 8.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.423 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.3 p -126.7 141.6 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 27.4 m -159.27 146.9 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.14 152.76 21.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 0.0 110.953 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -41.23 124.01 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.348 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -32.31 6.04 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.058 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 127.05 31.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.818 0.309 . . . . 0.0 111.505 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 t -94.8 150.62 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.541 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -145.65 153.04 40.58 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.516 0.598 . . . . 0.0 112.474 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 122.63 48.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.091 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.3 t90 -61.84 127.22 30.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.087 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.461 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -75.13 -64.19 0.63 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.893 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.461 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 46.3 Cg_endo -67.8 85.55 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.283 1.988 . . . . 0.0 112.025 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.43 -6.75 5.3 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.38 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.16 36.88 13.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.95 134.19 51.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.37 149.42 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.504 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 34.7 t -143.16 156.53 44.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.265 0.555 . . . . 0.0 112.492 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.99 158.59 18.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.415 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 12.9 m-85 -136.67 127.11 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.515 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -168.62 51.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.677 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.74 -80.78 0.13 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.44 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -155.89 176.92 12.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.036 0.446 . . . . 0.0 111.926 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.488 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -143.52 -174.32 0.4 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.488 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 97.0 Cg_exo -45.02 -22.81 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.131 1.887 . . . . 0.0 112.934 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 99' ' ' ARG . 1.6 mp -132.44 76.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.872 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.44 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -89.41 20.72 3.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.78 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.573 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.0 -9.14 15.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.281 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -155.36 -172.58 4.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.4 mt -103.9 106.4 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 27.9 mmm-85 -99.89 99.35 8.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.482 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 64.1 Cg_endo -71.24 -32.14 13.31 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.513 2.142 . . . . 0.0 112.579 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.62 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.816 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.69 -5.38 13.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.96 71.65 0.07 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 16.6 m -121.34 142.04 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.696 0.284 . . . . 0.0 111.222 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 1.7 m-20 -85.86 153.0 22.55 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.14 101.99 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.541 HG12 HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -87.51 22.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.4 -148.6 18.74 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.196 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -154.84 163.0 40.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -92.12 113.8 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.292 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.37 -86.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -73.56 63.95 0.85 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.267 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.71 41.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 ttt -69.15 70.52 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -166.04 1.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.137 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.46 45.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.393 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.432 ' CD1' ' CD2' ' A' ' 14' ' ' PHE . 5.2 tp -43.13 -38.64 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.515 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.78 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.062 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.27 34.98 3.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.423 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.525 ' HB ' ' NH1' ' A' ' 47' ' ' ARG . 3.3 m -81.5 153.75 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.7 147.31 43.73 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.379 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.481 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 2.4 p30 -53.35 135.86 38.28 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.433 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 55.32 99.4 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.243 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.01 153.29 41.32 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.92 157.74 24.05 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.482 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.614 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 47.5 t -148.54 129.05 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.023 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.401 ' CG2' ' CG ' ' A' ' 13' ' ' ARG . 24.9 m -124.27 107.13 17.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.436 HG22 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.37 128.97 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.739 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.448 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.2 OUTLIER -150.96 128.23 11.27 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.714 0.292 . . . . 0.0 111.147 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.44 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 90.91 3.05 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.688 179.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.86 0.362 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.66 -84.74 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -107.92 -62.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 0.0 110.994 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 58.45 20.77 7.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.62 -32.08 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.719 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 6' ' ' VAL . 32.8 m -118.34 65.9 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.207 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.26 47.26 1.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.01 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.6 115.37 29.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.79 145.22 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 112.346 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 163.67 19.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.507 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 144.62 31.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -145.89 100.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -108.77 156.21 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.832 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.499 ' CG ' HD11 ' A' ' 117' ' ' LEU . 2.9 m-85 -126.49 143.7 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.154 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -28.67 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.0 t -121.69 23.07 10.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.76 154.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.631 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -127.53 142.79 51.29 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.16 149.49 12.2 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.676 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -121.9 158.16 29.59 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.349 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.59 142.84 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.78 -178.27 4.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.498 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.416 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.5 tp -152.72 140.39 19.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.963 0.411 . . . . 0.0 110.95 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.13 143.14 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -8.49 2.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.02 -29.63 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.521 ' CE2' HG23 ' A' ' 31' ' ' THR . 0.5 OUTLIER -76.77 -54.14 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.128 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' HA ' ' HD2' ' A' ' 29' ' ' PRO . . . 162.59 116.24 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.804 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.4 Cg_endo -47.4 -34.61 19.52 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.578 2.185 . . . . 0.0 112.504 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.51 -37.51 80.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.353 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 HG23 ' CE2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.72 -43.95 74.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 110.28 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 65.3 t -50.04 -38.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.716 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -56.87 -35.13 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.72 -47.06 70.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.799 0.333 . . . . 0.0 111.011 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -49.24 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.601 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.1 -29.63 70.95 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.144 0.497 . . . . 0.0 110.284 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -70.43 -25.76 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.554 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.39 52.79 0.94 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.849 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.918 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.68 -159.91 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.692 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.918 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 27.9 Cg_exo -28.04 106.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.18 1.92 . . . . 0.0 114.099 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.6 mt -148.18 150.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.514 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -85.87 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 111.759 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.602 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -146.05 149.12 33.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.361 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.72 130.42 48.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.912 0.387 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -91.88 133.12 35.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -103.39 128.38 50.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.004 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -88.6 138.21 31.63 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.3 t-105 -155.1 148.98 25.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -37.31 97.16 0.01 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.492 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 88' ' ' PHE . 1.6 t0 53.27 24.6 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 111.356 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 136.93 39.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.489 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -138.4 129.42 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 52.6 p90 -137.92 122.11 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.371 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' VAL . 2.9 p90 -131.29 146.36 52.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 148.9 21.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.423 HG22 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.73 6.33 8.8 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER 82.89 -8.01 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -86.05 114.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.258 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.48 96.04 6.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 111.855 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.41 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 5.9 p -133.14 106.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.253 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -130.87 133.5 45.96 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.535 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.418 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 40.5 tttm -145.08 165.55 27.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.372 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.09 90.06 4.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.454 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.5 tt0 -170.21 158.49 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.454 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 35.8 t-20 63.21 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.85 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 19.9 m 25.63 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.326 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -104.13 162.03 13.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.852 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -120.94 -12.16 8.82 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.4 p -121.27 143.25 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.439 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.51 HG21 ' CZ ' ' A' ' 87' ' ' PHE . 36.0 m -158.31 157.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.71 150.15 24.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.338 0.59 . . . . 0.0 111.053 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.63 125.01 15.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.939 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.98 -31.43 6.53 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.223 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.2 p-10 -69.24 165.72 19.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 117.16 0.48 . . . . 0.0 111.825 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 76' ' ' ALA . 24.9 t -119.99 152.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.609 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.44 148.92 30.01 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.442 0.565 . . . . 0.0 112.381 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -104.57 135.42 46.02 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.161 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.454 ' O ' ' CE1' ' A' ' 77' ' ' TYR . 2.0 t90 -76.6 108.7 9.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.52 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -56.73 -70.65 0.32 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.145 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.52 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -58.64 87.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.266 1.977 . . . . 0.0 112.347 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.39 -6.03 5.61 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.774 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.8 32.42 9.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.959 0.38 . . . . 0.0 110.582 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.66 131.68 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.764 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.451 HG22 HD12 ' A' ' 84' ' ' ILE . 11.4 mt -87.76 150.6 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.087 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 18.6 t -143.34 156.35 44.67 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.37 137.8 54.54 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.144 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 70' ' ' VAL . 14.9 p90 -136.65 139.76 42.26 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.029 -0.419 . . . . 0.0 111.491 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -149.55 53.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.048 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.22 -135.03 5.47 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -57.35 -173.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.676 0.738 . . . . 0.0 111.2 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -167.93 -174.14 0.33 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.932 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 88.2 Cg_exo -45.83 -21.4 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.816 1.677 . . . . 0.0 112.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.2 mt -143.36 60.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -49.52 -75.4 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 110.761 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.62 -103.43 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.84 -8.46 11.34 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.725 0.298 . . . . 0.0 111.042 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -158.08 0.83 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.125 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.2 mt -123.13 117.61 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 111.275 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.64 99.42 52.81 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.998 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.61 -29.69 78.24 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.472 2.115 . . . . 0.0 112.604 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 173.37 -162.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.798 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.59 -5.92 22.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.536 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -176.31 77.54 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.413 HG13 ' CB ' ' A' ' 101' ' ' ALA . 24.5 m -125.35 141.5 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 111.611 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' A' ' 77' ' ' TYR . 1.4 m-20 -81.88 153.91 26.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.261 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -84.23 81.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.609 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -64.86 19.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.253 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 117.51 -138.07 13.81 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.849 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 74' ' ' ASP . 4.2 ptt180 -170.51 162.19 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -88.49 115.75 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -83.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.217 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -153.62 135.98 14.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.057 0.455 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.91 -58.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.481 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.2 tpt 179.01 77.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.407 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 10.4 pt-20 -70.31 63.02 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.09 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.18 13.62 3.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.906 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 14' ' ' PHE . 3.8 tp -56.87 -43.22 81.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.909 0.355 . . . . 0.0 111.104 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.19 -25.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.04 30.21 6.01 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.559 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.455 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 2.7 m -71.02 154.47 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 122.334 0.254 . . . . 0.0 111.56 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.18 148.57 32.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.581 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.7 p-10 -57.0 109.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.462 . . . . 0.0 111.947 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.04 101.54 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.93 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.02 154.46 33.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.969 0.414 . . . . 0.0 110.845 178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.66 167.24 0.77 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.964 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.602 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 58.6 t -158.01 129.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 28.4 m -127.78 108.05 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.311 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.31 128.79 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.457 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 5.2 pt-20 -153.75 131.62 11.64 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 111.29 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.11 89.89 3.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.85 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.748 179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.83 0.348 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.32 108.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.34 -38.4 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.66 -71.91 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.755 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.31 89.89 0.08 OUTLIER Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.354 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.402 ' O ' HG22 ' A' ' 6' ' ' VAL . 28.9 m -140.12 77.53 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.062 0.458 . . . . 0.0 111.232 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.98 33.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.28 105.95 14.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -116.9 145.39 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.173 0.511 . . . . 0.0 112.125 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.35 163.6 15.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.621 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 147.24 31.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.4 OUTLIER -143.93 102.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -100.5 156.36 17.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.446 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 126' ' ' VAL . 6.8 m-85 -139.71 134.9 32.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.72 -29.14 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -125.02 22.45 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.7 153.09 1.37 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.377 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.87 142.79 50.85 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.866 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.81 149.32 12.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.767 0.318 . . . . 0.0 111.475 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -128.77 158.9 37.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.056 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.1 144.16 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.657 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.0 mt-10 -97.47 -178.5 4.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.906 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.57 HD11 HG12 ' A' ' 107' ' ' ILE . 6.1 tp -153.52 148.1 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -125.37 148.14 48.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.692 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -57.54 -8.97 0.96 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.37 -28.3 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.259 -0.276 . . . . 0.0 111.512 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.506 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.77 -56.5 3.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.66 117.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.58 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.77 -34.76 12.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.449 2.1 . . . . 0.0 112.223 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -60.52 -52.0 67.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.476 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.01 -45.44 94.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.833 0.349 . . . . 0.0 110.349 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.4 t -49.83 -30.41 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.207 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -28.72 70.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.52 39.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.715 0.293 . . . . 0.0 110.979 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.36 -51.46 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.08 -28.64 69.75 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.362 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.44 -24.6 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 51.49 0.93 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.918 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -61.71 -160.09 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.622 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.918 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 24.6 Cg_exo -27.66 107.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.297 1.998 . . . . 0.0 114.085 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.0 mt -149.62 151.06 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.513 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 136.37 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.597 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.05 148.99 33.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.483 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 129.5 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.199 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB1' ' CG2' ' A' ' 126' ' ' VAL . . . -92.79 130.76 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -97.81 133.12 42.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.506 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.579 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.2 OUTLIER -100.05 133.02 45.05 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ASP . 1.9 t90 -157.22 148.32 21.77 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -25.6 87.29 0.01 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.203 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' TRP . 13.0 t70 69.12 -40.94 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 49' ' ' GLY . 15.6 tt0 -62.72 118.99 8.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.636 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -129.01 114.68 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.763 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -126.37 126.96 44.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.445 -179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.31 145.99 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 149.75 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.056 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -123.71 4.48 8.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.5 OUTLIER 83.2 -8.09 1.14 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.798 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.13 114.97 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.08 94.78 5.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 111.94 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 6.6 p -127.62 106.71 15.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.901 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' HG2' HG22 ' A' ' 79' ' ' ILE . 1.8 mt-10 -127.92 134.37 49.33 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.966 0.412 . . . . 0.0 111.898 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 13.8 tttp -142.14 165.74 26.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -103.63 88.65 3.12 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.058 0.456 . . . . 0.0 111.33 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.1 tt0 -170.2 161.38 8.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.443 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.2 t-20 63.9 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.469 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 13.2 m 30.8 81.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.732 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -99.58 157.41 16.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.209 178.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.29 -7.24 10.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.2 144.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.67 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.461 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.3 m -157.86 156.84 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -99.65 149.03 23.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.03 126.87 2.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.094 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.01 6.1 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.197 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.461 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.86 157.38 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.457 0.629 . . . . 0.0 111.945 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.32 152.61 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.252 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.528 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.69 150.94 34.06 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -110.62 132.43 54.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.687 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.667 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.3 t90 -73.62 143.71 46.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.189 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.644 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -94.13 -54.26 0.24 Allowed Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.667 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 8.6 Cg_exo -72.3 72.36 2.87 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.529 2.153 . . . . 0.0 111.649 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 143.05 -7.65 2.13 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.513 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 52.57 34.64 16.07 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.977 0.388 . . . . 0.0 110.867 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.84 131.13 55.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 4.3 mt -89.3 150.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.278 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.636 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -141.28 155.73 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.27 0.557 . . . . 0.0 112.259 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.01 161.59 15.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.482 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.497 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 28.2 m-85 -136.48 141.12 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' CD1' ' O ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER 175.34 43.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.9 -82.81 0.11 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.154 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -144.37 -168.75 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.469 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.468 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -162.45 -177.96 0.78 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.712 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 80.8 Cg_exo -42.5 -27.53 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.324 2.016 . . . . 0.0 112.81 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.423 ' HB ' ' HB2' ' A' ' 99' ' ' ARG . 3.3 mp -131.31 75.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.179 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.531 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -97.13 26.68 4.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.03 -82.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.229 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -88.71 -45.37 9.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -141.64 170.44 15.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 43.8 mt -75.9 98.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.423 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 12.9 mmm-85 -100.15 99.15 8.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.497 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.3 Cg_endo -69.63 -31.69 20.59 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.565 2.177 . . . . 0.0 112.655 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.403 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.29 -162.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.93 -9.4 15.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.537 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.31 72.76 0.19 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.484 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 19.7 m -121.36 141.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.815 0.341 . . . . 0.0 111.406 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' OD1' ' N ' ' A' ' 66' ' ' SER . 30.4 m-20 -85.35 151.47 24.0 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.67 98.17 7.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.57 HG12 HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.43 23.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.53 -159.94 13.74 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.663 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' N ' ' CD ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -143.26 168.19 20.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 111.717 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.94 115.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.601 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -85.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -85.03 -173.49 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 111.102 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.4 m 62.23 160.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -54.98 108.66 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 4.6 pm0 -90.75 17.16 7.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.371 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.39 43.31 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.333 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' HG ' HG13 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -49.41 -30.31 7.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.12 -27.2 0.12 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.917 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.99 30.01 4.06 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.4 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.499 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 3.9 m -81.81 154.33 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.943 0.371 . . . . 0.0 111.246 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.33 147.21 34.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.579 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 11.2 p-10 -55.35 116.46 2.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.072 0.463 . . . . 0.0 112.14 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.59 103.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.626 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -154.95 149.57 26.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 165.68 0.07 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.189 0.519 . . . . 0.0 112.173 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.597 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 43.9 t -158.09 128.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.61 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.54 107.89 19.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 111.233 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.418 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.99 128.6 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.521 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.469 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.3 pt-20 -152.12 130.46 12.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.667 0.27 . . . . 0.0 111.261 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.444 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -77.46 95.16 4.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.785 179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.733 0.301 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.97 -107.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -99.73 19.84 15.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.31 19.77 6.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.151 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 24' ' ' TYR . . . 179.13 86.83 0.07 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.49 92.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.984 0.421 . . . . 0.0 110.778 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -92.0 -126.55 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.546 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 40.7 tpp -125.19 143.16 51.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.04 145.36 27.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.09 156.69 25.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.965 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.51 141.63 36.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.066 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -141.73 100.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.02 156.11 17.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.028 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -133.17 138.58 46.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.322 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.08 -28.83 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 p -123.49 23.0 9.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 150.48 1.29 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.63 140.64 47.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.207 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.53 149.38 9.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.626 0.251 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.46 157.23 25.5 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.514 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.2 141.1 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 111.132 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.435 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 12.6 mt-10 -98.75 -178.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.057 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.431 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.5 tp -151.89 144.43 24.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.09 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 15.8 m-85 -120.76 146.46 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.553 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.44 -9.46 0.71 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -45.93 -27.58 0.93 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.197 -0.315 . . . . 0.0 111.363 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.525 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 6.6 t90 -80.23 -56.35 4.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 152.48 115.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.665 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -45.55 -36.19 13.53 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.05 -52.85 63.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -60.76 -45.66 93.49 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.356 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 23.8 t -48.9 -29.55 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.31 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -59.58 -38.54 81.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.63 73.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.671 0.272 . . . . 0.0 111.204 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.66 -51.78 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.29 -28.67 69.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.31 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -71.65 -25.02 61.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.373 . . . . 0.0 110.641 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.54 50.96 0.99 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.977 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.887 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 mt -62.42 -160.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.528 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.887 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 34.0 Cg_exo -29.35 106.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.191 1.927 . . . . 0.0 113.934 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.5 mt -149.99 149.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.635 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.82 136.78 33.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.097 0.475 . . . . 0.0 111.86 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.581 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.5 p -145.79 149.1 33.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.439 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 122.43 43.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.053 0.454 . . . . 0.0 110.285 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -81.14 132.44 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -104.33 123.84 48.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.597 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.93 137.33 32.46 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.4 t-105 -149.54 148.54 29.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.348 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.445 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.18 91.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.241 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 48' ' ' TRP . 35.7 t70 78.64 -42.0 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.536 0.334 . . . . 0.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' HG3' ' CG2' ' A' ' 91' ' ' THR . 4.6 mt-10 -80.5 150.87 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.2 OUTLIER -149.73 115.88 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.574 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.7 p90 -123.4 136.45 54.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 111.969 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' CD2' HG11 ' A' ' 126' ' ' VAL . 5.1 p90 -136.46 145.34 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.522 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.32 146.73 23.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -121.92 6.96 9.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.8 mt-30 82.07 -7.36 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.722 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.6 p -86.21 115.6 27.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.066 0 CA-C-O 120.79 0.328 . . . . 0.0 110.289 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.68 96.06 6.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.8 p -123.85 106.66 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.133 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.51 133.36 52.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.959 0.409 . . . . 0.0 111.515 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -147.61 164.48 33.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.261 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -100.54 83.46 2.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 110.757 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.21 154.71 5.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.521 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 21.2 t-20 71.67 -78.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.473 ' C ' ' O ' ' A' ' 65' ' ' ASN . 9.0 t 18.69 81.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.82 164.06 11.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.813 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -125.61 -5.6 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 39.6 t -131.8 141.92 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.9 m -158.31 157.97 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.59 152.06 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.308 0.575 . . . . 0.0 111.39 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.36 127.1 16.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.124 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.62 -32.33 6.11 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.819 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.43 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.7 p-10 -69.64 162.06 28.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.114 0.483 . . . . 0.0 111.927 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.422 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -122.54 152.45 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.911 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.15 147.14 26.68 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -97.7 121.57 39.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.954 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.511 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.5 t90 -64.21 117.77 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.037 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.641 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -69.07 -69.5 0.44 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 42.6 Cg_exo -54.73 85.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.796 1.664 . . . . 0.0 111.968 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 128.8 -6.74 6.51 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.647 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.99 37.68 14.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.035 0.417 . . . . 0.0 110.959 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . -113.11 137.0 52.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.678 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.6 mt -86.29 148.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.39 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.7 t -143.15 155.33 44.54 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.31 0.576 . . . . 0.0 112.444 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.89 156.21 22.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.949 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.446 ' CE2' ' HB1' ' A' ' 76' ' ' ALA . 3.9 m-85 -136.91 127.42 26.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.546 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.7 m-85 -147.57 29.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.343 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 150.47 -150.29 22.29 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.64 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -38.67 170.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.41 -176.44 0.61 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 94.3 Cg_exo -43.82 -25.86 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.989 1.792 . . . . 0.0 112.283 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.31 54.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.424 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -50.27 -40.62 48.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.234 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -47.22 -62.04 1.61 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.96 56.98 2.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.9 164.72 0.15 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.72 0.295 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.76 103.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -107.58 99.48 29.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.917 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.427 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 37.5 Cg_endo -64.57 -29.6 61.19 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.491 2.127 . . . . 0.0 112.6 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.46 ' HB2' ' CZ2' ' A' ' 78' ' ' TRP . . . 177.71 -164.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.09 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -6.16 23.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -178.06 80.38 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.446 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 7.1 m -125.96 142.39 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.521 ' HB3' ' ND2' ' A' ' 65' ' ' ASN . 15.1 m-20 -83.19 151.85 25.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.485 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.04 87.68 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.737 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -72.76 16.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.366 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.01 -149.68 18.76 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 7.3 mtp-105 -156.84 168.08 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.42 HG13 ' CG2' ' A' ' 75' ' ' VAL . 6.1 mt -100.28 114.82 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.357 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -87.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.626 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -70.79 143.73 51.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.958 0.409 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.53 28.14 15.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.214 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.42 ' HE3' ' CZ ' ' A' ' 88' ' ' PHE . 4.6 ttt -66.87 152.67 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.532 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -160.67 173.68 15.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 111.43 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.65 46.21 2.75 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.424 ' HG ' HG12 ' A' ' 120' ' ' VAL . 7.2 tt -42.25 -31.98 0.45 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.69 -27.22 0.16 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.0 32.31 3.53 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.983 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.536 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 5.6 m -73.11 154.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -75.91 147.47 38.96 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -58.55 108.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.072 0.463 . . . . 0.0 111.684 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.49 103.45 0.17 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.464 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -154.46 154.59 33.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.743 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t -53.26 164.16 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 111.748 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.581 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 46.9 t -158.02 128.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.577 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.3 m -126.66 108.11 18.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.401 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.94 128.74 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.337 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.459 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.7 pt-20 -153.54 130.73 11.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.672 0.272 . . . . 0.0 111.532 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.453 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.09 88.24 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.655 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.79 0.328 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.37 155.5 22.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.414 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.34 -32.63 55.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 67.94 -69.94 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.23 -28.8 0.22 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.352 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 33.7 m -123.82 67.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.228 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -153.9 40.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.223 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.03 111.38 24.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.48 145.44 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.541 . . . . 0.0 112.219 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.18 164.16 15.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.559 178.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.54 35.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.414 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -144.22 103.35 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -102.21 156.36 17.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.501 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.49 ' CE2' HG22 ' A' ' 126' ' ' VAL . 13.7 m-85 -138.18 137.71 37.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.763 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.44 -28.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.06 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 p -125.96 22.66 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.43 154.38 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.43 144.44 51.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.851 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.22 149.2 11.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.543 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.62 157.11 39.77 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.159 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.06 138.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mp0 -92.45 -178.53 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.296 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.538 HD12 HG12 ' A' ' 107' ' ' ILE . 7.0 tp -152.74 146.63 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.444 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-85 -123.33 146.53 47.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -57.17 -9.16 0.84 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -45.81 -25.79 0.57 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 122.259 -0.276 . . . . 0.0 111.551 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 6.9 t90 -81.14 -56.17 4.26 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 153.19 116.03 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.77 -27.78 5.98 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.488 2.126 . . . . 0.0 112.467 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.05 -43.35 78.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.306 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.514 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -70.25 -46.04 65.22 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.65 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.407 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 24.4 t -47.53 -29.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -60.36 -38.59 84.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.44 75.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.723 0.296 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -50.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.48 -27.23 69.13 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.39 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.838 0.351 . . . . 0.0 110.721 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.06 49.46 1.01 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.892 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.893 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.8 mt -61.82 -159.94 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.592 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.893 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.3 Cg_exo -28.52 106.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.158 1.905 . . . . 0.0 114.081 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.8 mt -149.28 149.66 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.507 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -85.91 134.09 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.965 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.604 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -145.32 149.57 35.06 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.61 132.7 47.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 47' ' ' ARG . . . -90.66 137.32 32.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -106.8 120.11 41.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.277 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' NH2' HG12 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -84.69 127.25 34.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.7 t-105 -146.71 148.43 31.99 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.41 93.02 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.196 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 25.3 t70 72.03 -38.29 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.306 0.242 . . . . 0.0 111.585 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' H ' ' C ' ' A' ' 49' ' ' GLY . 0.2 OUTLIER -78.94 139.38 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 110.875 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.556 HG12 ' NH2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -144.64 112.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.668 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 40.6 p90 -123.78 139.68 53.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.5 p90 -141.3 142.85 33.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.447 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.38 145.94 24.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.409 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.92 4.96 10.92 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 82.63 -7.38 1.27 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.56 116.08 28.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.209 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.59 94.87 6.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 111.707 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' HG23 ' A' ' 31' ' ' THR . 6.3 p -124.88 106.58 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.327 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -133.57 132.33 40.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.962 0.41 . . . . 0.0 111.442 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 163.76 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.47 88.15 5.82 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.878 0.37 . . . . 0.0 110.753 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.14 148.01 3.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.52 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 28.9 t-20 72.04 -83.18 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.463 0.173 . . . . 0.0 110.981 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.1 m 23.16 82.11 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -99.68 162.66 12.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.282 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.1 p30 -122.5 -0.09 9.3 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 47.2 t -138.53 145.36 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.101 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.421 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 26.8 m -158.75 158.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -94.05 150.81 20.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.16 124.96 7.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.35 -29.73 7.44 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.364 -0.922 . . . . 0.0 114.703 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -78.57 156.98 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.593 0.697 . . . . 0.0 111.921 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.416 HG11 ' N ' ' A' ' 76' ' ' ALA . 21.6 t -111.06 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.561 ' HB2' ' O ' ' A' ' 105' ' ' ASN . . . -149.3 150.34 32.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.977 0.417 . . . . 0.0 111.658 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.506 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -105.46 131.65 52.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.404 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.451 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.8 t90 -71.99 113.07 8.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.638 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -68.25 -66.16 1.17 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.621 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.638 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.39 80.28 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.932 1.755 . . . . 0.0 111.663 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.48 -8.13 3.13 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.596 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.447 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.18 37.2 17.72 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.857 0.361 . . . . 0.0 111.126 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.45 137.51 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.79 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 3.7 mt -87.58 147.64 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.43 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.3 m -142.86 131.53 22.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 HD11 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.99 159.78 18.87 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.373 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 35.0 m-85 -136.63 132.51 35.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.21 0.529 . . . . 0.0 111.878 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.446 ' CB ' ' HG2' ' A' ' 118' ' ' LYS . 1.4 m-85 -165.21 33.32 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.057 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.22 -150.53 21.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.388 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.487 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.19 -172.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.458 0.647 . . . . 0.0 112.131 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -159.83 -176.11 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.522 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 66.2 Cg_exo -41.81 -25.29 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.273 1.982 . . . . 0.0 113.042 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -146.65 67.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 111.678 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -50.98 -75.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.166 0.508 . . . . 0.0 110.483 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 64.47 -97.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.032 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -115.41 -27.34 7.22 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.81 0.338 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -128.43 -163.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.73 116.69 53.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.874 0.368 . . . . 0.0 110.962 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HB2' HG12 ' A' ' 93' ' ' ILE . 1.8 mtt85 -117.74 99.54 52.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 58.7 Cg_endo -69.73 -31.31 20.89 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.6 2.2 . . . . 0.0 112.564 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.11 -160.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.807 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -5.23 14.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.565 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.43 73.98 0.11 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.492 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 21.2 m -124.02 140.46 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 111.477 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.561 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 6.0 m-20 -84.66 150.37 25.18 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.59 100.35 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.538 HG12 HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.02 21.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.2 -129.46 8.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.192 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HB3' ' HA ' ' A' ' 74' ' ' ASP . 6.5 ptt180 -170.4 167.19 8.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.04 0.448 . . . . 0.0 111.484 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.8 mp -93.06 116.37 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.667 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -81.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.038 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -157.3 141.04 15.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.951 0.405 . . . . 0.0 111.131 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m 173.95 -36.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.626 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -168.57 -45.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 45.2 mt-10 58.76 20.46 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.353 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.39 31.97 2.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.988 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' CD2' HD11 ' A' ' 86' ' ' LEU . 4.5 tp -58.32 -42.72 87.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.973 0.387 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HG2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.6 -21.32 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.408 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -89.92 30.68 5.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.705 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.412 HG21 ' NH1' ' A' ' 47' ' ' ARG . 3.6 m -81.28 153.65 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 122.232 0.213 . . . . 0.0 111.34 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.491 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.63 143.47 46.3 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 4.6 p-10 -51.07 131.98 27.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.07 100.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.347 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -148.1 154.25 39.96 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 t -63.13 168.34 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.436 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.604 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 48.3 t -157.97 128.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.955 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.6 m -125.27 106.59 16.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 110.718 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.409 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.85 129.07 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.822 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.5 pt-20 -151.41 126.94 10.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.663 0.268 . . . . 0.0 111.327 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.458 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.36 92.16 2.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.817 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.743 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.57 27.17 5.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.393 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.26 -159.1 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.455 0.169 . . . . 0.0 110.782 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 63.84 19.34 11.69 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.54 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.617 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.6 p -90.38 54.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.327 0.584 . . . . 0.0 111.095 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.38 36.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -99.17 90.1 4.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.037 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -84.09 145.47 28.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.754 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.76 164.05 15.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.104 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 144.09 33.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.3 mt -145.11 100.39 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 109.963 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 156.04 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.965 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.0 m-85 -134.6 142.64 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.025 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.3 -29.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.7 m -126.2 20.89 7.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -179.13 155.92 0.75 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.37 148.89 30.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.9 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.65 150.05 11.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.46 156.54 18.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.759 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.22 140.19 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.7 mt-10 -90.91 -178.48 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.657 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 7.2 tp -147.73 136.26 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.077 0.465 . . . . 0.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.84 141.0 49.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.619 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.6 -8.95 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -45.38 -29.0 0.96 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.295 -0.253 . . . . 0.0 111.31 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.515 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -78.3 -56.69 4.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.57 118.54 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.775 178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.42 -33.31 12.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.436 2.091 . . . . 0.0 112.338 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.38 -52.27 66.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.848 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.425 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -66.31 -44.12 84.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.82 0.343 . . . . 0.0 110.419 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.425 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 75.8 t -44.62 -31.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.347 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -64.45 -38.32 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.93 -47.65 79.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.77 -52.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.15 -27.48 69.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.43 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.26 -25.39 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.57 50.71 1.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.797 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.895 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -61.73 -160.04 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.612 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.895 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.5 Cg_exo -28.95 103.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.116 1.877 . . . . 0.0 113.887 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 39' ' ' LEU . 18.5 mt -145.74 151.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.567 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 136.69 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.089 0.471 . . . . 0.0 111.604 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -145.1 148.91 34.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.94 127.19 48.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.037 0.446 . . . . 0.0 110.313 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -87.03 136.13 33.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -108.34 122.97 48.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.686 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.39 138.27 35.62 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 10.9 t-105 -153.87 148.95 26.83 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.862 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.03 94.51 0.01 OUTLIER Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.524 -0.37 . . . . 0.0 113.781 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 3.7 m-20 51.85 25.42 2.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.896 0.379 . . . . 0.0 111.578 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.2 138.91 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.149 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -137.29 119.93 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.225 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.2 p90 -128.5 126.94 41.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.492 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.8 p90 -135.49 145.93 47.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.94 149.65 21.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.455 HG22 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.22 7.9 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.41 -8.77 1.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.722 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -86.31 114.0 25.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.19 94.99 5.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.408 HG22 ' CG2' ' A' ' 31' ' ' THR . 3.2 p -122.79 106.78 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.879 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.95 125.26 54.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -140.83 165.32 27.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.3 pm0 -113.84 91.34 3.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.043 0.449 . . . . 0.0 111.023 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.45 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.5 tt0 -170.38 157.07 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.45 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 34.8 t-20 64.21 -81.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.081 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 m 31.88 82.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.212 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.43 154.9 18.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.589 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -119.78 -4.75 10.19 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.422 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.2 p -126.32 140.45 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.528 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 32.8 m -158.39 157.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.594 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -96.03 149.7 21.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.485 0.66 . . . . 0.0 111.732 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.26 126.76 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.002 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.19 -30.08 7.27 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.366 -0.921 . . . . 0.0 114.636 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.43 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -80.64 156.64 26.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.533 0.666 . . . . 0.0 112.032 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -116.34 152.4 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.283 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.616 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.01 151.1 30.72 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.971 -0.455 . . . . 0.0 111.696 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -106.9 132.58 52.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.679 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.449 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -68.49 120.81 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.648 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.486 HD11 ' OD1' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.07 -68.44 0.53 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.049 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 33.9 Cg_endo -63.62 75.8 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.165 1.91 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.67 -9.98 1.88 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.71 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.0 32.23 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.061 0.43 . . . . 0.0 111.161 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.97 131.04 55.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.221 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 10.0 mt -88.16 144.24 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.98 134.53 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.43 158.8 19.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.896 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.517 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 36.1 m-85 -136.62 117.11 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.507 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER -163.7 52.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.18 -78.72 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.721 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.432 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -147.26 -169.47 3.32 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.479 0.657 . . . . 0.0 111.93 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.526 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -154.44 174.89 3.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.035 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.5 Cg_exo -39.1 -25.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.696 2.264 . . . . 0.0 113.129 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . 2.1 mp -137.69 62.71 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.404 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -52.84 -64.05 0.95 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.162 0.506 . . . . 0.0 110.375 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.9 t70 48.59 -92.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.474 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -113.66 -46.03 3.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.8 0.333 . . . . 0.0 110.771 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -119.68 159.55 24.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.753 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.2 mt -78.93 103.65 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 99.22 8.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.022 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 55.4 Cg_endo -69.33 -31.12 23.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.515 2.144 . . . . 0.0 112.584 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 176.33 -161.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -6.99 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.83 71.11 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 17.6 m -117.69 141.49 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.555 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.486 ' OD1' HD11 ' A' ' 79' ' ' ILE . 2.9 m120 -81.88 150.29 27.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.278 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -83.97 82.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.616 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.7 18.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 119.12 -153.21 16.98 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.944 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.429 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 33.3 mtp180 -156.23 167.17 31.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.422 HG13 ' CG2' ' A' ' 75' ' ' VAL . 5.0 mt -98.83 114.96 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.36 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.28 -85.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.398 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.23 152.71 26.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.997 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.6 t 62.67 33.61 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.025 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.409 ' HA ' ' CG2' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -49.33 -70.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.993 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -174.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.054 0.454 . . . . 0.0 111.314 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -115.91 46.25 1.18 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.36 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.446 ' HG ' ' CG1' ' A' ' 120' ' ' VAL . 5.7 tt -42.06 -35.62 0.95 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.88 -22.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -92.24 36.1 3.79 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.495 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 6.4 m -69.19 154.87 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 122.513 0.325 . . . . 0.0 111.535 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.95 145.93 44.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.686 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.3 p-10 -57.88 121.24 10.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.122 0.487 . . . . 0.0 111.921 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.93 101.46 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.46 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 3.9 pt-20 -154.35 150.78 28.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.14 165.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.222 0.535 . . . . 0.0 111.904 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.615 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 46.5 t -157.74 128.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.312 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.5 m -127.3 108.49 18.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.978 0.418 . . . . 0.0 111.46 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.455 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.9 129.17 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.356 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.0 pt-20 -153.82 129.06 9.73 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.576 0.227 . . . . 0.0 111.344 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.42 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.5 89.45 1.68 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 110.785 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.649 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.85 0.357 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.72 153.4 6.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.452 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.86 27.03 5.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -146.91 0.54 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.41 33.21 0.14 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 31.6 m -112.87 62.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 111.274 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.67 39.18 1.68 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.078 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.57 115.65 30.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.043 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 145.43 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.131 0.491 . . . . 0.0 112.135 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.8 163.5 17.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.851 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 146.47 29.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.739 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 1.4 mt -147.32 100.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 109.787 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -104.79 156.0 18.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.635 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.448 ' CZ ' ' CG2' ' A' ' 126' ' ' VAL . 3.0 m-85 -130.76 138.55 50.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.448 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.77 -29.01 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -124.22 23.04 8.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.42 154.18 1.63 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -114.81 151.86 33.13 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.68 151.14 16.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.866 0.365 . . . . 0.0 111.779 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -137.53 150.4 47.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.87 143.76 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.138 0.494 . . . . 0.0 112.012 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -95.48 -178.38 4.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.199 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.46 HD11 HG12 ' A' ' 107' ' ' ILE . 7.6 tp -150.07 134.73 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.973 0.416 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 6.9 m-85 -116.73 139.25 50.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.566 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -8.46 3.02 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -44.66 -29.49 0.76 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.07 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.494 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -76.54 -56.01 5.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 163.2 116.05 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.739 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -46.58 -36.99 19.6 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.375 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -49.59 76.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.458 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.479 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.2 -44.5 97.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.757 0.313 . . . . 0.0 110.27 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 90.9 t -46.74 -37.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.693 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -33.35 71.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.009 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.41 -47.43 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.99 -50.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.75 -29.39 70.65 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.261 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -70.55 -25.74 63.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.12 51.96 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.914 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.25 -159.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.62 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.914 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.4 Cg_exo -27.8 105.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.083 1.855 . . . . 0.0 114.085 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.7 mt -145.16 149.11 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.366 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -85.9 133.64 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 111.887 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.631 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.9 p -142.33 149.02 38.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.299 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 131.33 48.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.354 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.422 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -92.05 135.54 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -106.92 122.88 47.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.061 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.604 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -83.18 137.04 34.21 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 12.7 t-105 -152.26 149.13 28.36 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.866 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.54 92.82 0.01 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.666 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER 53.27 25.98 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 48' ' ' TRP . 8.5 tp10 -136.77 139.36 41.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.952 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.529 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -139.18 122.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.593 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 50.8 p90 -130.04 123.37 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -133.15 145.38 50.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 146.48 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.415 HG22 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -117.85 5.61 12.22 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.3 mt-30 82.34 -8.2 1.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.0 p -87.23 115.43 27.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.61 94.79 5.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 111.911 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.431 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 3.5 p -131.53 106.73 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.299 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -130.16 133.18 46.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 53.4 tttt -140.8 164.77 29.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.291 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -99.14 90.87 4.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 0.0 110.966 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 5.9 tt0 -170.16 157.88 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.599 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 24.7 t-20 62.74 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.906 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 31.99 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.297 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -101.95 158.06 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.282 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -124.11 0.38 8.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 3.3 p -126.71 138.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.616 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 27.6 m -160.56 164.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.784 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.84 158.8 31.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.086 0.47 . . . . 0.0 110.769 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -38.56 129.67 1.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.24 -31.31 6.52 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.059 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.436 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.2 p30 -88.73 156.36 19.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 112.327 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG21 ' CD1' ' A' ' 110' ' ' ILE . 25.7 t -119.13 152.55 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.078 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.663 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.06 150.14 34.47 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.807 -0.558 . . . . 0.0 112.472 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.58 126.78 53.96 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.168 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.6 t90 -67.2 112.65 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.563 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -67.19 -61.1 5.06 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.786 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 14.8 Cg_exo -67.98 66.27 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.232 1.955 . . . . 0.0 111.807 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.68 -11.45 0.3 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.034 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.62 27.49 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.306 0.553 . . . . 0.0 110.957 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.92 55.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.522 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 84' ' ' ILE . 7.8 mt -88.05 143.38 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.331 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.7 132.39 36.85 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.89 161.07 18.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.168 178.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 20.8 m-85 -136.25 125.78 25.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' CE1' ' O ' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -163.88 54.54 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.209 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -75.1 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.372 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -158.83 174.02 15.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.796 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.487 ' CB ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -134.77 -175.11 0.45 Allowed Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.487 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 84.4 Cg_exo -47.93 -22.46 3.42 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.017 1.811 . . . . 0.0 112.724 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.69 68.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.862 0.363 . . . . 0.0 111.722 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -63.98 -74.96 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 50.23 52.78 14.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.54 4.13 4.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.609 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -142.67 178.65 7.48 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.8 mt -123.56 92.99 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 111.552 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -98.44 99.86 8.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.523 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 69.1 Cg_endo -70.57 -32.48 15.13 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.668 2.245 . . . . 0.0 112.969 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.421 ' CB ' HG12 ' A' ' 104' ' ' VAL . . . 179.05 -154.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.697 0.284 . . . . 0.0 110.879 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 -5.04 10.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.552 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.96 67.06 0.08 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 14.9 m -118.14 142.42 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.777 0.322 . . . . 0.0 111.552 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -84.28 152.99 23.81 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -85.57 86.56 2.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.663 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.55 23.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.97 -149.57 18.51 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.996 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -155.31 166.42 33.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.072 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.412 ' CD1' HG21 ' A' ' 75' ' ' VAL . 4.2 mt -99.85 114.43 38.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.24 -86.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.475 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -67.99 174.27 3.9 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 110.816 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t 61.61 161.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.7 130.58 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.949 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 4.2 pm0 -109.09 29.7 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.07 45.02 1.38 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.547 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.557 ' HG ' HG13 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -53.41 -38.91 63.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -42.4 -25.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -85.88 28.97 4.76 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.492 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.557 HG13 ' HG ' ' A' ' 117' ' ' LEU . 12.5 m -83.16 154.26 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.937 0.368 . . . . 0.0 111.534 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.53 148.76 30.26 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.604 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.1 p-10 -58.06 112.02 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.994 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.76 100.89 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.728 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 153.84 31.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.6 t -56.96 168.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.535 . . . . 0.0 111.894 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.631 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 47.0 t -157.88 128.84 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.06 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.9 m -127.59 108.63 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 111.473 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.415 HG23 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.21 129.04 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.4 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.466 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -152.92 130.16 11.24 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.709 0.29 . . . . 0.0 111.204 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.462 ' CB ' HD23 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.41 88.99 2.1 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.689 179.906 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.8 0.333 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 149.3 -136.85 5.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.31 -56.75 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.805 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' NH2' ' CB ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 62.91 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.82 -61.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.755 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 6' ' ' VAL . 34.2 m -126.82 68.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.466 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' CB ' ' NH2' ' A' ' 4' ' ' ARG . 52.1 mm-40 -159.96 44.46 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.022 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.32 21.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -108.68 145.3 35.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 163.75 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.703 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 144.89 34.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.401 HG13 HG12 ' A' ' 128' ' ' VAL . 1.3 mt -145.89 100.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -100.8 156.13 17.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.122 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 45' ' ' ALA . 2.7 m-85 -131.83 141.28 49.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.204 179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.47 -28.89 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -126.05 22.96 7.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -173.23 151.3 2.03 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 142.12 45.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.26 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.74 149.24 9.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -115.28 157.82 23.22 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.87 137.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.044 0.449 . . . . 0.0 111.439 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 14.6 mt-10 -92.51 -178.65 4.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.268 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 107' ' ' ILE . 3.3 tp -153.22 150.42 28.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.419 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 21.8 m-85 -129.23 147.95 51.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.027 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -58.21 -8.63 1.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.35 -29.2 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.85 0.296 . . . . 0.0 111.355 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.504 ' O ' ' CE3' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -80.92 -56.32 4.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.458 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 160.3 117.09 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.474 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.76 -35.86 18.37 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.6 -47.7 82.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.468 HG22 ' CE2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.95 -44.37 96.25 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.78 0.324 . . . . 0.0 110.397 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 46.3 t -50.05 -34.64 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -59.44 -37.01 77.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.79 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.04 -51.54 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.46 -28.71 70.0 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.65 -25.37 62.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 51.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.784 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.915 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.4 mt -61.58 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.539 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.915 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 25.6 Cg_exo -27.8 104.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.275 1.983 . . . . 0.0 114.033 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 39' ' ' LEU . 19.5 mt -145.57 151.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.309 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -85.72 136.57 33.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.064 0.459 . . . . 0.0 111.871 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.629 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -146.0 148.86 33.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.41 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.02 130.48 48.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.443 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.44 135.84 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -108.12 125.2 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.182 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.687 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.45 138.42 34.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 14.8 t-105 -154.17 148.95 26.53 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.069 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.13 99.86 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.768 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 45.62 30.15 0.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.382 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.35 33.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.118 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 HD13 ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -139.49 123.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 23.4 p90 -130.64 132.36 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.482 ' CE2' HG12 ' A' ' 126' ' ' VAL . 4.6 p90 -140.87 146.11 37.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.986 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.69 149.45 22.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.158 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.431 HG23 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.18 5.92 9.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 56' ' ' THR . 12.1 mt-30 80.94 -7.07 1.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.716 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.5 p -87.22 114.95 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.76 94.89 5.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.7 p -127.06 106.69 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.724 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HG2' HG22 ' A' ' 79' ' ' ILE . 2.5 mt-10 -125.28 134.98 52.07 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.082 0.467 . . . . 0.0 111.929 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 6.9 ttmt -144.55 165.62 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.165 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.68 90.74 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.021 0.438 . . . . 0.0 110.947 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.4 160.22 7.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.77 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 31.7 t-20 64.03 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.096 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.481 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 2.1 m 30.49 81.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.646 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.2 OUTLIER -100.47 156.71 17.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.73 -7.81 10.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.38 142.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.386 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.9 m -157.74 156.23 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.108 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.36 151.04 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.354 0.597 . . . . 0.0 111.368 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -48.16 126.39 10.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.214 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -31.99 6.21 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.093 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p-10 -70.04 163.17 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 112.085 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.406 ' CG2' ' CD1' ' A' ' 110' ' ' ILE . 16.0 t -121.41 152.02 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.074 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -149.58 152.36 35.36 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.463 0.574 . . . . 0.0 112.125 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -111.04 131.28 55.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.449 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.616 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.0 t90 -73.03 146.62 45.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -96.3 -53.14 0.22 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.522 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.616 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 6.9 Cg_exo -73.86 70.74 4.3 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.696 2.264 . . . . 0.0 111.623 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.414 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 144.38 -8.33 1.86 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.556 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 53.1 34.1 16.52 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.857 0.361 . . . . 0.0 110.827 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.76 130.85 55.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.167 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 6.4 mt -85.83 151.51 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.0 135.15 32.42 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.25 161.74 18.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.029 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 54.1 m-85 -136.25 118.61 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.499 . . . . 0.0 111.782 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.6 m-85 -157.43 30.35 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.851 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.55 -152.74 23.53 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.36 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -54.0 -173.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.507 0.67 . . . . 0.0 112.086 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.555 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -157.47 -173.54 0.38 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.81 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 72.9 Cg_exo -42.15 -23.63 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.976 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -146.38 87.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.817 179.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.507 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -82.16 27.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.391 179.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 97' ' ' LYS . 4.3 m-20 -60.69 78.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 71.23 -10.78 0.75 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.082 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.4 OUTLIER -146.41 -175.58 4.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 87.2 mt -114.17 97.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.845 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.424 ' CB ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -101.73 99.21 11.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.475 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 57.9 Cg_endo -70.44 -31.22 17.87 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.508 2.139 . . . . 0.0 112.645 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 179.2 -163.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -10.5 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.407 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -164.81 72.1 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 22.2 m -119.13 140.15 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.337 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.603 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 37.2 m-20 -84.91 148.14 26.4 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.41 ' CG1' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.18 97.82 5.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.064 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.558 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.96 21.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.31 -149.18 18.71 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.206 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -152.92 167.67 28.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.061 0.458 . . . . 0.0 111.362 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.7 mp -100.44 114.3 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.342 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.27 -85.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.593 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.03 109.81 14.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.809 0.338 . . . . 0.0 111.128 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.4 p -178.58 -80.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.0 mtm 53.33 50.5 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' LEU . 3.6 mp0 -119.15 30.79 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 115' ' ' GLU . . . 21.29 46.52 0.01 OUTLIER Glycine 0 C--N 1.338 0.69 0 O-C-N 123.613 0.57 . . . . 0.0 114.123 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 115' ' ' GLU . 8.2 tt -42.38 -36.3 1.25 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.34 -26.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.28 38.35 3.23 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.566 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.472 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 8.6 m -74.4 154.74 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 122.393 0.277 . . . . 0.0 111.465 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.98 146.09 44.11 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.687 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 6.1 p-10 -59.59 115.35 3.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 111.901 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.32 100.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.65 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 4.0 pt-20 -154.27 150.75 28.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.881 178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.79 166.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.629 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 52.4 t -157.81 129.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.433 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 17.6 m -128.14 108.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.355 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.431 HG21 HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.62 128.93 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.27 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.5 pt-20 -152.9 130.88 11.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.636 0.255 . . . . 0.0 111.339 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.431 ' CB ' HD21 ' A' ' 39' ' ' LEU . 5.9 tmm_? -75.22 92.91 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.686 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.832 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.789 0.328 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.84 1.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.17 -159.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.27 -73.47 0.21 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.726 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -176.85 42.37 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.547 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.446 HG12 ' CD1' ' A' ' 24' ' ' TYR . 26.0 t -102.55 58.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.17 51.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.78 116.55 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -110.1 145.47 37.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.0 112.314 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 164.78 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 145.96 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.7 OUTLIER -145.03 100.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -102.29 156.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.511 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.413 ' CE1' HG11 ' A' ' 126' ' ' VAL . 3.6 m-85 -134.71 137.79 43.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.384 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.44 -29.05 0.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.95 23.07 7.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.77 151.45 2.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -125.65 141.34 52.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.963 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 149.13 11.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.53 159.27 36.02 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.146 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.83 140.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 111.747 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mt-10 -94.28 -178.61 4.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.537 HD11 HG12 ' A' ' 107' ' ' ILE . 5.3 tp -153.98 148.27 25.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.087 0.47 . . . . 0.0 111.284 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.446 ' CD1' HG12 ' A' ' 6' ' ' VAL . 17.2 m-85 -126.06 148.45 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.635 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.27 -9.01 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.61 -27.68 0.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.249 -0.282 . . . . 0.0 111.533 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.512 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.07 -56.62 3.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 155.07 110.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -40.48 -30.0 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.817 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.78 -49.84 73.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.447 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.495 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -65.42 -45.66 83.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.39 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -47.87 -29.01 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.32 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -65.35 -38.64 90.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.09 74.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.21 -51.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.598 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.54 -29.53 70.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.16 -25.48 62.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.976 0.417 . . . . 0.0 110.611 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 51.92 1.0 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.917 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.22 -159.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.312 -0.852 . . . . 0.0 109.682 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.917 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.4 Cg_exo -27.58 105.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.216 1.944 . . . . 0.0 114.006 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.5 mt -146.5 150.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.498 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -86.27 134.12 33.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.596 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.7 p -142.06 149.1 39.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.75 128.24 48.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.398 . . . . 0.0 110.319 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB1' ' CG2' ' A' ' 126' ' ' VAL . . . -91.0 131.94 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -100.86 122.63 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.725 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.527 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -86.81 136.53 32.95 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.6 t-105 -155.01 148.62 25.36 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.833 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -33.22 86.92 0.01 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.294 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' TRP . 18.1 t0 72.68 -35.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.47 0.308 . . . . 0.0 111.512 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 49' ' ' GLY . 6.0 tm-20 -73.86 133.57 43.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.6 OUTLIER -138.87 125.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.203 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -137.14 128.79 28.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.374 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.51 145.97 47.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.59 147.89 22.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.403 HG22 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.63 7.91 10.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.3 mt-30 80.07 -6.34 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.654 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -88.53 115.13 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.708 0.29 . . . . 0.0 110.317 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.7 94.91 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.761 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 7.1 p -129.98 106.55 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.202 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.88 133.93 48.1 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.014 0.435 . . . . 0.0 111.667 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 159.22 42.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.149 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -92.81 88.8 6.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.386 0.612 . . . . 0.0 111.127 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.33 159.66 7.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.3 t-20 64.07 -82.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.3 t 27.82 82.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.325 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.444 ' HD3' ' CG1' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -100.72 156.65 17.22 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.37 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -117.33 -6.53 11.26 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 27.3 t -131.99 144.91 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.204 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.454 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.9 m -158.06 157.85 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.814 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -94.72 151.12 19.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.357 0.599 . . . . 0.0 111.638 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -45.95 125.75 6.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.979 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.4 -31.41 6.43 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.487 -0.863 . . . . 0.0 114.525 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.454 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p30 -75.91 156.56 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.464 0.632 . . . . 0.0 112.188 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.2 t -114.23 152.59 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.187 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.573 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.97 149.69 31.6 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.44 129.02 50.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.993 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.414 ' CB ' ' O ' ' A' ' 83' ' ' ALA . 2.0 t90 -69.5 117.89 11.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.986 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.543 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -65.66 -72.07 0.3 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 34.1 Cg_endo -63.43 80.45 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.081 1.854 . . . . 0.0 112.12 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.82 -11.17 2.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.732 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.98 31.46 11.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.066 0.433 . . . . 0.0 110.902 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.92 133.56 52.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.462 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.59 145.94 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.434 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 17.4 t -139.12 156.27 47.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.258 0.551 . . . . 0.0 112.389 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.47 156.03 20.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.263 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.6 m-85 -136.69 127.24 26.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 111.23 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.483 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.98 49.72 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.18 -82.35 0.11 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.1 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -154.14 176.39 12.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.119 0.485 . . . . 0.0 111.69 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -144.15 -174.26 0.4 Allowed Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.238 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 99.6 Cg_exo -45.17 -22.74 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.012 1.808 . . . . 0.0 112.598 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 77.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -90.5 29.19 1.32 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.042 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -69.07 75.37 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.757 0.313 . . . . 0.0 111.658 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 78.6 -9.32 1.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.176 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -145.61 -170.05 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.414 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.7 mt -123.16 105.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.26 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.32 99.36 8.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.476 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.8 Cg_endo -69.3 -31.14 23.18 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.467 2.112 . . . . 0.0 112.638 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.404 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 178.01 -163.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -3.4 20.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.58 77.4 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.428 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 19.3 m -127.52 142.04 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.722 0.296 . . . . 0.0 111.68 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.6 m-20 -86.31 153.66 21.81 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.62 99.48 7.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.573 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -85.47 22.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.36 -147.77 18.9 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.07 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -156.52 168.13 28.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 111.416 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mt -100.4 114.94 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.165 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.68 -85.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.593 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.39 -176.87 4.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.01 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.1 m 63.61 163.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 111.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 25.4 pt-20 -96.21 42.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.08 45.03 1.13 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -49.44 -30.35 7.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.483 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.45 -22.8 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -88.21 27.78 6.63 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.451 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 3.4 m -79.18 153.95 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.765 0.283 . . . . 0.0 111.247 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.64 146.99 29.77 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.527 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.2 p-10 -53.75 117.81 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.34 98.64 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.007 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -150.61 146.4 26.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.993 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.2 164.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 112.268 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.596 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 44.9 t -158.14 128.45 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 22.7 m -125.34 108.35 19.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 0.0 111.402 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.04 128.7 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.407 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.468 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.3 pt-20 -152.86 130.74 11.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.459 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.38 91.43 3.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.858 0.361 . . . . 0.0 110.809 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.743 179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mtp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.732 0.301 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.4 31.63 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.88 -55.63 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 111.057 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.41 -78.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.0 31.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 24' ' ' TYR . 25.6 t -101.23 58.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.04 38.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 117.45 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.71 145.31 40.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.153 0.501 . . . . 0.0 111.926 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.9 163.9 15.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.932 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 143.63 38.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.825 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.72 100.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -99.98 156.32 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.78 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.8 m-85 -136.82 137.99 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.697 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.79 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 22.19 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.79 151.37 1.41 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.63 143.43 48.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.179 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.84 149.01 10.68 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.308 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -119.25 156.05 30.63 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.437 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.71 144.41 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 111.083 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 5.9 mt-10 -99.18 -178.27 3.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 HD13 HG12 ' A' ' 107' ' ' ILE . 6.6 tp -151.37 144.4 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.078 0.466 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.437 ' CD1' HG11 ' A' ' 6' ' ' VAL . 17.1 m-85 -125.24 145.99 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.594 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.32 -9.04 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -45.66 -28.08 0.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.588 ' CZ2' ' CE1' ' A' ' 77' ' ' TYR . 7.2 t90 -80.03 -56.08 4.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.486 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 157.14 115.88 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.675 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.76 -34.82 16.42 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 112.49 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.78 -50.85 71.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.394 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.541 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.02 -45.42 92.42 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.43 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 84.2 t -46.65 -32.66 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.429 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -58.99 -38.7 79.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.482 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.9 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.66 -51.55 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.11 -27.92 69.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 110.211 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -71.74 -25.57 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.562 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.25 49.95 1.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.063 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.887 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -62.42 -160.08 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.312 -0.851 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.887 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 38.9 Cg_exo -29.85 107.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.125 1.883 . . . . 0.0 113.85 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.5 mt -150.02 148.54 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.638 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.92 136.07 33.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.101 0.477 . . . . 0.0 111.953 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.576 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.2 p -146.03 148.65 32.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 125.82 49.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.162 0.506 . . . . 0.0 110.376 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 124' ' ' GLU . . . -85.55 132.46 34.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.042 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -100.39 128.19 46.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.56 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.621 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -90.26 135.15 33.85 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.741 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 50' ' ' ASP . 10.1 t-105 -154.5 148.43 25.64 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.888 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.47 85.75 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.632 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 48' ' ' TRP . 36.6 t70 74.09 -38.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.882 0.326 . . . . 0.0 111.882 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 49' ' ' GLY . 44.3 tt0 -72.4 124.19 24.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 111.114 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 HD11 ' HG2' ' A' ' 47' ' ' ARG . 0.8 OUTLIER -126.74 111.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 110.179 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 43.7 p90 -122.48 134.06 54.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.068 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.452 ' CE2' HG13 ' A' ' 126' ' ' VAL . 5.2 p90 -140.15 145.61 37.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.599 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 147.58 22.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.426 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -122.38 6.48 9.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 83.45 -8.13 1.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.1 115.43 26.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.136 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.01 94.82 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.064 0.459 . . . . 0.0 112.029 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.412 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 4.4 p -120.66 106.68 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.139 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -120.2 136.43 54.64 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.25 163.4 39.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.205 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -104.62 87.02 2.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -170.13 149.69 3.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.4 t-20 72.03 -82.66 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.523 0.202 . . . . 0.0 111.273 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.7 m 27.46 82.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.77 156.18 17.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.457 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -121.25 -3.25 9.49 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.1 p -127.65 140.01 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.513 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 33.1 m -158.7 157.55 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.544 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.2 150.67 19.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.49 0.662 . . . . 0.0 111.719 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -45.0 126.09 5.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.964 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -30.77 6.82 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.599 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.434 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.01 157.06 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.528 0.664 . . . . 0.0 111.978 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -115.96 152.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.297 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.624 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.52 151.23 31.31 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 121.86 -0.525 . . . . 0.0 112.41 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.588 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -102.19 123.99 47.0 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.075 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.468 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 4.1 t90 -66.57 119.02 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.901 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.708 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -69.53 -71.01 0.3 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.601 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.48 83.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.628 1.552 . . . . 0.0 111.705 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 133.6 -8.35 4.95 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.416 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.66 39.79 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.841 0.353 . . . . 0.0 111.24 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.15 135.17 54.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.77 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 36.8 mt -84.35 145.3 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.42 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 m -140.69 132.42 27.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.63 158.0 19.57 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.1 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 23.7 m-85 -136.67 115.17 11.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 111.369 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.54 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -156.53 39.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.07 -89.16 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.934 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.47 -169.08 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 111.499 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -152.29 -177.68 0.74 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.558 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' CD ' ' CB ' ' A' ' 91' ' ' THR . 87.9 Cg_exo -47.49 -16.9 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 121.968 1.779 . . . . 0.0 112.896 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 93' ' ' ILE . 6.0 pt -145.75 62.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -52.99 -71.79 0.06 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.95 -95.07 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.56 -5.1 9.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.865 0.364 . . . . 0.0 111.238 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -150.38 -162.16 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.6 mt -118.69 101.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.197 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.35 99.16 7.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.6 Cg_endo -69.16 -31.21 23.68 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.473 2.115 . . . . 0.0 112.491 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' CB ' HG12 ' A' ' 104' ' ' VAL . . . 175.66 -158.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.776 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -6.96 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.779 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.48 69.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.507 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 6.2 m -116.8 142.83 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.827 0.346 . . . . 0.0 111.65 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 3.0 m120 -83.18 151.31 25.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.595 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.432 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -87.08 86.95 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.624 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.03 18.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.509 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.94 -150.91 18.52 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.678 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -156.37 168.19 28.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.187 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.9 mt -95.27 113.61 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.463 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.91 -86.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.418 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -69.02 149.61 48.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.23 34.18 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.24 2.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.2 176.45 6.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.035 0.445 . . . . 0.0 111.402 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -105.55 45.99 1.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.444 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.591 ' HG ' HG12 ' A' ' 120' ' ' VAL . 8.4 tt -42.25 -36.26 1.18 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.617 0.246 . . . . 0.0 111.424 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.54 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.53 -24.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.457 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -94.59 37.69 3.34 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.841 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.591 HG12 ' HG ' ' A' ' 117' ' ' LEU . 3.5 m -79.01 154.47 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.728 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.74 148.48 33.01 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.307 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.621 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.2 p-10 -50.72 110.84 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.37 111.62 0.04 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.314 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -155.46 139.05 15.98 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.561 0.219 . . . . 0.0 110.701 178.216 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.9 t -40.75 161.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.111 0.482 . . . . 0.0 112.0 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.576 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 41.8 t -154.17 128.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.4 m -126.57 108.09 18.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 120.86 0.362 . . . . 0.0 111.145 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.404 HG22 HG22 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.8 128.76 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.453 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 pt-20 -153.28 129.64 10.57 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.49 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.64 88.75 2.21 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.695 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.703 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.83 117.79 3.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -117.49 32.76 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.84 19.18 9.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.404 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -165.81 45.67 0.28 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.514 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.449 ' O ' HG21 ' A' ' 6' ' ' VAL . 31.9 m -124.77 72.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.181 0.515 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.93 36.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.667 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.0 106.96 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.87 145.42 38.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.851 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.73 162.31 18.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.828 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 142.95 34.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.824 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.26 101.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 109.824 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -102.03 156.77 17.33 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.778 0.799 . . . . 0.0 112.501 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.2 m-85 -134.56 137.45 43.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.499 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -28.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 p -124.79 22.24 8.19 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.09 150.76 1.22 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.28 144.05 48.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.127 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.57 148.31 7.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.56 155.96 26.63 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.675 0.274 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.2 138.57 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.972 0.415 . . . . 0.0 111.258 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 1.3 mt-10 -95.1 -178.39 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.3 tp -154.34 146.37 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 22.9 m-85 -126.76 147.71 49.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 16.8 mt-10 -56.28 -9.27 0.63 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.55 -28.78 1.01 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.857 0.298 . . . . 0.0 111.296 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.595 ' CZ2' ' CE2' ' A' ' 77' ' ' TYR . 7.9 t90 -80.81 -56.27 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 155.6 113.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.688 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -46.65 -35.9 17.97 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.456 2.104 . . . . 0.0 112.577 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.96 -51.94 67.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.528 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.18 -45.81 90.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.835 0.35 . . . . 0.0 110.503 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 59.3 t -46.16 -30.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.226 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -60.14 -38.95 84.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.101 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.15 84.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -56.5 -49.29 78.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.27 -27.17 68.86 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.249 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.13 -24.49 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.631 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.19 49.39 1.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.0 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.878 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.16 -159.97 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.356 -0.831 . . . . 0.0 109.592 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.878 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 39.0 Cg_exo -29.87 106.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.132 1.888 . . . . 0.0 114.085 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.11 149.44 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.621 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -85.92 134.95 33.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.003 0.43 . . . . 0.0 111.669 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.567 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 6.0 p -143.6 149.27 37.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.696 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.76 121.27 41.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 110.212 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -80.42 131.26 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -102.68 123.83 47.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.593 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.512 ' HD2' ' O ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.19 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -151.5 148.51 28.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.236 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -35.08 91.67 0.01 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.029 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 29.3 t70 75.94 -41.15 0.42 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.683 0.393 . . . . 0.0 111.309 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' HG3' ' CG2' ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.06 143.1 41.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.438 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.2 OUTLIER -146.81 114.9 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.529 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -126.27 133.34 51.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.144 0.497 . . . . 0.0 112.038 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.466 ' CD2' HG12 ' A' ' 126' ' ' VAL . 4.5 p90 -131.63 143.84 50.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.369 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 142.91 26.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.408 ' C ' ' HG3' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -119.82 8.48 11.14 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.7 mt-30 80.74 -6.33 1.66 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.4 p -83.94 115.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.4 106.59 17.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.747 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.6 p -137.08 106.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.395 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.73 133.65 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.91 0.386 . . . . 0.0 111.254 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -153.92 165.09 37.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.335 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.16 88.35 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -170.08 149.13 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.0 t-20 69.24 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.522 0.201 . . . . 0.0 111.162 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.3 m 24.73 82.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.72 156.53 17.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.518 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -120.72 -3.6 9.76 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 4.2 p -127.83 140.11 50.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.494 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 30.5 m -159.02 157.89 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.759 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -93.84 152.06 19.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.424 0.63 . . . . 0.0 111.684 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.64 126.49 10.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -28.86 8.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.131 -1.033 . . . . 0.0 114.63 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.407 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.0 p30 -80.14 156.11 27.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.641 0.72 . . . . 0.0 111.988 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.425 HG22 ' CD1' ' A' ' 110' ' ' ILE . 22.3 t -114.03 152.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.29 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.736 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.25 145.4 24.61 Favored 'General case' 0 C--N 1.342 0.249 0 O-C-N 121.9 -0.5 . . . . 0.0 112.169 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.84 137.26 36.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.167 179.155 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.45 ' HA ' HG13 ' A' ' 104' ' ' VAL . 1.8 t90 -79.47 121.97 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.622 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.516 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -72.89 -70.19 0.28 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 79.3 Cg_exo -33.14 -62.96 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.155 2.57 . . . . 0.0 113.845 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.68 -1.46 90.01 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.262 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.77 26.97 8.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.983 0.42 . . . . 0.0 110.485 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.99 137.76 46.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.638 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.63 148.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.604 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -143.26 155.24 44.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.285 0.564 . . . . 0.0 112.486 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.07 158.76 16.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.98 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.468 ' HE2' ' HB1' ' A' ' 76' ' ' ALA . 35.5 m-85 -136.53 115.39 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.676 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.536 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -139.33 25.46 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 152.63 -153.7 25.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.051 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -39.43 171.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.539 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -153.21 176.99 2.12 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.8 Cg_exo -39.01 -27.66 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.568 2.179 . . . . 0.0 112.714 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 mp -130.44 52.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.675 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -55.46 -77.68 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.99 0.424 . . . . 0.0 110.644 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.0 t0 56.06 -93.62 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.117 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -123.96 -7.15 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.598 0.237 . . . . 0.0 111.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -139.82 -175.29 4.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.759 0.314 . . . . 0.0 110.47 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.9 mt -116.53 116.86 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -121.53 99.46 45.24 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.998 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.431 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 61.4 Cg_endo -70.66 -31.6 16.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.466 2.111 . . . . 0.0 112.587 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.432 ' HB1' ' CZ2' ' A' ' 78' ' ' TRP . . . -178.39 -160.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -6.39 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.404 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.72 69.35 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 11.9 m -116.02 141.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.047 0.451 . . . . 0.0 111.783 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 3.0 m120 -82.49 150.96 26.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.618 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -84.02 86.53 2.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.736 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -71.77 16.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.527 -178.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.41 -147.79 18.6 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.749 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.412 ' HA ' ' CG2' ' A' ' 75' ' ' VAL . 11.5 mtp-105 -155.94 167.61 29.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.357 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.425 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.77 114.85 30.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.646 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -78.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.804 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -70.54 99.21 1.59 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -20.41 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -23.75 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 111.268 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 51.1 mm-40 -68.49 98.41 0.86 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.934 0.397 . . . . 0.0 111.028 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.06 45.87 2.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.557 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HG ' HG12 ' A' ' 120' ' ' VAL . 7.2 tt -42.61 -33.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.626 0.25 . . . . 0.0 111.621 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.536 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -25.35 0.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.411 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.82 34.29 4.12 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.91 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.512 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 4.8 m -74.73 154.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 111.302 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.8 38.06 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.508 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -56.54 110.16 0.74 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.058 0.456 . . . . 0.0 111.593 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.31 102.7 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.305 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.63 150.03 28.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.71 162.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 112.154 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.567 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 51.7 t -158.06 128.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.483 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.9 m -126.2 107.43 17.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.46 128.68 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.472 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -153.48 127.9 9.25 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.597 0.237 . . . . 0.0 111.319 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.46 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.6 89.97 2.77 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.766 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.924 0.392 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.24 -73.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.44 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -78.42 -61.05 2.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 -72.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.718 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.418 ' O ' ' HG2' ' A' ' 25' ' ' GLU . . . -175.69 32.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.474 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.449 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 31.3 m -127.93 69.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.421 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -145.99 32.51 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.54 116.37 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 145.3 46.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.071 0.462 . . . . 0.0 111.949 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.86 163.68 15.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.92 178.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.92 145.58 38.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.3 OUTLIER -142.25 102.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 14.7 ptm180 -102.4 156.22 17.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.582 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CE2' ' CG2' ' A' ' 126' ' ' VAL . 32.3 m-85 -140.69 139.54 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.915 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -28.84 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.064 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -125.79 22.44 7.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.9 154.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.389 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 144.29 47.32 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.877 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 150.09 12.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.5 158.6 34.08 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.339 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.02 143.56 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 111.212 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -90.96 -178.29 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.305 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' CD1' HG12 ' A' ' 107' ' ' ILE . 2.6 tp -151.04 130.43 12.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 111.525 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.449 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-85 -113.54 136.46 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.42 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -57.84 -8.83 1.05 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -45.0 -28.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.652 0.263 . . . . 0.0 111.009 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.498 ' CZ2' ' CG2' ' A' ' 31' ' ' THR . 6.4 t90 -75.94 -53.16 8.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 159.72 114.05 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.806 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 3.3 Cg_exo -47.2 -37.76 24.34 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.567 2.178 . . . . 0.0 112.547 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -62.43 -46.76 87.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.498 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -64.05 -44.7 91.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.261 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 58.5 t -47.02 -36.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.005 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.47 -39.0 72.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.528 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.73 80.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.48 -49.98 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.66 -26.83 68.85 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.6 -24.1 60.01 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.96 49.19 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.967 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.883 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mt -62.04 -159.78 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.697 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.883 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 36.2 Cg_exo -29.46 107.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.063 1.842 . . . . 0.0 114.049 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 39' ' ' LEU . 33.5 mt -150.13 149.87 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.6 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -85.94 133.88 33.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 111.866 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.59 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.8 p -145.91 149.5 34.34 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.517 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.53 133.39 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 47' ' ' ARG . . . -91.96 136.59 33.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.04 120.15 39.96 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.755 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -87.88 133.39 33.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' A' ' 50' ' ' ASP . 9.3 t-105 -155.65 148.7 24.5 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.369 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.69 89.76 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.415 -0.422 . . . . 0.0 113.391 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.9 t70 72.99 -36.82 0.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 49' ' ' GLY . 0.0 OUTLIER -75.87 132.08 40.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 111.092 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -138.86 121.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.768 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -134.01 131.59 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.613 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 6.2 p90 -136.61 145.13 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.66 144.28 25.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.175 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -119.7 5.79 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.26 -7.77 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.5 p -84.1 115.52 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.207 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.37 94.8 7.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.001 0.429 . . . . 0.0 111.716 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.412 ' CG2' HG21 ' A' ' 31' ' ' THR . 6.7 p -129.17 106.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.493 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.94 132.7 30.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.872 0.368 . . . . 0.0 111.328 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -148.74 164.33 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.426 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -94.32 87.91 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.455 0.645 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -170.23 148.79 3.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 43.2 t-20 71.85 -83.21 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.578 0.228 . . . . 0.0 111.165 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' ASN . 8.1 m 27.4 81.4 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -100.41 156.03 17.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.225 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.83 -6.75 11.02 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 5.9 p -127.48 143.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.631 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 33.3 m -158.56 157.6 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -94.56 150.51 20.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.373 0.606 . . . . 0.0 111.576 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.28 126.67 8.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.956 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.37 -30.64 6.87 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.385 -0.912 . . . . 0.0 114.535 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.424 ' HB3' ' NE ' ' A' ' 109' ' ' ARG . 2.4 p30 -79.21 156.39 28.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 111.957 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 109' ' ' ARG . 19.7 t -111.16 152.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.257 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.566 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.11 150.22 30.42 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.086 0.403 . . . . 0.0 111.882 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.473 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -106.32 137.91 43.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.443 ' O ' ' CE1' ' A' ' 77' ' ' TYR . 4.3 t90 -79.1 108.46 12.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.588 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -63.94 -65.84 1.82 Allowed Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.82 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.588 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.99 81.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.823 1.682 . . . . 0.0 111.714 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 136.56 -6.89 3.91 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.651 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 52.36 36.82 20.83 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.002 0.401 . . . . 0.0 110.931 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.84 54.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.044 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -88.38 151.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.401 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 16.9 t -143.47 157.06 44.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.2 159.68 17.17 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.353 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 33.7 m-85 -136.78 134.56 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 111.792 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.526 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -169.47 35.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.853 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.14 -153.53 24.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.323 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.4 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 112.097 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -163.79 -174.34 0.4 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.934 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 93.9 Cg_exo -44.89 -24.32 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.877 1.718 . . . . 0.0 112.519 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mp -142.25 69.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.548 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -59.51 -76.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 110.365 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.2 t70 60.09 -95.9 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.906 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -122.08 -5.38 8.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.586 0.232 . . . . 0.0 111.214 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -169.75 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 97.3 mt -116.59 104.24 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.818 0.342 . . . . 0.0 111.024 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -103.55 99.25 14.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 59.7 Cg_endo -70.39 -31.51 17.61 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.505 2.137 . . . . 0.0 112.69 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 104' ' ' VAL . . . 178.42 -161.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.62 -8.76 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.665 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -166.56 71.83 0.13 Allowed 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 18.4 m -119.08 141.24 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.004 0.431 . . . . 0.0 111.872 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.524 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 1.9 m120 -83.88 150.24 25.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.713 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -85.28 94.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.566 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -80.28 24.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.81 -149.98 17.38 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.41 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.424 ' NE ' ' HB3' ' A' ' 74' ' ' ASP . 26.2 mtp180 -157.01 168.06 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.454 . . . . 0.0 111.216 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.7 mp -95.15 113.86 30.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.5 -85.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -78.28 60.1 2.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 111.212 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 170.9 39.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.4 ptm -72.72 65.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.689 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -90.82 -168.81 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.164 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.64 45.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.316 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.434 HD11 ' CD1' ' A' ' 14' ' ' PHE . 2.0 tt -42.57 -36.73 1.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.586 0.232 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.526 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.43 -26.85 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.31 33.94 3.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.928 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.489 ' HB ' ' NH1' ' A' ' 47' ' ' ARG . 2.4 m -80.39 154.03 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.627 0.251 . . . . 0.0 111.473 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.53 146.81 44.53 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 12.8 p-10 -53.6 134.61 41.23 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.454 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 56.86 99.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.282 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -144.61 153.34 41.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 110.98 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 126' ' ' VAL . 14.3 t -65.09 158.17 26.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.542 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.59 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 40.8 t -148.06 129.18 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.087 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.402 ' CG2' ' CG ' ' A' ' 13' ' ' ARG . 28.0 m -124.55 106.1 16.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.595 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -82.17 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.813 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.456 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.3 pt-20 -153.2 125.04 7.82 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.665 0.269 . . . . 0.0 111.25 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.445 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.14 94.74 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.813 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.8 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.58 -108.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -135.58 -73.94 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.58 17.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.55 90.08 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.59 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 25.4 m -146.49 79.53 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -159.03 28.45 0.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.75 106.89 16.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.989 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -114.77 145.29 42.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.483 . . . . 0.0 112.113 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.26 163.61 16.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.951 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 147.37 33.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.4 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.6 OUTLIER -144.33 101.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.12 156.17 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.555 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.424 ' N ' ' O ' ' A' ' 17' ' ' ALA . 4.7 m-85 -138.25 136.47 36.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.1 -29.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 22.49 7.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.35 152.96 1.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.39 145.6 50.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.871 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 148.46 11.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.658 0.266 . . . . 0.0 111.607 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 158.88 41.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.163 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.23 148.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.107 0.48 . . . . 0.0 111.644 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.2 mt-10 -94.57 -178.29 4.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.021 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.0 tp -147.46 133.19 18.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.148 0.499 . . . . 0.0 111.4 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.407 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 11.6 m-85 -112.12 139.49 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.436 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -57.11 -8.92 0.76 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.29 -27.98 0.74 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.62 0.248 . . . . 0.0 111.427 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.494 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -79.26 -56.61 4.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.9 115.98 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.784 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.5 -34.67 11.2 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.396 2.064 . . . . 0.0 112.246 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -59.32 -52.74 64.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.49 HG22 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.78 -45.65 92.98 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 23' ' ' LEU . 87.4 t -46.72 -31.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.71 86.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.267 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.57 67.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.82 -52.05 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.85 -29.25 70.05 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.911 0.386 . . . . 0.0 110.395 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.01 -25.58 62.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.528 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.02 51.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.767 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.922 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -61.56 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.828 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.922 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.3 Cg_exo -26.83 108.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.275 1.983 . . . . 0.0 113.992 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 41' ' ' ILE . 14.5 mt -147.9 153.91 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.628 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -89.28 131.98 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.78 40.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.94 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 128.25 48.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' HB3' ' CG2' ' A' ' 126' ' ' VAL . . . -91.55 132.74 36.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -100.7 130.02 46.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.593 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -94.1 134.79 36.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' ASP . 7.5 t-105 -154.87 148.36 25.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.044 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -29.34 84.32 0.0 OUTLIER Glycine 0 C--N 1.336 0.557 0 O-C-N 123.375 0.422 . . . . 0.0 113.781 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' TRP . 27.8 t70 73.93 -37.23 0.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.406 0.282 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 49' ' ' GLY . 1.3 tm-20 -73.44 128.04 34.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.992 0.425 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -131.1 125.0 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.786 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -136.49 127.43 27.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.355 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 4.3 p90 -133.28 145.39 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.61 146.62 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.412 HG21 HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.82 6.79 10.42 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 82.57 -7.89 1.24 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -84.66 114.42 24.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.94 94.87 5.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 HG22 ' CG2' ' A' ' 31' ' ' THR . 6.1 p -132.47 106.74 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.143 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -124.12 134.64 53.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.027 0.441 . . . . 0.0 111.621 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -146.86 165.34 30.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.267 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 3.7 pm0 -102.02 92.4 4.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.048 0.451 . . . . 0.0 111.245 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.13 156.16 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.432 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.5 t-20 63.19 -81.48 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.706 0.289 . . . . 0.0 111.094 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.1 m 28.15 82.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.55 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.99 155.9 17.88 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.318 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -117.45 -7.01 11.18 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.409 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 5.7 p -127.03 144.43 37.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.623 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 27.5 m -158.47 163.19 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -108.65 143.22 38.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.036 0.446 . . . . 0.0 110.935 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -37.71 131.83 0.95 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.01 -31.52 6.47 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.711 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -83.25 156.83 22.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.247 0.546 . . . . 0.0 112.215 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -114.95 152.43 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.997 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.637 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.94 149.33 32.0 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.313 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.47 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -106.73 123.78 48.64 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.268 179.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.444 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.1 t90 -65.67 111.07 3.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.648 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -66.3 -68.31 0.76 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.69 80.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 121.914 1.743 . . . . 0.0 111.752 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.12 -9.41 3.29 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.607 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.04 32.29 17.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.096 0.448 . . . . 0.0 110.863 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.16 133.9 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.881 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.437 HD12 HG21 ' A' ' 84' ' ' ILE . 16.2 mt -90.78 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.236 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.569 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 35.3 t -143.14 157.26 44.67 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.37 156.41 22.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.941 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.461 ' CE2' ' HB2' ' A' ' 76' ' ' ALA . 4.9 m-85 -136.76 130.86 32.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 111.515 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -167.77 49.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.71 -82.22 0.12 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.268 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -138.94 -167.85 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.265 0.555 . . . . 0.0 111.748 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.493 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.4 -176.51 0.62 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.822 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.493 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 97.1 Cg_exo -45.18 -21.69 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.187 1.925 . . . . 0.0 112.997 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.432 HG23 HD11 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -147.51 65.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -49.85 -73.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.575 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.16 -90.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -119.32 -30.58 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -127.7 -164.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.5 mt -115.99 105.6 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 99.41 9.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.065 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.437 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.6 Cg_endo -68.95 -31.15 24.85 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.538 2.159 . . . . 0.0 112.564 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 175.99 -162.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -7.3 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.645 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.97 73.74 0.07 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 HG12 ' CD1' ' A' ' 78' ' ' TRP . 17.5 m -122.16 142.3 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.005 0.431 . . . . 0.0 111.774 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.468 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m120 -83.15 152.19 25.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.43 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.461 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -83.96 82.02 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.637 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -65.9 20.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 114.27 -149.51 18.74 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.871 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 mtt85 -156.23 163.6 39.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.182 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.8 mp -90.07 116.3 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.242 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -86.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -121.3 138.05 54.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.982 0.42 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 167.44 -73.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.582 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.48 -44.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.504 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 17.0 mt-10 61.1 38.61 16.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.022 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.26 25.47 2.63 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.928 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.42 ' HG ' HG11 ' A' ' 120' ' ' VAL . 4.1 tp -54.67 -37.5 65.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.768 0.284 . . . . 0.0 111.097 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.431 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -20.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 117' ' ' LEU . . . -91.31 30.34 6.45 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.644 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.522 ' O ' ' HD2' ' A' ' 47' ' ' ARG . 2.8 m -77.52 154.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.483 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 147.21 30.2 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.593 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 13.6 p-10 -53.81 112.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 112.01 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.25 100.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.565 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' OE2' ' HB ' ' A' ' 120' ' ' VAL . 5.5 pt-20 -152.82 148.37 27.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.68 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.324 0.583 . . . . 0.0 112.456 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 45' ' ' ALA . 40.1 t -158.13 127.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.258 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 29.8 m -125.22 107.29 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.0 111.228 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.412 HG22 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.21 128.72 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.573 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 pt-20 -152.45 129.07 10.77 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.751 0.31 . . . . 0.0 111.235 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.449 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.86 92.73 3.1 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.874 0.369 . . . . 0.0 110.735 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.724 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 mmt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.834 0.349 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.21 163.81 12.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -103.04 -35.12 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.716 0.294 . . . . 0.0 110.807 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.46 -74.12 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -175.02 25.74 0.07 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.789 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.442 ' HB ' ' CD1' ' A' ' 24' ' ' TYR . 31.5 m -130.01 70.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 111.41 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -154.14 25.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' MET . . . . . 0.445 ' O ' ' HG2' ' A' ' 8' ' ' MET . 0.0 OUTLIER -101.74 126.51 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.92 145.45 51.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.12 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.37 162.44 15.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.649 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.46 142.79 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -138.91 102.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 109.704 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.34 156.15 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.589 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.443 ' CD2' HG11 ' A' ' 120' ' ' VAL . 3.2 m-85 -137.64 138.34 39.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -29.14 0.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -126.22 22.1 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.87 153.34 1.35 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.66 145.06 48.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.085 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.36 148.85 11.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.561 0.22 . . . . 0.0 111.432 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -117.93 156.68 28.05 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.22 135.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.047 0.451 . . . . 0.0 111.338 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -178.39 5.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.409 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 tp -149.76 146.68 27.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.982 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.442 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-85 -121.56 146.14 47.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.858 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 33.3 mt-10 -59.73 -9.03 2.39 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -45.52 -28.25 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.603 0.24 . . . . 0.0 111.423 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.504 ' O ' ' CB ' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -80.07 -56.24 4.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 116.23 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.824 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.89 -29.77 8.69 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.521 2.147 . . . . 0.0 112.505 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.31 -43.56 81.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.183 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.466 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -67.18 -46.26 74.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.416 HG12 ' CE ' ' A' ' 8' ' ' MET . 31.0 t -45.98 -35.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -56.62 -37.76 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.01 -47.56 74.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.99 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -49.78 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.46 -28.79 70.21 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.247 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -71.19 -25.65 62.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 110.481 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.88 51.29 1.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.962 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.897 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.06 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.434 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.897 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 29.9 Cg_exo -28.64 103.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.058 1.839 . . . . 0.0 114.086 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.8 mt -145.62 150.62 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.395 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -85.88 135.62 33.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.164 0.506 . . . . 0.0 111.914 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.579 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.06 148.6 32.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.232 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.008 0.432 . . . . 0.0 110.374 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 124' ' ' GLU . . . -83.98 132.55 34.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -104.13 119.01 38.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.802 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.43 136.88 34.84 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 16.0 t-105 -148.44 148.56 30.43 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.588 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.503 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.177 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.503 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 26.4 t70 79.44 -41.31 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.712 0.405 . . . . 0.0 111.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.56 152.08 24.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.2 OUTLIER -150.13 117.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.726 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.1 p90 -125.15 140.17 53.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.243 0.545 . . . . 0.0 112.169 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 4.3 p90 -140.25 145.33 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.581 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 145.58 24.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.437 HG23 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.17 6.6 11.25 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.7 mt-30 81.75 -7.78 1.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.14 115.63 27.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.25 94.74 6.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.002 0.429 . . . . 0.0 111.706 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.436 ' CG2' ' CG2' ' A' ' 31' ' ' THR . 7.6 p -130.13 106.75 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.511 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.94 131.77 33.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.939 0.399 . . . . 0.0 111.412 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.437 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 52.1 tttm -141.07 165.65 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.354 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -99.56 89.27 4.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 111.374 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.8 tt0 -170.14 157.82 6.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.67 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.0 t-20 63.5 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 m 29.95 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.534 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -102.47 156.29 17.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.327 179.015 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.92 -7.01 10.96 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.4 p -126.63 142.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.537 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.433 ' HB ' ' CG ' ' A' ' 74' ' ' ASP . 35.6 m -157.81 157.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.26 151.08 19.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.357 0.599 . . . . 0.0 111.57 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -46.42 125.84 7.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.171 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.41 -31.72 6.27 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.369 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -75.66 155.81 35.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.619 0.709 . . . . 0.0 112.078 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 76' ' ' ALA . 21.5 t -113.09 152.54 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.027 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.707 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.03 145.92 28.68 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.343 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -101.54 121.37 41.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 179.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.474 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -64.83 114.48 4.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.821 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.642 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.5 OUTLIER -70.74 -67.34 0.63 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.735 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 27.8 Cg_exo -61.23 75.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.856 1.704 . . . . 0.0 111.633 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 147.11 -10.94 1.37 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 30.61 12.38 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.234 0.517 . . . . 0.0 110.973 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.72 136.64 52.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 9.5 mt -88.53 147.81 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.8 m -142.77 132.1 23.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.55 157.73 17.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.025 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.441 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 7.7 m-85 -136.49 134.67 37.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 111.536 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.569 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -153.58 28.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.708 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 148.53 -149.59 21.64 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.584 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.45 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -39.75 169.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.519 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.79 -176.58 0.63 Allowed Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 79.2 Cg_exo -42.64 -25.49 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.087 1.858 . . . . 0.0 112.571 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.7 mp -136.49 52.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.511 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.45 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -53.07 -75.98 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 53.57 -91.27 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.91 3.68 6.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.702 0.287 . . . . 0.0 111.222 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -149.81 -170.25 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.453 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 66.1 mt -123.15 110.53 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.914 0.388 . . . . 0.0 111.17 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.41 99.32 49.1 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.24 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -68.25 -30.6 30.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 112.494 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.408 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 179.2 -162.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.838 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -4.84 17.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.727 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.42 74.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 HG12 ' CD1' ' A' ' 78' ' ' TRP . 20.8 m -122.7 141.98 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 76' ' ' ALA . 1.3 m120 -82.15 152.77 26.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.624 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.6 90.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.707 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.93 19.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.263 -177.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.59 -149.24 18.65 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.572 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -151.52 164.18 37.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.003 0.43 . . . . 0.0 111.472 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.411 ' CD1' ' CG2' ' A' ' 75' ' ' VAL . 2.7 mp -93.83 115.78 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -169.31 -167.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.08 90.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.09 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.55 45.59 24.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 13.1 pt-20 -75.37 -6.69 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.265 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.19 45.64 3.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.83 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HG ' HG12 ' A' ' 120' ' ' VAL . 1.2 tp -42.77 -31.71 0.51 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.63 -19.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.417 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -91.52 27.35 9.75 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.051 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.462 HG12 ' HG ' ' A' ' 117' ' ' LEU . 5.3 m -81.62 153.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.763 0.281 . . . . 0.0 111.527 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.57 148.59 35.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -53.8 105.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 0.0 112.047 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.06 109.94 0.12 Allowed Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.989 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -156.18 138.72 14.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.639 0.257 . . . . 0.0 110.794 178.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.8 152.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 111.901 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.579 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 61.5 t -144.62 128.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.402 ' CG2' ' CG ' ' A' ' 13' ' ' ARG . 26.3 m -124.69 107.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.437 HG23 HG23 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.82 128.38 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.462 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.6 pt-20 -152.46 130.29 11.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 111.216 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.446 ' CB ' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.76 93.79 2.64 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.901 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.948 179.831 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.31 -147.73 16.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -141.29 -47.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 111.009 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.67 -146.67 0.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.95 -40.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.71 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.402 ' O ' HG21 ' A' ' 6' ' ' VAL . 24.4 m -108.58 60.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 111.305 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -156.95 44.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.03 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpp -109.63 115.68 30.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.64 145.26 38.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 112.03 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.54 163.6 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.719 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.45 145.06 33.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 12' ' ' ILE . 0.8 OUTLIER -147.35 102.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -108.58 155.99 20.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.854 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CG ' HD13 ' A' ' 117' ' ' LEU . 2.7 m-85 -128.82 140.31 51.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.159 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.07 -28.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -122.24 23.19 9.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.28 155.05 1.43 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -117.1 152.66 34.24 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.229 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.08 151.47 17.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.92 0.39 . . . . 0.0 111.926 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -137.45 149.96 47.26 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.235 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.13 141.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.131 0.491 . . . . 0.0 111.842 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 2.0 mp0 -95.03 -178.1 4.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.234 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.418 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 6.4 tp -154.79 142.33 19.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.05 146.92 48.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.32 -9.41 0.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.61 -28.59 1.0 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.186 -0.321 . . . . 0.0 111.219 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.52 ' CZ2' ' CG2' ' A' ' 31' ' ' THR . 6.2 t90 -79.78 -55.87 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 115.97 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.648 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -46.22 -36.7 17.37 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -62.12 -48.54 79.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.365 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.52 ' CG2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.38 -44.96 95.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.888 0.375 . . . . 0.0 110.353 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' CG1' ' CD2' ' A' ' 23' ' ' LEU . 43.7 t -51.31 -31.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -59.73 -36.06 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.48 -47.31 67.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -51.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.68 -28.69 69.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.983 0.42 . . . . 0.0 110.42 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.03 -23.83 60.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.44 50.81 0.89 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.877 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.89 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.506 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.89 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 30.7 Cg_exo -28.88 106.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.164 1.909 . . . . 0.0 113.979 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.2 mt -147.63 149.3 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.403 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 136.59 33.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.602 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.09 149.25 33.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.35 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.82 127.89 48.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 14' ' ' PHE . . . -87.16 136.27 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -108.83 123.56 49.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.235 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.693 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -80.85 138.17 36.19 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.414 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.5 t-105 -150.1 148.88 29.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.58 95.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.513 -0.375 . . . . 0.0 113.72 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.68 30.5 11.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.266 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' HG3' ' CG2' ' A' ' 91' ' ' THR . 0.9 OUTLIER -145.63 146.03 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.326 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -140.51 121.45 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 19.3 p90 -129.61 129.78 44.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.112 0.482 . . . . 0.0 110.98 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' VAL . 6.7 p90 -139.11 145.53 39.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.815 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 149.34 21.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.34 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.425 HG21 HG23 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.16 6.28 9.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.4 ' HG3' ' C ' ' A' ' 56' ' ' THR . 34.1 mt-30 80.41 -6.21 1.71 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.799 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.1 p -86.54 116.01 28.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.834 0.35 . . . . 0.0 110.2 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.32 94.79 5.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.0 0.429 . . . . 0.0 111.769 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' CG2' HG22 ' A' ' 31' ' ' THR . 7.5 p -124.07 106.59 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.016 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.34 136.56 51.13 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 111.587 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.4 ' HG2' ' N ' ' A' ' 63' ' ' GLU . 8.9 ttmt -141.51 164.79 29.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.242 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -101.24 76.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.051 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -170.11 160.78 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 28.3 t-20 72.78 -82.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER 22.43 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 104' ' ' VAL . 0.1 OUTLIER -101.97 160.55 14.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.639 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.38 -4.3 8.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 40.7 t -131.87 143.66 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.103 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.476 HG22 ' CZ ' ' A' ' 87' ' ' PHE . 26.8 m -158.77 158.21 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.029 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.33 150.54 24.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.362 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp -52.08 124.79 13.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.963 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -32.19 6.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.017 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -67.55 166.05 15.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.104 0.452 . . . . 0.0 111.883 -179.054 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' CG2' ' CD1' ' A' ' 110' ' ' ILE . 22.0 t -122.72 152.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.646 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 146.17 26.47 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.697 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.518 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -98.24 126.97 43.94 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.962 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.5 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 3.2 t90 -68.38 122.59 18.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.215 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -72.25 -68.53 0.41 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.453 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 38.8 Cg_exo -59.44 82.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.915 1.743 . . . . 0.0 111.837 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.53 -7.18 4.95 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.642 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.62 39.43 13.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 0.0 111.176 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -115.19 135.5 54.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.55 145.57 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.5 m -142.49 131.27 22.79 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -98.07 139.19 34.26 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.476 ' CZ ' HG22 ' A' ' 70' ' ' VAL . 14.3 p90 -136.52 138.05 40.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.075 0.464 . . . . 0.0 110.967 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.9 50.68 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.491 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.03 -81.14 0.13 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -123.49 -170.26 2.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.387 0.613 . . . . 0.0 111.553 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.555 ' CB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -166.16 178.09 1.37 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.807 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.6 Cg_exo -36.25 -30.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.659 2.239 . . . . 0.0 112.657 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ILE . 0.2 OUTLIER -142.11 69.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.348 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.444 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -44.88 -40.43 6.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 111.205 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -47.84 151.74 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 58.28 52.21 7.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.405 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.09 161.83 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.283 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.78 120.74 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.83 99.29 52.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.418 ' HA ' HG23 ' A' ' 91' ' ' THR . 40.0 Cg_endo -65.73 -31.43 49.02 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.552 2.168 . . . . 0.0 112.446 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.43 ' CB ' HG11 ' A' ' 104' ' ' VAL . . . 173.57 -159.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.62 -4.12 17.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.85 73.21 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' A' ' 67' ' ' LYS . 15.6 m -120.69 141.96 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.757 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.457 ' HB3' ' ND2' ' A' ' 65' ' ' ASN . 41.1 m-20 -80.71 151.03 29.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.687 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.449 ' C ' ' H ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -84.44 85.48 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.441 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.646 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -68.17 19.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.945 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 113.33 -146.74 18.52 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.933 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -154.98 168.09 28.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.515 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 114' ' ' MET . 3.6 mt -93.58 118.85 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -62.85 -74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -166.15 -31.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.445 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 m -40.56 -32.79 0.22 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.755 0.312 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.423 ' HB3' HG22 ' A' ' 110' ' ' ILE . 1.2 tmt? -87.5 155.37 20.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.705 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -125.66 -76.68 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.18 45.38 1.0 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.451 HD13 ' CG ' ' A' ' 14' ' ' PHE . 5.8 tp -45.76 -40.7 9.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.638 0.256 . . . . 0.0 111.076 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.1 OUTLIER -42.3 -24.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.418 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -91.32 35.04 4.05 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.057 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.477 ' O ' ' CD ' ' A' ' 47' ' ' ARG . 3.7 m -70.91 154.79 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 122.61 0.364 . . . . 0.0 111.853 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.79 146.66 44.09 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.693 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 p30 -58.1 116.35 3.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.089 0.471 . . . . 0.0 112.238 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.93 102.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.973 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.411 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 4.4 pt-20 -156.37 150.98 25.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.792 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.4 t -52.1 167.45 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 112.229 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.602 ' HB ' ' OG ' ' A' ' 43' ' ' SER . 89.2 t -157.7 128.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.21 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 30.6 m -127.84 108.23 17.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.425 HG23 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.02 129.01 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.7 pt-20 -152.05 128.22 10.48 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.607 0.242 . . . . 0.0 111.229 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.451 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.79 85.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.175 -0.916 . . . . 0.0 111.634 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -102.35 145.06 30.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 111.76 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 164.17 19.3 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.004 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.32 102.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.085 0.469 . . . . 0.0 109.779 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -99.82 156.23 17.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.376 0.608 . . . . 0.0 111.893 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.7 m-85 -135.88 138.87 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.495 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.6 p -125.98 21.83 7.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -176.53 153.32 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.91 146.58 37.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 149.01 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.168 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.29 155.66 24.74 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.81 142.06 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.223 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 7.4 mt-10 -100.58 -178.8 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.062 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.757 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.8 tp -150.92 149.36 29.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.067 0.46 . . . . 0.0 111.368 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' H ' HD12 ' A' ' 23' ' ' LEU . 19.3 m-85 -126.36 148.01 49.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.732 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.18 -8.88 1.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.65 -27.73 0.85 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.621 0.248 . . . . 0.0 111.593 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.653 ' CZ2' HG21 ' A' ' 31' ' ' THR . 8.9 t90 -81.61 -56.27 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.89 114.87 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.452 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -46.41 -35.23 15.73 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.555 2.17 . . . . 0.0 112.335 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.78 -53.5 57.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.539 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.51 -45.06 92.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.521 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.757 HG13 ' CD2' ' A' ' 23' ' ' LEU . 61.4 t -47.43 -28.42 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.33 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt-85 -61.21 -38.64 87.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.464 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.94 79.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.671 0.272 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.09 -51.29 55.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.03 -27.8 69.66 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 120.948 0.404 . . . . 0.0 110.369 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.93 -25.31 61.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 0.0 110.599 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.23 49.6 1.13 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.047 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.1 mt -61.91 -160.21 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.58 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 32.3 Cg_exo -29.2 107.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.04 150.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.627 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -85.77 136.61 33.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.111 0.481 . . . . 0.0 111.745 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.33 149.1 33.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.497 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 125.59 48.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.85 136.01 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -108.26 125.8 52.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.073 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HD3' ' O ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -85.39 135.37 33.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -150.91 148.97 29.08 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.902 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . -32.88 102.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.505 -0.379 . . . . 0.0 113.729 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.22 30.87 0.49 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.3 OUTLIER -144.02 142.91 30.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.351 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -139.92 124.83 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.299 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 34.9 p90 -133.83 127.84 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.0 p90 -133.58 146.5 51.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.049 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.01 145.19 24.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER 82.95 -8.14 1.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -84.34 115.78 26.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.33 94.56 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 112.053 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.69 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.3 p -123.21 106.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.41 136.39 46.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.041 0.448 . . . . 0.0 111.665 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -160.32 161.7 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.987 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -96.33 96.28 8.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.0 tt0 -170.37 149.87 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.884 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 57.4 t-20 63.33 -81.74 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.727 0.299 . . . . 0.0 111.108 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.2 m 29.97 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.676 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.802 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.54 157.06 16.71 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.145 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -120.98 -4.16 9.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.5 p -127.56 141.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.403 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.552 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.75 157.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.599 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.62 150.77 19.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.401 0.619 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -44.85 126.49 5.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.98 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.41 -26.96 10.44 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 120.256 -0.973 . . . . 0.0 114.614 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.432 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -82.53 156.21 24.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.844 0.822 . . . . 0.0 111.894 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.874 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -113.48 151.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.393 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.06 153.34 33.78 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CD2' ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -103.98 131.69 50.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.308 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.0 t90 -74.37 109.12 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -65.32 -69.17 0.61 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.311 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 39.0 Cg_exo -58.85 80.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.886 1.724 . . . . 0.0 111.518 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.46 -9.33 3.19 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.291 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 50.05 39.62 19.52 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.907 0.354 . . . . 0.0 111.121 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.02 136.38 54.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.53 147.05 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.5 m -143.12 135.89 27.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.778 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.07 160.82 19.18 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 57.1 m-85 -136.32 114.71 11.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 111.984 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.683 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -150.23 31.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.082 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.54 -153.07 24.1 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.663 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.6 -173.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.522 0.677 . . . . 0.0 112.203 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.725 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.31 -175.85 0.55 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.118 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.689 ' HB2' HD12 ' A' ' 93' ' ' ILE . 74.3 Cg_exo -42.6 -25.22 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.032 1.821 . . . . 0.0 112.888 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -142.02 72.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' OG1' ' A' ' 91' ' ' THR . 91.7 mt . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -109.32 99.26 35.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.959 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.725 ' HA ' HG21 ' A' ' 91' ' ' THR . 60.0 Cg_endo -70.66 -31.27 16.83 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.151 . . . . 0.0 112.719 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.69 -162.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.22 -5.37 14.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.613 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.27 70.06 0.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 101' ' ' ALA . 12.7 m -119.01 141.4 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.024 0.44 . . . . 0.0 111.805 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.689 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.1 m120 -84.43 151.39 24.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.419 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.802 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.7 96.89 6.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.618 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.27 20.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.74 -149.75 18.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.55 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HA ' HG23 ' A' ' 75' ' ' VAL . 30.6 mtp180 -156.75 168.03 28.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.19 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.586 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.84 112.72 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.531 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG21 ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.547 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.825 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.7 tt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.78 -21.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -93.43 34.35 4.65 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.427 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 117' ' ' LEU . 7.1 m -71.58 154.83 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 122.161 0.184 . . . . 0.0 111.088 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.635 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -81.22 147.92 29.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.603 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.1 p-10 -56.16 118.0 4.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.177 0.513 . . . . 0.0 112.328 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.63 101.15 0.02 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.008 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.635 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -149.8 155.55 40.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 110.48 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 t -55.56 164.98 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.681 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.5 t -157.96 127.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.562 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.39 108.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.759 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.68 128.89 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.407 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.7 pt-20 -153.41 129.18 10.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.66 0.267 . . . . 0.0 111.379 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.632 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.24 89.54 3.12 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.682 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -108.38 145.43 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.356 0.598 . . . . 0.0 112.319 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 163.92 18.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.62 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 144.87 31.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.7 mt -148.04 99.31 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.551 HH11 HG21 ' A' ' 127' ' ' VAL . 4.6 ptm180 -104.98 156.06 18.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.877 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.7 m-85 -129.63 139.11 51.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.277 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -28.53 0.43 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -121.34 22.97 10.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.76 151.46 1.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.37 138.35 54.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.791 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.499 ' SG ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -163.54 149.2 11.32 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.639 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.33 158.26 31.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.115 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.24 141.13 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.374 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.657 ' OE2' HG21 ' A' ' 111' ' ' VAL . 4.2 mt-10 -96.86 -178.46 4.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.979 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.806 ' CD2' HG13 ' A' ' 32' ' ' VAL . 8.1 tp -154.15 144.57 22.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.148 0.499 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.14 146.73 50.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.638 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -57.07 -9.29 0.83 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -45.49 -28.29 0.89 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.265 -0.272 . . . . 0.0 111.33 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.726 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.8 t90 -81.12 -56.18 4.26 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.41 115.47 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.597 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -46.17 -35.47 15.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.517 2.145 . . . . 0.0 112.341 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.15 -52.7 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.446 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.39 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.806 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.0 t -47.91 -30.04 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.307 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -60.66 -38.31 84.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.399 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.19 75.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.34 -52.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.9 -29.01 69.92 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.977 0.417 . . . . 0.0 110.445 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.92 -25.44 62.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.42 50.82 1.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.968 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.951 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.92 -160.05 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.45 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.4 Cg_exo -29.59 105.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.106 1.871 . . . . 0.0 113.953 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.7 mt -147.94 149.29 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.566 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.89 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.09 0.471 . . . . 0.0 111.766 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.7 p -146.08 149.01 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.463 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.92 129.38 48.17 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.865 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -89.46 134.45 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -106.06 122.02 45.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.045 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.807 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -81.79 136.73 35.4 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -154.45 148.34 25.59 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.47 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.83 86.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.497 0 O-C-N 123.278 0.361 . . . . 0.0 113.838 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.4 t70 76.15 -36.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 138.49 37.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 111.376 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -136.26 110.01 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.991 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 39.7 p90 -119.87 128.74 53.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.3 p90 -136.64 144.46 44.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.393 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.64 147.07 23.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.89 7.56 10.42 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 56' ' ' THR . 36.1 mt-30 81.02 -6.82 1.59 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.819 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -86.54 115.76 28.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.39 94.9 5.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.045 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 31' ' ' THR . 2.9 p -125.33 106.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.961 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 138.17 53.88 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.053 0.454 . . . . 0.0 111.623 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -152.99 164.5 37.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.335 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.12 87.2 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.78 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.0 tt0 -170.11 153.56 4.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 49.7 t-20 69.42 -80.27 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.277 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.456 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 5.3 m 25.28 82.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.473 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.883 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.77 157.02 17.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.536 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -118.97 -8.13 10.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.0 p -124.89 143.04 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.296 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.9 m -159.08 157.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.78 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.49 151.59 21.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.406 0.622 . . . . 0.0 111.483 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.38 125.36 10.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.805 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.59 -32.18 6.0 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.268 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 1.9 p30 -73.61 156.49 37.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.578 0.689 . . . . 0.0 111.942 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.0 t -112.93 152.35 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.4 148.94 31.83 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.262 0.483 . . . . 0.0 112.294 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.56 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -103.91 123.08 46.49 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.686 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.0 t90 -64.62 119.98 11.53 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.809 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.772 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -70.64 -68.03 0.55 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.753 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.772 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.07 78.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.846 1.697 . . . . 0.0 111.696 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 141.19 -9.24 2.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.737 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.02 36.23 14.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.0 0.4 . . . . 0.0 111.059 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.85 134.75 54.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.723 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.8 mt -84.3 141.16 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.451 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.5 m -135.65 130.36 34.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.825 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.58 156.3 19.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.8 m-85 -136.79 129.67 30.76 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.626 0.25 . . . . 0.0 110.989 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -165.79 42.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.304 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.47 -84.09 0.1 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.327 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -130.57 -166.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.259 0.552 . . . . 0.0 111.902 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.56 -176.65 0.63 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.7 Cg_exo -47.32 -24.62 4.05 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.793 1.662 . . . . 0.0 111.786 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 92' ' ' PRO . 1.9 mp -142.57 66.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.1 mt . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.84 0.352 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -103.47 99.21 14.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 91' ' ' THR . 52.4 Cg_endo -68.33 -31.39 28.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.482 2.121 . . . . 0.0 112.537 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.605 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.41 -158.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -6.93 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.697 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.01 73.12 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.7 m -122.74 142.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 111.826 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.5 m120 -83.58 152.0 25.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.854 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.883 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.73 99.84 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.457 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.571 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.66 21.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.79 -133.22 10.55 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.245 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.867 ' HA ' HG23 ' A' ' 75' ' ' VAL . 9.5 ptt85 -170.47 168.12 7.92 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.045 0.45 . . . . 0.0 111.484 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.607 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.0 mt -98.16 115.27 37.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.575 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.657 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.2 tt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.783 0.325 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.95 -24.38 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.173 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.92 31.29 4.72 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 117' ' ' LEU . 10.6 m -75.09 153.98 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.562 0.22 . . . . 0.0 111.299 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.26 146.61 32.91 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.618 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -57.28 111.64 1.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.99 98.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.401 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.41 149.71 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.68 166.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.281 0.562 . . . . 0.0 112.257 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.8 t -157.98 128.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.137 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 127' ' ' VAL . 27.5 m -129.46 109.14 17.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 111.589 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.89 129.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.243 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 11.8 pt-20 -154.31 128.04 8.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.622 0.249 . . . . 0.0 111.293 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.596 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.81 87.59 1.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 110.786 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.751 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -108.54 145.32 34.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.2 0.524 . . . . 0.0 112.329 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.48 163.96 17.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.682 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 145.68 38.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.796 0.332 . . . . 0.0 110.948 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.2 100.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -102.63 155.5 18.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.615 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE1' HG13 ' A' ' 126' ' ' VAL . 2.8 m-85 -131.2 138.05 49.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.441 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.53 -29.07 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -126.08 23.12 7.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.06 152.44 3.49 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.78 143.5 49.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.676 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 148.6 13.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.75 0.31 . . . . 0.0 111.769 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -136.31 157.83 45.86 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.054 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.15 146.57 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.446 . . . . 0.0 111.648 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 6.6 mt-10 -98.16 -178.29 4.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.871 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.758 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.9 tp -153.71 144.2 22.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -123.97 146.8 48.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.45 -9.27 0.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.61 -27.26 0.74 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.939 0.336 . . . . 0.0 111.443 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.655 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.5 t90 -81.28 -56.37 4.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.23 113.62 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.665 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.72 -29.62 8.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.35 -46.46 80.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.283 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.693 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -68.32 -46.2 70.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 23' ' ' LEU . 30.2 t -45.87 -29.82 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.339 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -33.44 72.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.477 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.53 55.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.3 -49.08 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.12 -28.62 69.89 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.319 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -71.4 -25.38 62.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.376 . . . . 0.0 110.543 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.01 51.11 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.988 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -62.21 -159.93 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.594 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.4 Cg_exo -29.08 107.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.186 1.924 . . . . 0.0 114.059 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.9 mt -150.04 149.78 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.642 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -85.84 136.85 33.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.919 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.58 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -146.05 149.19 33.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.45 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 124.44 47.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.894 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -84.93 133.58 34.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -103.4 124.98 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.931 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.865 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.52 135.88 33.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.6 t-105 -156.71 148.34 22.58 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.957 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.81 84.89 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.649 -0.31 . . . . 0.0 113.764 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' TRP . 30.5 t70 74.22 -36.64 0.34 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.3 tt0 -74.71 128.22 35.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.399 . . . . 0.0 111.346 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -132.29 119.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.849 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 53.4 p90 -131.47 125.03 31.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.319 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.0 p90 -129.87 145.8 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.05 144.12 25.76 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.89 6.4 11.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.6 mm-40 82.23 -7.44 1.33 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.7 p -84.98 116.87 29.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.159 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.87 94.56 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.703 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.693 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.0 p -126.08 106.74 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.3 133.93 43.21 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 161.14 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.083 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.73 93.97 7.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.51 148.39 3.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 0.4 OUTLIER 70.44 -76.87 0.06 Allowed 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.606 0.241 . . . . 0.0 111.165 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.474 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 11.0 t 21.41 83.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.887 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.58 161.51 13.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.361 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.28 1.04 8.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 49.6 t -138.41 142.33 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.483 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.99 157.55 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.887 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.79 152.2 19.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.495 0.664 . . . . 0.0 111.62 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -48.29 125.91 10.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.933 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.07 6.08 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.505 -0.855 . . . . 0.0 114.083 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -75.37 156.37 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.458 0.629 . . . . 0.0 111.984 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.9 t -113.05 152.25 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.08 149.39 29.47 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.151 0.432 . . . . 0.0 111.874 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -104.51 137.66 42.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.341 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.631 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.6 t90 -78.72 108.26 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.447 HG13 ' ND2' ' A' ' 105' ' ' ASN . 0.3 OUTLIER -63.94 -66.42 1.5 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.634 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 21.1 Cg_endo -60.72 77.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.255 1.97 . . . . 0.0 111.6 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 142.91 -9.99 2.31 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.324 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 54.47 33.6 19.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.965 0.382 . . . . 0.0 110.913 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.96 134.8 54.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.049 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.1 mt -87.37 150.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 24.8 t -143.52 156.09 44.52 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.087 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -113.66 157.76 21.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.943 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 5.5 m-85 -136.71 138.21 40.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.492 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -175.46 44.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.957 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.36 -91.14 0.1 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.973 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -133.36 -167.76 1.98 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.424 0.63 . . . . 0.0 111.724 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.841 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -163.61 -173.94 0.38 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.01 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.628 ' CD ' HG22 ' A' ' 91' ' ' THR . 90.4 Cg_exo -45.48 -22.2 0.97 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 121.81 1.673 . . . . 0.0 112.736 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 92' ' ' PRO . 2.7 mp -142.06 73.1 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -98.76 99.11 7.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.841 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.4 Cg_endo -68.87 -31.09 25.5 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.483 2.122 . . . . 0.0 112.561 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.77 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.76 -0.43 14.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.599 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.474 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -171.42 68.25 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 78' ' ' TRP . 18.6 m -121.45 141.63 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.132 0.492 . . . . 0.0 112.09 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.532 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.2 m120 -82.32 152.04 26.45 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.815 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -89.1 97.43 6.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.528 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.95 22.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.116 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.43 -144.65 17.9 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.079 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.847 ' HA ' HG23 ' A' ' 75' ' ' VAL . 5.0 mtt180 -156.79 168.1 28.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 111.33 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mp -91.41 116.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.076 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.087 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.782 0.325 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.51 -26.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.94 -179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.54 31.34 4.22 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.1 m -79.84 154.19 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.641 0.258 . . . . 0.0 111.202 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.96 146.55 32.01 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.578 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 16.0 p-10 -54.57 112.01 0.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.997 0.427 . . . . 0.0 111.593 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.61 100.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.179 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.82 148.88 28.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.371 . . . . 0.0 110.982 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.1 t -46.63 163.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.327 0.584 . . . . 0.0 112.233 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 45' ' ' ALA . 42.4 t -158.1 128.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.326 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.2 m -126.51 108.42 19.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.901 0.382 . . . . 0.0 111.547 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.05 128.53 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.289 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.4 pt-20 -154.0 130.26 10.45 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.43 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.603 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.19 89.53 3.09 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.801 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.719 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.692 0.282 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -111.27 145.32 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 112.099 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.39 164.57 14.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.796 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.35 143.82 36.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 0.0 111.159 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.45 100.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -102.48 156.26 17.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.597 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.1 m-85 -136.27 137.91 41.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.524 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.5 -29.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -123.88 22.81 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.86 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -126.68 141.5 51.83 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.83 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 148.94 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.717 0.294 . . . . 0.0 111.498 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.5 160.11 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.308 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.86 144.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.122 0.487 . . . . 0.0 111.571 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.3 mt-10 -96.21 -178.52 4.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.13 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.0 tp -151.02 147.02 26.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.029 0.442 . . . . 0.0 111.15 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.5 146.88 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -59.06 -9.03 1.7 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.4 -29.56 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -79.9 -56.38 4.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 158.24 117.2 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -45.99 -35.36 14.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.523 2.149 . . . . 0.0 112.208 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.63 76.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.708 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.539 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.91 -44.22 93.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.859 0.362 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 23' ' ' LEU . 63.7 t -47.68 -34.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.204 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -60.07 -36.98 78.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.39 70.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -54.95 -51.76 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.42 -28.7 69.98 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.028 0.442 . . . . 0.0 110.399 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.74 -26.16 63.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.452 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.0 51.48 1.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.778 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.964 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.7 -159.71 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.591 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.964 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.6 Cg_exo -28.92 105.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.996 1.798 . . . . 0.0 113.989 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 39' ' ' LEU . 21.0 mt -146.64 150.71 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.63 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.036 0.446 . . . . 0.0 111.82 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.608 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -144.05 148.97 35.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.453 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 126.95 48.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 110.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -88.84 132.75 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -102.63 122.3 44.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.712 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.925 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.66 136.18 33.18 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -155.74 148.26 23.9 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.81 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -32.07 85.47 0.01 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.178 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.1 t70 76.0 -39.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.9 tt0 -71.09 120.26 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 0.0 111.504 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -128.36 121.54 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.742 178.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -135.23 127.91 30.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.844 0.354 . . . . 0.0 111.296 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.7 p90 -133.4 145.76 50.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.013 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.15 146.19 24.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.63 6.31 10.53 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER 83.07 -8.08 1.16 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.2 p -85.76 115.02 26.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.38 94.7 5.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.975 0.417 . . . . 0.0 112.052 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.8 p -129.66 106.78 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.124 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.64 134.75 54.49 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 121.027 0.441 . . . . 0.0 111.641 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.26 167.26 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.065 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.03 88.78 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.972 0.415 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.33 160.79 7.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.757 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.8 t-20 63.42 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.3 m 28.5 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.368 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.841 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.19 155.45 17.75 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.398 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.655 ' OD1' HG23 ' A' ' 69' ' ' VAL . 1.5 p30 -120.41 2.11 10.74 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 68' ' ' ASP . 51.0 t -137.28 141.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -158.12 157.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.715 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -98.26 148.73 23.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.389 0.614 . . . . 0.0 111.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.61 129.42 4.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.948 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.51 -32.06 6.08 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.134 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 2.5 p30 -81.15 157.93 25.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.327 0.564 . . . . 0.0 111.929 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.87 HG23 ' HA ' ' A' ' 109' ' ' ARG . 38.4 t -116.21 152.53 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.48 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 151.32 32.54 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.305 0.502 . . . . 0.0 112.341 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -107.36 137.28 45.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.553 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -76.22 111.95 12.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -64.04 -67.37 1.08 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 32.2 Cg_endo -63.5 76.28 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.23 1.954 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.83 -10.84 1.65 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.545 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.38 28.72 11.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.147 0.474 . . . . 0.0 110.944 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.12 130.9 55.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.676 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.74 147.66 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.197 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.1 t -141.06 156.83 45.94 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.482 0.658 . . . . 0.0 112.769 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.922 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.75 161.76 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.069 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 10.5 m-85 -136.55 138.94 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -177.68 49.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.418 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.71 -78.54 0.19 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.619 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -141.47 -161.51 1.23 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.976 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.879 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -166.33 177.87 1.41 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.009 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -41.79 -23.67 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.473 2.115 . . . . 0.0 112.921 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 99' ' ' ARG . 10.0 pt -141.19 64.59 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 121.115 0.483 . . . . 0.0 110.662 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -100.09 99.06 8.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.767 ' HA ' HG21 ' A' ' 91' ' ' THR . 46.9 Cg_endo -68.16 -29.68 32.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.215 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.39 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.661 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.8 -2.97 15.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.654 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -172.16 70.1 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.4 m -120.03 141.64 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.956 0.408 . . . . 0.0 111.8 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.612 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.8 m120 -83.83 153.1 24.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.285 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.841 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.84 89.66 3.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.121 178.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.649 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.87 23.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 114.71 -150.46 18.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.87 ' HA ' HG23 ' A' ' 75' ' ' VAL . 27.2 mtp180 -156.94 168.16 28.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.2 mt -98.05 114.59 35.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.568 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.737 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.922 HD22 HD13 ' A' ' 86' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.41 -26.43 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.282 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.03 29.83 4.54 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.39 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.3 m -84.32 153.89 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.832 0.316 . . . . 0.0 111.381 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.67 147.18 32.08 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.475 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 5.2 p-10 -56.31 117.72 4.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.52 100.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.108 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.29 149.63 27.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.137 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.2 t -48.6 164.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 112.061 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 45' ' ' ALA . 48.0 t -158.02 128.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.578 HG23 ' OE2' ' A' ' 129' ' ' GLU . 17.4 m -125.83 108.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.453 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.0 128.79 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.225 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -154.43 131.66 11.1 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.799 0.333 . . . . 0.0 111.542 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.534 ' CB ' HD22 ' A' ' 39' ' ' LEU . 3.1 tmm_? -74.25 92.85 2.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.867 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -109.15 145.42 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 112.156 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 163.27 17.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.7 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 144.86 32.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.885 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.89 101.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 109.749 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -100.09 156.12 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.71 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.67 138.03 44.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.431 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.43 -28.91 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -125.56 22.37 7.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.14 150.26 1.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.415 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -131.92 139.23 48.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.188 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 149.2 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.7 0.286 . . . . 0.0 111.339 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -116.41 156.92 25.95 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.41 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.79 138.04 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.3 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.689 ' OE2' HG13 ' A' ' 111' ' ' VAL . 3.2 mt-10 -92.96 -178.3 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.325 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.836 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -155.43 145.87 21.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -126.65 146.71 50.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 29.6 mt-10 -56.59 -9.13 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.67 -27.4 0.79 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.212 -0.305 . . . . 0.0 111.383 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.776 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.6 t90 -80.56 -55.96 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.49 109.7 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.48 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.738 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 88.4 Cg_exo -40.9 -29.71 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.789 2.326 . . . . 0.0 112.967 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.97 -42.04 81.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.321 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.776 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.74 -45.03 72.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.784 0.326 . . . . 0.0 110.477 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 ' CD2' ' A' ' 23' ' ' LEU . 35.5 t -48.85 -33.64 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.244 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -58.03 -37.25 74.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -66.5 -48.44 69.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.45 -51.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.04 -29.03 70.01 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.331 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.7 -24.76 61.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.62 51.47 0.93 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.959 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.522 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.959 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.6 Cg_exo -29.49 105.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.071 1.848 . . . . 0.0 113.969 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.8 mt -147.23 150.79 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.569 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.9 136.85 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.612 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.0 p -145.23 148.88 34.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.504 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 123.65 46.09 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.068 0.461 . . . . 0.0 110.263 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.49 135.04 34.81 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -107.26 126.43 52.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.679 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.43 137.4 32.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 14.4 t-105 -149.47 148.37 29.34 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.431 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.17 92.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.053 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 27.9 t70 78.87 -41.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.724 0.41 . . . . 0.0 111.649 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 152.55 24.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 111.425 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -153.0 117.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.627 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.2 p90 -124.06 141.68 51.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.345 0.593 . . . . 0.0 112.226 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -140.45 145.39 36.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.33 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.57 149.5 21.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.697 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.89 5.23 8.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.2 mm-40 83.32 -8.08 1.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.764 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -85.02 116.7 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.33 94.95 5.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 0.0 112.187 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.614 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.0 p -124.55 106.62 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.874 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.71 136.44 50.6 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.026 0.441 . . . . 0.0 111.708 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -156.86 164.62 37.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.233 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.79 91.02 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.7 tt0 -170.12 152.04 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER 68.5 -79.96 0.04 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.492 ' OG ' HD12 ' A' ' 79' ' ' ILE . 4.4 m 23.8 80.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.624 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 158.67 16.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.558 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -120.64 -5.88 9.71 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.9 p -128.83 142.87 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.392 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.54 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 29.5 m -158.68 157.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -88.23 151.45 22.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.343 0.592 . . . . 0.0 111.412 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -50.43 126.2 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.143 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.53 -32.22 6.19 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.939 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.4 p-10 -68.98 162.49 26.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.074 0.464 . . . . 0.0 112.101 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -121.73 152.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.948 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.798 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.61 146.24 25.68 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.495 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.99 130.98 44.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.817 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.748 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.9 t90 -71.03 122.66 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.99 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -68.09 -67.84 0.75 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.903 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 47.1 Cg_endo -68.05 80.56 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.246 1.964 . . . . 0.0 112.181 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.46 -11.94 2.48 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 53.76 30.56 11.41 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.11 0.455 . . . . 0.0 110.749 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -109.65 135.07 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.63 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.5 mt -85.96 144.24 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.66 130.7 30.39 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.889 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.36 156.86 19.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.09 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.7 m-85 -136.5 130.13 32.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.538 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 2.6 m-85 -152.51 28.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 151.07 -151.78 23.7 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.518 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -40.73 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.619 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -151.2 -174.62 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.647 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.6 Cg_exo -46.18 -24.19 2.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.748 1.632 . . . . 0.0 112.297 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -139.94 55.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' A' ' 91' ' ' THR . 67.8 mt . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.7 mtt85 -136.33 99.2 10.93 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.556 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 54.0 Cg_endo -68.21 -31.66 28.67 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.44 2.093 . . . . 0.0 112.331 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.726 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.0 -161.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.748 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.16 -7.68 15.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.53 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.39 71.24 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.748 HG12 ' CD1' ' A' ' 78' ' ' TRP . 14.5 m -118.36 141.92 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.472 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.685 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 31.7 m-20 -82.15 150.94 27.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.624 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.51 92.61 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.798 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -79.17 19.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.423 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.11 -148.24 18.21 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.087 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.854 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.5 mtt180 -155.93 167.87 29.03 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.964 0.411 . . . . 0.0 111.518 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.625 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -94.15 114.8 31.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.689 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.4 tt . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.421 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.9 -24.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.727 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.46 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.34 32.54 4.11 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 117' ' ' LEU . 12.1 m -74.94 154.54 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.272 0.229 . . . . 0.0 110.825 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.45 144.53 46.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.536 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 12.2 p-10 -58.02 112.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.423 . . . . 0.0 111.866 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.2 103.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.522 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -158.16 151.49 23.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.934 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.11 164.54 0.11 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.307 0.575 . . . . 0.0 112.196 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.928 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.07 128.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.37 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.51 108.39 18.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 111.356 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.697 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.01 128.84 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.7 pt-20 -153.26 129.64 10.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.672 0.273 . . . . 0.0 111.274 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.628 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.81 89.96 2.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.798 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -106.66 145.32 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.205 0.526 . . . . 0.0 112.29 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.97 164.72 15.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.66 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 147.29 36.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.787 0.327 . . . . 0.0 111.11 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -142.88 102.92 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -102.37 156.24 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.481 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.822 ' CE1' HG22 ' A' ' 126' ' ' VAL . 43.9 m-85 -139.01 138.59 37.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.104 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -125.7 22.97 7.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -175.38 154.67 1.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.46 147.04 50.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 149.79 14.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.19 156.94 47.46 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.142 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.33 149.87 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 111.631 -179.256 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 13.5 mt-10 -102.23 -178.64 3.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.974 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 4.1 tp -153.29 149.52 27.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.11 0.481 . . . . 0.0 111.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.428 ' H ' HD12 ' A' ' 23' ' ' LEU . 22.7 m-85 -127.24 148.87 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.2 -8.97 0.55 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -45.61 -27.49 0.79 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.967 0.349 . . . . 0.0 111.533 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -82.42 -56.53 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.42 116.16 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.416 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -45.89 -34.41 12.34 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.478 2.119 . . . . 0.0 112.383 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -61.63 -49.99 74.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.38 -44.85 93.57 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.606 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.9 t -49.15 -31.48 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -61.97 -38.16 87.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.63 80.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.23 -51.31 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.02 -28.09 69.34 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.087 0.47 . . . . 0.0 110.445 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.85 -23.5 59.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.62 51.37 0.84 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.661 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.976 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.5 mt -61.95 -159.9 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.692 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.976 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.0 Cg_exo -27.66 105.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.167 1.911 . . . . 0.0 114.156 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.8 mt -147.18 150.71 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.395 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 135.42 33.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 0.0 111.748 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.619 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.5 p -146.06 149.13 33.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.391 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 132.03 47.69 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.11 136.07 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -100.79 117.55 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.914 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.601 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.11 133.0 33.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.039 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.4 t-105 -154.21 148.81 26.33 Favored 'General case' 0 C--O 1.229 0.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -30.72 85.61 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.282 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.0 t70 73.31 -37.8 0.39 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.542 0.337 . . . . 0.0 111.521 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.583 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.1 tt0 -72.08 129.29 38.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.855 0.359 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -133.26 124.63 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.129 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.41 ' CE1' ' ND2' ' A' ' 46' ' ' ASN . 55.0 p90 -135.7 133.15 37.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.944 0.402 . . . . 0.0 111.644 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.3 p90 -138.83 145.44 40.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -93.6 148.52 22.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.162 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.679 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.99 5.87 9.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 83.38 -8.18 1.11 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.0 p -85.89 114.15 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.124 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.31 98.47 8.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 112.055 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.1 p -134.42 106.81 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -126.64 133.93 50.87 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.054 0.454 . . . . 0.0 111.555 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 31.8 tttt -140.07 164.77 29.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.292 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -99.23 86.94 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.778 0.323 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.7 tt0 -170.18 160.61 8.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.4 t-20 63.31 -82.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 5.4 m 26.48 81.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.87 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.65 161.08 13.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.349 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -122.62 -7.44 8.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.3 p -126.7 141.6 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.4 m -159.27 146.9 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.14 152.76 21.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 0.0 110.953 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -41.23 124.01 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.348 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -32.31 6.04 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.058 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 127.05 31.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.818 0.309 . . . . 0.0 111.505 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 11.9 t -94.8 150.62 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -145.65 153.04 40.58 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.516 0.598 . . . . 0.0 112.474 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 122.63 48.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.091 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.753 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.3 t90 -61.84 127.22 30.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.087 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -75.13 -64.19 0.63 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.893 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 46.3 Cg_endo -67.8 85.55 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.283 1.988 . . . . 0.0 112.025 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.43 -6.75 5.3 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.38 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.16 36.88 13.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.95 134.19 51.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.37 149.42 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.504 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 34.7 t -143.16 156.53 44.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.265 0.555 . . . . 0.0 112.492 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.99 158.59 18.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.415 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 12.9 m-85 -136.67 127.11 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -168.62 51.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.677 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.403 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 162.74 -80.78 0.13 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.44 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -155.89 176.92 12.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.036 0.446 . . . . 0.0 111.926 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.773 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -143.52 -174.32 0.4 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.603 ' CD ' HG22 ' A' ' 91' ' ' THR . 97.0 Cg_exo -45.02 -22.81 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.131 1.887 . . . . 0.0 112.934 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 99' ' ' ARG . 1.6 mp -132.44 76.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.872 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' OG1' ' A' ' 91' ' ' THR . 14.4 mt . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.68 0.276 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' HB2' HD13 ' A' ' 93' ' ' ILE . 27.9 mmm-85 -99.89 99.35 8.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.773 ' HA ' HG21 ' A' ' 91' ' ' THR . 64.1 Cg_endo -71.24 -32.14 13.31 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.513 2.142 . . . . 0.0 112.579 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.63 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.62 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.816 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.69 -5.38 13.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 66' ' ' SER . . . -169.96 71.65 0.07 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.753 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.6 m -121.34 142.04 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.696 0.284 . . . . 0.0 111.222 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.626 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.7 m-20 -85.86 153.0 22.55 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.87 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.14 101.99 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -87.51 22.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 117.4 -148.6 18.74 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.196 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.8 mtt180 -154.84 163.0 40.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.12 113.8 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.292 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.802 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.2 tp . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.78 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.062 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.27 34.98 3.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.423 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.802 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.3 m -81.5 153.75 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.7 147.31 43.73 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.379 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.508 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 2.4 p30 -53.35 135.86 38.28 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.501 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 55.32 99.4 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.243 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.01 153.29 41.32 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.92 157.74 24.05 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.482 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.892 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.5 t -148.54 129.05 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.023 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 24.9 m -124.27 107.13 17.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.37 128.97 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.739 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.2 OUTLIER -150.96 128.23 11.27 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.714 0.292 . . . . 0.0 111.147 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 90.91 3.05 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.688 179.888 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.79 145.22 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 112.346 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 163.67 19.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.507 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 144.62 31.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -145.89 100.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -108.77 156.21 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.832 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.9 m-85 -126.49 143.7 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.154 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -28.67 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.0 t -121.69 23.07 10.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.76 154.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.631 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -127.53 142.79 51.29 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.16 149.49 12.2 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.676 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -121.9 158.16 29.59 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.349 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.59 142.84 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.78 -178.27 4.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.498 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.846 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -152.72 140.39 19.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.963 0.411 . . . . 0.0 110.95 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.13 143.14 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -60.61 -8.49 2.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.02 -29.63 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.678 ' NE1' HG21 ' A' ' 31' ' ' THR . 0.5 OUTLIER -76.77 -54.14 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.782 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 162.59 116.24 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.804 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.4 Cg_endo -47.4 -34.61 19.52 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.578 2.185 . . . . 0.0 112.504 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.51 -37.51 80.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.353 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.782 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -68.72 -43.95 74.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 110.28 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.846 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.3 t -50.04 -38.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.716 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -56.87 -35.13 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.72 -47.06 70.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.799 0.333 . . . . 0.0 111.011 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.54 -49.24 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.601 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.1 -29.63 70.95 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.144 0.497 . . . . 0.0 110.284 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -70.43 -25.76 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.554 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.39 52.79 0.94 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.849 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.68 -159.91 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.692 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 27.9 Cg_exo -28.04 106.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.18 1.92 . . . . 0.0 114.099 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.6 mt -148.18 150.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.514 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -85.87 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 111.759 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -146.05 149.12 33.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.361 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.72 130.42 48.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.912 0.387 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.88 133.12 35.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -103.39 128.38 50.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.004 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.873 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.6 138.21 31.63 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.3 t-105 -155.1 148.98 25.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -37.31 97.16 0.01 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.492 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 53.27 24.6 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 111.356 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.73 136.93 39.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.489 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -138.4 129.42 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 52.6 p90 -137.92 122.11 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.371 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.9 p90 -131.29 146.36 52.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 148.9 21.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.7 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.73 6.33 8.8 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER 82.89 -8.01 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -86.05 114.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.258 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.48 96.04 6.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 111.855 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.9 p -133.14 106.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.253 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -130.87 133.5 45.96 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.535 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 40.5 tttm -145.08 165.55 27.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.372 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.09 90.06 4.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.5 tt0 -170.21 158.49 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.471 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 35.8 t-20 63.21 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.85 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 19.9 m 25.63 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.326 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -104.13 162.03 13.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.852 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -120.94 -12.16 8.82 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.4 p -121.27 143.25 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.439 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.574 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 36.0 m -158.31 157.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.71 150.15 24.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.338 0.59 . . . . 0.0 111.053 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.63 125.01 15.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.939 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.98 -31.43 6.53 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.223 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.2 p-10 -69.24 165.72 19.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 117.16 0.48 . . . . 0.0 111.825 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.802 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.9 t -119.99 152.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.44 148.92 30.01 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.442 0.565 . . . . 0.0 112.381 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -104.57 135.42 46.02 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.161 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.694 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -76.6 108.7 9.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.527 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -56.73 -70.65 0.32 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.145 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -58.64 87.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.266 1.977 . . . . 0.0 112.347 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.39 -6.03 5.61 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.774 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.8 32.42 9.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.959 0.38 . . . . 0.0 110.582 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.66 131.68 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.764 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.4 mt -87.76 150.6 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.087 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 18.6 t -143.34 156.35 44.67 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -121.37 137.8 54.54 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.144 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.9 p90 -136.65 139.76 42.26 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.029 -0.419 . . . . 0.0 111.491 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 53.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.048 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.22 -135.03 5.47 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -57.35 -173.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.676 0.738 . . . . 0.0 111.2 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -167.93 -174.14 0.33 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.932 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 88.2 Cg_exo -45.83 -21.4 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.816 1.677 . . . . 0.0 112.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.2 mt -143.36 60.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 110.761 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.53 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.2 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.965 0.412 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.64 99.42 52.81 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.998 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 91' ' ' THR . 33.2 Cg_endo -62.61 -29.69 78.24 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.472 2.115 . . . . 0.0 112.604 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.37 -162.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.798 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.59 -5.92 22.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.536 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -176.31 77.54 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 78' ' ' TRP . 24.5 m -125.35 141.5 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 111.611 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m-20 -81.88 153.91 26.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.261 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.766 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.23 81.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.683 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -64.86 19.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.253 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 117.51 -138.07 13.81 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.849 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.802 ' HA ' HG23 ' A' ' 75' ' ' VAL . 4.2 ptt180 -170.51 162.19 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.622 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -88.49 115.75 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.217 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 86' ' ' LEU . 3.8 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.688 0.28 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.19 -25.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.04 30.21 6.01 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.559 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.7 m -71.02 154.47 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 122.334 0.254 . . . . 0.0 111.56 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.623 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -79.18 148.57 32.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.595 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.7 p-10 -57.0 109.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.462 . . . . 0.0 111.947 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.04 101.54 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.93 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -154.02 154.46 33.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.969 0.414 . . . . 0.0 110.845 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.405 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.1 OUTLIER -56.66 167.24 0.77 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.964 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.01 129.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.4 m -127.78 108.05 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.311 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.31 128.79 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 5.2 pt-20 -153.75 131.62 11.64 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 111.29 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.11 89.89 3.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.85 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.748 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -116.9 145.39 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.173 0.511 . . . . 0.0 112.125 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.35 163.6 15.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.621 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 147.24 31.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -143.93 102.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 127' ' ' VAL . 8.2 ptm180 -100.5 156.36 17.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.446 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 126' ' ' VAL . 6.8 m-85 -139.71 134.9 32.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.72 -29.14 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -125.02 22.45 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.7 153.09 1.37 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.377 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.87 142.79 50.85 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.866 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.81 149.32 12.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.767 0.318 . . . . 0.0 111.475 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -128.77 158.9 37.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.056 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.1 144.16 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.657 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.0 mt-10 -97.47 -178.5 4.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.906 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.1 tp -153.52 148.1 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -125.37 148.14 48.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.692 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -57.54 -8.97 0.96 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.37 -28.3 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.259 -0.276 . . . . 0.0 111.512 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.65 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.77 -56.5 3.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.66 117.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.58 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.77 -34.76 12.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.449 2.1 . . . . 0.0 112.223 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -60.52 -52.0 67.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.616 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -61.01 -45.44 94.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.833 0.349 . . . . 0.0 110.349 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -49.83 -30.41 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.207 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -28.72 70.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.52 39.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.715 0.293 . . . . 0.0 110.979 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.36 -51.46 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.08 -28.64 69.75 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.362 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.44 -24.6 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 51.49 0.93 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -61.71 -160.09 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.622 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 24.6 Cg_exo -27.66 107.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.297 1.998 . . . . 0.0 114.085 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.0 mt -149.62 151.06 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.513 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 136.37 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.05 148.99 33.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.483 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 129.5 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.199 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.937 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -92.79 130.76 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -97.81 133.12 42.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.506 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.949 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -100.05 133.02 45.05 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ASP . 1.9 t90 -157.22 148.32 21.77 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -25.6 87.29 0.01 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.203 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' TRP . 13.0 t70 69.12 -40.94 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 49' ' ' GLY . 15.6 tt0 -62.72 118.99 8.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -129.01 114.68 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.763 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 50.8 p90 -126.37 126.96 44.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.445 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.31 145.99 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 149.75 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.056 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.671 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.71 4.48 8.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.5 OUTLIER 83.2 -8.09 1.14 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.798 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.13 114.97 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.08 94.78 5.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 111.94 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.616 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.6 p -127.62 106.71 15.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.901 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' A' ' 79' ' ' ILE . 1.8 mt-10 -127.92 134.37 49.33 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.966 0.412 . . . . 0.0 111.898 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 13.8 tttp -142.14 165.74 26.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -103.63 88.65 3.12 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.058 0.456 . . . . 0.0 111.33 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.1 tt0 -170.2 161.38 8.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.2 t-20 63.9 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.469 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 13.2 m 30.8 81.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.732 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.901 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.58 157.41 16.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.209 178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.29 -7.24 10.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.2 144.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.67 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -157.86 156.84 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -99.65 149.03 23.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.03 126.87 2.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.094 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.01 6.1 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.197 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.86 157.38 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.457 0.629 . . . . 0.0 111.945 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -116.32 152.61 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.69 150.94 34.06 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -110.62 132.43 54.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.687 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.747 ' HD1' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -73.62 143.71 46.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.189 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.646 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -94.13 -54.26 0.24 Allowed Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 8.6 Cg_exo -72.3 72.36 2.87 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.529 2.153 . . . . 0.0 111.649 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 143.05 -7.65 2.13 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.513 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 52.57 34.64 16.07 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.977 0.388 . . . . 0.0 110.867 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.84 131.13 55.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.3 mt -89.3 150.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.278 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -141.28 155.73 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.27 0.557 . . . . 0.0 112.259 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.083 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.01 161.59 15.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.482 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 28.2 m-85 -136.48 141.12 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER 175.34 43.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.9 -82.81 0.11 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.154 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -144.37 -168.75 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.469 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.57 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -162.45 -177.96 0.78 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.712 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 80.8 Cg_exo -42.5 -27.53 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.324 2.016 . . . . 0.0 112.81 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.3 mp -131.31 75.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.179 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.57 HG23 ' OG1' ' A' ' 91' ' ' THR . 43.8 mt . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.67 0.272 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 12.9 mmm-85 -100.15 99.15 8.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.3 Cg_endo -69.63 -31.69 20.59 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.565 2.177 . . . . 0.0 112.655 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.29 -162.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.93 -9.4 15.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.537 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.31 72.76 0.19 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.747 HG12 ' HD1' ' A' ' 78' ' ' TRP . 19.7 m -121.36 141.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.815 0.341 . . . . 0.0 111.406 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.517 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 30.4 m-20 -85.35 151.47 24.0 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.901 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.67 98.17 7.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.593 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.43 23.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 109.53 -159.94 13.74 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.663 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.869 ' HA ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -143.26 168.19 20.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 111.717 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.94 115.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.601 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.466 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.083 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.12 -27.2 0.12 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.917 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.99 30.01 4.06 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.4 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.949 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.9 m -81.81 154.33 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.943 0.371 . . . . 0.0 111.246 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.33 147.21 34.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 11.2 p-10 -55.35 116.46 2.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.072 0.463 . . . . 0.0 112.14 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.59 103.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.626 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -154.95 149.57 26.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 165.68 0.07 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.189 0.519 . . . . 0.0 112.173 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.937 HG21 ' HB2' ' A' ' 45' ' ' ALA . 43.9 t -158.09 128.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.61 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 127' ' ' VAL . 16.6 m -124.54 107.89 19.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 111.233 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.99 128.6 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.521 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.3 pt-20 -152.12 130.46 12.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.667 0.27 . . . . 0.0 111.261 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.627 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -77.46 95.16 4.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.785 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 40.7 tpp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -86.04 145.36 27.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.09 156.69 25.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.965 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.51 141.63 36.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.066 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -141.73 100.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.02 156.11 17.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.028 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -133.17 138.58 46.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.322 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.08 -28.83 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 p -123.49 23.0 9.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 150.48 1.29 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.63 140.64 47.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.207 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.53 149.38 9.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.626 0.251 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.46 157.23 25.5 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.514 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.2 141.1 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 111.132 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 12.6 mt-10 -98.75 -178.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.057 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.769 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -151.89 144.43 24.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.09 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -120.76 146.46 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.553 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.44 -9.46 0.71 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -45.93 -27.58 0.93 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.197 -0.315 . . . . 0.0 111.363 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.668 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.6 t90 -80.23 -56.35 4.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 152.48 115.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.665 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -45.55 -36.19 13.53 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.05 -52.85 63.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.723 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.76 -45.66 93.49 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.356 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.769 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.8 t -48.9 -29.55 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.31 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -59.58 -38.54 81.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.63 73.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.671 0.272 . . . . 0.0 111.204 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -53.66 -51.78 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.29 -28.67 69.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.31 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -71.65 -25.02 61.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.373 . . . . 0.0 110.641 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.54 50.96 0.99 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.977 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.955 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 mt -62.42 -160.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.528 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 34.0 Cg_exo -29.35 106.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.191 1.927 . . . . 0.0 113.934 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.5 mt -149.99 149.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.635 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.82 136.78 33.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.097 0.475 . . . . 0.0 111.86 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.589 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.5 p -145.79 149.1 33.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.439 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 122.43 43.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.053 0.454 . . . . 0.0 110.285 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -81.14 132.44 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -104.33 123.84 48.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.597 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.913 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.93 137.33 32.46 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.4 t-105 -149.54 148.54 29.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.348 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.445 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.18 91.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.241 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 48' ' ' TRP . 35.7 t70 78.64 -42.0 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.536 0.334 . . . . 0.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 91' ' ' THR . 4.6 mt-10 -80.5 150.87 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -149.73 115.88 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.574 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.7 p90 -123.4 136.45 54.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 111.969 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 126' ' ' VAL . 5.1 p90 -136.46 145.34 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.522 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.32 146.73 23.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.92 6.96 9.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.8 mt-30 82.07 -7.36 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.722 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.6 p -86.21 115.6 27.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.066 0 CA-C-O 120.79 0.328 . . . . 0.0 110.289 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.68 96.06 6.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.723 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.8 p -123.85 106.66 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.133 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.51 133.36 52.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.959 0.409 . . . . 0.0 111.515 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -147.61 164.48 33.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.261 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -100.54 83.46 2.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 110.757 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.21 154.71 5.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER 71.67 -78.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.978 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.487 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 9.0 t 18.69 81.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.82 164.06 11.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.813 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 69' ' ' VAL . 11.9 p30 -125.61 -5.6 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.551 HG23 ' OD1' ' A' ' 68' ' ' ASP . 39.6 t -131.8 141.92 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.31 157.97 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.59 152.06 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.308 0.575 . . . . 0.0 111.39 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.36 127.1 16.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.124 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.62 -32.33 6.11 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.819 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.439 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.7 p-10 -69.64 162.06 28.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.114 0.483 . . . . 0.0 111.927 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -122.54 152.45 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.911 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.795 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.15 147.14 26.68 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -97.7 121.57 39.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.954 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.5 t90 -64.21 117.77 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.037 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -69.07 -69.5 0.44 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 42.6 Cg_exo -54.73 85.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.796 1.664 . . . . 0.0 111.968 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 128.8 -6.74 6.51 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.647 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.99 37.68 14.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.035 0.417 . . . . 0.0 110.959 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . -113.11 137.0 52.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.678 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.6 mt -86.29 148.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.39 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.7 t -143.15 155.33 44.54 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.31 0.576 . . . . 0.0 112.444 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.808 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -111.89 156.21 22.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.949 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 3.9 m-85 -136.91 127.42 26.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.7 m-85 -147.57 29.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.343 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 150.47 -150.29 22.29 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.64 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -38.67 170.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.41 -176.44 0.61 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 93' ' ' ILE . 94.3 Cg_exo -43.82 -25.86 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.989 1.792 . . . . 0.0 112.283 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.0 mp -138.31 54.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.234 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -107.58 99.48 29.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.917 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.535 ' HA ' HG21 ' A' ' 91' ' ' THR . 37.5 Cg_endo -64.57 -29.6 61.19 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.491 2.127 . . . . 0.0 112.6 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.71 -164.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.09 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -6.16 23.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.487 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -178.06 80.38 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 101' ' ' ALA . 7.1 m -125.96 142.39 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.703 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 15.1 m-20 -83.19 151.85 25.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.485 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.594 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.04 87.68 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.795 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -72.76 16.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.366 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.01 -149.68 18.76 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.827 ' HA ' HG23 ' A' ' 75' ' ' VAL . 7.3 mtp-105 -156.84 168.08 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 75' ' ' VAL . 6.1 mt -100.28 114.82 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.357 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.626 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.892 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.2 tt . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.592 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.69 -27.22 0.16 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.0 32.31 3.53 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.983 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.913 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.6 m -73.11 154.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.605 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -75.91 147.47 38.96 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -58.55 108.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.072 0.463 . . . . 0.0 111.684 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.49 103.45 0.17 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.464 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.605 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -154.46 154.59 33.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.743 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t -53.26 164.16 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 111.748 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.9 t -158.02 128.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.577 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.3 m -126.66 108.11 18.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.94 128.74 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.337 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.7 pt-20 -153.54 130.73 11.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.672 0.272 . . . . 0.0 111.532 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.598 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.09 88.24 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.655 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.48 145.44 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.541 . . . . 0.0 112.219 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.18 164.16 15.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.559 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.54 35.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -144.22 103.35 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -102.21 156.36 17.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.501 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 126' ' ' VAL . 13.7 m-85 -138.18 137.71 37.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.763 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.44 -28.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.06 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 p -125.96 22.66 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.43 154.38 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.43 144.44 51.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.851 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.22 149.2 11.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.543 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.62 157.11 39.77 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.159 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.06 138.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mp0 -92.45 -178.53 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.296 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.767 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.0 tp -152.74 146.63 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -123.33 146.53 47.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -57.17 -9.16 0.84 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -45.81 -25.79 0.57 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 122.259 -0.276 . . . . 0.0 111.551 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.651 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.9 t90 -81.14 -56.17 4.26 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 153.19 116.03 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.77 -27.78 5.98 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.488 2.126 . . . . 0.0 112.467 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.05 -43.35 78.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.306 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.718 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -70.25 -46.04 65.22 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.65 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.767 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.4 t -47.53 -29.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -60.36 -38.59 84.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.44 75.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.723 0.296 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -50.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.48 -27.23 69.13 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.39 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.838 0.351 . . . . 0.0 110.721 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.06 49.46 1.01 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.892 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.961 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.8 mt -61.82 -159.94 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.592 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.961 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.3 Cg_exo -28.52 106.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.158 1.905 . . . . 0.0 114.081 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.8 mt -149.28 149.66 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.507 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -85.91 134.09 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.965 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -145.32 149.57 35.06 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.61 132.7 47.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.953 ' HB1' ' NH2' ' A' ' 47' ' ' ARG . . . -90.66 137.32 32.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -106.8 120.11 41.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.277 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.953 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.69 127.25 34.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.7 t-105 -146.71 148.43 31.99 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -34.41 93.02 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.196 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 25.3 t70 72.03 -38.29 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.306 0.242 . . . . 0.0 111.585 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -78.94 139.38 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 110.875 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.57 HG12 ' NH2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -144.64 112.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.668 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 40.6 p90 -123.78 139.68 53.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.5 p90 -141.3 142.85 33.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.447 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -91.38 145.94 24.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.695 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.92 4.96 10.92 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 82.63 -7.38 1.27 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -85.56 116.08 28.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.59 94.87 6.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 111.707 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.3 p -124.88 106.58 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.327 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -133.57 132.33 40.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.962 0.41 . . . . 0.0 111.442 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 163.76 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.47 88.15 5.82 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.878 0.37 . . . . 0.0 110.753 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.14 148.01 3.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 0.4 OUTLIER 72.04 -83.18 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.463 0.173 . . . . 0.0 110.981 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.659 ' OG ' HD12 ' A' ' 79' ' ' ILE . 2.1 m 23.16 82.11 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.791 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.68 162.66 12.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.282 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' A' ' 69' ' ' VAL . 7.1 p30 -122.5 -0.09 9.3 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.662 HG23 ' OD1' ' A' ' 68' ' ' ASP . 47.2 t -138.53 145.36 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.101 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.75 158.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -94.05 150.81 20.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.16 124.96 7.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.35 -29.73 7.44 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.364 -0.922 . . . . 0.0 114.703 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 2.8 p30 -78.57 156.98 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.593 0.697 . . . . 0.0 111.921 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -111.06 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.3 150.34 32.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.977 0.417 . . . . 0.0 111.658 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.506 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -105.46 131.65 52.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.404 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.684 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -71.99 113.07 8.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -68.25 -66.16 1.17 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.621 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.39 80.28 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.932 1.755 . . . . 0.0 111.663 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.48 -8.13 3.13 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.596 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.18 37.2 17.72 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.857 0.361 . . . . 0.0 111.126 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.45 137.51 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.79 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 3.7 mt -87.58 147.64 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.43 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.3 m -142.86 131.53 22.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.02 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.99 159.78 18.87 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.373 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 35.0 m-85 -136.63 132.51 35.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.21 0.529 . . . . 0.0 111.878 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CB ' ' HG2' ' A' ' 118' ' ' LYS . 1.4 m-85 -165.21 33.32 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.057 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.22 -150.53 21.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.388 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.19 -172.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.458 0.647 . . . . 0.0 112.131 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.83 -176.11 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.522 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 66.2 Cg_exo -41.81 -25.29 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.273 1.982 . . . . 0.0 113.042 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -146.65 67.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 111.678 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.166 0.508 . . . . 0.0 110.483 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.411 HG23 ' OG1' ' A' ' 91' ' ' THR . 78.2 mt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.874 0.368 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 93' ' ' ILE . 1.8 mtt85 -117.74 99.54 52.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.707 ' HA ' HG21 ' A' ' 91' ' ' THR . 58.7 Cg_endo -69.73 -31.31 20.89 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.6 2.2 . . . . 0.0 112.564 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.569 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.11 -160.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.807 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -5.23 14.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.565 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.43 73.98 0.11 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 78' ' ' TRP . 21.2 m -124.02 140.46 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 111.477 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.495 HD21 HD11 ' A' ' 79' ' ' ILE . 6.0 m-20 -84.66 150.37 25.18 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.791 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.59 100.35 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.553 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -85.02 21.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.2 -129.46 8.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.192 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.864 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 ptt180 -170.4 167.19 8.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.04 0.448 . . . . 0.0 111.484 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -93.06 116.37 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.667 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.038 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.02 HD22 HD13 ' A' ' 86' ' ' LEU . 4.5 tp . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.492 0.186 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.6 -21.32 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -89.92 30.68 5.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.705 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.6 m -81.28 153.65 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 122.232 0.213 . . . . 0.0 111.34 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.63 143.47 46.3 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 4.6 p-10 -51.07 131.98 27.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.07 100.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.347 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -148.1 154.25 39.96 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 t -63.13 168.34 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.436 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.84 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.3 t -157.97 128.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.955 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -125.27 106.59 16.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 110.718 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.85 129.07 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.822 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 3.5 pt-20 -151.41 126.94 10.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.663 0.268 . . . . 0.0 111.327 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.699 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.36 92.16 2.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.817 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.743 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.229 0.024 0 CA-C-O 121.007 0.432 . . . . 0.0 111.037 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.536 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -84.09 145.47 28.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.754 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.76 164.05 15.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.104 179.008 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 144.09 33.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.11 100.39 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 109.963 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 156.04 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.965 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.0 m-85 -134.6 142.64 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.025 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.3 -29.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 49.7 m -126.2 20.89 7.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -179.13 155.92 0.75 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.37 148.89 30.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.9 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.65 150.05 11.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.46 156.54 18.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.759 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.22 140.19 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.7 mt-10 -90.91 -178.48 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.657 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.2 tp -147.73 136.26 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.077 0.465 . . . . 0.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.84 141.0 49.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.619 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.6 -8.95 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -45.38 -29.0 0.96 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.295 -0.253 . . . . 0.0 111.31 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.649 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -78.3 -56.69 4.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.57 118.54 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.775 178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.42 -33.31 12.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.436 2.091 . . . . 0.0 112.338 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.38 -52.27 66.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.848 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.31 -44.12 84.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.82 0.343 . . . . 0.0 110.419 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 23' ' ' LEU . 75.8 t -44.62 -31.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.347 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -64.45 -38.32 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -63.93 -47.65 79.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -55.77 -52.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.15 -27.48 69.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.43 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.26 -25.39 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.57 50.71 1.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.797 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.963 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -61.73 -160.04 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.612 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.963 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.5 Cg_exo -28.95 103.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.116 1.877 . . . . 0.0 113.887 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 18.5 mt -145.74 151.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.567 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 136.69 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.089 0.471 . . . . 0.0 111.604 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -145.1 148.91 34.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.94 127.19 48.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.037 0.446 . . . . 0.0 110.313 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.913 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -87.03 136.13 33.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -108.34 122.97 48.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.39 138.27 35.62 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 10.9 t-105 -153.87 148.95 26.83 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.862 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.03 94.51 0.01 OUTLIER Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.524 -0.37 . . . . 0.0 113.781 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.503 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 3.7 m-20 51.85 25.42 2.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.896 0.379 . . . . 0.0 111.578 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.4 OUTLIER -136.2 138.91 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.149 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -137.29 119.93 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.225 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.2 p90 -128.5 126.94 41.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.8 p90 -135.49 145.93 47.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.94 149.65 21.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.727 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.22 7.9 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.41 -8.77 1.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.722 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.8 p -86.31 114.0 25.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.19 94.99 5.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 31' ' ' THR . 3.2 p -122.79 106.78 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.879 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.95 125.26 54.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -140.83 165.32 27.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.3 pm0 -113.84 91.34 3.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.043 0.449 . . . . 0.0 111.023 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.5 tt0 -170.38 157.07 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 34.8 t-20 64.21 -81.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.081 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.46 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.5 m 31.88 82.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.212 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.764 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.43 154.9 18.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.589 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -119.78 -4.75 10.19 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -126.32 140.45 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.528 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 32.8 m -158.39 157.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.594 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -96.03 149.7 21.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.485 0.66 . . . . 0.0 111.732 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.26 126.76 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.002 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.19 -30.08 7.27 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.366 -0.921 . . . . 0.0 114.636 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.445 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -80.64 156.64 26.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.533 0.666 . . . . 0.0 112.032 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -116.34 152.4 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.283 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.01 151.1 30.72 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.971 -0.455 . . . . 0.0 111.696 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -106.9 132.58 52.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.679 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.582 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -68.49 120.81 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.648 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.07 -68.44 0.53 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.049 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 33.9 Cg_endo -63.62 75.8 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.165 1.91 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.67 -9.98 1.88 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.71 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.0 32.23 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.061 0.43 . . . . 0.0 111.161 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.97 131.04 55.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.221 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 10.0 mt -88.16 144.24 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.98 134.53 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.43 158.8 19.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.896 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 36.1 m-85 -136.62 117.11 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.546 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER -163.7 52.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.18 -78.72 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.721 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -147.26 -169.47 3.32 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.479 0.657 . . . . 0.0 111.93 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -154.44 174.89 3.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.035 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -39.1 -25.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.696 2.264 . . . . 0.0 113.129 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . 2.1 mp -137.69 62.71 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.162 0.506 . . . . 0.0 110.375 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 99.22 8.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.022 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.901 ' HA ' HG21 ' A' ' 91' ' ' THR . 55.4 Cg_endo -69.33 -31.12 23.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.515 2.144 . . . . 0.0 112.584 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.33 -161.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -6.99 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.83 71.11 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.6 m -117.69 141.49 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.555 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.691 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.9 m120 -81.88 150.29 27.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.278 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.97 82.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.688 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.7 18.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 119.12 -153.21 16.98 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.944 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.824 ' HA ' HG23 ' A' ' 75' ' ' VAL . 33.3 mtp180 -156.23 167.17 31.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.58 HG13 HG21 ' A' ' 75' ' ' VAL . 5.0 mt -98.83 114.96 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.36 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.398 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.883 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.7 tt . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.88 -22.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -92.24 36.1 3.79 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 117' ' ' LEU . 6.4 m -69.19 154.87 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 122.513 0.325 . . . . 0.0 111.535 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.95 145.93 44.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.3 p-10 -57.88 121.24 10.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.122 0.487 . . . . 0.0 111.921 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.93 101.46 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.46 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.35 150.78 28.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.14 165.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.222 0.535 . . . . 0.0 111.904 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.5 t -157.74 128.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.312 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.5 m -127.3 108.49 18.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.978 0.418 . . . . 0.0 111.46 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.727 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.9 129.17 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.356 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.0 pt-20 -153.82 129.06 9.73 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.576 0.227 . . . . 0.0 111.344 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.548 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.5 89.45 1.68 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 110.785 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.649 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.718 0.294 . . . . 0.0 111.043 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 145.43 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.131 0.491 . . . . 0.0 112.135 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.8 163.5 17.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.851 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 146.47 29.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.739 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.4 mt -147.32 100.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 109.787 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -104.79 156.0 18.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.635 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -130.76 138.55 50.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.448 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.77 -29.01 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -124.22 23.04 8.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.42 154.18 1.63 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -114.81 151.86 33.13 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.68 151.14 16.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.866 0.365 . . . . 0.0 111.779 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -137.53 150.4 47.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.87 143.76 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.138 0.494 . . . . 0.0 112.012 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' OE2' HG21 ' A' ' 111' ' ' VAL . 6.7 mt-10 -95.48 -178.38 4.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.199 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.6 tp -150.07 134.73 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.973 0.416 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.73 139.25 50.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.566 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CD ' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -60.76 -8.46 3.02 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -44.66 -29.49 0.76 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.07 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.754 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -76.54 -56.01 5.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 163.2 116.05 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.739 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -46.58 -36.99 19.6 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.375 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -49.59 76.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.458 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -61.2 -44.5 97.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.757 0.313 . . . . 0.0 110.27 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.856 HG13 ' CD2' ' A' ' 23' ' ' LEU . 90.9 t -46.74 -37.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.693 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -33.35 71.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.009 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.41 -47.43 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.99 -50.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.349 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.75 -29.39 70.65 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.261 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -70.55 -25.74 63.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.12 51.96 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.25 -159.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.62 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.989 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.4 Cg_exo -27.8 105.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.083 1.855 . . . . 0.0 114.085 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.7 mt -145.16 149.11 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.366 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -85.9 133.64 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 111.887 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.64 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.9 p -142.33 149.02 38.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.299 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 131.33 48.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.354 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -92.05 135.54 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -106.92 122.88 47.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.061 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.837 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.18 137.04 34.21 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.23 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' HB3' ' A' ' 51' ' ' GLU . 12.7 t-105 -152.26 149.13 28.36 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.866 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.54 92.82 0.01 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.666 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER 53.27 25.98 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' CD1' ' A' ' 48' ' ' TRP . 8.5 tp10 -136.77 139.36 41.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.952 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.612 HG21 HD21 ' A' ' 117' ' ' LEU . 0.7 OUTLIER -139.18 122.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.593 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 50.8 p90 -130.04 123.37 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -133.15 145.38 50.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 146.48 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.698 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -117.85 5.61 12.22 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.3 mt-30 82.34 -8.2 1.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -87.23 115.43 27.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.61 94.79 5.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 111.911 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 31' ' ' THR . 3.5 p -131.53 106.73 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.299 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -130.16 133.18 46.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 53.4 tttt -140.8 164.77 29.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.291 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -99.14 90.87 4.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 0.0 110.966 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 5.9 tt0 -170.16 157.88 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.599 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 24.7 t-20 62.74 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.906 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 31.99 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.297 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.825 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -101.95 158.06 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.282 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -124.11 0.38 8.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 70' ' ' VAL . 3.3 p -126.71 138.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.616 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.6 m -160.56 164.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.784 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.84 158.8 31.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.086 0.47 . . . . 0.0 110.769 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -38.56 129.67 1.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.24 -31.31 6.52 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.059 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.2 p30 -88.73 156.36 19.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 112.327 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.875 HG23 ' HA ' ' A' ' 109' ' ' ARG . 25.7 t -119.13 152.55 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.078 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.06 150.14 34.47 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.807 -0.558 . . . . 0.0 112.472 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.58 126.78 53.96 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.168 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.713 ' HD1' HG12 ' A' ' 104' ' ' VAL . 3.6 t90 -67.2 112.65 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.754 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -67.19 -61.1 5.06 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.786 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 14.8 Cg_exo -67.98 66.27 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.232 1.955 . . . . 0.0 111.807 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.68 -11.45 0.3 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.034 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.62 27.49 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.306 0.553 . . . . 0.0 110.957 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.92 55.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.522 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.8 mt -88.05 143.38 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.331 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.7 132.39 36.85 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.784 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.807 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.89 161.07 18.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.168 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 20.8 m-85 -136.25 125.78 25.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -163.88 54.54 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.209 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -75.1 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.372 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -158.83 174.02 15.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.796 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.645 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -134.77 -175.11 0.45 Allowed Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.645 ' CD ' HG22 ' A' ' 91' ' ' THR . 84.4 Cg_exo -47.93 -22.46 3.42 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.017 1.811 . . . . 0.0 112.724 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.69 68.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.862 0.363 . . . . 0.0 111.722 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.915 0.388 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -98.44 99.86 8.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 69.1 Cg_endo -70.57 -32.48 15.13 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.668 2.245 . . . . 0.0 112.969 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.05 -154.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.697 0.284 . . . . 0.0 110.879 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 -5.04 10.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.552 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.96 67.06 0.08 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' HD1' ' A' ' 78' ' ' TRP . 14.9 m -118.14 142.42 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.777 0.322 . . . . 0.0 111.552 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.509 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m120 -84.28 152.99 23.81 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.825 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -85.57 86.56 2.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.725 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.55 23.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.97 -149.57 18.51 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.996 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.875 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.2 mtt85 -155.31 166.42 33.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 75' ' ' VAL . 4.2 mt -99.85 114.43 38.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.475 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.807 HD22 HD13 ' A' ' 86' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.797 0.332 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -85.88 28.97 4.76 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.492 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.837 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.5 m -83.16 154.26 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.937 0.368 . . . . 0.0 111.534 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.646 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -80.53 148.76 30.26 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.619 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.1 p-10 -58.06 112.02 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.994 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.76 100.89 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.728 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.646 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -155.28 153.84 31.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 178.72 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.6 t -56.96 168.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.535 . . . . 0.0 111.894 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.884 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.0 t -157.88 128.84 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.06 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.9 m -127.59 108.63 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 111.473 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.21 129.04 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.4 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -152.92 130.16 11.24 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.709 0.29 . . . . 0.0 111.204 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.577 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.41 88.99 2.1 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.689 179.906 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -108.68 145.3 35.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 163.75 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.703 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 144.89 34.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.89 100.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -100.8 156.13 17.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.122 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.83 141.28 49.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.204 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.47 -28.89 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -126.05 22.96 7.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.23 151.3 2.03 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 142.12 45.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.26 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.74 149.24 9.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -115.28 157.82 23.22 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.87 137.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.044 0.449 . . . . 0.0 111.439 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 14.6 mt-10 -92.51 -178.65 4.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.268 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.834 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.3 tp -153.22 150.42 28.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.465 ' H ' HD12 ' A' ' 23' ' ' LEU . 21.8 m-85 -129.23 147.95 51.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.027 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -58.21 -8.63 1.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.35 -29.2 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.85 0.296 . . . . 0.0 111.355 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.633 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -80.92 -56.32 4.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 160.3 117.09 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.474 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.76 -35.86 18.37 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.6 -47.7 82.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.95 -44.37 96.25 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.78 0.324 . . . . 0.0 110.397 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 ' CD2' ' A' ' 23' ' ' LEU . 46.3 t -50.05 -34.64 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -59.44 -37.01 77.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.79 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.04 -51.54 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.46 -28.71 70.0 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.65 -25.37 62.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 51.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.784 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.4 mt -61.58 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.539 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 25.6 Cg_exo -27.8 104.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.275 1.983 . . . . 0.0 114.033 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 39' ' ' LEU . 19.5 mt -145.57 151.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.309 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -85.72 136.57 33.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.064 0.459 . . . . 0.0 111.871 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.639 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -146.0 148.86 33.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.41 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.02 130.48 48.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.44 135.84 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -108.12 125.2 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.182 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.45 138.42 34.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 14.8 t-105 -154.17 148.95 26.53 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.069 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.13 99.86 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.768 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 45.62 30.15 0.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.382 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.78 143.35 33.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.118 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -139.49 123.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 23.4 p90 -130.64 132.36 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.6 p90 -140.87 146.11 37.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.986 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.69 149.45 22.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.158 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.799 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.18 5.92 9.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG3' ' C ' ' A' ' 56' ' ' THR . 12.1 mt-30 80.94 -7.07 1.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.716 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.22 114.95 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.76 94.89 5.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.7 p -127.06 106.69 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.724 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.561 ' HG2' HG22 ' A' ' 79' ' ' ILE . 2.5 mt-10 -125.28 134.98 52.07 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.082 0.467 . . . . 0.0 111.929 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 6.9 ttmt -144.55 165.62 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.165 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.68 90.74 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.021 0.438 . . . . 0.0 110.947 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.4 160.22 7.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.77 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 31.7 t-20 64.03 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.096 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.459 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 2.1 m 30.49 81.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.646 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.976 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -100.47 156.71 17.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.73 -7.81 10.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.38 142.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.386 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -157.74 156.23 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.108 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.36 151.04 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.354 0.597 . . . . 0.0 111.368 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -48.16 126.39 10.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.214 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -31.99 6.21 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.093 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.484 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p-10 -70.04 163.17 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 112.085 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.743 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -121.41 152.02 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.074 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB3' ' HE2' ' A' ' 87' ' ' PHE . . . -149.58 152.36 35.36 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.463 0.574 . . . . 0.0 112.125 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -111.04 131.28 55.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.449 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.763 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -73.03 146.62 45.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -96.3 -53.14 0.22 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.522 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.652 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 6.9 Cg_exo -73.86 70.74 4.3 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.696 2.264 . . . . 0.0 111.623 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 144.38 -8.33 1.86 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.556 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 53.1 34.1 16.52 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.857 0.361 . . . . 0.0 110.827 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.76 130.85 55.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.167 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 6.4 mt -85.83 151.51 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.0 135.15 32.42 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.25 161.74 18.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.029 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 54.1 m-85 -136.25 118.61 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.499 . . . . 0.0 111.782 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.6 m-85 -157.43 30.35 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.851 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.55 -152.74 23.53 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.36 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -54.0 -173.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.507 0.67 . . . . 0.0 112.086 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -157.47 -173.54 0.38 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.81 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 72.9 Cg_exo -42.15 -23.63 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.976 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.38 87.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.817 179.411 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.391 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.703 HG23 ' OG1' ' A' ' 91' ' ' THR . 87.2 mt . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -101.73 99.21 11.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 91' ' ' THR . 57.9 Cg_endo -70.44 -31.22 17.87 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.508 2.139 . . . . 0.0 112.645 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -163.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -10.5 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.407 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -164.81 72.1 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.763 HG12 ' CD1' ' A' ' 78' ' ' TRP . 22.2 m -119.13 140.15 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.337 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.471 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 37.2 m-20 -84.91 148.14 26.4 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.976 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.18 97.82 5.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.064 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.637 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -82.96 21.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.312 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.31 -149.18 18.71 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.206 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.9 mtt180 -152.92 167.67 28.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.061 0.458 . . . . 0.0 111.362 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.672 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -100.44 114.3 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.342 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.593 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.95 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.2 tt . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.491 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.34 -26.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.28 38.35 3.23 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.566 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.95 HG13 ' O ' ' A' ' 117' ' ' LEU . 8.6 m -74.4 154.74 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 122.393 0.277 . . . . 0.0 111.465 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.98 146.09 44.11 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 6.1 p-10 -59.59 115.35 3.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 111.901 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.32 100.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.65 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -154.27 150.75 28.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.881 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -52.79 166.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -157.81 129.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.433 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 127' ' ' VAL . 17.6 m -128.14 108.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.62 128.93 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.27 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 4.5 pt-20 -152.9 130.88 11.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.636 0.255 . . . . 0.0 111.339 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.565 ' CB ' HD22 ' A' ' 39' ' ' LEU . 5.9 tmm_? -75.22 92.91 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.686 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.832 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.784 0.325 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -110.1 145.47 37.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.0 112.314 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 164.78 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 145.96 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -145.03 100.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -102.29 156.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.511 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.545 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.6 m-85 -134.71 137.79 43.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.384 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.44 -29.05 0.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.95 23.07 7.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.77 151.45 2.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -125.65 141.34 52.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.963 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 149.13 11.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.53 159.27 36.02 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.146 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.83 140.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 111.747 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mt-10 -94.28 -178.61 4.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.792 ' CD2' HG13 ' A' ' 32' ' ' VAL . 5.3 tp -153.98 148.27 25.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.087 0.47 . . . . 0.0 111.284 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.06 148.45 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.635 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.27 -9.01 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.61 -27.68 0.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.249 -0.282 . . . . 0.0 111.533 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.07 -56.62 3.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.07 110.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -40.48 -30.0 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.817 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.78 -49.84 73.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.447 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -65.42 -45.66 83.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.39 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.792 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -47.87 -29.01 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.32 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -65.35 -38.64 90.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.09 74.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.21 -51.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.598 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.54 -29.53 70.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.16 -25.48 62.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.976 0.417 . . . . 0.0 110.611 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 51.92 1.0 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.986 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.22 -159.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.312 -0.852 . . . . 0.0 109.682 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.986 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.4 Cg_exo -27.58 105.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.216 1.944 . . . . 0.0 114.006 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.5 mt -146.5 150.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.498 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -86.27 134.12 33.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.7 p -142.06 149.1 39.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.75 128.24 48.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.398 . . . . 0.0 110.319 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.934 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.0 131.94 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -100.86 122.63 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.725 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.917 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.81 136.53 32.95 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.6 t-105 -155.01 148.62 25.36 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.833 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -33.22 86.92 0.01 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.294 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' TRP . 18.1 t0 72.68 -35.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.47 0.308 . . . . 0.0 111.512 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 91' ' ' THR . 6.0 tm-20 -73.86 133.57 43.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -138.87 125.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.203 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -137.14 128.79 28.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.374 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.6 p90 -135.51 145.97 47.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.59 147.89 22.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.607 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.63 7.91 10.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.3 mt-30 80.07 -6.34 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.654 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -88.53 115.13 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.708 0.29 . . . . 0.0 110.317 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.7 94.91 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.761 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.1 p -129.98 106.55 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.202 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.88 133.93 48.1 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.014 0.435 . . . . 0.0 111.667 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 159.22 42.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.149 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -92.81 88.8 6.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.386 0.612 . . . . 0.0 111.127 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.33 159.66 7.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.3 t-20 64.07 -82.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.3 t 27.82 82.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.325 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.908 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.65 17.22 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.37 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.764 ' OD1' HG23 ' A' ' 69' ' ' VAL . 2.8 p30 -117.33 -6.53 11.26 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.764 HG23 ' OD1' ' A' ' 68' ' ' ASP . 27.3 t -131.99 144.91 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.204 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.542 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.06 157.85 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.814 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -94.72 151.12 19.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.357 0.599 . . . . 0.0 111.638 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -45.95 125.75 6.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.979 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.4 -31.41 6.43 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.487 -0.863 . . . . 0.0 114.525 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p30 -75.91 156.56 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.464 0.632 . . . . 0.0 112.188 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.2 t -114.23 152.59 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.97 149.69 31.6 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.44 129.02 50.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.993 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.645 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -69.5 117.89 11.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.986 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -65.66 -72.07 0.3 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.549 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 34.1 Cg_endo -63.43 80.45 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.081 1.854 . . . . 0.0 112.12 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.82 -11.17 2.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.732 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.98 31.46 11.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.066 0.433 . . . . 0.0 110.902 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.92 133.56 52.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.462 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.59 145.94 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.434 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 17.4 t -139.12 156.27 47.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.258 0.551 . . . . 0.0 112.389 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.023 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.47 156.03 20.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.263 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.6 m-85 -136.69 127.24 26.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 111.23 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.98 49.72 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 165.18 -82.35 0.11 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.1 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -154.14 176.39 12.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.119 0.485 . . . . 0.0 111.69 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.681 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -144.15 -174.26 0.4 Allowed Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.238 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.58 ' CD ' HG22 ' A' ' 91' ' ' THR . 99.6 Cg_exo -45.17 -22.74 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.012 1.808 . . . . 0.0 112.598 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 77.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.042 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.7 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.859 0.361 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.32 99.36 8.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.681 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.8 Cg_endo -69.3 -31.14 23.18 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.467 2.112 . . . . 0.0 112.638 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.01 -163.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -3.4 20.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.58 77.4 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 78' ' ' TRP . 19.3 m -127.52 142.04 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.722 0.296 . . . . 0.0 111.68 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m-20 -86.31 153.66 21.81 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.908 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.62 99.48 7.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.654 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.47 22.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.36 -147.77 18.9 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.07 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.877 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 mtt180 -156.52 168.13 28.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 111.416 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.5 mt -100.4 114.94 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.165 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.593 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.023 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.45 -22.8 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -88.21 27.78 6.63 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.917 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.4 m -79.18 153.95 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.765 0.283 . . . . 0.0 111.247 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.64 146.99 29.77 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.2 p-10 -53.75 117.81 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.34 98.64 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.007 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -150.61 146.4 26.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.993 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.2 164.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 112.268 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.9 t -158.14 128.45 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 127' ' ' VAL . 22.7 m -125.34 108.35 19.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 0.0 111.402 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.04 128.7 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.407 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.3 pt-20 -152.86 130.74 11.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.582 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.38 91.43 3.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.858 0.361 . . . . 0.0 110.809 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HB3' ' NH2' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.892 0.377 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.71 145.31 40.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.153 0.501 . . . . 0.0 111.926 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.9 163.9 15.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.932 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 143.63 38.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.825 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.72 100.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -99.98 156.32 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.78 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.569 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.8 m-85 -136.82 137.99 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.697 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.79 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 22.19 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.79 151.37 1.41 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.63 143.43 48.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.179 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.84 149.01 10.68 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.308 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -119.25 156.05 30.63 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.437 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.71 144.41 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 111.083 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 5.9 mt-10 -99.18 -178.27 3.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.813 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -151.37 144.4 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.078 0.466 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -125.24 145.99 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.594 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.32 -9.04 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -45.66 -28.08 0.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.743 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.2 t90 -80.03 -56.08 4.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.14 115.88 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.675 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.76 -34.82 16.42 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 112.49 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.78 -50.85 71.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.394 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.743 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.02 -45.42 92.42 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 23' ' ' LEU . 84.2 t -46.65 -32.66 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.429 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -58.99 -38.7 79.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.482 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.9 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -54.66 -51.55 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.11 -27.92 69.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 110.211 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -71.74 -25.57 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.562 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.25 49.95 1.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.063 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -62.42 -160.08 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.312 -0.851 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 38.9 Cg_exo -29.85 107.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.125 1.883 . . . . 0.0 113.85 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.5 mt -150.02 148.54 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.638 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.92 136.07 33.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.101 0.477 . . . . 0.0 111.953 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.2 p -146.03 148.65 32.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 125.82 49.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.162 0.506 . . . . 0.0 110.376 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.904 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -85.55 132.46 34.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.042 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -100.39 128.19 46.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.56 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.957 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -90.26 135.15 33.85 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.741 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 50' ' ' ASP . 10.1 t-105 -154.5 148.43 25.64 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.888 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.47 85.75 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.632 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 48' ' ' TRP . 36.6 t70 74.09 -38.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.882 0.326 . . . . 0.0 111.882 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.4 124.19 24.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 111.114 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -126.74 111.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 110.179 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 43.7 p90 -122.48 134.06 54.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.068 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.2 p90 -140.15 145.61 37.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.599 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 147.58 22.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.739 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.38 6.48 9.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 83.45 -8.13 1.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -85.1 115.43 26.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.136 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.01 94.82 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.064 0.459 . . . . 0.0 112.029 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.4 p -120.66 106.68 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.139 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -120.2 136.43 54.64 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.25 163.4 39.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.205 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -104.62 87.02 2.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -170.13 149.69 3.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.4 t-20 72.03 -82.66 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.523 0.202 . . . . 0.0 111.273 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.7 m 27.46 82.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.77 156.18 17.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.457 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -121.25 -3.25 9.49 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.1 p -127.65 140.01 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.513 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.535 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.1 m -158.7 157.55 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.544 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.2 150.67 19.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.49 0.662 . . . . 0.0 111.719 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -45.0 126.09 5.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.964 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -30.77 6.82 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.599 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.01 157.06 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.528 0.664 . . . . 0.0 111.978 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.821 HG23 ' HA ' ' A' ' 109' ' ' ARG . 17.8 t -115.96 152.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.52 151.23 31.31 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 121.86 -0.525 . . . . 0.0 112.41 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.588 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -102.19 123.99 47.0 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.075 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 104' ' ' VAL . 4.1 t90 -66.57 119.02 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.901 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.765 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -69.53 -71.01 0.3 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.601 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.765 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.48 83.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.628 1.552 . . . . 0.0 111.705 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 133.6 -8.35 4.95 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.416 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.66 39.79 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.841 0.353 . . . . 0.0 111.24 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.15 135.17 54.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.77 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 36.8 mt -84.35 145.3 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.42 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 m -140.69 132.42 27.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.724 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.63 158.0 19.57 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.1 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 23.7 m-85 -136.67 115.17 11.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 111.369 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.563 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -156.53 39.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' HD11 ' A' ' 98' ' ' ILE . . . 172.07 -89.16 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.934 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.47 -169.08 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 111.499 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -152.29 -177.68 0.74 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.558 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.611 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.9 Cg_exo -47.49 -16.9 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 121.968 1.779 . . . . 0.0 112.896 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 99' ' ' ARG . 6.0 pt -145.75 62.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 89' ' ' GLY . 78.6 mt . . . . . 0 CA--C 1.523 -0.096 0 CA-C-O 120.802 0.334 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -99.35 99.16 7.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.899 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -69.16 -31.21 23.68 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.473 2.115 . . . . 0.0 112.491 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.736 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.66 -158.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.776 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -6.96 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.779 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.48 69.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 101' ' ' ALA . 6.2 m -116.8 142.83 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.827 0.346 . . . . 0.0 111.65 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.756 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -83.18 151.31 25.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.595 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.647 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -87.08 86.95 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.69 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.03 18.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.509 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.94 -150.91 18.52 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.678 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.821 ' HA ' HG23 ' A' ' 75' ' ' VAL . 32.4 mtp180 -156.37 168.19 28.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.187 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mt -95.27 113.61 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.463 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.418 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.753 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.4 tt . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.617 0.246 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.53 -24.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -94.59 37.69 3.34 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.841 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.957 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.5 m -79.01 154.47 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.728 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.74 148.48 33.01 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.307 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.641 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.2 p-10 -50.72 110.84 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.37 111.62 0.04 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.314 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.46 139.05 15.98 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.561 0.219 . . . . 0.0 110.701 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.9 t -40.75 161.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.111 0.482 . . . . 0.0 112.0 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 45' ' ' ALA . 41.8 t -154.17 128.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.4 m -126.57 108.09 18.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 120.86 0.362 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.8 128.76 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 pt-20 -153.28 129.64 10.57 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.622 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.64 88.75 2.21 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.695 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.703 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.827 0.346 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.87 145.42 38.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.851 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.73 162.31 18.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.828 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 142.95 34.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.824 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.26 101.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 109.824 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -102.03 156.77 17.33 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.778 0.799 . . . . 0.0 112.501 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -134.56 137.45 43.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -28.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 p -124.79 22.24 8.19 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.09 150.76 1.22 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.28 144.05 48.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.127 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.57 148.31 7.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.56 155.96 26.63 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.675 0.274 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.2 138.57 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.972 0.415 . . . . 0.0 111.258 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.479 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 1.3 mt-10 -95.1 -178.39 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.3 tp -154.34 146.37 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -126.76 147.71 49.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.853 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -56.28 -9.27 0.63 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.55 -28.78 1.01 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.857 0.298 . . . . 0.0 111.296 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.643 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.9 t90 -80.81 -56.27 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.6 113.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.688 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -46.65 -35.9 17.97 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.456 2.104 . . . . 0.0 112.577 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.96 -51.94 67.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.712 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.18 -45.81 90.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.835 0.35 . . . . 0.0 110.503 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 59.3 t -46.16 -30.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.226 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -60.14 -38.95 84.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.101 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.15 84.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.5 -49.29 78.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.195 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.27 -27.17 68.86 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.249 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.13 -24.49 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.631 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.19 49.39 1.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.0 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.16 -159.97 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.356 -0.831 . . . . 0.0 109.592 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.941 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 39.0 Cg_exo -29.87 106.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.132 1.888 . . . . 0.0 114.085 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.11 149.44 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.621 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -85.92 134.95 33.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.003 0.43 . . . . 0.0 111.669 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.573 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 6.0 p -143.6 149.27 37.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.696 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.76 121.27 41.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 110.212 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -80.42 131.26 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -102.68 123.83 47.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.593 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.926 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.19 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -151.5 148.51 28.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.236 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -35.08 91.67 0.01 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.029 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 29.3 t70 75.94 -41.15 0.42 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.683 0.393 . . . . 0.0 111.309 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.06 143.1 41.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.438 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -146.81 114.9 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.529 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -126.27 133.34 51.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.144 0.497 . . . . 0.0 112.038 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 126' ' ' VAL . 4.5 p90 -131.63 143.84 50.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.369 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 142.91 26.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.665 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.82 8.48 11.14 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.7 mt-30 80.74 -6.33 1.66 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.4 p -83.94 115.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.4 106.59 17.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.747 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.712 HG21 HG22 ' A' ' 31' ' ' THR . 3.6 p -137.08 106.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.395 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.73 133.65 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.91 0.386 . . . . 0.0 111.254 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -153.92 165.09 37.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.335 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.16 88.35 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -170.08 149.13 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.0 t-20 69.24 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.522 0.201 . . . . 0.0 111.162 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.3 m 24.73 82.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.53 17.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.518 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -120.72 -3.6 9.76 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -127.83 140.11 50.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.494 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 30.5 m -159.02 157.89 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.759 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -93.84 152.06 19.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.424 0.63 . . . . 0.0 111.684 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.64 126.49 10.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -28.86 8.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.131 -1.033 . . . . 0.0 114.63 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.422 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.0 p30 -80.14 156.11 27.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.641 0.72 . . . . 0.0 111.988 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.842 HG23 ' HA ' ' A' ' 109' ' ' ARG . 22.3 t -114.03 152.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.29 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.25 145.4 24.61 Favored 'General case' 0 C--N 1.342 0.249 0 O-C-N 121.9 -0.5 . . . . 0.0 112.169 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.84 137.26 36.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.167 179.155 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.47 121.97 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.622 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -72.89 -70.19 0.28 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 79.3 Cg_exo -33.14 -62.96 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.155 2.57 . . . . 0.0 113.845 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.68 -1.46 90.01 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.262 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.77 26.97 8.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.983 0.42 . . . . 0.0 110.485 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.99 137.76 46.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.638 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.63 148.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.604 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -143.26 155.24 44.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.285 0.564 . . . . 0.0 112.486 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.877 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -107.07 158.76 16.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.98 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 35.5 m-85 -136.53 115.39 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.676 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.545 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -139.33 25.46 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 152.63 -153.7 25.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.051 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -39.43 171.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.833 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.21 176.99 2.12 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.8 Cg_exo -39.01 -27.66 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.568 2.179 . . . . 0.0 112.714 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 93' ' ' ILE . 3.7 mp -130.44 52.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.675 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.99 0.424 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -121.53 99.46 45.24 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.998 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.518 ' HA ' HG21 ' A' ' 91' ' ' THR . 61.4 Cg_endo -70.66 -31.6 16.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.466 2.111 . . . . 0.0 112.587 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -178.39 -160.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -6.39 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.404 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.72 69.35 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 101' ' ' ALA . 11.9 m -116.02 141.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.047 0.451 . . . . 0.0 111.783 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.758 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -82.49 150.96 26.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.618 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.613 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.02 86.53 2.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.789 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -71.77 16.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.527 -178.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.41 -147.79 18.6 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.749 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.842 ' HA ' HG23 ' A' ' 75' ' ' VAL . 11.5 mtp-105 -155.94 167.61 29.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.357 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.595 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.77 114.85 30.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.646 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 86' ' ' LEU . 7.2 tt . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 120.626 0.25 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -25.35 0.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.82 34.29 4.12 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.91 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' HD2' ' A' ' 47' ' ' ARG . 4.8 m -74.73 154.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 111.302 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.8 38.06 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -56.54 110.16 0.74 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.058 0.456 . . . . 0.0 111.593 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.31 102.7 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.305 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.63 150.03 28.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.71 162.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 112.154 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 45' ' ' ALA . 51.7 t -158.06 128.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.483 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.9 m -126.2 107.43 17.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.46 128.68 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.472 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.508 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -153.48 127.9 9.25 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.597 0.237 . . . . 0.0 111.319 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.6 89.97 2.77 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.766 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.858 0.361 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 145.3 46.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.071 0.462 . . . . 0.0 111.949 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -114.86 163.68 15.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.92 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.92 145.58 38.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -142.25 102.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 14.7 ptm180 -102.4 156.22 17.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.582 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.904 ' CE2' HG22 ' A' ' 126' ' ' VAL . 32.3 m-85 -140.69 139.54 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.915 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -28.84 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.064 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -125.79 22.44 7.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.9 154.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.389 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 144.29 47.32 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.877 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 150.09 12.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.5 158.6 34.08 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.339 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.02 143.56 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 111.212 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -90.96 -178.29 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.305 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 32' ' ' VAL . 2.6 tp -151.04 130.43 12.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 111.525 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -113.54 136.46 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -57.84 -8.83 1.05 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -45.0 -28.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.652 0.263 . . . . 0.0 111.009 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.633 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.4 t90 -75.94 -53.16 8.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.731 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 159.72 114.05 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.806 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 3.3 Cg_exo -47.2 -37.76 24.34 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.567 2.178 . . . . 0.0 112.547 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -62.43 -46.76 87.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.793 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -64.05 -44.7 91.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.261 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 HD21 ' A' ' 23' ' ' LEU . 58.5 t -47.02 -36.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.005 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.47 -39.0 72.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.528 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.73 80.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -49.98 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.66 -26.83 68.85 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.6 -24.1 60.01 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.96 49.19 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.967 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.946 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mt -62.04 -159.78 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.697 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.946 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 36.2 Cg_exo -29.46 107.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.063 1.842 . . . . 0.0 114.049 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' LEU . 33.5 mt -150.13 149.87 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.6 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -85.94 133.88 33.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 111.866 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.595 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.8 p -145.91 149.5 34.34 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.517 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.53 133.39 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -91.96 136.59 33.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.04 120.15 39.96 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.755 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.631 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -87.88 133.39 33.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' A' ' 50' ' ' ASP . 9.3 t-105 -155.65 148.7 24.5 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.369 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.69 89.76 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.415 -0.422 . . . . 0.0 113.391 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.9 t70 72.99 -36.82 0.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.82 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.87 132.08 40.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 111.092 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -138.86 121.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.768 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -134.01 131.59 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.613 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.2 p90 -136.61 145.13 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.66 144.28 25.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.175 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.7 5.79 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.26 -7.77 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.5 p -84.1 115.52 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.207 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.37 94.8 7.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.001 0.429 . . . . 0.0 111.716 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.793 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.7 p -129.17 106.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.493 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.94 132.7 30.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.872 0.368 . . . . 0.0 111.328 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -148.74 164.33 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.426 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -94.32 87.91 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.455 0.645 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -170.23 148.79 3.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 71.85 -83.21 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.578 0.228 . . . . 0.0 111.165 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 8.1 m 27.4 81.4 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.856 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.41 156.03 17.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.225 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.83 -6.75 11.02 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.9 p -127.48 143.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.631 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.572 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.3 m -158.56 157.6 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -94.56 150.51 20.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.373 0.606 . . . . 0.0 111.576 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.28 126.67 8.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.956 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.37 -30.64 6.87 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.385 -0.912 . . . . 0.0 114.535 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 109' ' ' ARG . 2.4 p30 -79.21 156.39 28.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 111.957 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.7 t -111.16 152.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.257 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.11 150.22 30.42 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.086 0.403 . . . . 0.0 111.882 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.473 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -106.32 137.91 43.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.62 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.3 t90 -79.1 108.46 12.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -63.94 -65.84 1.82 Allowed Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.82 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.99 81.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.823 1.682 . . . . 0.0 111.714 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 136.56 -6.89 3.91 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.651 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 52.36 36.82 20.83 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.002 0.401 . . . . 0.0 110.931 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.84 54.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.044 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -88.38 151.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.401 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 16.9 t -143.47 157.06 44.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.849 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -110.2 159.68 17.17 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.353 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 33.7 m-85 -136.78 134.56 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 111.792 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.583 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -169.47 35.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.853 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.14 -153.53 24.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.323 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.4 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 112.097 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.82 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -163.79 -174.34 0.4 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.934 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.68 ' HB2' HD12 ' A' ' 93' ' ' ILE . 93.9 Cg_exo -44.89 -24.32 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.877 1.718 . . . . 0.0 112.519 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -142.25 69.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 110.365 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.569 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.3 mt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.818 0.342 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -103.55 99.25 14.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.702 ' HA ' HG21 ' A' ' 91' ' ' THR . 59.7 Cg_endo -70.39 -31.51 17.61 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.505 2.137 . . . . 0.0 112.69 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.42 -161.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.62 -8.76 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.665 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -166.56 71.83 0.13 Allowed 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 101' ' ' ALA . 18.4 m -119.08 141.24 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.004 0.431 . . . . 0.0 111.872 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 66' ' ' SER . 1.9 m120 -83.88 150.24 25.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.713 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.28 94.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.605 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -80.28 24.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.81 -149.98 17.38 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.41 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 26.2 mtp180 -157.01 168.06 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.454 . . . . 0.0 111.216 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.618 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -95.15 113.86 30.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.849 HD22 HD13 ' A' ' 86' ' ' LEU . 2.0 tt . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.586 0.232 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.43 -26.85 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.31 33.94 3.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.928 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 117' ' ' LEU . 2.4 m -80.39 154.03 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.627 0.251 . . . . 0.0 111.473 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.53 146.81 44.53 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 12.8 p-10 -53.6 134.61 41.23 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.519 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 56.86 99.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.282 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -144.61 153.34 41.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 110.98 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.3 t -65.09 158.17 26.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.542 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.904 HG22 ' CE2' ' A' ' 14' ' ' PHE . 40.8 t -148.06 129.18 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.087 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.0 m -124.55 106.1 16.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.595 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.17 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.813 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.3 pt-20 -153.2 125.04 7.82 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.665 0.269 . . . . 0.0 111.25 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.698 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.14 94.74 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.813 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB3' ' NE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.8 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.809 0.337 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -114.77 145.29 42.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.483 . . . . 0.0 112.113 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.26 163.61 16.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.951 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 147.37 33.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -144.33 101.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.12 156.17 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.555 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.558 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.7 m-85 -138.25 136.47 36.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.1 -29.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 22.49 7.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.35 152.96 1.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.39 145.6 50.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.871 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 148.46 11.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.658 0.266 . . . . 0.0 111.607 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 158.88 41.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.163 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.23 148.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.107 0.48 . . . . 0.0 111.644 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.2 mt-10 -94.57 -178.29 4.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.021 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 32' ' ' VAL . 7.0 tp -147.46 133.19 18.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.148 0.499 . . . . 0.0 111.4 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.12 139.49 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.436 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -57.11 -8.92 0.76 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.29 -27.98 0.74 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.62 0.248 . . . . 0.0 111.427 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -79.26 -56.61 4.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.9 115.98 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.784 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.5 -34.67 11.2 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.396 2.064 . . . . 0.0 112.246 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -59.32 -52.74 64.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.475 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.78 -45.65 92.98 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 23' ' ' LEU . 87.4 t -46.72 -31.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.71 86.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.267 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.57 67.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.82 -52.05 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.85 -29.25 70.05 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.911 0.386 . . . . 0.0 110.395 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.01 -25.58 62.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.528 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.02 51.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.767 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -61.56 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.828 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.3 Cg_exo -26.83 108.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.275 1.983 . . . . 0.0 113.992 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 14.5 mt -147.9 153.91 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.628 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -89.28 131.98 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.78 40.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.94 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 128.25 48.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.55 132.74 36.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -100.7 130.02 46.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -94.1 134.79 36.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' ASP . 7.5 t-105 -154.87 148.36 25.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.044 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -29.34 84.32 0.0 OUTLIER Glycine 0 C--N 1.336 0.557 0 O-C-N 123.375 0.422 . . . . 0.0 113.781 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' TRP . 27.8 t70 73.93 -37.23 0.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.406 0.282 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.749 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.3 tm-20 -73.44 128.04 34.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.992 0.425 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -131.1 125.0 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.786 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -136.49 127.43 27.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.355 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.3 p90 -133.28 145.39 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.61 146.62 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.581 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.82 6.79 10.42 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 82.57 -7.89 1.24 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.3 p -84.66 114.42 24.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.94 94.87 5.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 60' ' ' VAL . 6.1 p -132.47 106.74 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.143 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -124.12 134.64 53.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.027 0.441 . . . . 0.0 111.621 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -146.86 165.34 30.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.267 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 3.7 pm0 -102.02 92.4 4.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.048 0.451 . . . . 0.0 111.245 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.13 156.16 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.5 t-20 63.19 -81.48 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.706 0.289 . . . . 0.0 111.094 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.1 m 28.15 82.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.55 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.786 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.99 155.9 17.88 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.318 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -117.45 -7.01 11.18 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.7 p -127.03 144.43 37.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.623 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.548 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.5 m -158.47 163.19 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -108.65 143.22 38.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.036 0.446 . . . . 0.0 110.935 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -37.71 131.83 0.95 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.01 -31.52 6.47 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.711 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -83.25 156.83 22.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.247 0.546 . . . . 0.0 112.215 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 109' ' ' ARG . 23.1 t -114.95 152.43 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.997 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.94 149.33 32.0 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.313 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.481 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -106.73 123.78 48.64 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.268 179.264 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.598 ' HA ' HG12 ' A' ' 104' ' ' VAL . 3.1 t90 -65.67 111.07 3.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -66.3 -68.31 0.76 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.69 80.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 121.914 1.743 . . . . 0.0 111.752 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.12 -9.41 3.29 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.607 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.04 32.29 17.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.096 0.448 . . . . 0.0 110.863 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.16 133.9 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.881 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.78 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.236 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 35.3 t -143.14 157.26 44.67 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -112.37 156.41 22.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.941 179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.9 m-85 -136.76 130.86 32.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 111.515 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.445 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.77 49.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.71 -82.22 0.12 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.268 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -138.94 -167.85 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.265 0.555 . . . . 0.0 111.748 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -155.4 -176.51 0.62 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.822 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 97.1 Cg_exo -45.18 -21.69 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.187 1.925 . . . . 0.0 112.997 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.677 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -147.51 65.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.575 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 99.41 9.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.065 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.881 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -68.95 -31.15 24.85 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.538 2.159 . . . . 0.0 112.564 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.665 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.99 -162.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -7.3 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.645 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.97 73.74 0.07 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.5 m -122.16 142.3 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.005 0.431 . . . . 0.0 111.774 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.511 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m120 -83.15 152.19 25.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.43 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.786 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.96 82.02 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.708 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -65.9 20.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 114.27 -149.51 18.74 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.871 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.873 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.6 mtt85 -156.23 163.6 39.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.182 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.615 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -90.07 116.3 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.242 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 86' ' ' LEU . 4.1 tp . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.583 0.23 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -20.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 117' ' ' LEU . . . -91.31 30.34 6.45 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.644 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.8 m -77.52 154.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.483 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 147.21 30.2 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.608 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 13.6 p-10 -53.81 112.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 112.01 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.25 100.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.565 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.412 ' OE2' ' HB ' ' A' ' 120' ' ' VAL . 5.5 pt-20 -152.82 148.37 27.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.68 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.324 0.583 . . . . 0.0 112.456 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 45' ' ' ALA . 40.1 t -158.13 127.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.258 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.8 m -125.22 107.29 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.0 111.228 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.21 128.72 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.573 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 pt-20 -152.45 129.07 10.77 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.751 0.31 . . . . 0.0 111.235 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.58 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.86 92.73 3.1 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.874 0.369 . . . . 0.0 110.735 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.724 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' MET . . . . . 0.455 ' O ' ' HG2' ' A' ' 8' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.07 0.462 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -131.92 145.45 51.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.12 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.37 162.44 15.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.649 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.46 142.79 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -138.91 102.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 109.704 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.34 156.15 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.589 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.2 m-85 -137.64 138.34 39.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -29.14 0.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -126.22 22.1 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.87 153.34 1.35 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.66 145.06 48.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.085 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.36 148.85 11.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.561 0.22 . . . . 0.0 111.432 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -117.93 156.68 28.05 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.22 135.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.047 0.451 . . . . 0.0 111.338 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -90.89 -178.39 5.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.409 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.781 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -149.76 146.68 27.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.982 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -121.56 146.14 47.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.858 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.73 -9.03 2.39 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -45.52 -28.25 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.603 0.24 . . . . 0.0 111.423 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.711 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -80.07 -56.24 4.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 116.23 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.824 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.89 -29.77 8.69 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.521 2.147 . . . . 0.0 112.505 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.31 -43.56 81.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.183 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.844 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -67.18 -46.26 74.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.781 HG13 ' CD2' ' A' ' 23' ' ' LEU . 31.0 t -45.98 -35.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -56.62 -37.76 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.01 -47.56 74.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.99 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.86 -49.78 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.46 -28.79 70.21 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.247 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -71.19 -25.65 62.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 110.481 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.88 51.29 1.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.962 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.968 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.06 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.434 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 29.9 Cg_exo -28.64 103.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.058 1.839 . . . . 0.0 114.086 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.8 mt -145.62 150.62 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.395 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -85.88 135.62 33.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.164 0.506 . . . . 0.0 111.914 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.06 148.6 32.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.232 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.008 0.432 . . . . 0.0 110.374 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.98 132.55 34.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -104.13 119.01 38.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.802 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -82.43 136.88 34.84 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.047 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 16.0 t-105 -148.44 148.56 30.43 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.588 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.177 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 26.4 t70 79.44 -41.31 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.712 0.405 . . . . 0.0 111.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.56 152.08 24.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.577 HG21 HD21 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -150.13 117.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.726 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.1 p90 -125.15 140.17 53.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.243 0.545 . . . . 0.0 112.169 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 4.3 p90 -140.25 145.33 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.581 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 145.58 24.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.672 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.17 6.6 11.25 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.7 mt-30 81.75 -7.78 1.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.9 p -85.14 115.63 27.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.25 94.74 6.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.002 0.429 . . . . 0.0 111.706 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.844 ' CG2' HG22 ' A' ' 31' ' ' THR . 7.6 p -130.13 106.75 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.511 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.94 131.77 33.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.939 0.399 . . . . 0.0 111.412 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 52.1 tttm -141.07 165.65 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.354 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -99.56 89.27 4.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 111.374 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.8 tt0 -170.14 157.82 6.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.67 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.0 t-20 63.5 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.405 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.9 m 29.95 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.534 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 156.29 17.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.327 179.015 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.92 -7.01 10.96 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.4 p -126.63 142.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.537 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.81 157.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.26 151.08 19.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.357 0.599 . . . . 0.0 111.57 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -46.42 125.84 7.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.171 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.41 -31.72 6.27 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.369 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -75.66 155.81 35.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.619 0.709 . . . . 0.0 112.078 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.5 t -113.09 152.54 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.027 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.03 145.92 28.68 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.343 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.446 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -101.54 121.37 41.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 179.159 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.562 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -64.83 114.48 4.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.821 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.711 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -70.74 -67.34 0.63 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.735 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 27.8 Cg_exo -61.23 75.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.856 1.704 . . . . 0.0 111.633 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 147.11 -10.94 1.37 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 30.61 12.38 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.234 0.517 . . . . 0.0 110.973 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.72 136.64 52.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 9.5 mt -88.53 147.81 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.8 m -142.77 132.1 23.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -89.55 157.73 17.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.025 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 7.7 m-85 -136.49 134.67 37.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 111.536 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -153.58 28.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.708 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 148.53 -149.59 21.64 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.584 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -39.75 169.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.79 -176.58 0.63 Allowed Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.639 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.2 Cg_exo -42.64 -25.49 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.087 1.858 . . . . 0.0 112.571 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -136.49 52.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.511 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.451 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.5 HG23 ' OG1' ' A' ' 91' ' ' THR . 66.1 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.41 99.32 49.1 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.24 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 55.1 Cg_endo -68.25 -30.6 30.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 112.494 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.635 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -162.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.838 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -4.84 17.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.727 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.42 74.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 101' ' ' ALA . 20.8 m -122.7 141.98 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.544 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.3 m120 -82.15 152.77 26.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.624 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.667 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.6 90.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.781 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.93 19.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.263 -177.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.59 -149.24 18.65 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.572 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.765 ' HA ' HG23 ' A' ' 75' ' ' VAL . 13.6 mtt180 -151.52 164.18 37.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.003 0.43 . . . . 0.0 111.472 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.683 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -93.83 115.78 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.291 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.63 -19.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.413 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -91.52 27.35 9.75 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.051 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.3 m -81.62 153.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.763 0.281 . . . . 0.0 111.527 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.57 148.59 35.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -53.8 105.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 0.0 112.047 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.06 109.94 0.12 Allowed Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.989 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.18 138.72 14.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.639 0.257 . . . . 0.0 110.794 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.8 152.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 111.901 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 45' ' ' ALA . 61.5 t -144.62 128.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.3 m -124.69 107.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.82 128.38 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.6 pt-20 -152.46 130.29 11.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 111.216 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.575 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.76 93.79 2.64 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.901 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpp . . . . . 0 CA--C 1.524 -0.039 0 CA-C-O 120.859 0.362 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.64 145.26 38.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 112.03 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.54 163.6 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.719 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.45 145.06 33.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -147.35 102.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -108.58 155.99 20.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.854 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CG ' HD11 ' A' ' 117' ' ' LEU . 2.7 m-85 -128.82 140.31 51.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.159 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.07 -28.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -122.24 23.19 9.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -176.28 155.05 1.43 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -117.1 152.66 34.24 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.229 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.08 151.47 17.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.92 0.39 . . . . 0.0 111.926 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -137.45 149.96 47.26 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.235 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.13 141.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.131 0.491 . . . . 0.0 111.842 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' OE2' HG13 ' A' ' 111' ' ' VAL . 2.0 mp0 -95.03 -178.1 4.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.234 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.797 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -154.79 142.33 19.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.05 146.92 48.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.32 -9.41 0.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.61 -28.59 1.0 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.186 -0.321 . . . . 0.0 111.219 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.2 t90 -79.78 -55.87 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.667 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 156.8 115.97 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.648 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 3.8 Cg_exo -46.22 -36.7 17.37 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -62.12 -48.54 79.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.365 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -62.38 -44.96 95.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.888 0.375 . . . . 0.0 110.353 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 ' CD2' ' A' ' 23' ' ' LEU . 43.7 t -51.31 -31.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -59.73 -36.06 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.48 -47.31 67.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.1 -51.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.68 -28.69 69.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.983 0.42 . . . . 0.0 110.42 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.03 -23.83 60.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.44 50.81 0.89 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.877 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.957 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.506 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 30.7 Cg_exo -28.88 106.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.164 1.909 . . . . 0.0 113.979 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.2 mt -147.63 149.3 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.403 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 136.59 33.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.09 149.25 33.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.35 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.82 127.89 48.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -87.16 136.27 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -108.83 123.56 49.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.235 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.713 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -80.85 138.17 36.19 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.414 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.5 t-105 -150.1 148.88 29.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.58 95.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.513 -0.375 . . . . 0.0 113.72 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.68 30.5 11.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.266 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.9 OUTLIER -145.63 146.03 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.326 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -140.51 121.45 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 19.3 p90 -129.61 129.78 44.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.112 0.482 . . . . 0.0 110.98 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.54 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.7 p90 -139.11 145.53 39.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.815 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 149.34 21.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.34 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.16 6.28 9.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 80.41 -6.21 1.71 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.799 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.1 p -86.54 116.01 28.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.834 0.35 . . . . 0.0 110.2 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.32 94.79 5.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.0 0.429 . . . . 0.0 111.769 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.847 HG22 HG22 ' A' ' 31' ' ' THR . 7.5 p -124.07 106.59 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.016 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.34 136.56 51.13 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 111.587 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 63' ' ' GLU . 8.9 ttmt -141.51 164.79 29.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.242 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -101.24 76.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.051 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -170.11 160.78 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.485 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER 72.78 -82.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.6 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER 22.43 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.97 160.55 14.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.639 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' HG23 ' A' ' 69' ' ' VAL . 12.1 p30 -122.38 -4.3 8.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 68' ' ' ASP . 40.7 t -131.87 143.66 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.103 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.524 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.77 158.21 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.029 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.33 150.54 24.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.362 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp -52.08 124.79 13.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.963 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -32.19 6.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.017 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -67.55 166.05 15.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.104 0.452 . . . . 0.0 111.883 -179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 ' CD1' ' A' ' 110' ' ' ILE . 22.0 t -122.72 152.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.719 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 146.17 26.47 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.697 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.518 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -98.24 126.97 43.94 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.962 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.738 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.2 t90 -68.38 122.59 18.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.215 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -72.25 -68.53 0.41 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.453 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 38.8 Cg_exo -59.44 82.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.915 1.743 . . . . 0.0 111.837 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.53 -7.18 4.95 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.642 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.62 39.43 13.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 0.0 111.176 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -115.19 135.5 54.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.55 145.57 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.5 m -142.49 131.27 22.79 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.815 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -98.07 139.19 34.26 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.3 p90 -136.52 138.05 40.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.075 0.464 . . . . 0.0 110.967 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.9 50.68 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.491 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.03 -81.14 0.13 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -123.49 -170.26 2.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.387 0.613 . . . . 0.0 111.553 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -166.16 178.09 1.37 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.807 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.6 Cg_exo -36.25 -30.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.659 2.239 . . . . 0.0 112.657 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -142.11 69.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.348 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 111.205 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -116.83 99.29 52.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.644 ' HA ' HG21 ' A' ' 91' ' ' THR . 40.0 Cg_endo -65.73 -31.43 49.02 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.552 2.168 . . . . 0.0 112.446 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.682 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.57 -159.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.62 -4.12 17.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.85 73.21 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.738 HG12 ' CD1' ' A' ' 78' ' ' TRP . 15.6 m -120.69 141.96 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.757 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.656 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 41.1 m-20 -80.71 151.03 29.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.687 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.44 85.48 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.441 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.719 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -68.17 19.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.945 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.33 -146.74 18.52 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.933 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 75' ' ' VAL . 10.5 mtt-85 -154.98 168.09 28.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.515 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.589 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.6 mt -93.58 118.85 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.8 tp . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 120.638 0.256 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.1 OUTLIER -42.3 -24.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.416 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -91.32 35.04 4.05 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.057 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.7 m -70.91 154.79 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 122.61 0.364 . . . . 0.0 111.853 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.79 146.66 44.09 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 p30 -58.1 116.35 3.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.089 0.471 . . . . 0.0 112.238 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.93 102.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.973 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.37 150.98 25.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.792 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.4 t -52.1 167.45 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 112.229 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 89.2 t -157.7 128.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.21 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -127.84 108.23 17.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.02 129.01 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.7 pt-20 -152.05 128.22 10.48 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.607 0.242 . . . . 0.0 111.229 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.678 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.79 85.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.175 -0.916 . . . . 0.0 111.634 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.37 38.88 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.448 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -114.19 25.85 10.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -147.33 -152.15 0.42 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.325 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.73 -50.22 0.05 OUTLIER Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.554 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG23 ' CD1' ' A' ' 24' ' ' TYR . 13.7 p -90.05 53.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.551 . . . . 0.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -157.8 48.79 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -112.64 90.2 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -102.35 145.06 30.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 111.76 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 164.17 19.3 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.004 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.32 102.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.085 0.469 . . . . 0.0 109.779 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -99.82 156.23 17.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.376 0.608 . . . . 0.0 111.893 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.7 m-85 -135.88 138.87 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.495 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.6 p -125.98 21.83 7.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -176.53 153.32 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.91 146.58 37.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 149.01 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.168 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.29 155.66 24.74 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.81 142.06 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.223 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 7.4 mt-10 -100.58 -178.8 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.062 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.757 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.8 tp -150.92 149.36 29.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.067 0.46 . . . . 0.0 111.368 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.694 ' CD1' HG23 ' A' ' 6' ' ' VAL . 19.3 m-85 -126.36 148.01 49.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.732 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.18 -8.88 1.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.65 -27.73 0.85 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.621 0.248 . . . . 0.0 111.593 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.653 ' CZ2' HG21 ' A' ' 31' ' ' THR . 8.9 t90 -81.61 -56.27 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.89 114.87 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.452 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -46.41 -35.23 15.73 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.555 2.17 . . . . 0.0 112.335 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.78 -53.5 57.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.539 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.51 -45.06 92.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.521 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.757 HG13 ' CD2' ' A' ' 23' ' ' LEU . 61.4 t -47.43 -28.42 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.33 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt-85 -61.21 -38.64 87.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.464 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.94 79.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.671 0.272 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.09 -51.29 55.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.03 -27.8 69.66 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 120.948 0.404 . . . . 0.0 110.369 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.93 -25.31 61.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 0.0 110.599 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.23 49.6 1.13 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.047 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.1 mt -61.91 -160.21 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.58 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 32.3 Cg_exo -29.2 107.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.04 150.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.627 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -85.77 136.61 33.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.111 0.481 . . . . 0.0 111.745 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.33 149.1 33.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.497 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 125.59 48.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.85 136.01 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -108.26 125.8 52.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.073 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HD3' ' O ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -85.39 135.37 33.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -150.91 148.97 29.08 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.902 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . -32.88 102.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.505 -0.379 . . . . 0.0 113.729 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.22 30.87 0.49 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.3 OUTLIER -144.02 142.91 30.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.351 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -139.92 124.83 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.299 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 34.9 p90 -133.83 127.84 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.0 p90 -133.58 146.5 51.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.049 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.01 145.19 24.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER 82.95 -8.14 1.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -84.34 115.78 26.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.33 94.56 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 112.053 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.69 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.3 p -123.21 106.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.41 136.39 46.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.041 0.448 . . . . 0.0 111.665 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -160.32 161.7 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.987 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -96.33 96.28 8.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.0 tt0 -170.37 149.87 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.884 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 57.4 t-20 63.33 -81.74 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.727 0.299 . . . . 0.0 111.108 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.2 m 29.97 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.676 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.802 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.54 157.06 16.71 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.145 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -120.98 -4.16 9.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.5 p -127.56 141.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.403 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.552 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.75 157.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.599 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.62 150.77 19.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.401 0.619 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -44.85 126.49 5.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.98 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.41 -26.96 10.44 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 120.256 -0.973 . . . . 0.0 114.614 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.432 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -82.53 156.21 24.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.844 0.822 . . . . 0.0 111.894 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.874 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -113.48 151.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.393 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.06 153.34 33.78 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CD2' ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -103.98 131.69 50.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.308 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.0 t90 -74.37 109.12 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -65.32 -69.17 0.61 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.311 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 39.0 Cg_exo -58.85 80.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.886 1.724 . . . . 0.0 111.518 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.46 -9.33 3.19 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.291 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 50.05 39.62 19.52 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.907 0.354 . . . . 0.0 111.121 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.02 136.38 54.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.53 147.05 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.5 m -143.12 135.89 27.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.778 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.07 160.82 19.18 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 57.1 m-85 -136.32 114.71 11.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 111.984 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.683 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -150.23 31.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.082 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.54 -153.07 24.1 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.663 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.6 -173.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.522 0.677 . . . . 0.0 112.203 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.725 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.31 -175.85 0.55 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.118 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.689 ' HB2' HD12 ' A' ' 93' ' ' ILE . 74.3 Cg_exo -42.6 -25.22 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.032 1.821 . . . . 0.0 112.888 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -142.02 72.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -60.6 -75.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.26 -91.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -119.51 -30.69 4.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -125.56 -161.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.319 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' OG1' ' A' ' 91' ' ' THR . 91.7 mt -118.69 110.3 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -109.32 99.26 35.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.959 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.725 ' HA ' HG21 ' A' ' 91' ' ' THR . 60.0 Cg_endo -70.66 -31.27 16.83 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.151 . . . . 0.0 112.719 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.69 -162.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.22 -5.37 14.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.613 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.27 70.06 0.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 101' ' ' ALA . 12.7 m -119.01 141.4 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.024 0.44 . . . . 0.0 111.805 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.689 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.1 m120 -84.43 151.39 24.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.419 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.802 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.7 96.89 6.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.618 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.27 20.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.74 -149.75 18.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.55 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HA ' HG23 ' A' ' 75' ' ' VAL . 30.6 mtp180 -156.75 168.03 28.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.19 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.586 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.84 112.72 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.531 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG21 ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -107.35 -86.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.547 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -67.57 74.35 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.81 -70.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 ttm 54.77 35.48 24.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.01 152.31 29.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.97 45.71 2.1 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.393 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.825 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.7 tt -42.45 -35.59 1.08 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 111.5 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.78 -21.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -93.43 34.35 4.65 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.427 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 117' ' ' LEU . 7.1 m -71.58 154.83 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 122.161 0.184 . . . . 0.0 111.088 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.635 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -81.22 147.92 29.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.603 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.1 p-10 -56.16 118.0 4.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.177 0.513 . . . . 0.0 112.328 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.63 101.15 0.02 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.008 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.635 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -149.8 155.55 40.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 110.48 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 t -55.56 164.98 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.681 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.5 t -157.96 127.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.562 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.39 108.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.759 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.68 128.89 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.407 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.7 pt-20 -153.41 129.18 10.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.66 0.267 . . . . 0.0 111.379 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.632 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.24 89.54 3.12 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.682 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.825 0.345 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.52 137.46 5.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.61 21.13 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.229 . . . . 0.0 111.077 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 58.69 -84.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.979 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -164.66 27.85 0.2 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.452 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 25' ' ' GLU . 32.8 m -115.68 63.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.086 0.47 . . . . 0.0 111.348 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 38.92 0.18 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.95 110.47 22.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -108.38 145.43 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.356 0.598 . . . . 0.0 112.319 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 163.92 18.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.62 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 144.87 31.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.7 mt -148.04 99.31 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.551 HH11 HG21 ' A' ' 127' ' ' VAL . 4.6 ptm180 -104.98 156.06 18.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.877 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.7 m-85 -129.63 139.11 51.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.277 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -28.53 0.43 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -121.34 22.97 10.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.76 151.46 1.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.37 138.35 54.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.791 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.499 ' SG ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -163.54 149.2 11.32 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.639 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.33 158.26 31.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.115 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.24 141.13 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.374 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.657 ' OE2' HG21 ' A' ' 111' ' ' VAL . 4.2 mt-10 -96.86 -178.46 4.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.979 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.806 ' CD2' HG13 ' A' ' 32' ' ' VAL . 8.1 tp -154.15 144.57 22.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.148 0.499 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 16.7 m-85 -127.14 146.73 50.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.638 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.602 ' H ' HG12 ' A' ' 6' ' ' VAL . 11.3 mt-10 -57.07 -9.29 0.83 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -45.49 -28.29 0.89 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.265 -0.272 . . . . 0.0 111.33 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.726 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.8 t90 -81.12 -56.18 4.26 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.41 115.47 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.597 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -46.17 -35.47 15.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.517 2.145 . . . . 0.0 112.341 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.15 -52.7 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.446 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.39 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.806 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.0 t -47.91 -30.04 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.307 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -60.66 -38.31 84.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.399 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.19 75.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.34 -52.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.9 -29.01 69.92 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.977 0.417 . . . . 0.0 110.445 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.92 -25.44 62.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.42 50.82 1.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.968 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.951 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.92 -160.05 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.45 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.4 Cg_exo -29.59 105.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.106 1.871 . . . . 0.0 113.953 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.7 mt -147.94 149.29 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.566 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.89 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.09 0.471 . . . . 0.0 111.766 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.7 p -146.08 149.01 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.463 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.92 129.38 48.17 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.865 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -89.46 134.45 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -106.06 122.02 45.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.045 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.807 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -81.79 136.73 35.4 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -154.45 148.34 25.59 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.47 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.83 86.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.497 0 O-C-N 123.278 0.361 . . . . 0.0 113.838 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.4 t70 76.15 -36.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 138.49 37.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 111.376 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -136.26 110.01 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.991 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 39.7 p90 -119.87 128.74 53.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.3 p90 -136.64 144.46 44.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.393 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.64 147.07 23.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.89 7.56 10.42 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 56' ' ' THR . 36.1 mt-30 81.02 -6.82 1.59 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.819 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -86.54 115.76 28.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.39 94.9 5.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.045 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 31' ' ' THR . 2.9 p -125.33 106.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.961 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 138.17 53.88 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.053 0.454 . . . . 0.0 111.623 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -152.99 164.5 37.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.335 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.12 87.2 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.78 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.0 tt0 -170.11 153.56 4.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 49.7 t-20 69.42 -80.27 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.277 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.456 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 5.3 m 25.28 82.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.473 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.883 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.77 157.02 17.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.536 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -118.97 -8.13 10.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.0 p -124.89 143.04 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.296 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.9 m -159.08 157.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.78 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.49 151.59 21.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.406 0.622 . . . . 0.0 111.483 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.38 125.36 10.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.805 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.59 -32.18 6.0 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.268 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 1.9 p30 -73.61 156.49 37.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.578 0.689 . . . . 0.0 111.942 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.0 t -112.93 152.35 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.4 148.94 31.83 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.262 0.483 . . . . 0.0 112.294 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.56 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -103.91 123.08 46.49 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.686 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.0 t90 -64.62 119.98 11.53 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.809 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.772 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -70.64 -68.03 0.55 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.753 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.772 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.07 78.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.846 1.697 . . . . 0.0 111.696 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 141.19 -9.24 2.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.737 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.02 36.23 14.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.0 0.4 . . . . 0.0 111.059 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.85 134.75 54.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.723 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.8 mt -84.3 141.16 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.451 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.5 m -135.65 130.36 34.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.58 156.3 19.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.8 m-85 -136.79 129.67 30.76 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.626 0.25 . . . . 0.0 110.989 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -165.79 42.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.304 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.47 -84.09 0.1 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.327 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -130.57 -166.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.259 0.552 . . . . 0.0 111.902 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.56 -176.65 0.63 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.7 Cg_exo -47.32 -24.62 4.05 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.793 1.662 . . . . 0.0 111.786 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 92' ' ' PRO . 1.9 mp -142.57 66.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -44.55 -33.33 1.72 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.83 146.57 8.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 9.8 m-20 60.63 52.24 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.483 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 66.08 163.32 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.612 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.1 mt -60.37 108.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.102 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -103.47 99.21 14.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 91' ' ' THR . 52.4 Cg_endo -68.33 -31.39 28.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.482 2.121 . . . . 0.0 112.537 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.605 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.41 -158.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -6.93 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.697 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.01 73.12 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.7 m -122.74 142.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 111.826 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.5 m120 -83.58 152.0 25.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.854 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.883 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.73 99.84 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.457 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.571 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.66 21.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.79 -133.22 10.55 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.245 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.867 ' HA ' HG23 ' A' ' 75' ' ' VAL . 9.5 ptt85 -170.47 168.12 7.92 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.045 0.45 . . . . 0.0 111.484 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.607 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.0 mt -98.16 115.27 37.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.575 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.657 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -99.74 -85.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.504 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -75.73 -176.34 3.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.074 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 57.9 m 62.06 162.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.3 tpp -57.88 129.43 41.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mp0 -104.66 25.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.003 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.84 32.67 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.392 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.2 tt -49.94 -31.87 13.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.95 -24.38 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.173 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.92 31.29 4.72 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 117' ' ' LEU . 10.6 m -75.09 153.98 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.562 0.22 . . . . 0.0 111.299 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.26 146.61 32.91 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.618 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -57.28 111.64 1.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.99 98.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.401 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.41 149.71 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.68 166.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.281 0.562 . . . . 0.0 112.257 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.8 t -157.98 128.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.137 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 127' ' ' VAL . 27.5 m -129.46 109.14 17.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 111.589 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.89 129.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.243 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 11.8 pt-20 -154.31 128.04 8.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.622 0.249 . . . . 0.0 111.293 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.596 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.81 87.59 1.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 110.786 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.751 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.26 123.28 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.65 -41.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.62 0.247 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.33 -63.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.44 28.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 25' ' ' GLU . 32.3 m -113.53 63.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -157.26 38.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.09 110.58 22.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -108.54 145.32 34.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.2 0.524 . . . . 0.0 112.329 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.48 163.96 17.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.682 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 145.68 38.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.796 0.332 . . . . 0.0 110.948 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.2 100.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -102.63 155.5 18.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.615 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE1' HG13 ' A' ' 126' ' ' VAL . 2.8 m-85 -131.2 138.05 49.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.441 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.53 -29.07 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -126.08 23.12 7.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.06 152.44 3.49 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.78 143.5 49.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.676 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 148.6 13.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.75 0.31 . . . . 0.0 111.769 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -136.31 157.83 45.86 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.054 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.15 146.57 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.446 . . . . 0.0 111.648 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 6.6 mt-10 -98.16 -178.29 4.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.871 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.758 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.9 tp -153.71 144.2 22.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.479 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 16.0 m-85 -123.97 146.8 48.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.641 ' H ' HG12 ' A' ' 6' ' ' VAL . 12.9 mt-10 -55.45 -9.27 0.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.61 -27.26 0.74 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.939 0.336 . . . . 0.0 111.443 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.655 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.5 t90 -81.28 -56.37 4.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.23 113.62 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.665 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.72 -29.62 8.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.35 -46.46 80.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.283 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.693 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -68.32 -46.2 70.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 23' ' ' LEU . 30.2 t -45.87 -29.82 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.339 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -33.44 72.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.477 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.53 55.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.3 -49.08 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.12 -28.62 69.89 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.319 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -71.4 -25.38 62.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.376 . . . . 0.0 110.543 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.01 51.11 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.988 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -62.21 -159.93 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.594 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.4 Cg_exo -29.08 107.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.186 1.924 . . . . 0.0 114.059 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.9 mt -150.04 149.78 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.642 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -85.84 136.85 33.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.919 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.58 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -146.05 149.19 33.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.45 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 124.44 47.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.894 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -84.93 133.58 34.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -103.4 124.98 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.931 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.865 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.52 135.88 33.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.6 t-105 -156.71 148.34 22.58 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.957 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.81 84.89 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.649 -0.31 . . . . 0.0 113.764 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' TRP . 30.5 t70 74.22 -36.64 0.34 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.3 tt0 -74.71 128.22 35.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.399 . . . . 0.0 111.346 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -132.29 119.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.849 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 53.4 p90 -131.47 125.03 31.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.319 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.0 p90 -129.87 145.8 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.05 144.12 25.76 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.89 6.4 11.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.6 mm-40 82.23 -7.44 1.33 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.7 p -84.98 116.87 29.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.159 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.87 94.56 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.703 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.693 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.0 p -126.08 106.74 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.3 133.93 43.21 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 161.14 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.083 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.73 93.97 7.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.51 148.39 3.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 0.4 OUTLIER 70.44 -76.87 0.06 Allowed 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.606 0.241 . . . . 0.0 111.165 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.474 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 11.0 t 21.41 83.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.887 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.58 161.51 13.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.361 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.28 1.04 8.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 49.6 t -138.41 142.33 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.483 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.99 157.55 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.887 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.79 152.2 19.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.495 0.664 . . . . 0.0 111.62 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -48.29 125.91 10.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.933 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.07 6.08 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.505 -0.855 . . . . 0.0 114.083 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -75.37 156.37 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.458 0.629 . . . . 0.0 111.984 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.9 t -113.05 152.25 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.08 149.39 29.47 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.151 0.432 . . . . 0.0 111.874 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -104.51 137.66 42.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.341 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.631 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.6 t90 -78.72 108.26 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.447 HG13 ' ND2' ' A' ' 105' ' ' ASN . 0.3 OUTLIER -63.94 -66.42 1.5 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.634 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 21.1 Cg_endo -60.72 77.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.255 1.97 . . . . 0.0 111.6 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 142.91 -9.99 2.31 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.324 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 54.47 33.6 19.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.965 0.382 . . . . 0.0 110.913 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.96 134.8 54.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.049 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.1 mt -87.37 150.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 24.8 t -143.52 156.09 44.52 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.087 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -113.66 157.76 21.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.943 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 5.5 m-85 -136.71 138.21 40.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.492 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -175.46 44.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.957 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.36 -91.14 0.1 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.973 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -133.36 -167.76 1.98 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.424 0.63 . . . . 0.0 111.724 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.841 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -163.61 -173.94 0.38 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.01 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.628 ' CD ' HG22 ' A' ' 91' ' ' THR . 90.4 Cg_exo -45.48 -22.2 0.97 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 121.81 1.673 . . . . 0.0 112.736 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 92' ' ' PRO . 2.7 mp -142.06 73.1 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -63.75 -13.2 41.54 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.7 t0 -26.1 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 41.47 31.94 0.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.058 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 175.39 163.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.804 0.335 . . . . 0.0 110.758 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.27 102.32 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -98.76 99.11 7.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.841 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.4 Cg_endo -68.87 -31.09 25.5 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.483 2.122 . . . . 0.0 112.561 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.77 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.76 -0.43 14.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.599 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.474 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -171.42 68.25 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 78' ' ' TRP . 18.6 m -121.45 141.63 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.132 0.492 . . . . 0.0 112.09 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.532 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.2 m120 -82.32 152.04 26.45 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.815 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -89.1 97.43 6.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.528 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.95 22.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.116 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.43 -144.65 17.9 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.079 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.847 ' HA ' HG23 ' A' ' 75' ' ' VAL . 5.0 mtt180 -156.79 168.1 28.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 111.33 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mp -91.41 116.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.076 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.46 -87.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.15 126.0 49.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.395 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.59 -67.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.633 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -169.17 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.699 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 22.2 mt-10 57.48 35.32 25.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.024 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.07 28.19 2.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.877 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.087 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp -52.17 -34.06 43.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.995 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.51 -26.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.94 -179.463 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.54 31.34 4.22 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.1 m -79.84 154.19 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.641 0.258 . . . . 0.0 111.202 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.96 146.55 32.01 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.578 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 16.0 p-10 -54.57 112.01 0.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.997 0.427 . . . . 0.0 111.593 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.61 100.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.179 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.82 148.88 28.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.371 . . . . 0.0 110.982 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.1 t -46.63 163.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.327 0.584 . . . . 0.0 112.233 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 45' ' ' ALA . 42.4 t -158.1 128.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.326 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.2 m -126.51 108.42 19.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.901 0.382 . . . . 0.0 111.547 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.05 128.53 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.289 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.4 pt-20 -154.0 130.26 10.45 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.43 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.603 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.19 89.53 3.09 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.801 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.719 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.775 0.322 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.09 -27.87 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.501 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 60.91 -160.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.473 0.178 . . . . 0.0 110.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 60.26 19.26 8.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.09 -32.01 0.12 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 25' ' ' GLU . 26.5 m -112.11 61.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 111.274 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -158.51 36.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 114.5 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -111.27 145.32 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 112.099 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.39 164.57 14.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.796 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.35 143.82 36.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 0.0 111.159 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.45 100.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -102.48 156.26 17.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.597 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.1 m-85 -136.27 137.91 41.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.524 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.5 -29.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -123.88 22.81 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.86 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -126.68 141.5 51.83 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.83 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 148.94 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.717 0.294 . . . . 0.0 111.498 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.5 160.11 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.308 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.86 144.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.122 0.487 . . . . 0.0 111.571 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.3 mt-10 -96.21 -178.52 4.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.13 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.0 tp -151.02 147.02 26.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.029 0.442 . . . . 0.0 111.15 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 19.4 m-85 -128.5 146.88 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.747 ' H ' HG12 ' A' ' 6' ' ' VAL . 20.5 mt-10 -59.06 -9.03 1.7 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.4 -29.56 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -79.9 -56.38 4.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 158.24 117.2 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -45.99 -35.36 14.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.523 2.149 . . . . 0.0 112.208 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.63 76.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.708 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.539 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.91 -44.22 93.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.859 0.362 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 23' ' ' LEU . 63.7 t -47.68 -34.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.204 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -60.07 -36.98 78.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.39 70.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -54.95 -51.76 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.42 -28.7 69.98 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.028 0.442 . . . . 0.0 110.399 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.74 -26.16 63.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.452 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.0 51.48 1.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.778 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.964 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.7 -159.71 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.591 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.964 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.6 Cg_exo -28.92 105.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.996 1.798 . . . . 0.0 113.989 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 39' ' ' LEU . 21.0 mt -146.64 150.71 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.63 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.036 0.446 . . . . 0.0 111.82 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.608 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -144.05 148.97 35.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.453 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 126.95 48.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 110.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -88.84 132.75 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -102.63 122.3 44.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.712 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.925 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.66 136.18 33.18 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -155.74 148.26 23.9 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.81 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -32.07 85.47 0.01 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.178 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.1 t70 76.0 -39.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.9 tt0 -71.09 120.26 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 0.0 111.504 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -128.36 121.54 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.742 178.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -135.23 127.91 30.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.844 0.354 . . . . 0.0 111.296 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.7 p90 -133.4 145.76 50.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.013 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.15 146.19 24.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.63 6.31 10.53 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER 83.07 -8.08 1.16 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.2 p -85.76 115.02 26.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.38 94.7 5.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.975 0.417 . . . . 0.0 112.052 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.8 p -129.66 106.78 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.124 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.64 134.75 54.49 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 121.027 0.441 . . . . 0.0 111.641 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.26 167.26 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.065 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.03 88.78 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.972 0.415 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.33 160.79 7.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.757 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.8 t-20 63.42 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.3 m 28.5 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.368 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.841 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.19 155.45 17.75 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.398 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.655 ' OD1' HG23 ' A' ' 69' ' ' VAL . 1.5 p30 -120.41 2.11 10.74 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 68' ' ' ASP . 51.0 t -137.28 141.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -158.12 157.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.715 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -98.26 148.73 23.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.389 0.614 . . . . 0.0 111.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.61 129.42 4.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.948 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.51 -32.06 6.08 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.134 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 2.5 p30 -81.15 157.93 25.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.327 0.564 . . . . 0.0 111.929 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.87 HG23 ' HA ' ' A' ' 109' ' ' ARG . 38.4 t -116.21 152.53 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.48 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 151.32 32.54 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.305 0.502 . . . . 0.0 112.341 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -107.36 137.28 45.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.553 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -76.22 111.95 12.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -64.04 -67.37 1.08 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 32.2 Cg_endo -63.5 76.28 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.23 1.954 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.83 -10.84 1.65 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.545 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.38 28.72 11.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.147 0.474 . . . . 0.0 110.944 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.12 130.9 55.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.676 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.74 147.66 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.197 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.1 t -141.06 156.83 45.94 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.482 0.658 . . . . 0.0 112.769 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.922 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.75 161.76 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.069 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 10.5 m-85 -136.55 138.94 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -177.68 49.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.418 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.71 -78.54 0.19 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.619 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -141.47 -161.51 1.23 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.976 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.879 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -166.33 177.87 1.41 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.009 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -41.79 -23.67 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.473 2.115 . . . . 0.0 112.921 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 99' ' ' ARG . 10.0 pt -141.19 64.59 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -54.53 -71.12 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.115 0.483 . . . . 0.0 110.662 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 64.0 -102.69 0.1 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.7 -12.17 10.9 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.908 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.97 -159.7 0.98 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.019 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.1 100.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 110.948 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -100.09 99.06 8.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.767 ' HA ' HG21 ' A' ' 91' ' ' THR . 46.9 Cg_endo -68.16 -29.68 32.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.215 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.39 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.661 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.8 -2.97 15.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.654 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -172.16 70.1 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.4 m -120.03 141.64 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.956 0.408 . . . . 0.0 111.8 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.612 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.8 m120 -83.83 153.1 24.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.285 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.841 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.84 89.66 3.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.121 178.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.649 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.87 23.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 114.71 -150.46 18.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.87 ' HA ' HG23 ' A' ' 75' ' ' VAL . 27.2 mtp180 -156.94 168.16 28.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.2 mt -98.05 114.59 35.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.568 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.99 -86.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.737 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -66.98 170.28 6.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.1 p 59.66 168.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 36.4 mmm -58.28 149.64 23.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' CB ' HG21 ' A' ' 110' ' ' ILE . 3.5 pm0 -131.29 36.17 3.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.89 45.31 1.3 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.755 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.922 HD22 HD13 ' A' ' 86' ' ' LEU . 1.5 tp -49.58 -34.7 18.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.41 -26.43 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.282 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.03 29.83 4.54 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.39 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.3 m -84.32 153.89 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.832 0.316 . . . . 0.0 111.381 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.67 147.18 32.08 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.475 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 5.2 p-10 -56.31 117.72 4.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.52 100.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.108 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.29 149.63 27.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.137 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.2 t -48.6 164.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 112.061 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 45' ' ' ALA . 48.0 t -158.02 128.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.578 HG23 ' OE2' ' A' ' 129' ' ' GLU . 17.4 m -125.83 108.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.453 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.0 128.79 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.225 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -154.43 131.66 11.1 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.799 0.333 . . . . 0.0 111.542 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.534 ' CB ' HD22 ' A' ' 39' ' ' LEU . 3.1 tmm_? -74.25 92.85 2.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.867 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.795 0.331 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 6' ' ' VAL . . . 123.2 170.24 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.525 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -147.27 -160.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.582 0.229 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 60.63 19.11 9.08 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.4 -28.12 0.16 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.61 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 25' ' ' GLU . 27.0 m -112.94 62.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.419 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -156.59 43.47 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 112.11 24.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -109.15 145.42 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 112.156 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 163.27 17.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.7 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 144.86 32.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.885 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.89 101.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 109.749 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -100.09 156.12 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.71 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.67 138.03 44.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.431 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.43 -28.91 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -125.56 22.37 7.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.14 150.26 1.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.415 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -131.92 139.23 48.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.188 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 149.2 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.7 0.286 . . . . 0.0 111.339 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -116.41 156.92 25.95 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.41 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.79 138.04 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.3 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.689 ' OE2' HG13 ' A' ' 111' ' ' VAL . 3.2 mt-10 -92.96 -178.3 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.325 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.836 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -155.43 145.87 21.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.439 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 20.6 m-85 -126.65 146.71 50.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.698 ' H ' HG12 ' A' ' 6' ' ' VAL . 29.6 mt-10 -56.59 -9.13 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.67 -27.4 0.79 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.212 -0.305 . . . . 0.0 111.383 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.776 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.6 t90 -80.56 -55.96 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.49 109.7 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.48 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.738 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 88.4 Cg_exo -40.9 -29.71 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.789 2.326 . . . . 0.0 112.967 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.97 -42.04 81.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.321 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.776 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.74 -45.03 72.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.784 0.326 . . . . 0.0 110.477 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 ' CD2' ' A' ' 23' ' ' LEU . 35.5 t -48.85 -33.64 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.244 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -58.03 -37.25 74.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -66.5 -48.44 69.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.45 -51.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.04 -29.03 70.01 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.331 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.7 -24.76 61.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.62 51.47 0.93 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.959 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.522 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.959 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.6 Cg_exo -29.49 105.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.071 1.848 . . . . 0.0 113.969 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.8 mt -147.23 150.79 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.569 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.9 136.85 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.612 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.0 p -145.23 148.88 34.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.504 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 123.65 46.09 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.068 0.461 . . . . 0.0 110.263 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.49 135.04 34.81 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -107.26 126.43 52.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.679 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.43 137.4 32.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 14.4 t-105 -149.47 148.37 29.34 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.431 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.17 92.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.053 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 27.9 t70 78.87 -41.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.724 0.41 . . . . 0.0 111.649 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 152.55 24.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 111.425 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -153.0 117.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.627 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.2 p90 -124.06 141.68 51.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.345 0.593 . . . . 0.0 112.226 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -140.45 145.39 36.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.33 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.57 149.5 21.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.697 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.89 5.23 8.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.2 mm-40 83.32 -8.08 1.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.764 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -85.02 116.7 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.33 94.95 5.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 0.0 112.187 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.614 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.0 p -124.55 106.62 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.874 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.71 136.44 50.6 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.026 0.441 . . . . 0.0 111.708 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -156.86 164.62 37.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.233 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.79 91.02 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.7 tt0 -170.12 152.04 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER 68.5 -79.96 0.04 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.492 ' OG ' HD12 ' A' ' 79' ' ' ILE . 4.4 m 23.8 80.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.624 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 158.67 16.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.558 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -120.64 -5.88 9.71 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.9 p -128.83 142.87 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.392 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 29.5 m -158.68 157.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -88.23 151.45 22.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.343 0.592 . . . . 0.0 111.412 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -50.43 126.2 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.143 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.53 -32.22 6.19 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.939 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.4 p-10 -68.98 162.49 26.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.074 0.464 . . . . 0.0 112.101 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -121.73 152.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.948 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.798 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.61 146.24 25.68 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.495 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.99 130.98 44.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.817 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.748 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.9 t90 -71.03 122.66 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.99 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -68.09 -67.84 0.75 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.903 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 47.1 Cg_endo -68.05 80.56 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.246 1.964 . . . . 0.0 112.181 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.46 -11.94 2.48 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 53.76 30.56 11.41 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.11 0.455 . . . . 0.0 110.749 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -109.65 135.07 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.63 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.5 mt -85.96 144.24 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.66 130.7 30.39 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.889 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.36 156.86 19.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.09 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.7 m-85 -136.5 130.13 32.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.538 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 2.6 m-85 -152.51 28.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 151.07 -151.78 23.7 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.518 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -40.73 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.619 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -151.2 -174.62 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.647 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.6 Cg_exo -46.18 -24.19 2.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.748 1.632 . . . . 0.0 112.297 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -139.94 55.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -48.99 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 49.25 58.46 5.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.702 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.2 11.41 4.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 94' ' ' SER . 2.7 mmpt? -149.02 177.68 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' A' ' 91' ' ' THR . 67.8 mt -123.53 129.11 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.7 mtt85 -136.33 99.2 10.93 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.556 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 54.0 Cg_endo -68.21 -31.66 28.67 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.44 2.093 . . . . 0.0 112.331 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.726 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.0 -161.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.748 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.16 -7.68 15.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.53 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.39 71.24 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.748 HG12 ' CD1' ' A' ' 78' ' ' TRP . 14.5 m -118.36 141.92 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.472 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.685 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 31.7 m-20 -82.15 150.94 27.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.624 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.51 92.61 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.798 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -79.17 19.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.423 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.11 -148.24 18.21 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.087 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.854 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.5 mtt180 -155.93 167.87 29.03 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.964 0.411 . . . . 0.0 111.518 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.625 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -94.15 114.8 31.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.689 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -54.09 -77.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.455 ' ND2' ' O ' ' A' ' 112' ' ' ASN . 3.5 p-10 -75.67 75.84 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -73.07 64.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -147.5 30.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -120.35 7.28 10.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.418 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 115' ' ' GLU . . . 21.3 46.39 0.01 OUTLIER Glycine 0 C--N 1.339 0.723 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.4 tt -42.5 -35.2 0.99 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.421 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.9 -24.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.727 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.46 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.34 32.54 4.11 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 117' ' ' LEU . 12.1 m -74.94 154.54 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.272 0.229 . . . . 0.0 110.825 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.45 144.53 46.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.536 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 12.2 p-10 -58.02 112.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.423 . . . . 0.0 111.866 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.2 103.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.522 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -158.16 151.49 23.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.934 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.11 164.54 0.11 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.307 0.575 . . . . 0.0 112.196 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.928 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.07 128.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.37 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.51 108.39 18.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 111.356 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.697 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.01 128.84 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.7 pt-20 -153.26 129.64 10.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.672 0.273 . . . . 0.0 111.274 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.628 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.81 89.96 2.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.798 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.8 0.333 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.57 43.69 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.533 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.65 -158.7 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.571 0.224 . . . . 0.0 110.725 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.39 -82.52 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.616 0.246 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.09 -41.55 0.19 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.586 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 6' ' ' VAL . 32.6 m -120.19 65.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 111.372 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -159.89 44.22 0.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.956 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.59 109.33 21.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.833 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -106.66 145.32 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.205 0.526 . . . . 0.0 112.29 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.97 164.72 15.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.66 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 147.29 36.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.787 0.327 . . . . 0.0 111.11 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -142.88 102.92 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -102.37 156.24 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.481 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.822 ' CE1' HG22 ' A' ' 126' ' ' VAL . 43.9 m-85 -139.01 138.59 37.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.104 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -125.7 22.97 7.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -175.38 154.67 1.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.46 147.04 50.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 149.79 14.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.19 156.94 47.46 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.142 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.33 149.87 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 111.631 -179.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 13.5 mt-10 -102.23 -178.64 3.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.974 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 4.1 tp -153.29 149.52 27.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.11 0.481 . . . . 0.0 111.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.428 ' H ' HD12 ' A' ' 23' ' ' LEU . 22.7 m-85 -127.24 148.87 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' H ' HG12 ' A' ' 6' ' ' VAL . 39.0 mt-10 -56.2 -8.97 0.55 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -45.61 -27.49 0.79 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.967 0.349 . . . . 0.0 111.533 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -82.42 -56.53 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.42 116.16 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.416 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -45.89 -34.41 12.34 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.478 2.119 . . . . 0.0 112.383 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -61.63 -49.99 74.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.38 -44.85 93.57 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.606 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.9 t -49.15 -31.48 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -61.97 -38.16 87.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.63 80.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.23 -51.31 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.02 -28.09 69.34 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.087 0.47 . . . . 0.0 110.445 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.85 -23.5 59.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.62 51.37 0.84 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.661 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.976 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.5 mt -61.95 -159.9 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.692 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.976 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.0 Cg_exo -27.66 105.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.167 1.911 . . . . 0.0 114.156 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.8 mt -147.18 150.71 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.395 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 135.42 33.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 0.0 111.748 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.619 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.5 p -146.06 149.13 33.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.391 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 132.03 47.69 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.11 136.07 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -100.79 117.55 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.914 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.601 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.11 133.0 33.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.039 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.4 t-105 -154.21 148.81 26.33 Favored 'General case' 0 C--O 1.229 0.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -30.72 85.61 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.282 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.0 t70 73.31 -37.8 0.39 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.542 0.337 . . . . 0.0 111.521 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.583 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.1 tt0 -72.08 129.29 38.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.855 0.359 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -133.26 124.63 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.129 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.41 ' CE1' ' ND2' ' A' ' 46' ' ' ASN . 55.0 p90 -135.7 133.15 37.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.944 0.402 . . . . 0.0 111.644 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.3 p90 -138.83 145.44 40.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -93.6 148.52 22.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.162 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.679 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.99 5.87 9.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 83.38 -8.18 1.11 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.0 p -85.89 114.15 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.124 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.31 98.47 8.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 112.055 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.1 p -134.42 106.81 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -126.64 133.93 50.87 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.054 0.454 . . . . 0.0 111.555 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 31.8 tttt -140.07 164.77 29.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.292 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -99.23 86.94 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.778 0.323 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.7 tt0 -170.18 160.61 8.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.4 t-20 63.31 -82.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 5.4 m 26.48 81.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.87 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.65 161.08 13.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.349 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -122.62 -7.44 8.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.3 p -126.7 141.6 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.4 m -159.27 146.9 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.14 152.76 21.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 0.0 110.953 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -41.23 124.01 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.348 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -32.31 6.04 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.058 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 127.05 31.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.818 0.309 . . . . 0.0 111.505 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 11.9 t -94.8 150.62 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -145.65 153.04 40.58 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.516 0.598 . . . . 0.0 112.474 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 122.63 48.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.091 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.753 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.3 t90 -61.84 127.22 30.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.087 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -75.13 -64.19 0.63 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.893 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 46.3 Cg_endo -67.8 85.55 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.283 1.988 . . . . 0.0 112.025 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.43 -6.75 5.3 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.38 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.16 36.88 13.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.95 134.19 51.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.37 149.42 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.504 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 34.7 t -143.16 156.53 44.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.265 0.555 . . . . 0.0 112.492 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.99 158.59 18.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.415 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 12.9 m-85 -136.67 127.11 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -168.62 51.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.677 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.403 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 162.74 -80.78 0.13 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.44 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -155.89 176.92 12.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.036 0.446 . . . . 0.0 111.926 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.773 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -143.52 -174.32 0.4 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.603 ' CD ' HG22 ' A' ' 91' ' ' THR . 97.0 Cg_exo -45.02 -22.81 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.131 1.887 . . . . 0.0 112.934 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 99' ' ' ARG . 1.6 mp -132.44 76.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.872 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -89.41 20.72 3.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.78 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.573 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.0 -9.14 15.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.281 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -155.36 -172.58 4.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' OG1' ' A' ' 91' ' ' THR . 14.4 mt -103.9 106.4 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' HB2' HD13 ' A' ' 93' ' ' ILE . 27.9 mmm-85 -99.89 99.35 8.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.773 ' HA ' HG21 ' A' ' 91' ' ' THR . 64.1 Cg_endo -71.24 -32.14 13.31 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.513 2.142 . . . . 0.0 112.579 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.63 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.62 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.816 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.69 -5.38 13.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 66' ' ' SER . . . -169.96 71.65 0.07 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.753 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.6 m -121.34 142.04 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.696 0.284 . . . . 0.0 111.222 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.626 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.7 m-20 -85.86 153.0 22.55 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.87 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.14 101.99 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -87.51 22.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 117.4 -148.6 18.74 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.196 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.8 mtt180 -154.84 163.0 40.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.12 113.8 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.292 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.37 -86.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -73.56 63.95 0.85 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.267 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.71 41.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 ttt -69.15 70.52 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -166.04 1.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.137 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.46 45.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.393 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.802 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.2 tp -43.13 -38.64 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.78 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.062 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.27 34.98 3.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.423 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.802 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.3 m -81.5 153.75 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.7 147.31 43.73 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.379 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.508 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 2.4 p30 -53.35 135.86 38.28 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.501 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 55.32 99.4 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.243 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.01 153.29 41.32 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.92 157.74 24.05 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.482 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.892 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.5 t -148.54 129.05 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.023 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 24.9 m -124.27 107.13 17.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.37 128.97 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.739 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.2 OUTLIER -150.96 128.23 11.27 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.714 0.292 . . . . 0.0 111.147 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 90.91 3.05 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.688 179.888 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.86 0.362 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.66 -84.74 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.703 ' OE2' HG23 ' A' ' 6' ' ' VAL . 4.0 mm-40 -107.92 -62.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 58.45 20.77 7.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.62 -32.08 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.719 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.703 HG23 ' OE2' ' A' ' 3' ' ' GLU . 32.8 m -118.34 65.9 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.207 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.26 47.26 1.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.01 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.6 115.37 29.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.79 145.22 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 112.346 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 163.67 19.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.507 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 144.62 31.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -145.89 100.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -108.77 156.21 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.832 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.9 m-85 -126.49 143.7 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.154 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -28.67 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.0 t -121.69 23.07 10.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.76 154.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.631 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -127.53 142.79 51.29 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.16 149.49 12.2 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.676 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -121.9 158.16 29.59 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.349 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.59 142.84 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.78 -178.27 4.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.498 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.846 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -152.72 140.39 19.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.963 0.411 . . . . 0.0 110.95 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.13 143.14 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -60.61 -8.49 2.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.02 -29.63 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.678 ' NE1' HG21 ' A' ' 31' ' ' THR . 0.5 OUTLIER -76.77 -54.14 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.782 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 162.59 116.24 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.804 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.4 Cg_endo -47.4 -34.61 19.52 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.578 2.185 . . . . 0.0 112.504 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.51 -37.51 80.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.353 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.782 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -68.72 -43.95 74.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 110.28 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.846 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.3 t -50.04 -38.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.716 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -56.87 -35.13 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.72 -47.06 70.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.799 0.333 . . . . 0.0 111.011 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.54 -49.24 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.601 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.1 -29.63 70.95 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.144 0.497 . . . . 0.0 110.284 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -70.43 -25.76 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.554 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.39 52.79 0.94 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.849 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.68 -159.91 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.692 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 27.9 Cg_exo -28.04 106.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.18 1.92 . . . . 0.0 114.099 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.6 mt -148.18 150.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.514 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -85.87 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 111.759 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -146.05 149.12 33.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.361 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.72 130.42 48.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.912 0.387 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.88 133.12 35.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -103.39 128.38 50.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.004 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.873 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.6 138.21 31.63 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.3 t-105 -155.1 148.98 25.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -37.31 97.16 0.01 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.492 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 53.27 24.6 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 111.356 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.73 136.93 39.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.489 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -138.4 129.42 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 52.6 p90 -137.92 122.11 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.371 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.9 p90 -131.29 146.36 52.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 148.9 21.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.7 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.73 6.33 8.8 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER 82.89 -8.01 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -86.05 114.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.258 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.48 96.04 6.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 111.855 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.9 p -133.14 106.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.253 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -130.87 133.5 45.96 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.535 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 40.5 tttm -145.08 165.55 27.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.372 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.09 90.06 4.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.5 tt0 -170.21 158.49 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.471 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 35.8 t-20 63.21 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.85 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 19.9 m 25.63 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.326 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -104.13 162.03 13.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.852 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -120.94 -12.16 8.82 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.4 p -121.27 143.25 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.439 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.574 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 36.0 m -158.31 157.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.71 150.15 24.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.338 0.59 . . . . 0.0 111.053 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.63 125.01 15.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.939 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.98 -31.43 6.53 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.223 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.2 p-10 -69.24 165.72 19.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 117.16 0.48 . . . . 0.0 111.825 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.802 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.9 t -119.99 152.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.44 148.92 30.01 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.442 0.565 . . . . 0.0 112.381 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -104.57 135.42 46.02 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.161 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.694 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -76.6 108.7 9.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.527 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -56.73 -70.65 0.32 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.145 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -58.64 87.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.266 1.977 . . . . 0.0 112.347 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.39 -6.03 5.61 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.774 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.8 32.42 9.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.959 0.38 . . . . 0.0 110.582 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.66 131.68 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.764 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.4 mt -87.76 150.6 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.087 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 18.6 t -143.34 156.35 44.67 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -121.37 137.8 54.54 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.144 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.9 p90 -136.65 139.76 42.26 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.029 -0.419 . . . . 0.0 111.491 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -149.55 53.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.048 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.22 -135.03 5.47 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -57.35 -173.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.676 0.738 . . . . 0.0 111.2 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -167.93 -174.14 0.33 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.932 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 88.2 Cg_exo -45.83 -21.4 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.816 1.677 . . . . 0.0 112.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.2 mt -143.36 60.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -49.52 -75.4 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 110.761 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.62 -103.43 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.84 -8.46 11.34 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.725 0.298 . . . . 0.0 111.042 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -158.08 0.83 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.125 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.53 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.2 mt -123.13 117.61 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 111.275 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.64 99.42 52.81 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.998 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 91' ' ' THR . 33.2 Cg_endo -62.61 -29.69 78.24 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.472 2.115 . . . . 0.0 112.604 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.37 -162.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.798 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.59 -5.92 22.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.536 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -176.31 77.54 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 78' ' ' TRP . 24.5 m -125.35 141.5 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 111.611 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m-20 -81.88 153.91 26.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.261 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.766 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.23 81.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.683 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -64.86 19.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.253 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 117.51 -138.07 13.81 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.849 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.802 ' HA ' HG23 ' A' ' 75' ' ' VAL . 4.2 ptt180 -170.51 162.19 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.622 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -88.49 115.75 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -83.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.217 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -153.62 135.98 14.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.057 0.455 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.91 -58.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.481 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.2 tpt 179.01 77.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.407 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 10.4 pt-20 -70.31 63.02 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.09 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.18 13.62 3.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.906 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 86' ' ' LEU . 3.8 tp -56.87 -43.22 81.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.909 0.355 . . . . 0.0 111.104 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.19 -25.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.04 30.21 6.01 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.559 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.7 m -71.02 154.47 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 122.334 0.254 . . . . 0.0 111.56 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.623 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -79.18 148.57 32.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.595 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.7 p-10 -57.0 109.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.462 . . . . 0.0 111.947 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.04 101.54 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.93 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -154.02 154.46 33.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.969 0.414 . . . . 0.0 110.845 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.405 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.1 OUTLIER -56.66 167.24 0.77 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.964 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.01 129.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.4 m -127.78 108.05 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.311 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.31 128.79 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 5.2 pt-20 -153.75 131.62 11.64 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 111.29 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.11 89.89 3.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.85 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.748 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.83 0.348 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.32 108.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.34 -38.4 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.66 -71.91 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.755 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.31 89.89 0.08 OUTLIER Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.354 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 6' ' ' VAL . 28.9 m -140.12 77.53 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.062 0.458 . . . . 0.0 111.232 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.98 33.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.28 105.95 14.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -116.9 145.39 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.173 0.511 . . . . 0.0 112.125 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.35 163.6 15.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.621 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 147.24 31.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -143.93 102.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 127' ' ' VAL . 8.2 ptm180 -100.5 156.36 17.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.446 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 126' ' ' VAL . 6.8 m-85 -139.71 134.9 32.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.72 -29.14 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -125.02 22.45 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.7 153.09 1.37 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.377 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.87 142.79 50.85 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.866 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.81 149.32 12.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.767 0.318 . . . . 0.0 111.475 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -128.77 158.9 37.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.056 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.1 144.16 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.657 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.0 mt-10 -97.47 -178.5 4.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.906 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.1 tp -153.52 148.1 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -125.37 148.14 48.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.692 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -57.54 -8.97 0.96 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.37 -28.3 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.259 -0.276 . . . . 0.0 111.512 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.65 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.77 -56.5 3.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.66 117.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.58 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.77 -34.76 12.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.449 2.1 . . . . 0.0 112.223 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -60.52 -52.0 67.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.616 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -61.01 -45.44 94.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.833 0.349 . . . . 0.0 110.349 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -49.83 -30.41 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.207 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -28.72 70.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.52 39.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.715 0.293 . . . . 0.0 110.979 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.36 -51.46 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.08 -28.64 69.75 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.362 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.44 -24.6 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 51.49 0.93 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -61.71 -160.09 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.622 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 24.6 Cg_exo -27.66 107.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.297 1.998 . . . . 0.0 114.085 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.0 mt -149.62 151.06 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.513 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 136.37 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.05 148.99 33.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.483 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 129.5 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.199 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.937 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -92.79 130.76 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -97.81 133.12 42.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.506 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.949 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -100.05 133.02 45.05 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ASP . 1.9 t90 -157.22 148.32 21.77 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -25.6 87.29 0.01 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.203 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' TRP . 13.0 t70 69.12 -40.94 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 49' ' ' GLY . 15.6 tt0 -62.72 118.99 8.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -129.01 114.68 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.763 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 50.8 p90 -126.37 126.96 44.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.445 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.31 145.99 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 149.75 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.056 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.671 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.71 4.48 8.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.5 OUTLIER 83.2 -8.09 1.14 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.798 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.13 114.97 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.08 94.78 5.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 111.94 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.616 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.6 p -127.62 106.71 15.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.901 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' A' ' 79' ' ' ILE . 1.8 mt-10 -127.92 134.37 49.33 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.966 0.412 . . . . 0.0 111.898 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 13.8 tttp -142.14 165.74 26.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -103.63 88.65 3.12 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.058 0.456 . . . . 0.0 111.33 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.1 tt0 -170.2 161.38 8.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.2 t-20 63.9 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.469 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 13.2 m 30.8 81.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.732 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.901 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.58 157.41 16.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.209 178.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.29 -7.24 10.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.2 144.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.67 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -157.86 156.84 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -99.65 149.03 23.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.03 126.87 2.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.094 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.01 6.1 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.197 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.86 157.38 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.457 0.629 . . . . 0.0 111.945 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -116.32 152.61 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.69 150.94 34.06 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -110.62 132.43 54.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.687 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.747 ' HD1' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -73.62 143.71 46.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.189 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.646 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -94.13 -54.26 0.24 Allowed Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 8.6 Cg_exo -72.3 72.36 2.87 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.529 2.153 . . . . 0.0 111.649 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 143.05 -7.65 2.13 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.513 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 52.57 34.64 16.07 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.977 0.388 . . . . 0.0 110.867 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.84 131.13 55.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.3 mt -89.3 150.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.278 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -141.28 155.73 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.27 0.557 . . . . 0.0 112.259 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.083 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.01 161.59 15.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.482 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 28.2 m-85 -136.48 141.12 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER 175.34 43.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.9 -82.81 0.11 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.154 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -144.37 -168.75 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.469 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.57 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -162.45 -177.96 0.78 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.712 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 80.8 Cg_exo -42.5 -27.53 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.324 2.016 . . . . 0.0 112.81 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.3 mp -131.31 75.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.179 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -97.13 26.68 4.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.03 -82.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.229 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -88.71 -45.37 9.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -141.64 170.44 15.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.57 HG23 ' OG1' ' A' ' 91' ' ' THR . 43.8 mt -75.9 98.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 12.9 mmm-85 -100.15 99.15 8.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.3 Cg_endo -69.63 -31.69 20.59 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.565 2.177 . . . . 0.0 112.655 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.29 -162.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.93 -9.4 15.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.537 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.31 72.76 0.19 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.747 HG12 ' HD1' ' A' ' 78' ' ' TRP . 19.7 m -121.36 141.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.815 0.341 . . . . 0.0 111.406 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.517 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 30.4 m-20 -85.35 151.47 24.0 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.901 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.67 98.17 7.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.593 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.43 23.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 109.53 -159.94 13.74 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.663 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.869 ' HA ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -143.26 168.19 20.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 111.717 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.94 115.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.601 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -85.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -85.03 -173.49 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 111.102 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.4 m 62.23 160.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -54.98 108.66 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 4.6 pm0 -90.75 17.16 7.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.371 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.39 43.31 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.333 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.083 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -49.41 -30.31 7.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.12 -27.2 0.12 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.917 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.99 30.01 4.06 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.4 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.949 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.9 m -81.81 154.33 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.943 0.371 . . . . 0.0 111.246 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.33 147.21 34.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 11.2 p-10 -55.35 116.46 2.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.072 0.463 . . . . 0.0 112.14 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.59 103.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.626 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -154.95 149.57 26.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 165.68 0.07 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.189 0.519 . . . . 0.0 112.173 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.937 HG21 ' HB2' ' A' ' 45' ' ' ALA . 43.9 t -158.09 128.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.61 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 127' ' ' VAL . 16.6 m -124.54 107.89 19.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 111.233 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.99 128.6 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.521 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.3 pt-20 -152.12 130.46 12.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.667 0.27 . . . . 0.0 111.261 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.627 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -77.46 95.16 4.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.785 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.733 0.301 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.97 -107.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -99.73 19.84 15.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.31 19.77 6.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.151 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 24' ' ' TYR . . . 179.13 86.83 0.07 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 6' ' ' VAL . 7.3 p -152.49 92.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.984 0.421 . . . . 0.0 110.778 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' HG2' HG11 ' A' ' 32' ' ' VAL . 4.8 tp10 -92.0 -126.55 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.546 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 40.7 tpp -125.19 143.16 51.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -86.04 145.36 27.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.09 156.69 25.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.965 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.51 141.63 36.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.066 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -141.73 100.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.02 156.11 17.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.028 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -133.17 138.58 46.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.322 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.08 -28.83 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 p -123.49 23.0 9.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 150.48 1.29 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.63 140.64 47.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.207 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.53 149.38 9.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.626 0.251 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.46 157.23 25.5 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.514 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.2 141.1 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 111.132 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 12.6 mt-10 -98.75 -178.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.057 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.769 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -151.89 144.43 24.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.09 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 15.8 m-85 -120.76 146.46 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.553 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.44 -9.46 0.71 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -45.93 -27.58 0.93 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.197 -0.315 . . . . 0.0 111.363 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.668 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.6 t90 -80.23 -56.35 4.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 152.48 115.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.665 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -45.55 -36.19 13.53 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.05 -52.85 63.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.723 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.76 -45.66 93.49 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.356 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.769 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.8 t -48.9 -29.55 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.31 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -59.58 -38.54 81.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.63 73.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.671 0.272 . . . . 0.0 111.204 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -53.66 -51.78 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.29 -28.67 69.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.31 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -71.65 -25.02 61.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.373 . . . . 0.0 110.641 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.54 50.96 0.99 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.977 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.955 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 mt -62.42 -160.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.528 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 34.0 Cg_exo -29.35 106.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.191 1.927 . . . . 0.0 113.934 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.5 mt -149.99 149.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.635 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.82 136.78 33.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.097 0.475 . . . . 0.0 111.86 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.589 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.5 p -145.79 149.1 33.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.439 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 122.43 43.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.053 0.454 . . . . 0.0 110.285 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -81.14 132.44 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -104.33 123.84 48.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.597 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.913 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.93 137.33 32.46 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.4 t-105 -149.54 148.54 29.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.348 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.445 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.18 91.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.241 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 48' ' ' TRP . 35.7 t70 78.64 -42.0 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.536 0.334 . . . . 0.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 91' ' ' THR . 4.6 mt-10 -80.5 150.87 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -149.73 115.88 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.574 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.7 p90 -123.4 136.45 54.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 111.969 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 126' ' ' VAL . 5.1 p90 -136.46 145.34 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.522 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.32 146.73 23.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.92 6.96 9.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.8 mt-30 82.07 -7.36 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.722 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.6 p -86.21 115.6 27.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.066 0 CA-C-O 120.79 0.328 . . . . 0.0 110.289 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.68 96.06 6.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.723 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.8 p -123.85 106.66 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.133 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.51 133.36 52.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.959 0.409 . . . . 0.0 111.515 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -147.61 164.48 33.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.261 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -100.54 83.46 2.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 110.757 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.21 154.71 5.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER 71.67 -78.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.978 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.487 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 9.0 t 18.69 81.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.82 164.06 11.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.813 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 69' ' ' VAL . 11.9 p30 -125.61 -5.6 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.551 HG23 ' OD1' ' A' ' 68' ' ' ASP . 39.6 t -131.8 141.92 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.31 157.97 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.59 152.06 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.308 0.575 . . . . 0.0 111.39 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.36 127.1 16.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.124 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.62 -32.33 6.11 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.819 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.439 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.7 p-10 -69.64 162.06 28.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.114 0.483 . . . . 0.0 111.927 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -122.54 152.45 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.911 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.795 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.15 147.14 26.68 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -97.7 121.57 39.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.954 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.5 t90 -64.21 117.77 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.037 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -69.07 -69.5 0.44 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 42.6 Cg_exo -54.73 85.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.796 1.664 . . . . 0.0 111.968 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 128.8 -6.74 6.51 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.647 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.99 37.68 14.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.035 0.417 . . . . 0.0 110.959 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . -113.11 137.0 52.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.678 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.6 mt -86.29 148.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.39 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.7 t -143.15 155.33 44.54 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.31 0.576 . . . . 0.0 112.444 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.808 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -111.89 156.21 22.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.949 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 3.9 m-85 -136.91 127.42 26.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.7 m-85 -147.57 29.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.343 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 150.47 -150.29 22.29 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.64 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -38.67 170.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.41 -176.44 0.61 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 93' ' ' ILE . 94.3 Cg_exo -43.82 -25.86 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.989 1.792 . . . . 0.0 112.283 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.0 mp -138.31 54.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -50.27 -40.62 48.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.234 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -47.22 -62.04 1.61 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.96 56.98 2.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.9 164.72 0.15 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.72 0.295 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.76 103.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -107.58 99.48 29.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.917 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.535 ' HA ' HG21 ' A' ' 91' ' ' THR . 37.5 Cg_endo -64.57 -29.6 61.19 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.491 2.127 . . . . 0.0 112.6 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.71 -164.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.09 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -6.16 23.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.487 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -178.06 80.38 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 101' ' ' ALA . 7.1 m -125.96 142.39 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.703 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 15.1 m-20 -83.19 151.85 25.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.485 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.594 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.04 87.68 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.795 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -72.76 16.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.366 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.01 -149.68 18.76 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.827 ' HA ' HG23 ' A' ' 75' ' ' VAL . 7.3 mtp-105 -156.84 168.08 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 75' ' ' VAL . 6.1 mt -100.28 114.82 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.357 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -87.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.626 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -70.79 143.73 51.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.958 0.409 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.53 28.14 15.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.214 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.6 ttt -66.87 152.67 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -160.67 173.68 15.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 111.43 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.65 46.21 2.75 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.892 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.2 tt -42.25 -31.98 0.45 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.592 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.69 -27.22 0.16 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.0 32.31 3.53 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.983 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.913 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.6 m -73.11 154.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.605 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -75.91 147.47 38.96 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -58.55 108.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.072 0.463 . . . . 0.0 111.684 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.49 103.45 0.17 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.464 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.605 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -154.46 154.59 33.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.743 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t -53.26 164.16 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 111.748 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.9 t -158.02 128.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.577 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.3 m -126.66 108.11 18.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.94 128.74 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.337 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.7 pt-20 -153.54 130.73 11.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.672 0.272 . . . . 0.0 111.532 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.598 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.09 88.24 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.655 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.79 0.328 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.37 155.5 22.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.414 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.34 -32.63 55.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 67.94 -69.94 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.23 -28.8 0.22 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.352 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 6' ' ' VAL . 33.7 m -123.82 67.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.228 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -153.9 40.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.223 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.03 111.38 24.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.48 145.44 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.541 . . . . 0.0 112.219 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.18 164.16 15.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.559 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.54 35.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -144.22 103.35 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -102.21 156.36 17.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.501 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 126' ' ' VAL . 13.7 m-85 -138.18 137.71 37.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.763 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.44 -28.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.06 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 p -125.96 22.66 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.43 154.38 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.43 144.44 51.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.851 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -163.22 149.2 11.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.543 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.62 157.11 39.77 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.159 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.06 138.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mp0 -92.45 -178.53 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.296 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.767 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.0 tp -152.74 146.63 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.456 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-85 -123.33 146.53 47.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' H ' HG12 ' A' ' 6' ' ' VAL . 65.6 mt-10 -57.17 -9.16 0.84 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -45.81 -25.79 0.57 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 122.259 -0.276 . . . . 0.0 111.551 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.651 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.9 t90 -81.14 -56.17 4.26 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 153.19 116.03 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.77 -27.78 5.98 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.488 2.126 . . . . 0.0 112.467 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.05 -43.35 78.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.306 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.718 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -70.25 -46.04 65.22 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.65 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.767 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.4 t -47.53 -29.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -60.36 -38.59 84.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.44 75.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.723 0.296 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -50.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.48 -27.23 69.13 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.39 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.838 0.351 . . . . 0.0 110.721 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.06 49.46 1.01 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.892 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.961 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.8 mt -61.82 -159.94 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.592 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.961 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.3 Cg_exo -28.52 106.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.158 1.905 . . . . 0.0 114.081 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.8 mt -149.28 149.66 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.507 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -85.91 134.09 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.965 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -145.32 149.57 35.06 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.61 132.7 47.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.953 ' HB1' ' NH2' ' A' ' 47' ' ' ARG . . . -90.66 137.32 32.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -106.8 120.11 41.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.277 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.953 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.69 127.25 34.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.7 t-105 -146.71 148.43 31.99 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -34.41 93.02 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.196 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 25.3 t70 72.03 -38.29 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.306 0.242 . . . . 0.0 111.585 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -78.94 139.38 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 110.875 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.57 HG12 ' NH2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -144.64 112.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.668 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 40.6 p90 -123.78 139.68 53.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.5 p90 -141.3 142.85 33.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.447 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -91.38 145.94 24.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.695 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.92 4.96 10.92 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 82.63 -7.38 1.27 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -85.56 116.08 28.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.59 94.87 6.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 111.707 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.3 p -124.88 106.58 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.327 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -133.57 132.33 40.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.962 0.41 . . . . 0.0 111.442 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 163.76 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.47 88.15 5.82 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.878 0.37 . . . . 0.0 110.753 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.14 148.01 3.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 0.4 OUTLIER 72.04 -83.18 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.463 0.173 . . . . 0.0 110.981 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.659 ' OG ' HD12 ' A' ' 79' ' ' ILE . 2.1 m 23.16 82.11 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.791 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.68 162.66 12.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.282 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' A' ' 69' ' ' VAL . 7.1 p30 -122.5 -0.09 9.3 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.662 HG23 ' OD1' ' A' ' 68' ' ' ASP . 47.2 t -138.53 145.36 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.101 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.75 158.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -94.05 150.81 20.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.16 124.96 7.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.35 -29.73 7.44 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.364 -0.922 . . . . 0.0 114.703 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 2.8 p30 -78.57 156.98 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.593 0.697 . . . . 0.0 111.921 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -111.06 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.3 150.34 32.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.977 0.417 . . . . 0.0 111.658 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.506 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -105.46 131.65 52.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.404 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.684 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -71.99 113.07 8.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -68.25 -66.16 1.17 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.621 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.39 80.28 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.932 1.755 . . . . 0.0 111.663 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.48 -8.13 3.13 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.596 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.18 37.2 17.72 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.857 0.361 . . . . 0.0 111.126 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.45 137.51 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.79 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 3.7 mt -87.58 147.64 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.43 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.3 m -142.86 131.53 22.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.02 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.99 159.78 18.87 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.373 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 35.0 m-85 -136.63 132.51 35.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.21 0.529 . . . . 0.0 111.878 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CB ' ' HG2' ' A' ' 118' ' ' LYS . 1.4 m-85 -165.21 33.32 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.057 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.22 -150.53 21.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.388 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.19 -172.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.458 0.647 . . . . 0.0 112.131 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.83 -176.11 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.522 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 66.2 Cg_exo -41.81 -25.29 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.273 1.982 . . . . 0.0 113.042 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -146.65 67.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 111.678 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -50.98 -75.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.166 0.508 . . . . 0.0 110.483 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 64.47 -97.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.032 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -115.41 -27.34 7.22 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.81 0.338 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -128.43 -163.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.411 HG23 ' OG1' ' A' ' 91' ' ' THR . 78.2 mt -116.73 116.69 53.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.874 0.368 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 93' ' ' ILE . 1.8 mtt85 -117.74 99.54 52.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.707 ' HA ' HG21 ' A' ' 91' ' ' THR . 58.7 Cg_endo -69.73 -31.31 20.89 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.6 2.2 . . . . 0.0 112.564 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.569 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.11 -160.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.807 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -5.23 14.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.565 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.43 73.98 0.11 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 78' ' ' TRP . 21.2 m -124.02 140.46 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 111.477 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.495 HD21 HD11 ' A' ' 79' ' ' ILE . 6.0 m-20 -84.66 150.37 25.18 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.791 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.59 100.35 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.553 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -85.02 21.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.2 -129.46 8.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.192 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.864 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 ptt180 -170.4 167.19 8.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.04 0.448 . . . . 0.0 111.484 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -93.06 116.37 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.667 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -81.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.038 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -157.3 141.04 15.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.951 0.405 . . . . 0.0 111.131 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 1.1 m 173.95 -36.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.626 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -168.57 -45.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 45.2 mt-10 58.76 20.46 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.353 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.39 31.97 2.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.988 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.02 HD22 HD13 ' A' ' 86' ' ' LEU . 4.5 tp -58.32 -42.72 87.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.973 0.387 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.6 -21.32 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -89.92 30.68 5.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.705 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.6 m -81.28 153.65 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 122.232 0.213 . . . . 0.0 111.34 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.63 143.47 46.3 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 4.6 p-10 -51.07 131.98 27.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.07 100.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.347 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -148.1 154.25 39.96 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 t -63.13 168.34 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.436 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.84 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.3 t -157.97 128.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.955 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -125.27 106.59 16.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 110.718 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.85 129.07 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.822 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 3.5 pt-20 -151.41 126.94 10.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.663 0.268 . . . . 0.0 111.327 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.699 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.36 92.16 2.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.817 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.743 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.57 27.17 5.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.393 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.26 -159.1 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.455 0.169 . . . . 0.0 110.782 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 63.84 19.34 11.69 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.54 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.617 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 24' ' ' TYR . 14.6 p -90.38 54.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.327 0.584 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.38 36.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -99.17 90.1 4.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.037 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.536 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -84.09 145.47 28.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.754 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.76 164.05 15.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.104 179.008 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 144.09 33.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.11 100.39 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 109.963 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 156.04 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.965 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.0 m-85 -134.6 142.64 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.025 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.3 -29.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 49.7 m -126.2 20.89 7.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -179.13 155.92 0.75 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.37 148.89 30.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.9 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.65 150.05 11.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.46 156.54 18.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.759 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.22 140.19 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.7 mt-10 -90.91 -178.48 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.657 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.2 tp -147.73 136.26 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.077 0.465 . . . . 0.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.596 ' HA ' HG23 ' A' ' 6' ' ' VAL . 9.6 m-85 -118.84 141.0 49.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.619 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.6 -8.95 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -45.38 -29.0 0.96 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.295 -0.253 . . . . 0.0 111.31 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.649 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -78.3 -56.69 4.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.57 118.54 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.775 178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.42 -33.31 12.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.436 2.091 . . . . 0.0 112.338 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.38 -52.27 66.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.848 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.31 -44.12 84.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.82 0.343 . . . . 0.0 110.419 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 23' ' ' LEU . 75.8 t -44.62 -31.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.347 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -64.45 -38.32 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -63.93 -47.65 79.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -55.77 -52.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.15 -27.48 69.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.43 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.26 -25.39 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.57 50.71 1.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.797 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.963 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -61.73 -160.04 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.612 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.963 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.5 Cg_exo -28.95 103.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.116 1.877 . . . . 0.0 113.887 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 18.5 mt -145.74 151.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.567 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 136.69 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.089 0.471 . . . . 0.0 111.604 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -145.1 148.91 34.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.94 127.19 48.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.037 0.446 . . . . 0.0 110.313 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.913 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -87.03 136.13 33.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -108.34 122.97 48.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.39 138.27 35.62 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 10.9 t-105 -153.87 148.95 26.83 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.862 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.03 94.51 0.01 OUTLIER Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.524 -0.37 . . . . 0.0 113.781 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.503 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 3.7 m-20 51.85 25.42 2.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.896 0.379 . . . . 0.0 111.578 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.4 OUTLIER -136.2 138.91 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.149 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -137.29 119.93 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.225 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.2 p90 -128.5 126.94 41.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.8 p90 -135.49 145.93 47.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.94 149.65 21.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.727 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.22 7.9 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.41 -8.77 1.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.722 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.8 p -86.31 114.0 25.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.19 94.99 5.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 31' ' ' THR . 3.2 p -122.79 106.78 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.879 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.95 125.26 54.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -140.83 165.32 27.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.3 pm0 -113.84 91.34 3.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.043 0.449 . . . . 0.0 111.023 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.5 tt0 -170.38 157.07 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 34.8 t-20 64.21 -81.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.081 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.46 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.5 m 31.88 82.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.212 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.764 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.43 154.9 18.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.589 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -119.78 -4.75 10.19 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -126.32 140.45 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.528 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 32.8 m -158.39 157.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.594 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -96.03 149.7 21.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.485 0.66 . . . . 0.0 111.732 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.26 126.76 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.002 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.19 -30.08 7.27 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.366 -0.921 . . . . 0.0 114.636 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.445 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -80.64 156.64 26.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.533 0.666 . . . . 0.0 112.032 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -116.34 152.4 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.283 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.01 151.1 30.72 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.971 -0.455 . . . . 0.0 111.696 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -106.9 132.58 52.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.679 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.582 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -68.49 120.81 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.648 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.07 -68.44 0.53 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.049 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 33.9 Cg_endo -63.62 75.8 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.165 1.91 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.67 -9.98 1.88 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.71 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.0 32.23 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.061 0.43 . . . . 0.0 111.161 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.97 131.04 55.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.221 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 10.0 mt -88.16 144.24 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.98 134.53 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.43 158.8 19.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.896 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 36.1 m-85 -136.62 117.11 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.546 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER -163.7 52.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.18 -78.72 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.721 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -147.26 -169.47 3.32 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.479 0.657 . . . . 0.0 111.93 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -154.44 174.89 3.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.035 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -39.1 -25.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.696 2.264 . . . . 0.0 113.129 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . 2.1 mp -137.69 62.71 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -52.84 -64.05 0.95 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.162 0.506 . . . . 0.0 110.375 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.9 t70 48.59 -92.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.474 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -113.66 -46.03 3.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.8 0.333 . . . . 0.0 110.771 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -119.68 159.55 24.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.753 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.2 mt -78.93 103.65 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 99.22 8.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.022 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.901 ' HA ' HG21 ' A' ' 91' ' ' THR . 55.4 Cg_endo -69.33 -31.12 23.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.515 2.144 . . . . 0.0 112.584 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.33 -161.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -6.99 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.83 71.11 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.6 m -117.69 141.49 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.555 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.691 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.9 m120 -81.88 150.29 27.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.278 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.97 82.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.688 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.7 18.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 119.12 -153.21 16.98 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.944 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.824 ' HA ' HG23 ' A' ' 75' ' ' VAL . 33.3 mtp180 -156.23 167.17 31.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.58 HG13 HG21 ' A' ' 75' ' ' VAL . 5.0 mt -98.83 114.96 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.36 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.28 -85.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.398 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.23 152.71 26.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.997 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.6 t 62.67 33.61 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.025 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.42 ' HA ' ' CG2' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -49.33 -70.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.993 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -174.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.054 0.454 . . . . 0.0 111.314 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -115.91 46.25 1.18 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.36 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.883 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.7 tt -42.06 -35.62 0.95 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.88 -22.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -92.24 36.1 3.79 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 117' ' ' LEU . 6.4 m -69.19 154.87 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 122.513 0.325 . . . . 0.0 111.535 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.95 145.93 44.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.3 p-10 -57.88 121.24 10.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.122 0.487 . . . . 0.0 111.921 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.93 101.46 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.46 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.35 150.78 28.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.14 165.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.222 0.535 . . . . 0.0 111.904 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.5 t -157.74 128.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.312 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.5 m -127.3 108.49 18.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.978 0.418 . . . . 0.0 111.46 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.727 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.9 129.17 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.356 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.0 pt-20 -153.82 129.06 9.73 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.576 0.227 . . . . 0.0 111.344 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.548 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.5 89.45 1.68 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 110.785 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.649 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.85 0.357 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.72 153.4 6.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.452 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.86 27.03 5.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -146.91 0.54 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.41 33.21 0.14 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.6 m -112.87 62.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 111.274 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.67 39.18 1.68 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.078 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -109.57 115.65 30.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.043 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 145.43 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.131 0.491 . . . . 0.0 112.135 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.8 163.5 17.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.851 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 146.47 29.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.739 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.4 mt -147.32 100.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 109.787 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -104.79 156.0 18.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.635 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -130.76 138.55 50.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.448 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.77 -29.01 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -124.22 23.04 8.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.42 154.18 1.63 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -114.81 151.86 33.13 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.68 151.14 16.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.866 0.365 . . . . 0.0 111.779 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -137.53 150.4 47.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.87 143.76 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.138 0.494 . . . . 0.0 112.012 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' OE2' HG21 ' A' ' 111' ' ' VAL . 6.7 mt-10 -95.48 -178.38 4.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.199 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.6 tp -150.07 134.73 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.973 0.416 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 6.9 m-85 -116.73 139.25 50.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.566 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.56 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -60.76 -8.46 3.02 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -44.66 -29.49 0.76 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.07 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.754 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -76.54 -56.01 5.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 163.2 116.05 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.739 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -46.58 -36.99 19.6 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.375 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -49.59 76.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.458 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -61.2 -44.5 97.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.757 0.313 . . . . 0.0 110.27 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.856 HG13 ' CD2' ' A' ' 23' ' ' LEU . 90.9 t -46.74 -37.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.693 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -33.35 71.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.009 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.41 -47.43 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.99 -50.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.349 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.75 -29.39 70.65 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.261 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -70.55 -25.74 63.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.12 51.96 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.25 -159.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.62 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.989 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.4 Cg_exo -27.8 105.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.083 1.855 . . . . 0.0 114.085 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.7 mt -145.16 149.11 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.366 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -85.9 133.64 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 111.887 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.64 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.9 p -142.33 149.02 38.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.299 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 131.33 48.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.354 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -92.05 135.54 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -106.92 122.88 47.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.061 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.837 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.18 137.04 34.21 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' HB3' ' A' ' 51' ' ' GLU . 12.7 t-105 -152.26 149.13 28.36 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.866 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.54 92.82 0.01 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.666 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER 53.27 25.98 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' CD1' ' A' ' 48' ' ' TRP . 8.5 tp10 -136.77 139.36 41.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.952 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.612 HG21 HD21 ' A' ' 117' ' ' LEU . 0.7 OUTLIER -139.18 122.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.593 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 50.8 p90 -130.04 123.37 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -133.15 145.38 50.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 146.48 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.698 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -117.85 5.61 12.22 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.3 mt-30 82.34 -8.2 1.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -87.23 115.43 27.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.61 94.79 5.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 111.911 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 31' ' ' THR . 3.5 p -131.53 106.73 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.299 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -130.16 133.18 46.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 53.4 tttt -140.8 164.77 29.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.291 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -99.14 90.87 4.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 0.0 110.966 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 5.9 tt0 -170.16 157.88 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.599 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 24.7 t-20 62.74 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.906 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 31.99 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.297 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.825 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -101.95 158.06 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.282 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -124.11 0.38 8.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 70' ' ' VAL . 3.3 p -126.71 138.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.616 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.6 m -160.56 164.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.784 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.84 158.8 31.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.086 0.47 . . . . 0.0 110.769 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -38.56 129.67 1.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.24 -31.31 6.52 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.059 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.2 p30 -88.73 156.36 19.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 112.327 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.875 HG23 ' HA ' ' A' ' 109' ' ' ARG . 25.7 t -119.13 152.55 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.078 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.06 150.14 34.47 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.807 -0.558 . . . . 0.0 112.472 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.58 126.78 53.96 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.168 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.713 ' HD1' HG12 ' A' ' 104' ' ' VAL . 3.6 t90 -67.2 112.65 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.754 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -67.19 -61.1 5.06 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.786 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 14.8 Cg_exo -67.98 66.27 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.232 1.955 . . . . 0.0 111.807 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.68 -11.45 0.3 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.034 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.62 27.49 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.306 0.553 . . . . 0.0 110.957 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.92 55.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.522 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.8 mt -88.05 143.38 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.331 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.7 132.39 36.85 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.807 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.89 161.07 18.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.168 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 20.8 m-85 -136.25 125.78 25.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -163.88 54.54 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.209 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -75.1 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.372 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -158.83 174.02 15.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.796 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.645 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -134.77 -175.11 0.45 Allowed Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.645 ' CD ' HG22 ' A' ' 91' ' ' THR . 84.4 Cg_exo -47.93 -22.46 3.42 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.017 1.811 . . . . 0.0 112.724 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.69 68.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.862 0.363 . . . . 0.0 111.722 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -63.98 -74.96 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 50.23 52.78 14.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.54 4.13 4.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.609 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -142.67 178.65 7.48 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.8 mt -123.56 92.99 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 111.552 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -98.44 99.86 8.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 69.1 Cg_endo -70.57 -32.48 15.13 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.668 2.245 . . . . 0.0 112.969 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.05 -154.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.697 0.284 . . . . 0.0 110.879 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 -5.04 10.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.552 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.96 67.06 0.08 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' HD1' ' A' ' 78' ' ' TRP . 14.9 m -118.14 142.42 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.777 0.322 . . . . 0.0 111.552 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.509 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m120 -84.28 152.99 23.81 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.825 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -85.57 86.56 2.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.725 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.55 23.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.97 -149.57 18.51 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.996 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.875 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.2 mtt85 -155.31 166.42 33.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 75' ' ' VAL . 4.2 mt -99.85 114.43 38.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.24 -86.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.475 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -67.99 174.27 3.9 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 110.816 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t 61.61 161.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.7 130.58 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.949 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 4.2 pm0 -109.09 29.7 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.07 45.02 1.38 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.547 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.807 HD22 HD13 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -53.41 -38.91 63.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -85.88 28.97 4.76 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.492 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.837 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.5 m -83.16 154.26 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.937 0.368 . . . . 0.0 111.534 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.646 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -80.53 148.76 30.26 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.619 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.1 p-10 -58.06 112.02 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.994 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.76 100.89 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.728 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.646 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -155.28 153.84 31.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 178.72 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.6 t -56.96 168.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.535 . . . . 0.0 111.894 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.884 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.0 t -157.88 128.84 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.06 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.9 m -127.59 108.63 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 111.473 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.21 129.04 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.4 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -152.92 130.16 11.24 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.709 0.29 . . . . 0.0 111.204 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.577 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.41 88.99 2.1 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.689 179.906 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.8 0.333 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 149.3 -136.85 5.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.31 -56.75 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.805 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' NH2' ' CB ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 62.91 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.82 -61.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.755 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 6' ' ' VAL . 34.2 m -126.82 68.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.466 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' CB ' ' NH2' ' A' ' 4' ' ' ARG . 52.1 mm-40 -159.96 44.46 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.022 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.32 21.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -108.68 145.3 35.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 163.75 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.703 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 144.89 34.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.89 100.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -100.8 156.13 17.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.122 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.83 141.28 49.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.204 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.47 -28.89 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -126.05 22.96 7.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.23 151.3 2.03 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 142.12 45.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.26 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.74 149.24 9.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -115.28 157.82 23.22 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.87 137.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.044 0.449 . . . . 0.0 111.439 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 14.6 mt-10 -92.51 -178.65 4.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.268 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.834 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.3 tp -153.22 150.42 28.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.465 ' H ' HD12 ' A' ' 23' ' ' LEU . 21.8 m-85 -129.23 147.95 51.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.027 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -58.21 -8.63 1.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.35 -29.2 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.85 0.296 . . . . 0.0 111.355 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.633 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -80.92 -56.32 4.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 160.3 117.09 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.474 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.76 -35.86 18.37 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.6 -47.7 82.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.95 -44.37 96.25 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.78 0.324 . . . . 0.0 110.397 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 ' CD2' ' A' ' 23' ' ' LEU . 46.3 t -50.05 -34.64 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -59.44 -37.01 77.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.79 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.04 -51.54 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.46 -28.71 70.0 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.65 -25.37 62.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 51.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.784 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.4 mt -61.58 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.539 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 25.6 Cg_exo -27.8 104.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.275 1.983 . . . . 0.0 114.033 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 39' ' ' LEU . 19.5 mt -145.57 151.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.309 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -85.72 136.57 33.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.064 0.459 . . . . 0.0 111.871 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.639 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -146.0 148.86 33.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.41 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.02 130.48 48.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.44 135.84 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -108.12 125.2 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.182 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.45 138.42 34.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 14.8 t-105 -154.17 148.95 26.53 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.069 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.13 99.86 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.768 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 45.62 30.15 0.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.382 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.78 143.35 33.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.118 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -139.49 123.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 23.4 p90 -130.64 132.36 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.6 p90 -140.87 146.11 37.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.986 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.69 149.45 22.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.158 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.799 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.18 5.92 9.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG3' ' C ' ' A' ' 56' ' ' THR . 12.1 mt-30 80.94 -7.07 1.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.716 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.22 114.95 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.76 94.89 5.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.7 p -127.06 106.69 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.724 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.561 ' HG2' HG22 ' A' ' 79' ' ' ILE . 2.5 mt-10 -125.28 134.98 52.07 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.082 0.467 . . . . 0.0 111.929 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 6.9 ttmt -144.55 165.62 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.165 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.68 90.74 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.021 0.438 . . . . 0.0 110.947 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.4 160.22 7.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.77 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 31.7 t-20 64.03 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.096 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.459 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 2.1 m 30.49 81.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.646 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.976 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -100.47 156.71 17.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.73 -7.81 10.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.38 142.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.386 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -157.74 156.23 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.108 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.36 151.04 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.354 0.597 . . . . 0.0 111.368 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -48.16 126.39 10.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.214 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -31.99 6.21 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.093 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p-10 -70.04 163.17 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 112.085 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.743 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -121.41 152.02 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.074 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB3' ' HE2' ' A' ' 87' ' ' PHE . . . -149.58 152.36 35.36 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.463 0.574 . . . . 0.0 112.125 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -111.04 131.28 55.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.449 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.763 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -73.03 146.62 45.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -96.3 -53.14 0.22 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.522 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.652 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 6.9 Cg_exo -73.86 70.74 4.3 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.696 2.264 . . . . 0.0 111.623 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 144.38 -8.33 1.86 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.556 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 53.1 34.1 16.52 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.857 0.361 . . . . 0.0 110.827 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.76 130.85 55.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.167 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 6.4 mt -85.83 151.51 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.0 135.15 32.42 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.25 161.74 18.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.029 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 54.1 m-85 -136.25 118.61 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.499 . . . . 0.0 111.782 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.6 m-85 -157.43 30.35 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.851 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.55 -152.74 23.53 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.36 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -54.0 -173.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.507 0.67 . . . . 0.0 112.086 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -157.47 -173.54 0.38 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.81 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 72.9 Cg_exo -42.15 -23.63 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.976 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.38 87.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.817 179.411 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -82.16 27.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.391 179.289 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.69 78.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 71.23 -10.78 0.75 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.082 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.4 OUTLIER -146.41 -175.58 4.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.703 HG23 ' OG1' ' A' ' 91' ' ' THR . 87.2 mt -114.17 97.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -101.73 99.21 11.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 91' ' ' THR . 57.9 Cg_endo -70.44 -31.22 17.87 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.508 2.139 . . . . 0.0 112.645 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -163.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -10.5 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.407 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -164.81 72.1 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.763 HG12 ' CD1' ' A' ' 78' ' ' TRP . 22.2 m -119.13 140.15 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.337 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.471 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 37.2 m-20 -84.91 148.14 26.4 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.976 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.18 97.82 5.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.064 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.637 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -82.96 21.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.312 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.31 -149.18 18.71 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.206 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.9 mtt180 -152.92 167.67 28.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.061 0.458 . . . . 0.0 111.362 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.672 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -100.44 114.3 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.342 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.27 -85.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.593 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.03 109.81 14.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.809 0.338 . . . . 0.0 111.128 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.4 p -178.58 -80.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.0 mtm 53.33 50.5 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' LEU . 3.6 mp0 -119.15 30.79 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 115' ' ' GLU . . . 21.29 46.52 0.01 OUTLIER Glycine 0 C--N 1.338 0.69 0 O-C-N 123.613 0.57 . . . . 0.0 114.123 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.95 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.2 tt -42.38 -36.3 1.25 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.491 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.34 -26.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.28 38.35 3.23 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.566 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.95 HG13 ' O ' ' A' ' 117' ' ' LEU . 8.6 m -74.4 154.74 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 122.393 0.277 . . . . 0.0 111.465 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.98 146.09 44.11 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 6.1 p-10 -59.59 115.35 3.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 111.901 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.32 100.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.65 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -154.27 150.75 28.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.881 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -52.79 166.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -157.81 129.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.433 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 127' ' ' VAL . 17.6 m -128.14 108.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.62 128.93 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.27 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 4.5 pt-20 -152.9 130.88 11.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.636 0.255 . . . . 0.0 111.339 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.565 ' CB ' HD22 ' A' ' 39' ' ' LEU . 5.9 tmm_? -75.22 92.91 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.686 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.832 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.789 0.328 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.84 1.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.17 -159.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.27 -73.47 0.21 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.726 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -176.85 42.37 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.547 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG22 ' CD ' ' A' ' 25' ' ' GLU . 26.0 t -102.55 58.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.17 51.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.78 116.55 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -110.1 145.47 37.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.0 112.314 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 164.78 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 145.96 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -145.03 100.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -102.29 156.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.511 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.6 m-85 -134.71 137.79 43.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.384 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.44 -29.05 0.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.95 23.07 7.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.77 151.45 2.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -125.65 141.34 52.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.963 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 149.13 11.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.53 159.27 36.02 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.146 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.83 140.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 111.747 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mt-10 -94.28 -178.61 4.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.792 ' CD2' HG13 ' A' ' 32' ' ' VAL . 5.3 tp -153.98 148.27 25.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.087 0.47 . . . . 0.0 111.284 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.06 148.45 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.635 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' CD ' HG22 ' A' ' 6' ' ' VAL . 46.5 mt-10 -58.27 -9.01 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.61 -27.68 0.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.249 -0.282 . . . . 0.0 111.533 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.07 -56.62 3.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.07 110.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -40.48 -30.0 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.817 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.78 -49.84 73.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.447 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -65.42 -45.66 83.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.39 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.792 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -47.87 -29.01 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.32 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -65.35 -38.64 90.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.09 74.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.21 -51.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.598 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.54 -29.53 70.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.16 -25.48 62.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.976 0.417 . . . . 0.0 110.611 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 51.92 1.0 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.986 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.22 -159.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.312 -0.852 . . . . 0.0 109.682 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.986 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.4 Cg_exo -27.58 105.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.216 1.944 . . . . 0.0 114.006 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.5 mt -146.5 150.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.498 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -86.27 134.12 33.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.7 p -142.06 149.1 39.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.75 128.24 48.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.398 . . . . 0.0 110.319 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.934 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.0 131.94 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -100.86 122.63 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.725 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.917 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.81 136.53 32.95 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.6 t-105 -155.01 148.62 25.36 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.833 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -33.22 86.92 0.01 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.294 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' TRP . 18.1 t0 72.68 -35.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.47 0.308 . . . . 0.0 111.512 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 91' ' ' THR . 6.0 tm-20 -73.86 133.57 43.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -138.87 125.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.203 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -137.14 128.79 28.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.374 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.6 p90 -135.51 145.97 47.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.59 147.89 22.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.607 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.63 7.91 10.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.3 mt-30 80.07 -6.34 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.654 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -88.53 115.13 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.708 0.29 . . . . 0.0 110.317 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.7 94.91 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.761 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.1 p -129.98 106.55 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.202 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.88 133.93 48.1 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.014 0.435 . . . . 0.0 111.667 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 159.22 42.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.149 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -92.81 88.8 6.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.386 0.612 . . . . 0.0 111.127 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.33 159.66 7.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.3 t-20 64.07 -82.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.3 t 27.82 82.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.325 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.908 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.65 17.22 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.37 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.764 ' OD1' HG23 ' A' ' 69' ' ' VAL . 2.8 p30 -117.33 -6.53 11.26 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.764 HG23 ' OD1' ' A' ' 68' ' ' ASP . 27.3 t -131.99 144.91 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.204 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.542 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.06 157.85 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.814 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -94.72 151.12 19.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.357 0.599 . . . . 0.0 111.638 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -45.95 125.75 6.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.979 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.4 -31.41 6.43 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.487 -0.863 . . . . 0.0 114.525 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p30 -75.91 156.56 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.464 0.632 . . . . 0.0 112.188 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.2 t -114.23 152.59 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.97 149.69 31.6 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.44 129.02 50.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.993 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.645 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -69.5 117.89 11.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.986 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -65.66 -72.07 0.3 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.549 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 34.1 Cg_endo -63.43 80.45 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.081 1.854 . . . . 0.0 112.12 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.82 -11.17 2.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.732 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.98 31.46 11.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.066 0.433 . . . . 0.0 110.902 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.92 133.56 52.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.462 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.59 145.94 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.434 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 17.4 t -139.12 156.27 47.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.258 0.551 . . . . 0.0 112.389 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.023 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.47 156.03 20.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.263 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.6 m-85 -136.69 127.24 26.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 111.23 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.98 49.72 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 165.18 -82.35 0.11 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.1 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -154.14 176.39 12.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.119 0.485 . . . . 0.0 111.69 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.681 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -144.15 -174.26 0.4 Allowed Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.238 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.58 ' CD ' HG22 ' A' ' 91' ' ' THR . 99.6 Cg_exo -45.17 -22.74 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.012 1.808 . . . . 0.0 112.598 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 77.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -90.5 29.19 1.32 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.042 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -69.07 75.37 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.757 0.313 . . . . 0.0 111.658 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 78.6 -9.32 1.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.176 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -145.61 -170.05 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.414 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.7 mt -123.16 105.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.26 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.32 99.36 8.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.681 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.8 Cg_endo -69.3 -31.14 23.18 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.467 2.112 . . . . 0.0 112.638 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.01 -163.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -3.4 20.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.58 77.4 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 78' ' ' TRP . 19.3 m -127.52 142.04 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.722 0.296 . . . . 0.0 111.68 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m-20 -86.31 153.66 21.81 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.908 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.62 99.48 7.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.654 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.47 22.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.36 -147.77 18.9 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.07 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.877 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 mtt180 -156.52 168.13 28.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 111.416 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.5 mt -100.4 114.94 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.165 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.68 -85.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.593 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -78.39 -176.87 4.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.01 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.1 m 63.61 163.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 111.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 25.4 pt-20 -96.21 42.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.08 45.03 1.13 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.023 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -49.44 -30.35 7.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.45 -22.8 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -88.21 27.78 6.63 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.917 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.4 m -79.18 153.95 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.765 0.283 . . . . 0.0 111.247 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.64 146.99 29.77 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.2 p-10 -53.75 117.81 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.34 98.64 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.007 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -150.61 146.4 26.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.993 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.2 164.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 112.268 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.9 t -158.14 128.45 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 127' ' ' VAL . 22.7 m -125.34 108.35 19.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 0.0 111.402 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.04 128.7 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.407 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.3 pt-20 -152.86 130.74 11.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.582 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.38 91.43 3.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.858 0.361 . . . . 0.0 110.809 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HB3' ' NH2' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mtp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.732 0.301 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.4 31.63 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.88 -55.63 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 111.057 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.41 -78.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.0 31.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 6' ' ' VAL . 25.6 t -101.23 58.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.04 38.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 117.45 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.71 145.31 40.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.153 0.501 . . . . 0.0 111.926 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.9 163.9 15.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.932 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 143.63 38.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.825 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.72 100.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -99.98 156.32 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.78 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.569 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.8 m-85 -136.82 137.99 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.697 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.79 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 22.19 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.79 151.37 1.41 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.63 143.43 48.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.179 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.84 149.01 10.68 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.308 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -119.25 156.05 30.63 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.437 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.71 144.41 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 111.083 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 5.9 mt-10 -99.18 -178.27 3.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.813 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -151.37 144.4 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.078 0.466 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -125.24 145.99 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.594 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.32 -9.04 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -45.66 -28.08 0.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.743 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.2 t90 -80.03 -56.08 4.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.14 115.88 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.675 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.76 -34.82 16.42 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 112.49 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.78 -50.85 71.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.394 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.743 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.02 -45.42 92.42 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 23' ' ' LEU . 84.2 t -46.65 -32.66 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.429 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -58.99 -38.7 79.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.482 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.9 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -54.66 -51.55 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.11 -27.92 69.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 110.211 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -71.74 -25.57 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.562 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.25 49.95 1.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.063 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -62.42 -160.08 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.312 -0.851 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 38.9 Cg_exo -29.85 107.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.125 1.883 . . . . 0.0 113.85 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.5 mt -150.02 148.54 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.638 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.92 136.07 33.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.101 0.477 . . . . 0.0 111.953 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.2 p -146.03 148.65 32.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 125.82 49.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.162 0.506 . . . . 0.0 110.376 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.904 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -85.55 132.46 34.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.042 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -100.39 128.19 46.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.56 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.957 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -90.26 135.15 33.85 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.741 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 50' ' ' ASP . 10.1 t-105 -154.5 148.43 25.64 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.888 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.47 85.75 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.632 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 48' ' ' TRP . 36.6 t70 74.09 -38.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.882 0.326 . . . . 0.0 111.882 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.4 124.19 24.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 111.114 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -126.74 111.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 110.179 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 43.7 p90 -122.48 134.06 54.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.068 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.2 p90 -140.15 145.61 37.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.599 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 147.58 22.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.739 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.38 6.48 9.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 83.45 -8.13 1.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -85.1 115.43 26.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.136 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.01 94.82 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.064 0.459 . . . . 0.0 112.029 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.4 p -120.66 106.68 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.139 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -120.2 136.43 54.64 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.25 163.4 39.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.205 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -104.62 87.02 2.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -170.13 149.69 3.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.4 t-20 72.03 -82.66 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.523 0.202 . . . . 0.0 111.273 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.7 m 27.46 82.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.77 156.18 17.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.457 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -121.25 -3.25 9.49 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.1 p -127.65 140.01 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.513 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.535 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.1 m -158.7 157.55 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.544 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.2 150.67 19.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.49 0.662 . . . . 0.0 111.719 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -45.0 126.09 5.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.964 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -30.77 6.82 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.599 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.01 157.06 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.528 0.664 . . . . 0.0 111.978 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.821 HG23 ' HA ' ' A' ' 109' ' ' ARG . 17.8 t -115.96 152.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.52 151.23 31.31 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 121.86 -0.525 . . . . 0.0 112.41 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.588 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -102.19 123.99 47.0 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.075 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 104' ' ' VAL . 4.1 t90 -66.57 119.02 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.901 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.765 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -69.53 -71.01 0.3 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.601 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.765 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.48 83.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.628 1.552 . . . . 0.0 111.705 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 133.6 -8.35 4.95 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.416 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.66 39.79 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.841 0.353 . . . . 0.0 111.24 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.15 135.17 54.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.77 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 36.8 mt -84.35 145.3 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.42 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 m -140.69 132.42 27.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.724 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.63 158.0 19.57 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.1 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 23.7 m-85 -136.67 115.17 11.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 111.369 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.563 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -156.53 39.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' HD11 ' A' ' 98' ' ' ILE . . . 172.07 -89.16 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.934 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.47 -169.08 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 111.499 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -152.29 -177.68 0.74 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.558 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.611 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.9 Cg_exo -47.49 -16.9 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 121.968 1.779 . . . . 0.0 112.896 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 99' ' ' ARG . 6.0 pt -145.75 62.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -52.99 -71.79 0.06 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.95 -95.07 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.56 -5.1 9.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.865 0.364 . . . . 0.0 111.238 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -150.38 -162.16 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 89' ' ' GLY . 78.6 mt -118.69 101.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.197 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -99.35 99.16 7.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.899 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -69.16 -31.21 23.68 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.473 2.115 . . . . 0.0 112.491 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.736 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.66 -158.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.776 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -6.96 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.779 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.48 69.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 101' ' ' ALA . 6.2 m -116.8 142.83 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.827 0.346 . . . . 0.0 111.65 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.756 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -83.18 151.31 25.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.595 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.647 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -87.08 86.95 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.69 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.03 18.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.509 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.94 -150.91 18.52 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.678 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.821 ' HA ' HG23 ' A' ' 75' ' ' VAL . 32.4 mtp180 -156.37 168.19 28.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.187 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mt -95.27 113.61 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.463 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.91 -86.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.418 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -69.02 149.61 48.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.23 34.18 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.24 2.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.2 176.45 6.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.035 0.445 . . . . 0.0 111.402 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -105.55 45.99 1.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.444 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.753 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.4 tt -42.25 -36.26 1.18 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.617 0.246 . . . . 0.0 111.424 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.53 -24.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -94.59 37.69 3.34 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.841 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.957 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.5 m -79.01 154.47 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.728 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.74 148.48 33.01 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.307 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.641 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.2 p-10 -50.72 110.84 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.37 111.62 0.04 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.314 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.46 139.05 15.98 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.561 0.219 . . . . 0.0 110.701 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.9 t -40.75 161.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.111 0.482 . . . . 0.0 112.0 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 45' ' ' ALA . 41.8 t -154.17 128.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.4 m -126.57 108.09 18.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 120.86 0.362 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.8 128.76 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 pt-20 -153.28 129.64 10.57 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.622 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.64 88.75 2.21 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.695 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.703 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.83 117.79 3.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -117.49 32.76 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.84 19.18 9.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -165.81 45.67 0.28 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.514 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.9 m -124.77 72.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.181 0.515 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.93 36.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.667 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.0 106.96 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.87 145.42 38.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.851 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.73 162.31 18.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.828 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 142.95 34.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.824 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.26 101.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 109.824 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -102.03 156.77 17.33 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.778 0.799 . . . . 0.0 112.501 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -134.56 137.45 43.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -28.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 p -124.79 22.24 8.19 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.09 150.76 1.22 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.28 144.05 48.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.127 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.57 148.31 7.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.56 155.96 26.63 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.675 0.274 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.2 138.57 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.972 0.415 . . . . 0.0 111.258 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.479 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 1.3 mt-10 -95.1 -178.39 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.3 tp -154.34 146.37 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.442 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 22.9 m-85 -126.76 147.71 49.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 16.8 mt-10 -56.28 -9.27 0.63 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.55 -28.78 1.01 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.857 0.298 . . . . 0.0 111.296 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.643 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.9 t90 -80.81 -56.27 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.6 113.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.688 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -46.65 -35.9 17.97 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.456 2.104 . . . . 0.0 112.577 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.96 -51.94 67.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.712 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.18 -45.81 90.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.835 0.35 . . . . 0.0 110.503 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 59.3 t -46.16 -30.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.226 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -60.14 -38.95 84.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.101 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.15 84.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.5 -49.29 78.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.195 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.27 -27.17 68.86 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.249 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.13 -24.49 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.631 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.19 49.39 1.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.0 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.16 -159.97 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.356 -0.831 . . . . 0.0 109.592 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.941 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 39.0 Cg_exo -29.87 106.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.132 1.888 . . . . 0.0 114.085 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.11 149.44 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.621 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -85.92 134.95 33.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.003 0.43 . . . . 0.0 111.669 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.573 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 6.0 p -143.6 149.27 37.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.696 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.76 121.27 41.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 110.212 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -80.42 131.26 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -102.68 123.83 47.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.593 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.926 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.19 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -151.5 148.51 28.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.236 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -35.08 91.67 0.01 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.029 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 29.3 t70 75.94 -41.15 0.42 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.683 0.393 . . . . 0.0 111.309 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.06 143.1 41.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.438 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -146.81 114.9 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.529 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -126.27 133.34 51.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.144 0.497 . . . . 0.0 112.038 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 126' ' ' VAL . 4.5 p90 -131.63 143.84 50.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.369 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 142.91 26.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.665 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.82 8.48 11.14 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.7 mt-30 80.74 -6.33 1.66 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.4 p -83.94 115.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.4 106.59 17.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.747 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.712 HG21 HG22 ' A' ' 31' ' ' THR . 3.6 p -137.08 106.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.395 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.73 133.65 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.91 0.386 . . . . 0.0 111.254 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -153.92 165.09 37.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.335 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.16 88.35 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -170.08 149.13 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.0 t-20 69.24 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.522 0.201 . . . . 0.0 111.162 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.3 m 24.73 82.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.53 17.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.518 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -120.72 -3.6 9.76 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -127.83 140.11 50.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.494 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 30.5 m -159.02 157.89 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.759 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -93.84 152.06 19.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.424 0.63 . . . . 0.0 111.684 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.64 126.49 10.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -28.86 8.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.131 -1.033 . . . . 0.0 114.63 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.422 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.0 p30 -80.14 156.11 27.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.641 0.72 . . . . 0.0 111.988 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.842 HG23 ' HA ' ' A' ' 109' ' ' ARG . 22.3 t -114.03 152.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.29 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.25 145.4 24.61 Favored 'General case' 0 C--N 1.342 0.249 0 O-C-N 121.9 -0.5 . . . . 0.0 112.169 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.84 137.26 36.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.167 179.155 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.47 121.97 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.622 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -72.89 -70.19 0.28 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 79.3 Cg_exo -33.14 -62.96 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.155 2.57 . . . . 0.0 113.845 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.68 -1.46 90.01 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.262 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.77 26.97 8.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.983 0.42 . . . . 0.0 110.485 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.99 137.76 46.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.638 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.63 148.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.604 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -143.26 155.24 44.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.285 0.564 . . . . 0.0 112.486 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.877 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -107.07 158.76 16.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.98 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 35.5 m-85 -136.53 115.39 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.676 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.545 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -139.33 25.46 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 152.63 -153.7 25.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.051 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -39.43 171.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.833 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.21 176.99 2.12 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.8 Cg_exo -39.01 -27.66 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.568 2.179 . . . . 0.0 112.714 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 93' ' ' ILE . 3.7 mp -130.44 52.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.675 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -55.46 -77.68 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.99 0.424 . . . . 0.0 110.644 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.0 t0 56.06 -93.62 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.117 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -123.96 -7.15 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.598 0.237 . . . . 0.0 111.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -139.82 -175.29 4.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.759 0.314 . . . . 0.0 110.47 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.9 mt -116.53 116.86 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -121.53 99.46 45.24 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.998 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.518 ' HA ' HG21 ' A' ' 91' ' ' THR . 61.4 Cg_endo -70.66 -31.6 16.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.466 2.111 . . . . 0.0 112.587 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -178.39 -160.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -6.39 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.404 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.72 69.35 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 101' ' ' ALA . 11.9 m -116.02 141.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.047 0.451 . . . . 0.0 111.783 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.758 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -82.49 150.96 26.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.618 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.613 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.02 86.53 2.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.789 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -71.77 16.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.527 -178.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.41 -147.79 18.6 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.749 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.842 ' HA ' HG23 ' A' ' 75' ' ' VAL . 11.5 mtp-105 -155.94 167.61 29.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.357 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.595 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.77 114.85 30.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.646 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -78.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.804 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -70.54 99.21 1.59 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -20.41 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -23.75 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 111.268 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 51.1 mm-40 -68.49 98.41 0.86 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.934 0.397 . . . . 0.0 111.028 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.06 45.87 2.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.557 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 86' ' ' LEU . 7.2 tt -42.61 -33.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.626 0.25 . . . . 0.0 111.621 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -25.35 0.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.82 34.29 4.12 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.91 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' HD2' ' A' ' 47' ' ' ARG . 4.8 m -74.73 154.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 111.302 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.8 38.06 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -56.54 110.16 0.74 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.058 0.456 . . . . 0.0 111.593 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.31 102.7 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.305 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.63 150.03 28.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.71 162.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 112.154 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 45' ' ' ALA . 51.7 t -158.06 128.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.483 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.9 m -126.2 107.43 17.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.46 128.68 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.472 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.508 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -153.48 127.9 9.25 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.597 0.237 . . . . 0.0 111.319 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.6 89.97 2.77 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.766 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.924 0.392 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.24 -73.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.44 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -78.42 -61.05 2.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 -72.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.718 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 25' ' ' GLU . . . -175.69 32.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.474 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.3 m -127.93 69.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.421 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -145.99 32.51 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.54 116.37 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 145.3 46.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.071 0.462 . . . . 0.0 111.949 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -114.86 163.68 15.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.92 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.92 145.58 38.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -142.25 102.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 14.7 ptm180 -102.4 156.22 17.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.582 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.904 ' CE2' HG22 ' A' ' 126' ' ' VAL . 32.3 m-85 -140.69 139.54 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.915 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -28.84 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.064 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -125.79 22.44 7.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.9 154.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.389 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 144.29 47.32 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.877 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 150.09 12.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.5 158.6 34.08 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.339 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.02 143.56 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 111.212 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -90.96 -178.29 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.305 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 32' ' ' VAL . 2.6 tp -151.04 130.43 12.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 111.525 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.457 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-85 -113.54 136.46 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -57.84 -8.83 1.05 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -45.0 -28.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.652 0.263 . . . . 0.0 111.009 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.633 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.4 t90 -75.94 -53.16 8.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.731 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 159.72 114.05 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.806 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 3.3 Cg_exo -47.2 -37.76 24.34 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.567 2.178 . . . . 0.0 112.547 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -62.43 -46.76 87.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.793 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -64.05 -44.7 91.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.261 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 HD21 ' A' ' 23' ' ' LEU . 58.5 t -47.02 -36.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.005 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.47 -39.0 72.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.528 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.73 80.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -49.98 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.66 -26.83 68.85 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.6 -24.1 60.01 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.96 49.19 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.967 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.946 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mt -62.04 -159.78 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.697 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.946 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 36.2 Cg_exo -29.46 107.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.063 1.842 . . . . 0.0 114.049 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' LEU . 33.5 mt -150.13 149.87 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.6 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -85.94 133.88 33.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 111.866 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.595 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.8 p -145.91 149.5 34.34 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.517 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.53 133.39 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -91.96 136.59 33.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.04 120.15 39.96 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.755 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.631 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -87.88 133.39 33.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' A' ' 50' ' ' ASP . 9.3 t-105 -155.65 148.7 24.5 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.369 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.69 89.76 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.415 -0.422 . . . . 0.0 113.391 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.9 t70 72.99 -36.82 0.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.82 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.87 132.08 40.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 111.092 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -138.86 121.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.768 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -134.01 131.59 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.613 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.2 p90 -136.61 145.13 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.66 144.28 25.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.175 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.7 5.79 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.26 -7.77 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.5 p -84.1 115.52 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.207 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.37 94.8 7.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.001 0.429 . . . . 0.0 111.716 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.793 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.7 p -129.17 106.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.493 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.94 132.7 30.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.872 0.368 . . . . 0.0 111.328 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -148.74 164.33 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.426 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -94.32 87.91 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.455 0.645 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -170.23 148.79 3.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' SER . 0.5 OUTLIER 71.85 -83.21 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.578 0.228 . . . . 0.0 111.165 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 8.1 m 27.4 81.4 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.856 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.41 156.03 17.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.225 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.83 -6.75 11.02 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.9 p -127.48 143.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.631 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.572 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.3 m -158.56 157.6 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -94.56 150.51 20.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.373 0.606 . . . . 0.0 111.576 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.28 126.67 8.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.956 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.37 -30.64 6.87 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.385 -0.912 . . . . 0.0 114.535 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 109' ' ' ARG . 2.4 p30 -79.21 156.39 28.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 111.957 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.7 t -111.16 152.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.257 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.11 150.22 30.42 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.086 0.403 . . . . 0.0 111.882 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.473 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -106.32 137.91 43.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.62 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.3 t90 -79.1 108.46 12.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -63.94 -65.84 1.82 Allowed Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.82 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.99 81.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.823 1.682 . . . . 0.0 111.714 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 136.56 -6.89 3.91 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.651 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 52.36 36.82 20.83 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.002 0.401 . . . . 0.0 110.931 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.84 54.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.044 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -88.38 151.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.401 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 16.9 t -143.47 157.06 44.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.849 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -110.2 159.68 17.17 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.353 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 33.7 m-85 -136.78 134.56 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 111.792 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -169.47 35.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.853 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.14 -153.53 24.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.323 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.4 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 112.097 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.82 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -163.79 -174.34 0.4 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.934 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.68 ' HB2' HD12 ' A' ' 93' ' ' ILE . 93.9 Cg_exo -44.89 -24.32 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.877 1.718 . . . . 0.0 112.519 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -142.25 69.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -59.51 -76.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 110.365 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.2 t70 60.09 -95.9 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.906 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -122.08 -5.38 8.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.586 0.232 . . . . 0.0 111.214 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -169.75 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.569 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.3 mt -116.59 104.24 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.818 0.342 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -103.55 99.25 14.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.702 ' HA ' HG21 ' A' ' 91' ' ' THR . 59.7 Cg_endo -70.39 -31.51 17.61 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.505 2.137 . . . . 0.0 112.69 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.42 -161.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.62 -8.76 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.665 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -166.56 71.83 0.13 Allowed 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 101' ' ' ALA . 18.4 m -119.08 141.24 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.004 0.431 . . . . 0.0 111.872 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 66' ' ' SER . 1.9 m120 -83.88 150.24 25.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.713 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.28 94.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.605 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -80.28 24.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.81 -149.98 17.38 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.41 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 26.2 mtp180 -157.01 168.06 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.454 . . . . 0.0 111.216 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.618 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -95.15 113.86 30.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -100.5 -85.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' H ' HG23 ' A' ' 111' ' ' VAL . 11.9 p-10 -78.28 60.1 2.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 111.212 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 170.9 39.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.4 ptm -72.72 65.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.689 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -90.82 -168.81 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.164 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.64 45.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.316 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.849 HD22 HD13 ' A' ' 86' ' ' LEU . 2.0 tt -42.57 -36.73 1.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.586 0.232 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.43 -26.85 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.31 33.94 3.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.928 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 117' ' ' LEU . 2.4 m -80.39 154.03 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.627 0.251 . . . . 0.0 111.473 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.53 146.81 44.53 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 12.8 p-10 -53.6 134.61 41.23 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 56.86 99.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.282 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -144.61 153.34 41.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 110.98 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.3 t -65.09 158.17 26.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.542 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.904 HG22 ' CE2' ' A' ' 14' ' ' PHE . 40.8 t -148.06 129.18 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.087 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.0 m -124.55 106.1 16.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.595 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.17 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.813 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.3 pt-20 -153.2 125.04 7.82 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.665 0.269 . . . . 0.0 111.25 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.698 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.14 94.74 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.813 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB3' ' NE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.8 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.58 -108.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -135.58 -73.94 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.58 17.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.55 90.08 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.59 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 6' ' ' VAL . 25.4 m -146.49 79.53 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -159.03 28.45 0.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.75 106.89 16.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.989 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -114.77 145.29 42.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.483 . . . . 0.0 112.113 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.26 163.61 16.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.951 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 147.37 33.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -144.33 101.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.12 156.17 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.555 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.558 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.7 m-85 -138.25 136.47 36.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.1 -29.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 22.49 7.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.35 152.96 1.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.39 145.6 50.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.871 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -163.43 148.46 11.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.658 0.266 . . . . 0.0 111.607 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 158.88 41.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.163 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.23 148.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.107 0.48 . . . . 0.0 111.644 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.2 mt-10 -94.57 -178.29 4.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.021 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 32' ' ' VAL . 7.0 tp -147.46 133.19 18.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.148 0.499 . . . . 0.0 111.4 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.415 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 11.6 m-85 -112.12 139.49 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.436 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -57.11 -8.92 0.76 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.29 -27.98 0.74 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.62 0.248 . . . . 0.0 111.427 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -79.26 -56.61 4.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.9 115.98 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.784 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.5 -34.67 11.2 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.396 2.064 . . . . 0.0 112.246 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -59.32 -52.74 64.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.475 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.78 -45.65 92.98 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 23' ' ' LEU . 87.4 t -46.72 -31.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.71 86.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.267 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.57 67.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.82 -52.05 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.85 -29.25 70.05 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.911 0.386 . . . . 0.0 110.395 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.01 -25.58 62.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.528 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.02 51.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.767 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -61.56 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.828 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.3 Cg_exo -26.83 108.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.275 1.983 . . . . 0.0 113.992 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 14.5 mt -147.9 153.91 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.628 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -89.28 131.98 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.78 40.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.94 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 128.25 48.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.55 132.74 36.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -100.7 130.02 46.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -94.1 134.79 36.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' ASP . 7.5 t-105 -154.87 148.36 25.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.044 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -29.34 84.32 0.0 OUTLIER Glycine 0 C--N 1.336 0.557 0 O-C-N 123.375 0.422 . . . . 0.0 113.781 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' TRP . 27.8 t70 73.93 -37.23 0.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.406 0.282 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.749 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.3 tm-20 -73.44 128.04 34.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.992 0.425 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -131.1 125.0 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.786 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -136.49 127.43 27.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.355 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.3 p90 -133.28 145.39 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.61 146.62 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.581 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.82 6.79 10.42 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 82.57 -7.89 1.24 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.3 p -84.66 114.42 24.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.94 94.87 5.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 60' ' ' VAL . 6.1 p -132.47 106.74 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.143 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -124.12 134.64 53.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.027 0.441 . . . . 0.0 111.621 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -146.86 165.34 30.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.267 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 3.7 pm0 -102.02 92.4 4.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.048 0.451 . . . . 0.0 111.245 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.13 156.16 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.5 t-20 63.19 -81.48 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.706 0.289 . . . . 0.0 111.094 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.1 m 28.15 82.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.55 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.786 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.99 155.9 17.88 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.318 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -117.45 -7.01 11.18 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.7 p -127.03 144.43 37.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.623 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.548 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.5 m -158.47 163.19 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -108.65 143.22 38.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.036 0.446 . . . . 0.0 110.935 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -37.71 131.83 0.95 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.01 -31.52 6.47 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.711 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -83.25 156.83 22.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.247 0.546 . . . . 0.0 112.215 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 109' ' ' ARG . 23.1 t -114.95 152.43 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.997 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.94 149.33 32.0 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.313 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.481 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -106.73 123.78 48.64 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.268 179.264 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.598 ' HA ' HG12 ' A' ' 104' ' ' VAL . 3.1 t90 -65.67 111.07 3.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -66.3 -68.31 0.76 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.69 80.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 121.914 1.743 . . . . 0.0 111.752 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.12 -9.41 3.29 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.607 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.04 32.29 17.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.096 0.448 . . . . 0.0 110.863 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.16 133.9 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.881 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.78 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.236 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 35.3 t -143.14 157.26 44.67 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -112.37 156.41 22.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.941 179.074 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.9 m-85 -136.76 130.86 32.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 111.515 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -167.77 49.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.71 -82.22 0.12 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.268 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -138.94 -167.85 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.265 0.555 . . . . 0.0 111.748 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -155.4 -176.51 0.62 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.822 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 97.1 Cg_exo -45.18 -21.69 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.187 1.925 . . . . 0.0 112.997 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.677 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -147.51 65.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -49.85 -73.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.575 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.16 -90.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -119.32 -30.58 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -127.7 -164.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.5 mt -115.99 105.6 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 99.41 9.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.065 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.881 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -68.95 -31.15 24.85 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.538 2.159 . . . . 0.0 112.564 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.665 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.99 -162.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -7.3 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.645 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.97 73.74 0.07 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.5 m -122.16 142.3 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.005 0.431 . . . . 0.0 111.774 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.511 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m120 -83.15 152.19 25.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.43 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.786 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.96 82.02 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.708 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -65.9 20.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 114.27 -149.51 18.74 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.871 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.873 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.6 mtt85 -156.23 163.6 39.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.182 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.615 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -90.07 116.3 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.242 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -86.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -121.3 138.05 54.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.982 0.42 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER 167.44 -73.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.582 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.48 -44.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.504 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 17.0 mt-10 61.1 38.61 16.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.022 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.26 25.47 2.63 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.928 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 86' ' ' LEU . 4.1 tp -54.67 -37.5 65.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.768 0.284 . . . . 0.0 111.097 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -20.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 117' ' ' LEU . . . -91.31 30.34 6.45 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.644 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.8 m -77.52 154.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.483 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 147.21 30.2 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.608 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 13.6 p-10 -53.81 112.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 112.01 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.25 100.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.565 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.412 ' OE2' ' HB ' ' A' ' 120' ' ' VAL . 5.5 pt-20 -152.82 148.37 27.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.68 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.324 0.583 . . . . 0.0 112.456 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 45' ' ' ALA . 40.1 t -158.13 127.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.258 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.8 m -125.22 107.29 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.0 111.228 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.21 128.72 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.573 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 pt-20 -152.45 129.07 10.77 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.751 0.31 . . . . 0.0 111.235 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.58 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.86 92.73 3.1 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.874 0.369 . . . . 0.0 110.735 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.724 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 mmt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.834 0.349 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.21 163.81 12.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -103.04 -35.12 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.716 0.294 . . . . 0.0 110.807 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.46 -74.12 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -175.02 25.74 0.07 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.789 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.5 m -130.01 70.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 111.41 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -154.14 25.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' MET . . . . . 0.455 ' O ' ' HG2' ' A' ' 8' ' ' MET . 0.0 OUTLIER -101.74 126.51 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -131.92 145.45 51.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.12 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.37 162.44 15.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.649 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.46 142.79 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -138.91 102.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 109.704 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.34 156.15 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.589 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.2 m-85 -137.64 138.34 39.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -29.14 0.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -126.22 22.1 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.87 153.34 1.35 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.66 145.06 48.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.085 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.36 148.85 11.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.561 0.22 . . . . 0.0 111.432 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -117.93 156.68 28.05 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.22 135.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.047 0.451 . . . . 0.0 111.338 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -90.89 -178.39 5.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.409 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.781 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -149.76 146.68 27.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.982 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-85 -121.56 146.14 47.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.858 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 33.3 mt-10 -59.73 -9.03 2.39 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -45.52 -28.25 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.603 0.24 . . . . 0.0 111.423 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.711 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -80.07 -56.24 4.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 116.23 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.824 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.89 -29.77 8.69 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.521 2.147 . . . . 0.0 112.505 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.31 -43.56 81.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.183 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.844 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -67.18 -46.26 74.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.781 HG13 ' CD2' ' A' ' 23' ' ' LEU . 31.0 t -45.98 -35.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -56.62 -37.76 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.01 -47.56 74.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.99 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.86 -49.78 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.46 -28.79 70.21 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.247 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -71.19 -25.65 62.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 110.481 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.88 51.29 1.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.962 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.968 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.06 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.434 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 29.9 Cg_exo -28.64 103.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.058 1.839 . . . . 0.0 114.086 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.8 mt -145.62 150.62 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.395 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -85.88 135.62 33.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.164 0.506 . . . . 0.0 111.914 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.06 148.6 32.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.232 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.008 0.432 . . . . 0.0 110.374 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.98 132.55 34.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -104.13 119.01 38.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.802 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -82.43 136.88 34.84 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.047 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 16.0 t-105 -148.44 148.56 30.43 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.588 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.177 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 26.4 t70 79.44 -41.31 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.712 0.405 . . . . 0.0 111.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.56 152.08 24.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.577 HG21 HD21 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -150.13 117.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.726 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.1 p90 -125.15 140.17 53.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.243 0.545 . . . . 0.0 112.169 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 4.3 p90 -140.25 145.33 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.581 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 145.58 24.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.672 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.17 6.6 11.25 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.7 mt-30 81.75 -7.78 1.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.9 p -85.14 115.63 27.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.25 94.74 6.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.002 0.429 . . . . 0.0 111.706 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.844 ' CG2' HG22 ' A' ' 31' ' ' THR . 7.6 p -130.13 106.75 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.511 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.94 131.77 33.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.939 0.399 . . . . 0.0 111.412 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 52.1 tttm -141.07 165.65 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.354 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -99.56 89.27 4.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 111.374 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.8 tt0 -170.14 157.82 6.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.67 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.0 t-20 63.5 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.405 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.9 m 29.95 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.534 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 156.29 17.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.327 179.015 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.92 -7.01 10.96 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.4 p -126.63 142.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.537 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.81 157.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.26 151.08 19.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.357 0.599 . . . . 0.0 111.57 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -46.42 125.84 7.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.171 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.41 -31.72 6.27 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.369 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -75.66 155.81 35.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.619 0.709 . . . . 0.0 112.078 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.5 t -113.09 152.54 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.027 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.03 145.92 28.68 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.343 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.446 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -101.54 121.37 41.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 179.159 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.562 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -64.83 114.48 4.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.821 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.711 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -70.74 -67.34 0.63 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.735 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 27.8 Cg_exo -61.23 75.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.856 1.704 . . . . 0.0 111.633 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 147.11 -10.94 1.37 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 30.61 12.38 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.234 0.517 . . . . 0.0 110.973 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.72 136.64 52.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 9.5 mt -88.53 147.81 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.8 m -142.77 132.1 23.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -89.55 157.73 17.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.025 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 7.7 m-85 -136.49 134.67 37.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 111.536 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -153.58 28.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.708 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 148.53 -149.59 21.64 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.584 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -39.75 169.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.79 -176.58 0.63 Allowed Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.639 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.2 Cg_exo -42.64 -25.49 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.087 1.858 . . . . 0.0 112.571 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -136.49 52.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.511 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.451 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -53.07 -75.98 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 53.57 -91.27 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.91 3.68 6.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.702 0.287 . . . . 0.0 111.222 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -149.81 -170.25 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.453 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.5 HG23 ' OG1' ' A' ' 91' ' ' THR . 66.1 mt -123.15 110.53 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.914 0.388 . . . . 0.0 111.17 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.41 99.32 49.1 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.24 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 55.1 Cg_endo -68.25 -30.6 30.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 112.494 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.635 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -162.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.838 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -4.84 17.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.727 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.42 74.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 101' ' ' ALA . 20.8 m -122.7 141.98 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.544 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.3 m120 -82.15 152.77 26.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.624 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.667 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.6 90.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.781 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.93 19.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.263 -177.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.59 -149.24 18.65 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.572 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.765 ' HA ' HG23 ' A' ' 75' ' ' VAL . 13.6 mtt180 -151.52 164.18 37.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.003 0.43 . . . . 0.0 111.472 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.683 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -93.83 115.78 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -169.31 -167.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.08 90.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.09 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.55 45.59 24.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 13.1 pt-20 -75.37 -6.69 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.265 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.19 45.64 3.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.83 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp -42.77 -31.71 0.51 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.63 -19.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.413 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -91.52 27.35 9.75 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.051 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.3 m -81.62 153.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.763 0.281 . . . . 0.0 111.527 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.57 148.59 35.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -53.8 105.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 0.0 112.047 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.06 109.94 0.12 Allowed Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.989 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.18 138.72 14.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.639 0.257 . . . . 0.0 110.794 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.8 152.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 111.901 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 45' ' ' ALA . 61.5 t -144.62 128.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.3 m -124.69 107.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.82 128.38 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.6 pt-20 -152.46 130.29 11.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 111.216 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.575 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.76 93.79 2.64 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.901 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.31 -147.73 16.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -141.29 -47.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 111.009 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.67 -146.67 0.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.95 -40.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.71 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 25' ' ' GLU . 24.4 m -108.58 60.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 111.305 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -156.95 44.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.03 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpp -109.63 115.68 30.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.64 145.26 38.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 112.03 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.54 163.6 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.719 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.45 145.06 33.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -147.35 102.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -108.58 155.99 20.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.854 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CG ' HD11 ' A' ' 117' ' ' LEU . 2.7 m-85 -128.82 140.31 51.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.159 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.07 -28.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -122.24 23.19 9.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -176.28 155.05 1.43 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -117.1 152.66 34.24 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.229 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.08 151.47 17.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.92 0.39 . . . . 0.0 111.926 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -137.45 149.96 47.26 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.235 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.13 141.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.131 0.491 . . . . 0.0 111.842 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' OE2' HG13 ' A' ' 111' ' ' VAL . 2.0 mp0 -95.03 -178.1 4.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.234 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.797 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -154.79 142.33 19.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.05 146.92 48.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.689 ' H ' HG12 ' A' ' 6' ' ' VAL . 39.7 mt-10 -55.32 -9.41 0.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.61 -28.59 1.0 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.186 -0.321 . . . . 0.0 111.219 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.2 t90 -79.78 -55.87 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.667 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 156.8 115.97 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.648 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 3.8 Cg_exo -46.22 -36.7 17.37 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -62.12 -48.54 79.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.365 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -62.38 -44.96 95.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.888 0.375 . . . . 0.0 110.353 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 ' CD2' ' A' ' 23' ' ' LEU . 43.7 t -51.31 -31.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -59.73 -36.06 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.48 -47.31 67.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.1 -51.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.68 -28.69 69.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.983 0.42 . . . . 0.0 110.42 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.03 -23.83 60.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.44 50.81 0.89 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.877 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.957 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.506 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 30.7 Cg_exo -28.88 106.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.164 1.909 . . . . 0.0 113.979 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.2 mt -147.63 149.3 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.403 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 136.59 33.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.09 149.25 33.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.35 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.82 127.89 48.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -87.16 136.27 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -108.83 123.56 49.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.235 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.713 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -80.85 138.17 36.19 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.414 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.5 t-105 -150.1 148.88 29.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.58 95.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.513 -0.375 . . . . 0.0 113.72 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.68 30.5 11.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.266 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.9 OUTLIER -145.63 146.03 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.326 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -140.51 121.45 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 19.3 p90 -129.61 129.78 44.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.112 0.482 . . . . 0.0 110.98 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.54 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.7 p90 -139.11 145.53 39.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.815 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 149.34 21.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.34 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.16 6.28 9.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 80.41 -6.21 1.71 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.799 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.1 p -86.54 116.01 28.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.834 0.35 . . . . 0.0 110.2 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.32 94.79 5.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.0 0.429 . . . . 0.0 111.769 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.847 HG22 HG22 ' A' ' 31' ' ' THR . 7.5 p -124.07 106.59 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.016 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.34 136.56 51.13 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 111.587 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 63' ' ' GLU . 8.9 ttmt -141.51 164.79 29.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.242 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -101.24 76.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.051 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -170.11 160.78 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.485 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.4 OUTLIER 72.78 -82.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.641 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.6 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER 22.43 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.97 160.55 14.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.639 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' HG23 ' A' ' 69' ' ' VAL . 12.1 p30 -122.38 -4.3 8.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 68' ' ' ASP . 40.7 t -131.87 143.66 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.103 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.77 158.21 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.029 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.33 150.54 24.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.362 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp -52.08 124.79 13.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.963 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -32.19 6.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.017 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -67.55 166.05 15.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.104 0.452 . . . . 0.0 111.883 -179.054 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 ' CD1' ' A' ' 110' ' ' ILE . 22.0 t -122.72 152.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.719 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 146.17 26.47 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.697 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.518 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -98.24 126.97 43.94 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.962 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.738 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.2 t90 -68.38 122.59 18.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.215 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -72.25 -68.53 0.41 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.453 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 38.8 Cg_exo -59.44 82.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.915 1.743 . . . . 0.0 111.837 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.53 -7.18 4.95 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.642 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.62 39.43 13.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 0.0 111.176 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -115.19 135.5 54.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.55 145.57 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.5 m -142.49 131.27 22.79 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.815 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -98.07 139.19 34.26 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.3 p90 -136.52 138.05 40.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.075 0.464 . . . . 0.0 110.967 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.9 50.68 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.491 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.03 -81.14 0.13 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -123.49 -170.26 2.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.387 0.613 . . . . 0.0 111.553 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -166.16 178.09 1.37 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.807 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.6 Cg_exo -36.25 -30.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.659 2.239 . . . . 0.0 112.657 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -142.11 69.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.348 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -44.88 -40.43 6.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 111.205 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -47.84 151.74 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 58.28 52.21 7.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.405 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.09 161.83 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.283 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.78 120.74 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -116.83 99.29 52.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.644 ' HA ' HG21 ' A' ' 91' ' ' THR . 40.0 Cg_endo -65.73 -31.43 49.02 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.552 2.168 . . . . 0.0 112.446 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.682 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.57 -159.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.62 -4.12 17.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.85 73.21 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.738 HG12 ' CD1' ' A' ' 78' ' ' TRP . 15.6 m -120.69 141.96 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.757 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.656 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 41.1 m-20 -80.71 151.03 29.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.687 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.44 85.48 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.441 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.719 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -68.17 19.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.945 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.33 -146.74 18.52 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.933 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 75' ' ' VAL . 10.5 mtt-85 -154.98 168.09 28.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.515 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.589 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.6 mt -93.58 118.85 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -62.85 -74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -166.15 -31.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.445 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 m -40.56 -32.79 0.22 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.755 0.312 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 110' ' ' ILE . 1.2 tmt? -87.5 155.37 20.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.705 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -125.66 -76.68 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.18 45.38 1.0 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.8 tp -45.76 -40.7 9.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.638 0.256 . . . . 0.0 111.076 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.1 OUTLIER -42.3 -24.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.416 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -91.32 35.04 4.05 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.057 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.7 m -70.91 154.79 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 122.61 0.364 . . . . 0.0 111.853 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.79 146.66 44.09 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 p30 -58.1 116.35 3.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.089 0.471 . . . . 0.0 112.238 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.93 102.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.973 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.37 150.98 25.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.792 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.4 t -52.1 167.45 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 112.229 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 89.2 t -157.7 128.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.21 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -127.84 108.23 17.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.02 129.01 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.7 pt-20 -152.05 128.22 10.48 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.607 0.242 . . . . 0.0 111.229 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.678 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.79 85.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.175 -0.916 . . . . 0.0 111.634 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.767 0.318 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -102.35 145.06 30.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 111.76 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 164.17 19.3 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.004 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.32 102.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.085 0.469 . . . . 0.0 109.779 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -99.82 156.23 17.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.376 0.608 . . . . 0.0 111.893 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.7 m-85 -135.88 138.87 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.495 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.6 p -125.98 21.83 7.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -176.53 153.32 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.91 146.58 37.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 149.01 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.168 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.29 155.66 24.74 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.81 142.06 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.223 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 7.4 mt-10 -100.58 -178.8 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.062 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.757 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.8 tp -150.92 149.36 29.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.067 0.46 . . . . 0.0 111.368 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.433 ' H ' HD12 ' A' ' 23' ' ' LEU . 19.3 m-85 -126.36 148.01 49.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.732 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.18 -8.88 1.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.65 -27.73 0.85 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.621 0.248 . . . . 0.0 111.593 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.653 ' CZ2' HG21 ' A' ' 31' ' ' THR . 8.9 t90 -81.61 -56.27 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.89 114.87 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.452 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -46.41 -35.23 15.73 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.555 2.17 . . . . 0.0 112.335 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.78 -53.5 57.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.539 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.51 -45.06 92.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.521 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.757 HG13 ' CD2' ' A' ' 23' ' ' LEU . 61.4 t -47.43 -28.42 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.33 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt-85 -61.21 -38.64 87.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.464 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.94 79.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.671 0.272 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.09 -51.29 55.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.03 -27.8 69.66 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 120.948 0.404 . . . . 0.0 110.369 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.93 -25.31 61.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 0.0 110.599 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.23 49.6 1.13 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.047 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.1 mt -61.91 -160.21 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.58 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 32.3 Cg_exo -29.2 107.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.04 150.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.627 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -85.77 136.61 33.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.111 0.481 . . . . 0.0 111.745 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.33 149.1 33.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.497 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 125.59 48.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.85 136.01 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -108.26 125.8 52.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.073 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HD3' ' O ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -85.39 135.37 33.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -150.91 148.97 29.08 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.902 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . -32.88 102.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.505 -0.379 . . . . 0.0 113.729 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.22 30.87 0.49 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.3 OUTLIER -144.02 142.91 30.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.351 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -139.92 124.83 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.299 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 34.9 p90 -133.83 127.84 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.0 p90 -133.58 146.5 51.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.049 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.01 145.19 24.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER 82.95 -8.14 1.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -84.34 115.78 26.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.33 94.56 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 112.053 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.69 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.3 p -123.21 106.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.41 136.39 46.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.041 0.448 . . . . 0.0 111.665 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -160.32 161.7 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.987 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -96.33 96.28 8.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.0 tt0 -170.37 149.87 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.884 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 57.4 t-20 63.33 -81.74 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.727 0.299 . . . . 0.0 111.108 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.2 m 29.97 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.676 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.802 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.54 157.06 16.71 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.145 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -120.98 -4.16 9.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.5 p -127.56 141.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.403 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.552 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.75 157.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.599 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.62 150.77 19.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.401 0.619 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -44.85 126.49 5.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.98 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.41 -26.96 10.44 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 120.256 -0.973 . . . . 0.0 114.614 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.432 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -82.53 156.21 24.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.844 0.822 . . . . 0.0 111.894 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.874 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -113.48 151.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.393 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.06 153.34 33.78 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CD2' ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -103.98 131.69 50.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.308 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.0 t90 -74.37 109.12 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -65.32 -69.17 0.61 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.311 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 39.0 Cg_exo -58.85 80.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.886 1.724 . . . . 0.0 111.518 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.46 -9.33 3.19 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.291 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 50.05 39.62 19.52 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.907 0.354 . . . . 0.0 111.121 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.02 136.38 54.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.53 147.05 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.5 m -143.12 135.89 27.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.778 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.07 160.82 19.18 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 57.1 m-85 -136.32 114.71 11.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 111.984 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.683 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -150.23 31.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.082 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.54 -153.07 24.1 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.663 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.6 -173.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.522 0.677 . . . . 0.0 112.203 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.725 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.31 -175.85 0.55 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.118 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.689 ' HB2' HD12 ' A' ' 93' ' ' ILE . 74.3 Cg_exo -42.6 -25.22 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.032 1.821 . . . . 0.0 112.888 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -142.02 72.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' OG1' ' A' ' 91' ' ' THR . 91.7 mt . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -109.32 99.26 35.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.959 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.725 ' HA ' HG21 ' A' ' 91' ' ' THR . 60.0 Cg_endo -70.66 -31.27 16.83 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.151 . . . . 0.0 112.719 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.69 -162.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.22 -5.37 14.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.613 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.27 70.06 0.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 101' ' ' ALA . 12.7 m -119.01 141.4 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.024 0.44 . . . . 0.0 111.805 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.689 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.1 m120 -84.43 151.39 24.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.419 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.802 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.7 96.89 6.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.618 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.27 20.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.74 -149.75 18.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.55 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HA ' HG23 ' A' ' 75' ' ' VAL . 30.6 mtp180 -156.75 168.03 28.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.19 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.586 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.84 112.72 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.531 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.457 HG21 ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.547 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.825 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.7 tt . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.78 -21.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.402 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -93.43 34.35 4.65 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.427 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 117' ' ' LEU . 7.1 m -71.58 154.83 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 122.161 0.184 . . . . 0.0 111.088 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.635 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -81.22 147.92 29.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.603 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.1 p-10 -56.16 118.0 4.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.177 0.513 . . . . 0.0 112.328 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.63 101.15 0.02 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.008 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.635 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -149.8 155.55 40.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 110.48 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 t -55.56 164.98 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.681 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.5 t -157.96 127.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.562 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.39 108.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.759 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.68 128.89 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.407 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.7 pt-20 -153.41 129.18 10.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.66 0.267 . . . . 0.0 111.379 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.632 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.24 89.54 3.12 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.682 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.458 -0.035 0 CA-C-O 120.879 0.371 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -108.38 145.43 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.356 0.598 . . . . 0.0 112.319 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 163.92 18.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.62 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 144.87 31.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.7 mt -148.04 99.31 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.551 HH11 HG21 ' A' ' 127' ' ' VAL . 4.6 ptm180 -104.98 156.06 18.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.877 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.7 m-85 -129.63 139.11 51.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.277 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -28.53 0.43 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -121.34 22.97 10.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.76 151.46 1.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.37 138.35 54.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.791 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.499 ' SG ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -163.54 149.2 11.32 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.639 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.33 158.26 31.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.115 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.24 141.13 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.374 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.657 ' OE2' HG21 ' A' ' 111' ' ' VAL . 4.2 mt-10 -96.86 -178.46 4.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.979 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.806 ' CD2' HG13 ' A' ' 32' ' ' VAL . 8.1 tp -154.15 144.57 22.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.148 0.499 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -127.14 146.73 50.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.638 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -57.07 -9.29 0.83 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -45.49 -28.29 0.89 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.265 -0.272 . . . . 0.0 111.33 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.726 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.8 t90 -81.12 -56.18 4.26 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.41 115.47 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.597 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -46.17 -35.47 15.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.517 2.145 . . . . 0.0 112.341 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.15 -52.7 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.446 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.39 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.806 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.0 t -47.91 -30.04 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.307 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -60.66 -38.31 84.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.399 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.19 75.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.34 -52.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.9 -29.01 69.92 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.977 0.417 . . . . 0.0 110.445 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.92 -25.44 62.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.42 50.82 1.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.968 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.951 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.92 -160.05 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.45 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.4 Cg_exo -29.59 105.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.106 1.871 . . . . 0.0 113.953 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.7 mt -147.94 149.29 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.566 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.89 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.09 0.471 . . . . 0.0 111.766 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.7 p -146.08 149.01 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.463 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.92 129.38 48.17 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.865 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -89.46 134.45 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -106.06 122.02 45.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.045 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.807 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -81.79 136.73 35.4 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -154.45 148.34 25.59 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.47 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.83 86.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.497 0 O-C-N 123.278 0.361 . . . . 0.0 113.838 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.4 t70 76.15 -36.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 138.49 37.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 111.376 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -136.26 110.01 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.991 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 39.7 p90 -119.87 128.74 53.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.3 p90 -136.64 144.46 44.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.393 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.64 147.07 23.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.89 7.56 10.42 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 56' ' ' THR . 36.1 mt-30 81.02 -6.82 1.59 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.819 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -86.54 115.76 28.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.39 94.9 5.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.045 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 31' ' ' THR . 2.9 p -125.33 106.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.961 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 138.17 53.88 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.053 0.454 . . . . 0.0 111.623 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -152.99 164.5 37.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.335 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.12 87.2 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.78 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.0 tt0 -170.11 153.56 4.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.478 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 49.7 t-20 69.42 -80.27 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.277 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.456 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 5.3 m 25.28 82.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.473 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.883 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.77 157.02 17.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.536 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -118.97 -8.13 10.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.0 p -124.89 143.04 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.296 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.9 m -159.08 157.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.78 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.49 151.59 21.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.406 0.622 . . . . 0.0 111.483 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.38 125.36 10.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.805 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.59 -32.18 6.0 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.268 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 1.9 p30 -73.61 156.49 37.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.578 0.689 . . . . 0.0 111.942 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.0 t -112.93 152.35 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.4 148.94 31.83 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.262 0.483 . . . . 0.0 112.294 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.56 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -103.91 123.08 46.49 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.686 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.0 t90 -64.62 119.98 11.53 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.809 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.772 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -70.64 -68.03 0.55 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.753 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.772 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.07 78.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.846 1.697 . . . . 0.0 111.696 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 141.19 -9.24 2.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.737 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.02 36.23 14.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.0 0.4 . . . . 0.0 111.059 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.85 134.75 54.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.723 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.8 mt -84.3 141.16 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.451 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.5 m -135.65 130.36 34.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.825 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.58 156.3 19.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.8 m-85 -136.79 129.67 30.76 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.626 0.25 . . . . 0.0 110.989 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -165.79 42.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.304 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.47 -84.09 0.1 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.327 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -130.57 -166.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.259 0.552 . . . . 0.0 111.902 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.56 -176.65 0.63 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.7 Cg_exo -47.32 -24.62 4.05 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.793 1.662 . . . . 0.0 111.786 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 92' ' ' PRO . 1.9 mp -142.57 66.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.464 0.239 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.1 mt . . . . . 0 N--CA 1.464 0.262 0 CA-C-O 120.84 0.352 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -103.47 99.21 14.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 91' ' ' THR . 52.4 Cg_endo -68.33 -31.39 28.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.482 2.121 . . . . 0.0 112.537 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.605 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.41 -158.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -6.93 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.697 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.01 73.12 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.7 m -122.74 142.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 111.826 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.5 m120 -83.58 152.0 25.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.854 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.883 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.73 99.84 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.571 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.66 21.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.79 -133.22 10.55 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.245 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.867 ' HA ' HG23 ' A' ' 75' ' ' VAL . 9.5 ptt85 -170.47 168.12 7.92 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.045 0.45 . . . . 0.0 111.484 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.607 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.0 mt -98.16 115.27 37.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.575 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.657 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.504 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.2 tt . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.783 0.325 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.95 -24.38 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.173 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.92 31.29 4.72 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 117' ' ' LEU . 10.6 m -75.09 153.98 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.562 0.22 . . . . 0.0 111.299 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.26 146.61 32.91 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.618 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -57.28 111.64 1.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.99 98.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.401 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.41 149.71 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.68 166.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.281 0.562 . . . . 0.0 112.257 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.865 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.8 t -157.98 128.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.137 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 127' ' ' VAL . 27.5 m -129.46 109.14 17.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 111.589 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.89 129.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.243 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 11.8 pt-20 -154.31 128.04 8.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.622 0.249 . . . . 0.0 111.293 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.596 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.81 87.59 1.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 110.786 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.751 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.822 0.344 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -108.54 145.32 34.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.2 0.524 . . . . 0.0 112.329 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.48 163.96 17.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.682 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 145.68 38.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.796 0.332 . . . . 0.0 110.948 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.607 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.2 100.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -102.63 155.5 18.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.615 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE1' HG13 ' A' ' 126' ' ' VAL . 2.8 m-85 -131.2 138.05 49.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.441 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.53 -29.07 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -126.08 23.12 7.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.06 152.44 3.49 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.78 143.5 49.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.676 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 148.6 13.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.75 0.31 . . . . 0.0 111.769 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -136.31 157.83 45.86 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.054 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.15 146.57 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.446 . . . . 0.0 111.648 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 6.6 mt-10 -98.16 -178.29 4.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.871 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.758 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.9 tp -153.71 144.2 22.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -123.97 146.8 48.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -55.45 -9.27 0.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.61 -27.26 0.74 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.939 0.336 . . . . 0.0 111.443 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.655 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.5 t90 -81.28 -56.37 4.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.23 113.62 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.665 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.72 -29.62 8.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.35 -46.46 80.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.283 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.693 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -68.32 -46.2 70.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 23' ' ' LEU . 30.2 t -45.87 -29.82 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.339 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -33.44 72.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.477 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.53 55.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.3 -49.08 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.12 -28.62 69.89 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.319 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -71.4 -25.38 62.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.376 . . . . 0.0 110.543 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.01 51.11 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.988 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -62.21 -159.93 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.594 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.4 Cg_exo -29.08 107.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.186 1.924 . . . . 0.0 114.059 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.9 mt -150.04 149.78 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.642 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -85.84 136.85 33.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.919 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.58 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -146.05 149.19 33.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.45 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 124.44 47.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.894 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -84.93 133.58 34.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -103.4 124.98 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.931 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.865 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.52 135.88 33.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.6 t-105 -156.71 148.34 22.58 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.957 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.81 84.89 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.649 -0.31 . . . . 0.0 113.764 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' TRP . 30.5 t70 74.22 -36.64 0.34 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.3 tt0 -74.71 128.22 35.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.399 . . . . 0.0 111.346 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -132.29 119.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.849 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 53.4 p90 -131.47 125.03 31.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.319 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.0 p90 -129.87 145.8 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.05 144.12 25.76 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.89 6.4 11.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.6 mm-40 82.23 -7.44 1.33 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.7 p -84.98 116.87 29.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.159 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.87 94.56 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.703 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.693 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.0 p -126.08 106.74 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.3 133.93 43.21 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 161.14 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.083 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.73 93.97 7.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.51 148.39 3.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 35.5 t-20 70.44 -76.87 0.06 Allowed 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.606 0.241 . . . . 0.0 111.165 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.474 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 11.0 t 21.41 83.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.887 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.58 161.51 13.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.361 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.28 1.04 8.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 49.6 t -138.41 142.33 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.483 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.99 157.55 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.887 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.79 152.2 19.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.495 0.664 . . . . 0.0 111.62 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -48.29 125.91 10.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.933 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.07 6.08 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.505 -0.855 . . . . 0.0 114.083 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -75.37 156.37 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.458 0.629 . . . . 0.0 111.984 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.9 t -113.05 152.25 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.08 149.39 29.47 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.151 0.432 . . . . 0.0 111.874 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -104.51 137.66 42.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.341 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.631 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.6 t90 -78.72 108.26 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.447 HG13 ' ND2' ' A' ' 105' ' ' ASN . 0.3 OUTLIER -63.94 -66.42 1.5 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.634 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 21.1 Cg_endo -60.72 77.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.255 1.97 . . . . 0.0 111.6 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 142.91 -9.99 2.31 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.324 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 54.47 33.6 19.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.965 0.382 . . . . 0.0 110.913 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.96 134.8 54.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.049 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.1 mt -87.37 150.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 24.8 t -143.52 156.09 44.52 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.087 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -113.66 157.76 21.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.943 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 5.5 m-85 -136.71 138.21 40.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.492 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -175.46 44.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.957 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.36 -91.14 0.1 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.973 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -133.36 -167.76 1.98 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.424 0.63 . . . . 0.0 111.724 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.841 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -163.61 -173.94 0.38 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.01 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.628 ' CD ' HG22 ' A' ' 91' ' ' THR . 90.4 Cg_exo -45.48 -22.2 0.97 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 121.81 1.673 . . . . 0.0 112.736 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 92' ' ' PRO . 2.7 mp -142.06 73.1 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.711 0.291 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -98.76 99.11 7.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.841 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.4 Cg_endo -68.87 -31.09 25.5 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.483 2.122 . . . . 0.0 112.561 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.77 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.76 -0.43 14.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.599 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.474 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -171.42 68.25 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 78' ' ' TRP . 18.6 m -121.45 141.63 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.132 0.492 . . . . 0.0 112.09 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.532 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.2 m120 -82.32 152.04 26.45 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.815 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -89.1 97.43 6.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.528 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.95 22.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.43 -144.65 17.9 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.079 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.847 ' HA ' HG23 ' A' ' 75' ' ' VAL . 5.0 mtt180 -156.79 168.1 28.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 111.33 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mp -91.41 116.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.076 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.3 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.087 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.782 0.325 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.51 -26.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.94 -179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.54 31.34 4.22 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.1 m -79.84 154.19 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.641 0.258 . . . . 0.0 111.202 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.96 146.55 32.01 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.578 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 16.0 p-10 -54.57 112.01 0.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.997 0.427 . . . . 0.0 111.593 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.61 100.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.179 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.82 148.88 28.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.371 . . . . 0.0 110.982 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.1 t -46.63 163.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.327 0.584 . . . . 0.0 112.233 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 45' ' ' ALA . 42.4 t -158.1 128.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.326 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.2 m -126.51 108.42 19.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.901 0.382 . . . . 0.0 111.547 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.05 128.53 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.289 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.4 pt-20 -154.0 130.26 10.45 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.43 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.603 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.19 89.53 3.09 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.801 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.719 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.692 0.282 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -111.27 145.32 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 112.099 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.39 164.57 14.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.796 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.35 143.82 36.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 0.0 111.159 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.45 100.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -102.48 156.26 17.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.597 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.1 m-85 -136.27 137.91 41.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.524 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.5 -29.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -123.88 22.81 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.86 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -126.68 141.5 51.83 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.83 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 148.94 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.717 0.294 . . . . 0.0 111.498 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.5 160.11 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.308 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.86 144.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.122 0.487 . . . . 0.0 111.571 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.3 mt-10 -96.21 -178.52 4.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.13 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.0 tp -151.02 147.02 26.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.029 0.442 . . . . 0.0 111.15 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.5 146.88 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -59.06 -9.03 1.7 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.4 -29.56 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -79.9 -56.38 4.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 158.24 117.2 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -45.99 -35.36 14.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.523 2.149 . . . . 0.0 112.208 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.63 76.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.708 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.539 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.91 -44.22 93.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.859 0.362 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 23' ' ' LEU . 63.7 t -47.68 -34.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.204 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -60.07 -36.98 78.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.39 70.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -54.95 -51.76 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.42 -28.7 69.98 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.028 0.442 . . . . 0.0 110.399 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.74 -26.16 63.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.452 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.0 51.48 1.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.778 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.964 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.7 -159.71 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.591 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.964 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.6 Cg_exo -28.92 105.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.996 1.798 . . . . 0.0 113.989 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 39' ' ' LEU . 21.0 mt -146.64 150.71 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.63 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.036 0.446 . . . . 0.0 111.82 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.608 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -144.05 148.97 35.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.453 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 126.95 48.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 110.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -88.84 132.75 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -102.63 122.3 44.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.712 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.925 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.66 136.18 33.18 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -155.74 148.26 23.9 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.81 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -32.07 85.47 0.01 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.178 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.1 t70 76.0 -39.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.9 tt0 -71.09 120.26 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 0.0 111.504 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -128.36 121.54 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.742 178.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -135.23 127.91 30.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.844 0.354 . . . . 0.0 111.296 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.7 p90 -133.4 145.76 50.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.013 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.15 146.19 24.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.63 6.31 10.53 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER 83.07 -8.08 1.16 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.2 p -85.76 115.02 26.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.38 94.7 5.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.975 0.417 . . . . 0.0 112.052 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.8 p -129.66 106.78 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.124 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.64 134.75 54.49 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 121.027 0.441 . . . . 0.0 111.641 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.26 167.26 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.065 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.03 88.78 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.972 0.415 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.33 160.79 7.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.757 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.8 t-20 63.42 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.3 m 28.5 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.368 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.841 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.19 155.45 17.75 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.398 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.655 ' OD1' HG23 ' A' ' 69' ' ' VAL . 1.5 p30 -120.41 2.11 10.74 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 68' ' ' ASP . 51.0 t -137.28 141.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -158.12 157.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.715 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -98.26 148.73 23.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.389 0.614 . . . . 0.0 111.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.61 129.42 4.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.948 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.51 -32.06 6.08 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.134 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 2.5 p30 -81.15 157.93 25.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.327 0.564 . . . . 0.0 111.929 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.87 HG23 ' HA ' ' A' ' 109' ' ' ARG . 38.4 t -116.21 152.53 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.48 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 151.32 32.54 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.305 0.502 . . . . 0.0 112.341 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -107.36 137.28 45.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.553 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -76.22 111.95 12.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -64.04 -67.37 1.08 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 32.2 Cg_endo -63.5 76.28 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.23 1.954 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.83 -10.84 1.65 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.545 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.38 28.72 11.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.147 0.474 . . . . 0.0 110.944 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.12 130.9 55.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.676 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.74 147.66 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.197 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.1 t -141.06 156.83 45.94 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.482 0.658 . . . . 0.0 112.769 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.922 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.75 161.76 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.069 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 10.5 m-85 -136.55 138.94 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -177.68 49.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.418 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.71 -78.54 0.19 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.619 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -141.47 -161.51 1.23 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.976 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.879 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -166.33 177.87 1.41 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.009 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -41.79 -23.67 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.473 2.115 . . . . 0.0 112.921 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 99' ' ' ARG . 10.0 pt -141.19 64.59 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 121.115 0.483 . . . . 0.0 110.662 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.749 0.309 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -100.09 99.06 8.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.767 ' HA ' HG21 ' A' ' 91' ' ' THR . 46.9 Cg_endo -68.16 -29.68 32.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.215 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.39 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.661 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.8 -2.97 15.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.654 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -172.16 70.1 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.4 m -120.03 141.64 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.956 0.408 . . . . 0.0 111.8 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.612 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.8 m120 -83.83 153.1 24.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.285 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.841 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.84 89.66 3.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.121 178.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.649 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.87 23.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 114.71 -150.46 18.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.87 ' HA ' HG23 ' A' ' 75' ' ' VAL . 27.2 mtp180 -156.94 168.16 28.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.2 mt -98.05 114.59 35.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.568 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.737 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.922 HD22 HD13 ' A' ' 86' ' ' LEU . 1.5 tp . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.41 -26.43 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.282 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.03 29.83 4.54 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.39 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.3 m -84.32 153.89 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.832 0.316 . . . . 0.0 111.381 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.67 147.18 32.08 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.475 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 5.2 p-10 -56.31 117.72 4.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.52 100.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.108 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.29 149.63 27.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.137 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.2 t -48.6 164.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 112.061 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 45' ' ' ALA . 48.0 t -158.02 128.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.578 HG23 ' OE2' ' A' ' 129' ' ' GLU . 17.4 m -125.83 108.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.453 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.0 128.79 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.225 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -154.43 131.66 11.1 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.799 0.333 . . . . 0.0 111.542 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.534 ' CB ' HD22 ' A' ' 39' ' ' LEU . 3.1 tmm_? -74.25 92.85 2.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.867 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -109.15 145.42 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 112.156 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 163.27 17.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.7 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 144.86 32.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.885 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.89 101.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 109.749 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -100.09 156.12 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.71 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.67 138.03 44.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.431 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.43 -28.91 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -125.56 22.37 7.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.14 150.26 1.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.415 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -131.92 139.23 48.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.188 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 149.2 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.7 0.286 . . . . 0.0 111.339 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -116.41 156.92 25.95 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.41 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.79 138.04 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.3 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.689 ' OE2' HG13 ' A' ' 111' ' ' VAL . 3.2 mt-10 -92.96 -178.3 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.325 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.836 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -155.43 145.87 21.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -126.65 146.71 50.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.402 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 29.6 mt-10 -56.59 -9.13 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.67 -27.4 0.79 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.212 -0.305 . . . . 0.0 111.383 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.776 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.6 t90 -80.56 -55.96 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.49 109.7 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.48 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.738 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 88.4 Cg_exo -40.9 -29.71 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.789 2.326 . . . . 0.0 112.967 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.97 -42.04 81.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.321 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.776 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.74 -45.03 72.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.784 0.326 . . . . 0.0 110.477 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 ' CD2' ' A' ' 23' ' ' LEU . 35.5 t -48.85 -33.64 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.244 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -58.03 -37.25 74.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -66.5 -48.44 69.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.45 -51.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.04 -29.03 70.01 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.331 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.7 -24.76 61.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.62 51.47 0.93 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.959 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.522 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.959 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.6 Cg_exo -29.49 105.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.071 1.848 . . . . 0.0 113.969 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.8 mt -147.23 150.79 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.569 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.9 136.85 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.612 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.0 p -145.23 148.88 34.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.504 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 123.65 46.09 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.068 0.461 . . . . 0.0 110.263 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.49 135.04 34.81 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -107.26 126.43 52.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.679 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.43 137.4 32.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 14.4 t-105 -149.47 148.37 29.34 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.431 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.17 92.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.053 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 27.9 t70 78.87 -41.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.724 0.41 . . . . 0.0 111.649 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 152.55 24.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 111.425 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -153.0 117.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.627 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.2 p90 -124.06 141.68 51.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.345 0.593 . . . . 0.0 112.226 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -140.45 145.39 36.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.33 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.57 149.5 21.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.697 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.89 5.23 8.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.2 mm-40 83.32 -8.08 1.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.764 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -85.02 116.7 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.33 94.95 5.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 0.0 112.187 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.614 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.0 p -124.55 106.62 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.874 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.71 136.44 50.6 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.026 0.441 . . . . 0.0 111.708 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -156.86 164.62 37.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.233 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.79 91.02 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.7 tt0 -170.12 152.04 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.7 t-20 68.5 -79.96 0.04 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.492 ' OG ' HD12 ' A' ' 79' ' ' ILE . 4.4 m 23.8 80.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.624 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 158.67 16.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.558 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -120.64 -5.88 9.71 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.9 p -128.83 142.87 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.392 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.54 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 29.5 m -158.68 157.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -88.23 151.45 22.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.343 0.592 . . . . 0.0 111.412 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -50.43 126.2 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.143 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.53 -32.22 6.19 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.939 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.4 p-10 -68.98 162.49 26.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.074 0.464 . . . . 0.0 112.101 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -121.73 152.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.948 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.798 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.61 146.24 25.68 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.495 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.99 130.98 44.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.817 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.748 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.9 t90 -71.03 122.66 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.99 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -68.09 -67.84 0.75 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.903 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 47.1 Cg_endo -68.05 80.56 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.246 1.964 . . . . 0.0 112.181 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.46 -11.94 2.48 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 53.76 30.56 11.41 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.11 0.455 . . . . 0.0 110.749 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -109.65 135.07 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.63 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.5 mt -85.96 144.24 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.66 130.7 30.39 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.889 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.36 156.86 19.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.09 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.7 m-85 -136.5 130.13 32.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.538 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 2.6 m-85 -152.51 28.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 151.07 -151.78 23.7 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.518 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -40.73 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.619 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -151.2 -174.62 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.647 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.6 Cg_exo -46.18 -24.19 2.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.748 1.632 . . . . 0.0 112.297 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -139.94 55.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' A' ' 91' ' ' THR . 67.8 mt . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.7 mtt85 -136.33 99.2 10.93 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.556 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 54.0 Cg_endo -68.21 -31.66 28.67 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.44 2.093 . . . . 0.0 112.331 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.726 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.0 -161.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.748 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.16 -7.68 15.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.53 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.39 71.24 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.748 HG12 ' CD1' ' A' ' 78' ' ' TRP . 14.5 m -118.36 141.92 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.472 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.685 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 31.7 m-20 -82.15 150.94 27.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.624 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.51 92.61 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.798 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -79.17 19.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.423 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.11 -148.24 18.21 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.087 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.854 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.5 mtt180 -155.93 167.87 29.03 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.964 0.411 . . . . 0.0 111.518 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.625 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -94.15 114.8 31.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.689 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.4 tt . . . . . 0 N--CA 1.462 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.421 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.9 -24.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.727 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.46 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.34 32.54 4.11 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 117' ' ' LEU . 12.1 m -74.94 154.54 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.272 0.229 . . . . 0.0 110.825 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.45 144.53 46.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.536 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 12.2 p-10 -58.02 112.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.423 . . . . 0.0 111.866 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.2 103.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.522 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -158.16 151.49 23.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.934 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.11 164.54 0.11 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.307 0.575 . . . . 0.0 112.196 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.928 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.07 128.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.37 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.51 108.39 18.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 111.356 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.697 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.01 128.84 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.444 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.7 pt-20 -153.26 129.64 10.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.672 0.273 . . . . 0.0 111.274 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.628 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.81 89.96 2.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.798 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -106.66 145.32 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.205 0.526 . . . . 0.0 112.29 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.97 164.72 15.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.66 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 147.29 36.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.787 0.327 . . . . 0.0 111.11 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -142.88 102.92 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -102.37 156.24 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.481 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.822 ' CE1' HG22 ' A' ' 126' ' ' VAL . 43.9 m-85 -139.01 138.59 37.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.104 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -125.7 22.97 7.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -175.38 154.67 1.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.46 147.04 50.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 149.79 14.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.19 156.94 47.46 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.142 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.33 149.87 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 111.631 -179.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 13.5 mt-10 -102.23 -178.64 3.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.974 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 4.1 tp -153.29 149.52 27.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.11 0.481 . . . . 0.0 111.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.428 ' H ' HD12 ' A' ' 23' ' ' LEU . 22.7 m-85 -127.24 148.87 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -56.2 -8.97 0.55 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -45.61 -27.49 0.79 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.967 0.349 . . . . 0.0 111.533 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -82.42 -56.53 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.42 116.16 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.416 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -45.89 -34.41 12.34 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.478 2.119 . . . . 0.0 112.383 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -61.63 -49.99 74.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.38 -44.85 93.57 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.606 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.9 t -49.15 -31.48 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -61.97 -38.16 87.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.63 80.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.23 -51.31 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.02 -28.09 69.34 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.087 0.47 . . . . 0.0 110.445 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.85 -23.5 59.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.62 51.37 0.84 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.661 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.976 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.5 mt -61.95 -159.9 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.692 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.976 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.0 Cg_exo -27.66 105.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.167 1.911 . . . . 0.0 114.156 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.8 mt -147.18 150.71 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.395 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 135.42 33.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 0.0 111.748 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.619 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.5 p -146.06 149.13 33.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.391 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 132.03 47.69 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.11 136.07 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -100.79 117.55 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.914 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.601 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.11 133.0 33.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.4 t-105 -154.21 148.81 26.33 Favored 'General case' 0 C--O 1.229 0.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -30.72 85.61 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.282 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.0 t70 73.31 -37.8 0.39 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.542 0.337 . . . . 0.0 111.521 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.583 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.1 tt0 -72.08 129.29 38.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.855 0.359 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -133.26 124.63 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.129 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.41 ' CE1' ' ND2' ' A' ' 46' ' ' ASN . 55.0 p90 -135.7 133.15 37.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.944 0.402 . . . . 0.0 111.644 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.3 p90 -138.83 145.44 40.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -93.6 148.52 22.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.162 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.679 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.99 5.87 9.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 83.38 -8.18 1.11 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.0 p -85.89 114.15 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.124 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.31 98.47 8.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 112.055 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.1 p -134.42 106.81 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -126.64 133.93 50.87 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.054 0.454 . . . . 0.0 111.555 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 31.8 tttt -140.07 164.77 29.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.292 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -99.23 86.94 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.778 0.323 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.7 tt0 -170.18 160.61 8.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.4 t-20 63.31 -82.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 5.4 m 26.48 81.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.87 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.65 161.08 13.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.349 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -122.62 -7.44 8.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.3 p -126.7 141.6 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.484 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.4 m -159.27 146.9 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.14 152.76 21.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 0.0 110.953 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -41.23 124.01 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.348 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -32.31 6.04 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.058 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 127.05 31.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.818 0.309 . . . . 0.0 111.505 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 11.9 t -94.8 150.62 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -145.65 153.04 40.58 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.516 0.598 . . . . 0.0 112.474 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 122.63 48.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.091 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.753 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.3 t90 -61.84 127.22 30.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.087 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -75.13 -64.19 0.63 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.893 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 46.3 Cg_endo -67.8 85.55 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.283 1.988 . . . . 0.0 112.025 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.43 -6.75 5.3 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.38 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.16 36.88 13.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.95 134.19 51.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.37 149.42 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.504 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 34.7 t -143.16 156.53 44.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.265 0.555 . . . . 0.0 112.492 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.99 158.59 18.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.415 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 12.9 m-85 -136.67 127.11 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -168.62 51.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.677 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.403 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 162.74 -80.78 0.13 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.44 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -155.89 176.92 12.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.036 0.446 . . . . 0.0 111.926 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.773 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -143.52 -174.32 0.4 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.603 ' CD ' HG22 ' A' ' 91' ' ' THR . 97.0 Cg_exo -45.02 -22.81 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.131 1.887 . . . . 0.0 112.934 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 99' ' ' ARG . 1.6 mp -132.44 76.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.872 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' OG1' ' A' ' 91' ' ' THR . 14.4 mt . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.68 0.276 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' HB2' HD13 ' A' ' 93' ' ' ILE . 27.9 mmm-85 -99.89 99.35 8.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.773 ' HA ' HG21 ' A' ' 91' ' ' THR . 64.1 Cg_endo -71.24 -32.14 13.31 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.513 2.142 . . . . 0.0 112.579 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.63 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.62 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.816 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.69 -5.38 13.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 66' ' ' SER . . . -169.96 71.65 0.07 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.753 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.6 m -121.34 142.04 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.696 0.284 . . . . 0.0 111.222 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.626 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.7 m-20 -85.86 153.0 22.55 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.87 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.14 101.99 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -87.51 22.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 117.4 -148.6 18.74 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.196 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.8 mtt180 -154.84 163.0 40.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.12 113.8 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.292 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.802 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.2 tp . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.78 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.062 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.27 34.98 3.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.423 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.802 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.3 m -81.5 153.75 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.7 147.31 43.73 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.379 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.508 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 2.4 p30 -53.35 135.86 38.28 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.501 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 55.32 99.4 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.243 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.01 153.29 41.32 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.92 157.74 24.05 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.482 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.892 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.5 t -148.54 129.05 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.023 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 24.9 m -124.27 107.13 17.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.37 128.97 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.739 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.2 OUTLIER -150.96 128.23 11.27 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.714 0.292 . . . . 0.0 111.147 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 90.91 3.05 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.688 179.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.067 0 CA-C-O 120.875 0.369 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.79 145.22 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 112.346 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 163.67 19.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.507 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 144.62 31.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -145.89 100.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -108.77 156.21 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.832 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.9 m-85 -126.49 143.7 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.154 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -28.67 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.0 t -121.69 23.07 10.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.76 154.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.631 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -127.53 142.79 51.29 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.16 149.49 12.2 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.676 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -121.9 158.16 29.59 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.349 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.59 142.84 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.78 -178.27 4.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.498 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.846 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -152.72 140.39 19.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.963 0.411 . . . . 0.0 110.95 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.13 143.14 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -60.61 -8.49 2.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.02 -29.63 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.678 ' NE1' HG21 ' A' ' 31' ' ' THR . 0.5 OUTLIER -76.77 -54.14 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.782 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 162.59 116.24 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.804 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.4 Cg_endo -47.4 -34.61 19.52 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.578 2.185 . . . . 0.0 112.504 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.51 -37.51 80.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.353 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.782 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -68.72 -43.95 74.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 110.28 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.846 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.3 t -50.04 -38.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.716 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -56.87 -35.13 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.72 -47.06 70.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.799 0.333 . . . . 0.0 111.011 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.54 -49.24 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.601 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.1 -29.63 70.95 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.144 0.497 . . . . 0.0 110.284 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -70.43 -25.76 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.554 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.39 52.79 0.94 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.849 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.68 -159.91 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.692 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 27.9 Cg_exo -28.04 106.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.18 1.92 . . . . 0.0 114.099 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.6 mt -148.18 150.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.514 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -85.87 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 111.759 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -146.05 149.12 33.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.361 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.72 130.42 48.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.912 0.387 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.88 133.12 35.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -103.39 128.38 50.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.004 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.873 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.6 138.21 31.63 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.3 t-105 -155.1 148.98 25.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -37.31 97.16 0.01 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.492 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 53.27 24.6 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 111.356 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.73 136.93 39.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.489 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -138.4 129.42 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 52.6 p90 -137.92 122.11 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.371 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.9 p90 -131.29 146.36 52.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 148.9 21.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.7 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.73 6.33 8.8 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER 82.89 -8.01 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -86.05 114.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.258 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.48 96.04 6.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 111.855 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.9 p -133.14 106.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.253 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -130.87 133.5 45.96 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.535 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 40.5 tttm -145.08 165.55 27.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.372 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.09 90.06 4.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.5 tt0 -170.21 158.49 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.471 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 35.8 t-20 63.21 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.85 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 19.9 m 25.63 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.326 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -104.13 162.03 13.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.852 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -120.94 -12.16 8.82 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.4 p -121.27 143.25 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.439 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.574 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 36.0 m -158.31 157.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.71 150.15 24.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.338 0.59 . . . . 0.0 111.053 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.63 125.01 15.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.939 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.98 -31.43 6.53 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.223 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.2 p-10 -69.24 165.72 19.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 117.16 0.48 . . . . 0.0 111.825 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.802 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.9 t -119.99 152.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.44 148.92 30.01 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.442 0.565 . . . . 0.0 112.381 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -104.57 135.42 46.02 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.161 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.694 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -76.6 108.7 9.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.527 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -56.73 -70.65 0.32 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.145 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -58.64 87.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.266 1.977 . . . . 0.0 112.347 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.39 -6.03 5.61 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.774 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.8 32.42 9.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.959 0.38 . . . . 0.0 110.582 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.66 131.68 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.764 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.4 mt -87.76 150.6 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.087 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 18.6 t -143.34 156.35 44.67 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -121.37 137.8 54.54 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.144 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.9 p90 -136.65 139.76 42.26 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.029 -0.419 . . . . 0.0 111.491 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 53.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.048 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.22 -135.03 5.47 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -57.35 -173.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.676 0.738 . . . . 0.0 111.2 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -167.93 -174.14 0.33 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.932 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 88.2 Cg_exo -45.83 -21.4 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.816 1.677 . . . . 0.0 112.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.2 mt -143.36 60.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 110.761 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.53 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.2 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.965 0.412 . . . . 0.0 111.275 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.64 99.42 52.81 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.998 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 91' ' ' THR . 33.2 Cg_endo -62.61 -29.69 78.24 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.472 2.115 . . . . 0.0 112.604 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.37 -162.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.798 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.59 -5.92 22.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.536 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -176.31 77.54 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 78' ' ' TRP . 24.5 m -125.35 141.5 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 111.611 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m-20 -81.88 153.91 26.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.261 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.766 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.23 81.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.683 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -64.86 19.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 117.51 -138.07 13.81 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.849 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.802 ' HA ' HG23 ' A' ' 75' ' ' VAL . 4.2 ptt180 -170.51 162.19 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.622 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -88.49 115.75 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.217 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 86' ' ' LEU . 3.8 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.688 0.28 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.19 -25.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.04 30.21 6.01 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.559 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.7 m -71.02 154.47 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 122.334 0.254 . . . . 0.0 111.56 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.623 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -79.18 148.57 32.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.595 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.7 p-10 -57.0 109.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.462 . . . . 0.0 111.947 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.04 101.54 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.93 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.623 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -154.02 154.46 33.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.969 0.414 . . . . 0.0 110.845 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.405 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.1 OUTLIER -56.66 167.24 0.77 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.964 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.01 129.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.4 m -127.78 108.05 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.311 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.31 128.79 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 5.2 pt-20 -153.75 131.62 11.64 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 111.29 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.11 89.89 3.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.85 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.748 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.878 0.37 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -116.9 145.39 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.173 0.511 . . . . 0.0 112.125 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.35 163.6 15.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.621 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 147.24 31.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -143.93 102.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 127' ' ' VAL . 8.2 ptm180 -100.5 156.36 17.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.446 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 126' ' ' VAL . 6.8 m-85 -139.71 134.9 32.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.72 -29.14 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -125.02 22.45 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.7 153.09 1.37 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.377 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.87 142.79 50.85 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.866 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.81 149.32 12.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.767 0.318 . . . . 0.0 111.475 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -128.77 158.9 37.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.056 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.1 144.16 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.657 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.0 mt-10 -97.47 -178.5 4.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.906 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.1 tp -153.52 148.1 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -125.37 148.14 48.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.692 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -57.54 -8.97 0.96 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.37 -28.3 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.259 -0.276 . . . . 0.0 111.512 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.65 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.77 -56.5 3.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.66 117.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.58 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.77 -34.76 12.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.449 2.1 . . . . 0.0 112.223 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -60.52 -52.0 67.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.616 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -61.01 -45.44 94.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.833 0.349 . . . . 0.0 110.349 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -49.83 -30.41 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.207 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -28.72 70.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.52 39.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.715 0.293 . . . . 0.0 110.979 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.36 -51.46 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.08 -28.64 69.75 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.362 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.44 -24.6 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 51.49 0.93 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -61.71 -160.09 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.622 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 24.6 Cg_exo -27.66 107.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.297 1.998 . . . . 0.0 114.085 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.0 mt -149.62 151.06 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.513 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 136.37 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.05 148.99 33.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.483 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 129.5 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.199 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.937 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -92.79 130.76 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -97.81 133.12 42.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.506 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.949 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -100.05 133.02 45.05 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ASP . 1.9 t90 -157.22 148.32 21.77 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -25.6 87.29 0.01 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.203 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' TRP . 13.0 t70 69.12 -40.94 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 49' ' ' GLY . 15.6 tt0 -62.72 118.99 8.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -129.01 114.68 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.763 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 50.8 p90 -126.37 126.96 44.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.445 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.31 145.99 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 149.75 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.056 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.671 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.71 4.48 8.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.5 OUTLIER 83.2 -8.09 1.14 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.798 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.13 114.97 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.08 94.78 5.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 111.94 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.616 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.6 p -127.62 106.71 15.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.901 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' A' ' 79' ' ' ILE . 1.8 mt-10 -127.92 134.37 49.33 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.966 0.412 . . . . 0.0 111.898 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 13.8 tttp -142.14 165.74 26.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -103.63 88.65 3.12 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.058 0.456 . . . . 0.0 111.33 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.1 tt0 -170.2 161.38 8.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.2 t-20 63.9 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.469 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 13.2 m 30.8 81.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.732 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.901 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.58 157.41 16.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.209 178.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.29 -7.24 10.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.2 144.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.67 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -157.86 156.84 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -99.65 149.03 23.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.03 126.87 2.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.094 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.01 6.1 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.197 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.86 157.38 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.457 0.629 . . . . 0.0 111.945 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -116.32 152.61 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.69 150.94 34.06 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -110.62 132.43 54.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.687 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.747 ' HD1' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -73.62 143.71 46.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.189 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.646 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -94.13 -54.26 0.24 Allowed Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 8.6 Cg_exo -72.3 72.36 2.87 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.529 2.153 . . . . 0.0 111.649 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 143.05 -7.65 2.13 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.513 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 52.57 34.64 16.07 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.977 0.388 . . . . 0.0 110.867 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.84 131.13 55.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.3 mt -89.3 150.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.278 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -141.28 155.73 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.27 0.557 . . . . 0.0 112.259 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.083 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.01 161.59 15.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.482 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 28.2 m-85 -136.48 141.12 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER 175.34 43.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.9 -82.81 0.11 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.154 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -144.37 -168.75 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.469 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.57 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -162.45 -177.96 0.78 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.712 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 80.8 Cg_exo -42.5 -27.53 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.324 2.016 . . . . 0.0 112.81 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.3 mp -131.31 75.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.179 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.57 HG23 ' OG1' ' A' ' 91' ' ' THR . 43.8 mt . . . . . 0 N--CA 1.462 0.139 0 CA-C-O 120.67 0.272 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 12.9 mmm-85 -100.15 99.15 8.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.3 Cg_endo -69.63 -31.69 20.59 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.565 2.177 . . . . 0.0 112.655 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.29 -162.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.93 -9.4 15.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.537 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.31 72.76 0.19 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.747 HG12 ' HD1' ' A' ' 78' ' ' TRP . 19.7 m -121.36 141.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.815 0.341 . . . . 0.0 111.406 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.517 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 30.4 m-20 -85.35 151.47 24.0 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.901 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.67 98.17 7.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.593 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.43 23.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 109.53 -159.94 13.74 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.663 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.869 ' HA ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -143.26 168.19 20.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 111.717 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.94 115.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.601 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.466 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.083 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.12 -27.2 0.12 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.917 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.99 30.01 4.06 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.4 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.949 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.9 m -81.81 154.33 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.943 0.371 . . . . 0.0 111.246 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.33 147.21 34.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 11.2 p-10 -55.35 116.46 2.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.072 0.463 . . . . 0.0 112.14 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.59 103.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.626 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -154.95 149.57 26.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 165.68 0.07 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.189 0.519 . . . . 0.0 112.173 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.937 HG21 ' HB2' ' A' ' 45' ' ' ALA . 43.9 t -158.09 128.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.61 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 127' ' ' VAL . 16.6 m -124.54 107.89 19.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 111.233 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.99 128.6 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.521 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.3 pt-20 -152.12 130.46 12.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.667 0.27 . . . . 0.0 111.261 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.627 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -77.46 95.16 4.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.785 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 40.7 tpp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.518 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -86.04 145.36 27.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.09 156.69 25.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.965 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.51 141.63 36.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.066 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -141.73 100.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.02 156.11 17.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.028 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -133.17 138.58 46.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.322 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.08 -28.83 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 p -123.49 23.0 9.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 150.48 1.29 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.63 140.64 47.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.207 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.53 149.38 9.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.626 0.251 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.46 157.23 25.5 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.514 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.2 141.1 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 111.132 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 12.6 mt-10 -98.75 -178.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.057 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.769 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -151.89 144.43 24.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.09 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -120.76 146.46 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.553 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.44 -9.46 0.71 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -45.93 -27.58 0.93 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.197 -0.315 . . . . 0.0 111.363 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.668 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.6 t90 -80.23 -56.35 4.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 152.48 115.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.665 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -45.55 -36.19 13.53 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.05 -52.85 63.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.723 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.76 -45.66 93.49 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.356 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.769 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.8 t -48.9 -29.55 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.31 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -59.58 -38.54 81.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.63 73.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.671 0.272 . . . . 0.0 111.204 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -53.66 -51.78 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.29 -28.67 69.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.31 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -71.65 -25.02 61.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.373 . . . . 0.0 110.641 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.54 50.96 0.99 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.977 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.955 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 mt -62.42 -160.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.528 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 34.0 Cg_exo -29.35 106.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.191 1.927 . . . . 0.0 113.934 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.5 mt -149.99 149.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.635 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.82 136.78 33.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.097 0.475 . . . . 0.0 111.86 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.589 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.5 p -145.79 149.1 33.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.439 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 122.43 43.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.053 0.454 . . . . 0.0 110.285 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -81.14 132.44 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -104.33 123.84 48.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.597 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.913 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.93 137.33 32.46 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.4 t-105 -149.54 148.54 29.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.348 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.445 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.18 91.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.241 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 48' ' ' TRP . 35.7 t70 78.64 -42.0 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.536 0.334 . . . . 0.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 91' ' ' THR . 4.6 mt-10 -80.5 150.87 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -149.73 115.88 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.574 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.7 p90 -123.4 136.45 54.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 111.969 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 126' ' ' VAL . 5.1 p90 -136.46 145.34 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.522 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.32 146.73 23.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.92 6.96 9.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.8 mt-30 82.07 -7.36 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.722 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.6 p -86.21 115.6 27.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.066 0 CA-C-O 120.79 0.328 . . . . 0.0 110.289 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.68 96.06 6.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.723 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.8 p -123.85 106.66 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.133 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.51 133.36 52.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.959 0.409 . . . . 0.0 111.515 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -147.61 164.48 33.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.261 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -100.54 83.46 2.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 110.757 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.21 154.71 5.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 21.2 t-20 71.67 -78.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.487 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 9.0 t 18.69 81.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.82 164.06 11.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.813 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 69' ' ' VAL . 11.9 p30 -125.61 -5.6 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.551 HG23 ' OD1' ' A' ' 68' ' ' ASP . 39.6 t -131.8 141.92 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.31 157.97 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.59 152.06 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.308 0.575 . . . . 0.0 111.39 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.36 127.1 16.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.124 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.62 -32.33 6.11 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.819 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.439 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.7 p-10 -69.64 162.06 28.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.114 0.483 . . . . 0.0 111.927 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -122.54 152.45 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.911 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.795 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.15 147.14 26.68 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -97.7 121.57 39.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.954 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.5 t90 -64.21 117.77 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.037 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -69.07 -69.5 0.44 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 42.6 Cg_exo -54.73 85.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.796 1.664 . . . . 0.0 111.968 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 128.8 -6.74 6.51 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.647 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.99 37.68 14.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.035 0.417 . . . . 0.0 110.959 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . -113.11 137.0 52.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.678 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.6 mt -86.29 148.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.39 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.7 t -143.15 155.33 44.54 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.31 0.576 . . . . 0.0 112.444 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.808 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -111.89 156.21 22.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.949 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 3.9 m-85 -136.91 127.42 26.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.592 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.7 m-85 -147.57 29.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.343 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 150.47 -150.29 22.29 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.64 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -38.67 170.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.41 -176.44 0.61 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 93' ' ' ILE . 94.3 Cg_exo -43.82 -25.86 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.989 1.792 . . . . 0.0 112.283 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.0 mp -138.31 54.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.149 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.234 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt . . . . . 0 N--CA 1.462 0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -107.58 99.48 29.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.917 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.535 ' HA ' HG21 ' A' ' 91' ' ' THR . 37.5 Cg_endo -64.57 -29.6 61.19 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.491 2.127 . . . . 0.0 112.6 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.71 -164.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.09 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -6.16 23.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.487 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -178.06 80.38 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 101' ' ' ALA . 7.1 m -125.96 142.39 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.703 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 15.1 m-20 -83.19 151.85 25.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.485 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.594 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.04 87.68 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.795 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -72.76 16.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.366 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.01 -149.68 18.76 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.827 ' HA ' HG23 ' A' ' 75' ' ' VAL . 7.3 mtp-105 -156.84 168.08 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 75' ' ' VAL . 6.1 mt -100.28 114.82 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.357 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.626 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.892 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.2 tt . . . . . 0 N--CA 1.464 0.248 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.592 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.69 -27.22 0.16 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.0 32.31 3.53 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.983 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.913 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.6 m -73.11 154.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.605 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -75.91 147.47 38.96 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -58.55 108.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.072 0.463 . . . . 0.0 111.684 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.49 103.45 0.17 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.464 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.605 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -154.46 154.59 33.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.743 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t -53.26 164.16 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 111.748 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.9 t -158.02 128.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.577 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.3 m -126.66 108.11 18.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.94 128.74 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.337 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.7 pt-20 -153.54 130.73 11.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.672 0.272 . . . . 0.0 111.532 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.598 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.09 88.24 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.655 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.818 0.342 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.48 145.44 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.541 . . . . 0.0 112.219 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.18 164.16 15.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.559 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.54 35.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -144.22 103.35 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -102.21 156.36 17.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.501 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 126' ' ' VAL . 13.7 m-85 -138.18 137.71 37.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.763 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.44 -28.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.06 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 p -125.96 22.66 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.43 154.38 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.43 144.44 51.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.851 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.22 149.2 11.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.543 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.62 157.11 39.77 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.159 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.06 138.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mp0 -92.45 -178.53 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.296 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.767 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.0 tp -152.74 146.63 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -123.33 146.53 47.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -57.17 -9.16 0.84 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -45.81 -25.79 0.57 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 122.259 -0.276 . . . . 0.0 111.551 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.651 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.9 t90 -81.14 -56.17 4.26 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 153.19 116.03 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.77 -27.78 5.98 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.488 2.126 . . . . 0.0 112.467 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.05 -43.35 78.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.306 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.718 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -70.25 -46.04 65.22 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.65 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.767 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.4 t -47.53 -29.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -60.36 -38.59 84.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.44 75.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.723 0.296 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -50.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.48 -27.23 69.13 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.39 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.838 0.351 . . . . 0.0 110.721 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.06 49.46 1.01 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.892 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.961 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.8 mt -61.82 -159.94 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.592 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.961 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.3 Cg_exo -28.52 106.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.158 1.905 . . . . 0.0 114.081 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.8 mt -149.28 149.66 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.507 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -85.91 134.09 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.965 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -145.32 149.57 35.06 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.61 132.7 47.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.953 ' HB1' ' NH2' ' A' ' 47' ' ' ARG . . . -90.66 137.32 32.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -106.8 120.11 41.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.277 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.953 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.69 127.25 34.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.7 t-105 -146.71 148.43 31.99 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -34.41 93.02 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.196 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 25.3 t70 72.03 -38.29 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.306 0.242 . . . . 0.0 111.585 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -78.94 139.38 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 110.875 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.57 HG12 ' NH2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -144.64 112.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.668 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 40.6 p90 -123.78 139.68 53.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.5 p90 -141.3 142.85 33.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.447 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -91.38 145.94 24.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.695 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.92 4.96 10.92 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 82.63 -7.38 1.27 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -85.56 116.08 28.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.59 94.87 6.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 111.707 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.3 p -124.88 106.58 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.327 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -133.57 132.33 40.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.962 0.41 . . . . 0.0 111.442 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 163.76 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.47 88.15 5.82 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.878 0.37 . . . . 0.0 110.753 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.14 148.01 3.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 28.9 t-20 72.04 -83.18 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.463 0.173 . . . . 0.0 110.981 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.659 ' OG ' HD12 ' A' ' 79' ' ' ILE . 2.1 m 23.16 82.11 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.791 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.68 162.66 12.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.282 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' A' ' 69' ' ' VAL . 7.1 p30 -122.5 -0.09 9.3 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.662 HG23 ' OD1' ' A' ' 68' ' ' ASP . 47.2 t -138.53 145.36 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.101 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.75 158.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -94.05 150.81 20.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.16 124.96 7.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.35 -29.73 7.44 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.364 -0.922 . . . . 0.0 114.703 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 2.8 p30 -78.57 156.98 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.593 0.697 . . . . 0.0 111.921 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -111.06 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.3 150.34 32.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.977 0.417 . . . . 0.0 111.658 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.506 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -105.46 131.65 52.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.404 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.684 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -71.99 113.07 8.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -68.25 -66.16 1.17 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.621 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.39 80.28 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.932 1.755 . . . . 0.0 111.663 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.48 -8.13 3.13 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.596 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.18 37.2 17.72 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.857 0.361 . . . . 0.0 111.126 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.45 137.51 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.79 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 3.7 mt -87.58 147.64 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.43 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.3 m -142.86 131.53 22.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.02 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.99 159.78 18.87 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.373 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 35.0 m-85 -136.63 132.51 35.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.21 0.529 . . . . 0.0 111.878 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CB ' ' HG2' ' A' ' 118' ' ' LYS . 1.4 m-85 -165.21 33.32 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.057 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.22 -150.53 21.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.388 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.19 -172.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.458 0.647 . . . . 0.0 112.131 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.83 -176.11 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.522 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 66.2 Cg_exo -41.81 -25.29 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.273 1.982 . . . . 0.0 113.042 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -146.65 67.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 111.678 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.299 0 CA-C-O 121.166 0.508 . . . . 0.0 110.483 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.411 HG23 ' OG1' ' A' ' 91' ' ' THR . 78.2 mt . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.874 0.368 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 93' ' ' ILE . 1.8 mtt85 -117.74 99.54 52.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.707 ' HA ' HG21 ' A' ' 91' ' ' THR . 58.7 Cg_endo -69.73 -31.31 20.89 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.6 2.2 . . . . 0.0 112.564 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.569 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.11 -160.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.807 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -5.23 14.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.565 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.43 73.98 0.11 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 78' ' ' TRP . 21.2 m -124.02 140.46 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 111.477 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.527 ' HB3' ' ND2' ' A' ' 65' ' ' ASN . 6.0 m-20 -84.66 150.37 25.18 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.791 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.59 100.35 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.553 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -85.02 21.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.2 -129.46 8.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.192 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.864 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 ptt180 -170.4 167.19 8.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.04 0.448 . . . . 0.0 111.484 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -93.06 116.37 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.667 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.038 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.02 HD22 HD13 ' A' ' 86' ' ' LEU . 4.5 tp . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.492 0.186 . . . . 0.0 111.058 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.6 -21.32 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -89.92 30.68 5.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.705 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.6 m -81.28 153.65 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 122.232 0.213 . . . . 0.0 111.34 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.63 143.47 46.3 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 4.6 p-10 -51.07 131.98 27.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.07 100.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.347 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -148.1 154.25 39.96 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 t -63.13 168.34 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.436 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.84 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.3 t -157.97 128.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.955 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -125.27 106.59 16.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 110.718 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.85 129.07 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.822 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 3.5 pt-20 -151.41 126.94 10.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.663 0.268 . . . . 0.0 111.327 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.699 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.36 92.16 2.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.817 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.743 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.229 0.024 0 CA-C-O 121.007 0.432 . . . . 0.0 111.037 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.536 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -84.09 145.47 28.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.754 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.76 164.05 15.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.104 179.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 144.09 33.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.11 100.39 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 109.963 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 156.04 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.965 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.0 m-85 -134.6 142.64 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.025 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.3 -29.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 49.7 m -126.2 20.89 7.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -179.13 155.92 0.75 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.37 148.89 30.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.9 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.65 150.05 11.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.46 156.54 18.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.759 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.22 140.19 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.7 mt-10 -90.91 -178.48 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.657 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.2 tp -147.73 136.26 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.077 0.465 . . . . 0.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -118.84 141.0 49.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.619 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.6 -8.95 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -45.38 -29.0 0.96 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.295 -0.253 . . . . 0.0 111.31 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.649 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -78.3 -56.69 4.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.57 118.54 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.775 178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.42 -33.31 12.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.436 2.091 . . . . 0.0 112.338 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.38 -52.27 66.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.848 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.31 -44.12 84.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.82 0.343 . . . . 0.0 110.419 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 23' ' ' LEU . 75.8 t -44.62 -31.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.347 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -64.45 -38.32 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -63.93 -47.65 79.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -55.77 -52.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.15 -27.48 69.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.43 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.26 -25.39 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.57 50.71 1.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.797 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.963 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -61.73 -160.04 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.612 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.963 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.5 Cg_exo -28.95 103.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.116 1.877 . . . . 0.0 113.887 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 18.5 mt -145.74 151.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.567 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 136.69 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.089 0.471 . . . . 0.0 111.604 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -145.1 148.91 34.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.94 127.19 48.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.037 0.446 . . . . 0.0 110.313 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.913 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -87.03 136.13 33.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -108.34 122.97 48.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.39 138.27 35.62 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 10.9 t-105 -153.87 148.95 26.83 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.862 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.03 94.51 0.01 OUTLIER Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.524 -0.37 . . . . 0.0 113.781 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.503 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 3.7 m-20 51.85 25.42 2.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.896 0.379 . . . . 0.0 111.578 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.4 OUTLIER -136.2 138.91 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.149 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -137.29 119.93 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.225 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.2 p90 -128.5 126.94 41.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.8 p90 -135.49 145.93 47.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.94 149.65 21.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.727 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.22 7.9 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.41 -8.77 1.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.722 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.8 p -86.31 114.0 25.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.19 94.99 5.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 31' ' ' THR . 3.2 p -122.79 106.78 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.879 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.95 125.26 54.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -140.83 165.32 27.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.3 pm0 -113.84 91.34 3.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.043 0.449 . . . . 0.0 111.023 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.5 tt0 -170.38 157.07 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 34.8 t-20 64.21 -81.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.081 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.46 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.5 m 31.88 82.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.212 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.764 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.43 154.9 18.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.589 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -119.78 -4.75 10.19 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -126.32 140.45 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.528 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 32.8 m -158.39 157.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.594 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -96.03 149.7 21.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.485 0.66 . . . . 0.0 111.732 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.26 126.76 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.002 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.19 -30.08 7.27 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.366 -0.921 . . . . 0.0 114.636 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.445 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -80.64 156.64 26.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.533 0.666 . . . . 0.0 112.032 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -116.34 152.4 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.283 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.01 151.1 30.72 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.971 -0.455 . . . . 0.0 111.696 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -106.9 132.58 52.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.679 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.582 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -68.49 120.81 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.648 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.07 -68.44 0.53 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.049 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 33.9 Cg_endo -63.62 75.8 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.165 1.91 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.67 -9.98 1.88 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.71 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.0 32.23 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.061 0.43 . . . . 0.0 111.161 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.97 131.04 55.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.221 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 10.0 mt -88.16 144.24 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.98 134.53 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.43 158.8 19.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.896 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 36.1 m-85 -136.62 117.11 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.546 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER -163.7 52.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.18 -78.72 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.721 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.503 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -147.26 -169.47 3.32 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.479 0.657 . . . . 0.0 111.93 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -154.44 174.89 3.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.035 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -39.1 -25.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.696 2.264 . . . . 0.0 113.129 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . 2.1 mp -137.69 62.71 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 121.162 0.506 . . . . 0.0 110.375 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.2 mt . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 99.22 8.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.022 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.901 ' HA ' HG21 ' A' ' 91' ' ' THR . 55.4 Cg_endo -69.33 -31.12 23.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.515 2.144 . . . . 0.0 112.584 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.33 -161.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -6.99 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.83 71.11 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.6 m -117.69 141.49 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.555 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.691 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.9 m120 -81.88 150.29 27.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.278 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.97 82.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.688 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.7 18.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 119.12 -153.21 16.98 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.944 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.824 ' HA ' HG23 ' A' ' 75' ' ' VAL . 33.3 mtp180 -156.23 167.17 31.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.58 HG13 HG21 ' A' ' 75' ' ' VAL . 5.0 mt -98.83 114.96 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.36 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.398 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.883 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.7 tt . . . . . 0 N--CA 1.463 0.191 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.88 -22.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.405 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -92.24 36.1 3.79 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 117' ' ' LEU . 6.4 m -69.19 154.87 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 122.513 0.325 . . . . 0.0 111.535 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.95 145.93 44.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.3 p-10 -57.88 121.24 10.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.122 0.487 . . . . 0.0 111.921 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.93 101.46 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.46 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.35 150.78 28.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.14 165.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.222 0.535 . . . . 0.0 111.904 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.5 t -157.74 128.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.312 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.5 m -127.3 108.49 18.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.978 0.418 . . . . 0.0 111.46 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.727 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.9 129.17 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.356 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.0 pt-20 -153.82 129.06 9.73 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.576 0.227 . . . . 0.0 111.344 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.548 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.5 89.45 1.68 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 110.785 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.649 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.718 0.294 . . . . 0.0 111.043 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 145.43 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.131 0.491 . . . . 0.0 112.135 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.8 163.5 17.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.851 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 146.47 29.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.739 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.4 mt -147.32 100.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 109.787 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -104.79 156.0 18.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.635 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -130.76 138.55 50.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.448 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.77 -29.01 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -124.22 23.04 8.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.42 154.18 1.63 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -114.81 151.86 33.13 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.68 151.14 16.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.866 0.365 . . . . 0.0 111.779 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -137.53 150.4 47.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.87 143.76 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.138 0.494 . . . . 0.0 112.012 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.456 ' OE2' HG21 ' A' ' 111' ' ' VAL . 6.7 mt-10 -95.48 -178.38 4.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.199 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.6 tp -150.07 134.73 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.973 0.416 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -116.73 139.25 50.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.566 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CD ' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -60.76 -8.46 3.02 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -44.66 -29.49 0.76 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.07 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.754 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -76.54 -56.01 5.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 163.2 116.05 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.739 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -46.58 -36.99 19.6 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.375 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -49.59 76.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.458 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -61.2 -44.5 97.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.757 0.313 . . . . 0.0 110.27 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.856 HG13 ' CD2' ' A' ' 23' ' ' LEU . 90.9 t -46.74 -37.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.693 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -33.35 71.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.009 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.41 -47.43 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.99 -50.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.75 -29.39 70.65 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.261 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -70.55 -25.74 63.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.12 51.96 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.25 -159.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.62 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.989 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.4 Cg_exo -27.8 105.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.083 1.855 . . . . 0.0 114.085 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.7 mt -145.16 149.11 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.366 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -85.9 133.64 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 111.887 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.64 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.9 p -142.33 149.02 38.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.299 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 131.33 48.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.354 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -92.05 135.54 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -106.92 122.88 47.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.061 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.837 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.18 137.04 34.21 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' HB3' ' A' ' 51' ' ' GLU . 12.7 t-105 -152.26 149.13 28.36 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.866 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.54 92.82 0.01 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.666 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER 53.27 25.98 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' CD1' ' A' ' 48' ' ' TRP . 8.5 tp10 -136.77 139.36 41.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.952 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.612 HG21 HD21 ' A' ' 117' ' ' LEU . 0.7 OUTLIER -139.18 122.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.593 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 50.8 p90 -130.04 123.37 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -133.15 145.38 50.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 146.48 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.698 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -117.85 5.61 12.22 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.3 mt-30 82.34 -8.2 1.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -87.23 115.43 27.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.61 94.79 5.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 111.911 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 31' ' ' THR . 3.5 p -131.53 106.73 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.299 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -130.16 133.18 46.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 53.4 tttt -140.8 164.77 29.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.291 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -99.14 90.87 4.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 0.0 110.966 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 5.9 tt0 -170.16 157.88 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.599 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 24.7 t-20 62.74 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.906 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 31.99 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.297 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.825 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -101.95 158.06 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.282 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -124.11 0.38 8.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 70' ' ' VAL . 3.3 p -126.71 138.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.616 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.6 m -160.56 164.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.784 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.84 158.8 31.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.086 0.47 . . . . 0.0 110.769 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -38.56 129.67 1.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.24 -31.31 6.52 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.059 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.2 p30 -88.73 156.36 19.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 112.327 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.875 HG23 ' HA ' ' A' ' 109' ' ' ARG . 25.7 t -119.13 152.55 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.078 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.06 150.14 34.47 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.807 -0.558 . . . . 0.0 112.472 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.58 126.78 53.96 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.168 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.713 ' HD1' HG12 ' A' ' 104' ' ' VAL . 3.6 t90 -67.2 112.65 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.754 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -67.19 -61.1 5.06 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.786 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 14.8 Cg_exo -67.98 66.27 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.232 1.955 . . . . 0.0 111.807 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.68 -11.45 0.3 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.034 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.62 27.49 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.306 0.553 . . . . 0.0 110.957 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.92 55.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.522 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.8 mt -88.05 143.38 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.331 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.7 132.39 36.85 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.807 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.89 161.07 18.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.168 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 20.8 m-85 -136.25 125.78 25.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -163.88 54.54 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.209 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -75.1 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.372 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -158.83 174.02 15.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.796 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.645 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -134.77 -175.11 0.45 Allowed Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.645 ' CD ' HG22 ' A' ' 91' ' ' THR . 84.4 Cg_exo -47.93 -22.46 3.42 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.017 1.811 . . . . 0.0 112.724 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.69 68.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.862 0.363 . . . . 0.0 111.722 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 N--CA 1.456 -0.153 0 CA-C-O 120.915 0.388 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -98.44 99.86 8.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 69.1 Cg_endo -70.57 -32.48 15.13 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.668 2.245 . . . . 0.0 112.969 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.05 -154.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.697 0.284 . . . . 0.0 110.879 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 -5.04 10.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.552 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.96 67.06 0.08 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' HD1' ' A' ' 78' ' ' TRP . 14.9 m -118.14 142.42 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.777 0.322 . . . . 0.0 111.552 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.509 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m120 -84.28 152.99 23.81 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.825 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -85.57 86.56 2.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.725 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.55 23.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.97 -149.57 18.51 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.996 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.875 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.2 mtt85 -155.31 166.42 33.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 75' ' ' VAL . 4.2 mt -99.85 114.43 38.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.456 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.475 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.807 HD22 HD13 ' A' ' 86' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.797 0.332 . . . . 0.0 111.171 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -85.88 28.97 4.76 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.492 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.837 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.5 m -83.16 154.26 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.937 0.368 . . . . 0.0 111.534 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.646 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -80.53 148.76 30.26 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.619 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.1 p-10 -58.06 112.02 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.994 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.76 100.89 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.728 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.646 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -155.28 153.84 31.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 178.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.6 t -56.96 168.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.535 . . . . 0.0 111.894 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.884 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.0 t -157.88 128.84 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.06 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.9 m -127.59 108.63 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 111.473 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.21 129.04 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.4 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -152.92 130.16 11.24 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.709 0.29 . . . . 0.0 111.204 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.577 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.41 88.99 2.1 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.689 179.906 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.839 0.352 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -108.68 145.3 35.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 163.75 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.703 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 144.89 34.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.89 100.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -100.8 156.13 17.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.122 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.83 141.28 49.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.204 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.47 -28.89 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -126.05 22.96 7.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.23 151.3 2.03 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 142.12 45.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.26 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.74 149.24 9.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -115.28 157.82 23.22 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.87 137.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.044 0.449 . . . . 0.0 111.439 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 14.6 mt-10 -92.51 -178.65 4.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.268 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.834 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.3 tp -153.22 150.42 28.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.465 ' H ' HD12 ' A' ' 23' ' ' LEU . 21.8 m-85 -129.23 147.95 51.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.027 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -58.21 -8.63 1.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.35 -29.2 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.85 0.296 . . . . 0.0 111.355 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.633 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -80.92 -56.32 4.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 160.3 117.09 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.474 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.76 -35.86 18.37 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.6 -47.7 82.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.95 -44.37 96.25 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.78 0.324 . . . . 0.0 110.397 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 ' CD2' ' A' ' 23' ' ' LEU . 46.3 t -50.05 -34.64 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -59.44 -37.01 77.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.79 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.04 -51.54 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.46 -28.71 70.0 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.65 -25.37 62.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 51.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.784 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.4 mt -61.58 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.539 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 25.6 Cg_exo -27.8 104.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.275 1.983 . . . . 0.0 114.033 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 39' ' ' LEU . 19.5 mt -145.57 151.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.309 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -85.72 136.57 33.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.064 0.459 . . . . 0.0 111.871 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.639 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -146.0 148.86 33.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.41 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.02 130.48 48.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.44 135.84 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -108.12 125.2 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.182 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.45 138.42 34.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 14.8 t-105 -154.17 148.95 26.53 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.069 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.13 99.86 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.768 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 45.62 30.15 0.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.382 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.78 143.35 33.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.118 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -139.49 123.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 23.4 p90 -130.64 132.36 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.6 p90 -140.87 146.11 37.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.986 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.69 149.45 22.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.158 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.799 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.18 5.92 9.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG3' ' C ' ' A' ' 56' ' ' THR . 12.1 mt-30 80.94 -7.07 1.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.716 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.22 114.95 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.76 94.89 5.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.7 p -127.06 106.69 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.724 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.561 ' HG2' HG22 ' A' ' 79' ' ' ILE . 2.5 mt-10 -125.28 134.98 52.07 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.082 0.467 . . . . 0.0 111.929 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 6.9 ttmt -144.55 165.62 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.165 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.68 90.74 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.021 0.438 . . . . 0.0 110.947 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.4 160.22 7.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.77 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 31.7 t-20 64.03 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.096 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.459 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 2.1 m 30.49 81.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.646 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.976 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -100.47 156.71 17.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.73 -7.81 10.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.38 142.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.386 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -157.74 156.23 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.108 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.36 151.04 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.354 0.597 . . . . 0.0 111.368 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -48.16 126.39 10.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.214 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -31.99 6.21 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.093 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.484 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p-10 -70.04 163.17 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 112.085 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.743 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -121.41 152.02 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.074 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB3' ' HE2' ' A' ' 87' ' ' PHE . . . -149.58 152.36 35.36 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.463 0.574 . . . . 0.0 112.125 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -111.04 131.28 55.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.449 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.763 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -73.03 146.62 45.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -96.3 -53.14 0.22 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.522 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.652 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 6.9 Cg_exo -73.86 70.74 4.3 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.696 2.264 . . . . 0.0 111.623 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.409 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 144.38 -8.33 1.86 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.556 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 53.1 34.1 16.52 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.857 0.361 . . . . 0.0 110.827 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.76 130.85 55.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.167 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 6.4 mt -85.83 151.51 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.0 135.15 32.42 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.25 161.74 18.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.029 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 54.1 m-85 -136.25 118.61 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.499 . . . . 0.0 111.782 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.6 m-85 -157.43 30.35 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.851 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.55 -152.74 23.53 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.36 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -54.0 -173.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.507 0.67 . . . . 0.0 112.086 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -157.47 -173.54 0.38 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.81 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 72.9 Cg_exo -42.15 -23.63 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.976 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.38 87.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.817 179.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.391 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.703 HG23 ' OG1' ' A' ' 91' ' ' THR . 87.2 mt . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 120.654 0.264 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -101.73 99.21 11.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 91' ' ' THR . 57.9 Cg_endo -70.44 -31.22 17.87 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.508 2.139 . . . . 0.0 112.645 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -163.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -10.5 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.407 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -164.81 72.1 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.763 HG12 ' CD1' ' A' ' 78' ' ' TRP . 22.2 m -119.13 140.15 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.337 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.471 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 37.2 m-20 -84.91 148.14 26.4 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.976 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.18 97.82 5.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.064 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.637 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -82.96 21.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.31 -149.18 18.71 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.206 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.9 mtt180 -152.92 167.67 28.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.061 0.458 . . . . 0.0 111.362 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.672 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -100.44 114.3 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.342 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.593 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.95 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.2 tt . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.491 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.34 -26.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.28 38.35 3.23 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.566 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.95 HG13 ' O ' ' A' ' 117' ' ' LEU . 8.6 m -74.4 154.74 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 122.393 0.277 . . . . 0.0 111.465 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.98 146.09 44.11 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 6.1 p-10 -59.59 115.35 3.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 111.901 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.32 100.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.65 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -154.27 150.75 28.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.881 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -52.79 166.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -157.81 129.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.433 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 127' ' ' VAL . 17.6 m -128.14 108.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.62 128.93 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.27 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 4.5 pt-20 -152.9 130.88 11.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.636 0.255 . . . . 0.0 111.339 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.565 ' CB ' HD22 ' A' ' 39' ' ' LEU . 5.9 tmm_? -75.22 92.91 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.686 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.832 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.784 0.325 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -110.1 145.47 37.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.0 112.314 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 164.78 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 145.96 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -145.03 100.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -102.29 156.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.511 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.545 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.6 m-85 -134.71 137.79 43.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.384 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.44 -29.05 0.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.95 23.07 7.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.77 151.45 2.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -125.65 141.34 52.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.963 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 149.13 11.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.53 159.27 36.02 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.146 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.83 140.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 111.747 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mt-10 -94.28 -178.61 4.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.792 ' CD2' HG13 ' A' ' 32' ' ' VAL . 5.3 tp -153.98 148.27 25.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.087 0.47 . . . . 0.0 111.284 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.06 148.45 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.635 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.27 -9.01 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.61 -27.68 0.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.249 -0.282 . . . . 0.0 111.533 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.07 -56.62 3.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.07 110.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -40.48 -30.0 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.817 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.78 -49.84 73.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.447 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -65.42 -45.66 83.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.39 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.792 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -47.87 -29.01 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.32 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -65.35 -38.64 90.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.09 74.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.21 -51.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.598 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.54 -29.53 70.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.16 -25.48 62.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.976 0.417 . . . . 0.0 110.611 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 51.92 1.0 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.986 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.22 -159.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.312 -0.852 . . . . 0.0 109.682 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.986 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.4 Cg_exo -27.58 105.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.216 1.944 . . . . 0.0 114.006 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.5 mt -146.5 150.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.498 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -86.27 134.12 33.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.7 p -142.06 149.1 39.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.75 128.24 48.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.398 . . . . 0.0 110.319 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.934 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.0 131.94 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -100.86 122.63 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.725 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.917 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.81 136.53 32.95 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.6 t-105 -155.01 148.62 25.36 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.833 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -33.22 86.92 0.01 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.294 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' TRP . 18.1 t0 72.68 -35.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.47 0.308 . . . . 0.0 111.512 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 91' ' ' THR . 6.0 tm-20 -73.86 133.57 43.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -138.87 125.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.203 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -137.14 128.79 28.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.374 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.6 p90 -135.51 145.97 47.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.59 147.89 22.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.607 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.63 7.91 10.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.3 mt-30 80.07 -6.34 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.654 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -88.53 115.13 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.708 0.29 . . . . 0.0 110.317 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.7 94.91 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.761 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.1 p -129.98 106.55 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.202 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.88 133.93 48.1 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.014 0.435 . . . . 0.0 111.667 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 159.22 42.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.149 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -92.81 88.8 6.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.386 0.612 . . . . 0.0 111.127 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.33 159.66 7.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.475 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.3 t-20 64.07 -82.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.3 t 27.82 82.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.325 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.908 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.65 17.22 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.37 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.764 ' OD1' HG23 ' A' ' 69' ' ' VAL . 2.8 p30 -117.33 -6.53 11.26 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.764 HG23 ' OD1' ' A' ' 68' ' ' ASP . 27.3 t -131.99 144.91 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.204 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.542 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.06 157.85 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.814 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -94.72 151.12 19.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.357 0.599 . . . . 0.0 111.638 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -45.95 125.75 6.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.979 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.4 -31.41 6.43 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.487 -0.863 . . . . 0.0 114.525 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.471 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p30 -75.91 156.56 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.464 0.632 . . . . 0.0 112.188 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.2 t -114.23 152.59 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.97 149.69 31.6 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.44 129.02 50.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.993 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.645 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -69.5 117.89 11.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.986 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -65.66 -72.07 0.3 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.549 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 34.1 Cg_endo -63.43 80.45 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.081 1.854 . . . . 0.0 112.12 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.82 -11.17 2.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.732 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.98 31.46 11.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.066 0.433 . . . . 0.0 110.902 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.92 133.56 52.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.462 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.59 145.94 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.434 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 17.4 t -139.12 156.27 47.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.258 0.551 . . . . 0.0 112.389 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.023 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.47 156.03 20.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.263 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.6 m-85 -136.69 127.24 26.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 111.23 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.98 49.72 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 165.18 -82.35 0.11 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.1 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -154.14 176.39 12.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.119 0.485 . . . . 0.0 111.69 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.681 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -144.15 -174.26 0.4 Allowed Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.238 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.58 ' CD ' HG22 ' A' ' 91' ' ' THR . 99.6 Cg_exo -45.17 -22.74 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.012 1.808 . . . . 0.0 112.598 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 77.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.042 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.7 mt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.859 0.361 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.32 99.36 8.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.681 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.8 Cg_endo -69.3 -31.14 23.18 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.467 2.112 . . . . 0.0 112.638 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.01 -163.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -3.4 20.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.58 77.4 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 78' ' ' TRP . 19.3 m -127.52 142.04 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.722 0.296 . . . . 0.0 111.68 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m-20 -86.31 153.66 21.81 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.908 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.62 99.48 7.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.654 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.47 22.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.36 -147.77 18.9 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.07 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.877 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 mtt180 -156.52 168.13 28.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 111.416 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.5 mt -100.4 114.94 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.165 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.593 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.023 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.462 0.166 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.45 -22.8 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -88.21 27.78 6.63 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.917 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.4 m -79.18 153.95 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.765 0.283 . . . . 0.0 111.247 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.64 146.99 29.77 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.2 p-10 -53.75 117.81 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.34 98.64 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.007 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -150.61 146.4 26.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.993 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.2 164.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 112.268 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.9 t -158.14 128.45 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 127' ' ' VAL . 22.7 m -125.34 108.35 19.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 0.0 111.402 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.04 128.7 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.407 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.3 pt-20 -152.86 130.74 11.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.582 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.38 91.43 3.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.858 0.361 . . . . 0.0 110.809 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HB3' ' NH2' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.081 0 CA-C-O 120.892 0.377 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.71 145.31 40.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.153 0.501 . . . . 0.0 111.926 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.9 163.9 15.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.932 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 143.63 38.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.825 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.603 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.72 100.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -99.98 156.32 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.78 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.569 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.8 m-85 -136.82 137.99 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.697 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.79 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 22.19 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.79 151.37 1.41 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.63 143.43 48.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.179 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.84 149.01 10.68 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.308 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -119.25 156.05 30.63 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.437 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.71 144.41 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 111.083 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 5.9 mt-10 -99.18 -178.27 3.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.813 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -151.37 144.4 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.078 0.466 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -125.24 145.99 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.594 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.32 -9.04 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -45.66 -28.08 0.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.743 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.2 t90 -80.03 -56.08 4.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.14 115.88 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.675 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.76 -34.82 16.42 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 112.49 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.78 -50.85 71.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.394 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.743 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.02 -45.42 92.42 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 23' ' ' LEU . 84.2 t -46.65 -32.66 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.429 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -58.99 -38.7 79.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.482 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.9 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -54.66 -51.55 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.11 -27.92 69.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 110.211 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -71.74 -25.57 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.562 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.25 49.95 1.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.063 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -62.42 -160.08 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.312 -0.851 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 38.9 Cg_exo -29.85 107.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.125 1.883 . . . . 0.0 113.85 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.5 mt -150.02 148.54 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.638 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.92 136.07 33.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.101 0.477 . . . . 0.0 111.953 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.2 p -146.03 148.65 32.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 125.82 49.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.162 0.506 . . . . 0.0 110.376 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.904 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -85.55 132.46 34.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.042 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -100.39 128.19 46.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.56 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.957 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -90.26 135.15 33.85 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 50' ' ' ASP . 10.1 t-105 -154.5 148.43 25.64 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.888 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.47 85.75 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.632 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 48' ' ' TRP . 36.6 t70 74.09 -38.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.882 0.326 . . . . 0.0 111.882 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.4 124.19 24.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 111.114 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -126.74 111.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 110.179 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 43.7 p90 -122.48 134.06 54.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.068 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.2 p90 -140.15 145.61 37.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.599 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 147.58 22.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.739 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.38 6.48 9.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 83.45 -8.13 1.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -85.1 115.43 26.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.136 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.01 94.82 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.064 0.459 . . . . 0.0 112.029 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.4 p -120.66 106.68 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.139 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -120.2 136.43 54.64 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.25 163.4 39.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.205 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -104.62 87.02 2.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -170.13 149.69 3.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.4 t-20 72.03 -82.66 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.523 0.202 . . . . 0.0 111.273 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.7 m 27.46 82.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.77 156.18 17.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.457 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -121.25 -3.25 9.49 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.1 p -127.65 140.01 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.513 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.535 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.1 m -158.7 157.55 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.544 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.2 150.67 19.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.49 0.662 . . . . 0.0 111.719 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -45.0 126.09 5.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.964 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -30.77 6.82 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.599 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.452 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.01 157.06 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.528 0.664 . . . . 0.0 111.978 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.821 HG23 ' HA ' ' A' ' 109' ' ' ARG . 17.8 t -115.96 152.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.52 151.23 31.31 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 121.86 -0.525 . . . . 0.0 112.41 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.588 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -102.19 123.99 47.0 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.075 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 104' ' ' VAL . 4.1 t90 -66.57 119.02 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.901 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.765 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -69.53 -71.01 0.3 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.601 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.765 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.48 83.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.628 1.552 . . . . 0.0 111.705 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 133.6 -8.35 4.95 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.416 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.66 39.79 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.841 0.353 . . . . 0.0 111.24 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.15 135.17 54.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.77 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 36.8 mt -84.35 145.3 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.42 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 m -140.69 132.42 27.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.724 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.63 158.0 19.57 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.1 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 23.7 m-85 -136.67 115.17 11.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 111.369 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.563 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -156.53 39.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' HD11 ' A' ' 98' ' ' ILE . . . 172.07 -89.16 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.934 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.47 -169.08 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 111.499 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -152.29 -177.68 0.74 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.558 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.611 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.9 Cg_exo -47.49 -16.9 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 121.968 1.779 . . . . 0.0 112.896 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 99' ' ' ARG . 6.0 pt -145.75 62.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 89' ' ' GLY . 78.6 mt . . . . . 0 CA--C 1.523 -0.096 0 CA-C-O 120.802 0.334 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -99.35 99.16 7.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.899 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -69.16 -31.21 23.68 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.473 2.115 . . . . 0.0 112.491 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.736 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.66 -158.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.776 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -6.96 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.779 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.48 69.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 101' ' ' ALA . 6.2 m -116.8 142.83 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.827 0.346 . . . . 0.0 111.65 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.756 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -83.18 151.31 25.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.595 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.647 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -87.08 86.95 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.69 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.03 18.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.509 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.94 -150.91 18.52 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.678 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.821 ' HA ' HG23 ' A' ' 75' ' ' VAL . 32.4 mtp180 -156.37 168.19 28.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.187 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mt -95.27 113.61 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.463 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.418 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.753 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.4 tt . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.617 0.246 . . . . 0.0 111.424 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.53 -24.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -94.59 37.69 3.34 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.841 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.957 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.5 m -79.01 154.47 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.728 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.74 148.48 33.01 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.307 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.641 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.2 p-10 -50.72 110.84 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.37 111.62 0.04 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.314 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.46 139.05 15.98 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.561 0.219 . . . . 0.0 110.701 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.9 t -40.75 161.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.111 0.482 . . . . 0.0 112.0 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 45' ' ' ALA . 41.8 t -154.17 128.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.4 m -126.57 108.09 18.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 120.86 0.362 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.8 128.76 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 pt-20 -153.28 129.64 10.57 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.622 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.64 88.75 2.21 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.695 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.703 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.827 0.346 . . . . 0.0 110.971 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.87 145.42 38.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.851 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.73 162.31 18.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.828 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 142.95 34.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.824 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.26 101.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 109.824 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -102.03 156.77 17.33 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.778 0.799 . . . . 0.0 112.501 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -134.56 137.45 43.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -28.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 p -124.79 22.24 8.19 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.09 150.76 1.22 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.28 144.05 48.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.127 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.57 148.31 7.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.56 155.96 26.63 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.675 0.274 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.2 138.57 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.972 0.415 . . . . 0.0 111.258 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.479 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 1.3 mt-10 -95.1 -178.39 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.3 tp -154.34 146.37 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -126.76 147.71 49.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.853 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -56.28 -9.27 0.63 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.55 -28.78 1.01 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.857 0.298 . . . . 0.0 111.296 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.643 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.9 t90 -80.81 -56.27 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.6 113.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.688 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -46.65 -35.9 17.97 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.456 2.104 . . . . 0.0 112.577 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.96 -51.94 67.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.712 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.18 -45.81 90.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.835 0.35 . . . . 0.0 110.503 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 59.3 t -46.16 -30.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.226 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -60.14 -38.95 84.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.101 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.15 84.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.5 -49.29 78.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.195 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.27 -27.17 68.86 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.249 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.13 -24.49 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.631 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.19 49.39 1.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.0 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.16 -159.97 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.356 -0.831 . . . . 0.0 109.592 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.941 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 39.0 Cg_exo -29.87 106.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.132 1.888 . . . . 0.0 114.085 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.11 149.44 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.621 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -85.92 134.95 33.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.003 0.43 . . . . 0.0 111.669 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.573 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 6.0 p -143.6 149.27 37.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.696 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.76 121.27 41.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 110.212 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -80.42 131.26 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -102.68 123.83 47.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.593 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.926 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.19 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -151.5 148.51 28.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.236 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -35.08 91.67 0.01 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.029 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 29.3 t70 75.94 -41.15 0.42 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.683 0.393 . . . . 0.0 111.309 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.06 143.1 41.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.438 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -146.81 114.9 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.529 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -126.27 133.34 51.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.144 0.497 . . . . 0.0 112.038 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 126' ' ' VAL . 4.5 p90 -131.63 143.84 50.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.369 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 142.91 26.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.665 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.82 8.48 11.14 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.7 mt-30 80.74 -6.33 1.66 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.4 p -83.94 115.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.4 106.59 17.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.747 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.712 HG21 HG22 ' A' ' 31' ' ' THR . 3.6 p -137.08 106.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.395 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.73 133.65 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.91 0.386 . . . . 0.0 111.254 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -153.92 165.09 37.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.335 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.16 88.35 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -170.08 149.13 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.0 t-20 69.24 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.522 0.201 . . . . 0.0 111.162 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.3 m 24.73 82.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.53 17.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.518 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -120.72 -3.6 9.76 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -127.83 140.11 50.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.494 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 30.5 m -159.02 157.89 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.759 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -93.84 152.06 19.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.424 0.63 . . . . 0.0 111.684 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.64 126.49 10.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -28.86 8.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.131 -1.033 . . . . 0.0 114.63 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.422 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.0 p30 -80.14 156.11 27.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.641 0.72 . . . . 0.0 111.988 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.842 HG23 ' HA ' ' A' ' 109' ' ' ARG . 22.3 t -114.03 152.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.29 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.25 145.4 24.61 Favored 'General case' 0 C--N 1.342 0.249 0 O-C-N 121.9 -0.5 . . . . 0.0 112.169 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.84 137.26 36.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.167 179.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.47 121.97 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.622 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -72.89 -70.19 0.28 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 79.3 Cg_exo -33.14 -62.96 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.155 2.57 . . . . 0.0 113.845 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.68 -1.46 90.01 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.262 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.77 26.97 8.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.983 0.42 . . . . 0.0 110.485 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.99 137.76 46.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.638 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.63 148.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.604 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -143.26 155.24 44.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.285 0.564 . . . . 0.0 112.486 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.877 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -107.07 158.76 16.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.98 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 35.5 m-85 -136.53 115.39 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.676 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.545 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -139.33 25.46 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 152.63 -153.7 25.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.051 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -39.43 171.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.833 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.21 176.99 2.12 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.8 Cg_exo -39.01 -27.66 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.568 2.179 . . . . 0.0 112.714 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 93' ' ' ILE . 3.7 mp -130.44 52.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.675 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.99 0.424 . . . . 0.0 110.644 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.9 mt . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -121.53 99.46 45.24 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.998 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.518 ' HA ' HG21 ' A' ' 91' ' ' THR . 61.4 Cg_endo -70.66 -31.6 16.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.466 2.111 . . . . 0.0 112.587 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -178.39 -160.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -6.39 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.404 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.72 69.35 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 101' ' ' ALA . 11.9 m -116.02 141.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.047 0.451 . . . . 0.0 111.783 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.758 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -82.49 150.96 26.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.618 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.613 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.02 86.53 2.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.789 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -71.77 16.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.527 -178.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.41 -147.79 18.6 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.749 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.842 ' HA ' HG23 ' A' ' 75' ' ' VAL . 11.5 mtp-105 -155.94 167.61 29.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.357 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.595 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.77 114.85 30.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.646 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.804 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 86' ' ' LEU . 7.2 tt . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 120.626 0.25 . . . . 0.0 111.621 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -25.35 0.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.423 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.82 34.29 4.12 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.91 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' HD2' ' A' ' 47' ' ' ARG . 4.8 m -74.73 154.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 111.302 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.8 38.06 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -56.54 110.16 0.74 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.058 0.456 . . . . 0.0 111.593 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.31 102.7 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.305 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.63 150.03 28.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.71 162.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 112.154 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 45' ' ' ALA . 51.7 t -158.06 128.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.483 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.9 m -126.2 107.43 17.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.46 128.68 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.472 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.508 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -153.48 127.9 9.25 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.597 0.237 . . . . 0.0 111.319 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.6 89.97 2.77 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.766 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.858 0.361 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 145.3 46.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.071 0.462 . . . . 0.0 111.949 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -114.86 163.68 15.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.92 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.92 145.58 38.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -142.25 102.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 14.7 ptm180 -102.4 156.22 17.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.582 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.904 ' CE2' HG22 ' A' ' 126' ' ' VAL . 32.3 m-85 -140.69 139.54 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.915 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -28.84 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.064 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -125.79 22.44 7.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.9 154.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.389 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 144.29 47.32 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.877 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 150.09 12.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.5 158.6 34.08 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.339 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.02 143.56 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 111.212 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -90.96 -178.29 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.305 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 32' ' ' VAL . 2.6 tp -151.04 130.43 12.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 111.525 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -113.54 136.46 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -57.84 -8.83 1.05 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -45.0 -28.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.652 0.263 . . . . 0.0 111.009 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.633 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.4 t90 -75.94 -53.16 8.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.731 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 159.72 114.05 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.806 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 3.3 Cg_exo -47.2 -37.76 24.34 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.567 2.178 . . . . 0.0 112.547 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -62.43 -46.76 87.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.793 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -64.05 -44.7 91.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.261 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 HD21 ' A' ' 23' ' ' LEU . 58.5 t -47.02 -36.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.005 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.47 -39.0 72.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.528 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.73 80.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -49.98 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.66 -26.83 68.85 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.6 -24.1 60.01 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.96 49.19 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.967 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.946 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mt -62.04 -159.78 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.697 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.946 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 36.2 Cg_exo -29.46 107.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.063 1.842 . . . . 0.0 114.049 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' LEU . 33.5 mt -150.13 149.87 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.6 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -85.94 133.88 33.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 111.866 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.595 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.8 p -145.91 149.5 34.34 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.517 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.53 133.39 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -91.96 136.59 33.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.04 120.15 39.96 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.755 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.631 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -87.88 133.39 33.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' A' ' 50' ' ' ASP . 9.3 t-105 -155.65 148.7 24.5 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.369 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.69 89.76 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.415 -0.422 . . . . 0.0 113.391 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.9 t70 72.99 -36.82 0.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.82 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.87 132.08 40.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 111.092 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -138.86 121.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.768 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -134.01 131.59 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.613 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.2 p90 -136.61 145.13 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.66 144.28 25.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.175 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.7 5.79 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.26 -7.77 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.5 p -84.1 115.52 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.207 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.37 94.8 7.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.001 0.429 . . . . 0.0 111.716 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.793 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.7 p -129.17 106.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.493 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.94 132.7 30.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.872 0.368 . . . . 0.0 111.328 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -148.74 164.33 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.426 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -94.32 87.91 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.455 0.645 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -170.23 148.79 3.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 43.2 t-20 71.85 -83.21 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.578 0.228 . . . . 0.0 111.165 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 8.1 m 27.4 81.4 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.856 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.41 156.03 17.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.225 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.83 -6.75 11.02 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.9 p -127.48 143.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.631 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.572 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.3 m -158.56 157.6 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -94.56 150.51 20.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.373 0.606 . . . . 0.0 111.576 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.28 126.67 8.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.956 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.37 -30.64 6.87 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.385 -0.912 . . . . 0.0 114.535 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 109' ' ' ARG . 2.4 p30 -79.21 156.39 28.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 111.957 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.7 t -111.16 152.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.257 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.11 150.22 30.42 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.086 0.403 . . . . 0.0 111.882 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.473 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -106.32 137.91 43.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.62 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.3 t90 -79.1 108.46 12.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -63.94 -65.84 1.82 Allowed Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.82 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.99 81.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.823 1.682 . . . . 0.0 111.714 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 136.56 -6.89 3.91 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.651 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 52.36 36.82 20.83 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.002 0.401 . . . . 0.0 110.931 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.84 54.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.044 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -88.38 151.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.401 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 16.9 t -143.47 157.06 44.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.849 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -110.2 159.68 17.17 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.353 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 33.7 m-85 -136.78 134.56 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 111.792 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.583 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -169.47 35.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.853 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.14 -153.53 24.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.323 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.4 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 112.097 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.82 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -163.79 -174.34 0.4 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.934 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.68 ' HB2' HD12 ' A' ' 93' ' ' ILE . 93.9 Cg_exo -44.89 -24.32 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.877 1.718 . . . . 0.0 112.519 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -142.25 69.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 110.365 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.569 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.3 mt . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.818 0.342 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -103.55 99.25 14.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.702 ' HA ' HG21 ' A' ' 91' ' ' THR . 59.7 Cg_endo -70.39 -31.51 17.61 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.505 2.137 . . . . 0.0 112.69 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.42 -161.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.62 -8.76 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.665 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -166.56 71.83 0.13 Allowed 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 101' ' ' ALA . 18.4 m -119.08 141.24 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.004 0.431 . . . . 0.0 111.872 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 66' ' ' SER . 1.9 m120 -83.88 150.24 25.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.713 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.28 94.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.605 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -80.28 24.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.81 -149.98 17.38 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.41 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 26.2 mtp180 -157.01 168.06 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.454 . . . . 0.0 111.216 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.618 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -95.15 113.86 30.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.849 HD22 HD13 ' A' ' 86' ' ' LEU . 2.0 tt . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.586 0.232 . . . . 0.0 111.601 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.43 -26.85 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.31 33.94 3.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.928 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 117' ' ' LEU . 2.4 m -80.39 154.03 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.627 0.251 . . . . 0.0 111.473 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.53 146.81 44.53 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 12.8 p-10 -53.6 134.61 41.23 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.519 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 56.86 99.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.282 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -144.61 153.34 41.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 110.98 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.3 t -65.09 158.17 26.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.542 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.904 HG22 ' CE2' ' A' ' 14' ' ' PHE . 40.8 t -148.06 129.18 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.087 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.0 m -124.55 106.1 16.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.595 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.17 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.813 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.3 pt-20 -153.2 125.04 7.82 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.665 0.269 . . . . 0.0 111.25 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.698 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.14 94.74 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.813 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB3' ' NE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.8 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.809 0.337 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -114.77 145.29 42.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.483 . . . . 0.0 112.113 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.26 163.61 16.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.951 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 147.37 33.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -144.33 101.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.12 156.17 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.555 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.558 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.7 m-85 -138.25 136.47 36.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.1 -29.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 22.49 7.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.35 152.96 1.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.39 145.6 50.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.871 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 148.46 11.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.658 0.266 . . . . 0.0 111.607 -179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 158.88 41.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.163 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.23 148.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.107 0.48 . . . . 0.0 111.644 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.2 mt-10 -94.57 -178.29 4.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.021 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 32' ' ' VAL . 7.0 tp -147.46 133.19 18.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.148 0.499 . . . . 0.0 111.4 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -112.12 139.49 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.436 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -57.11 -8.92 0.76 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.29 -27.98 0.74 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.62 0.248 . . . . 0.0 111.427 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -79.26 -56.61 4.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.9 115.98 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.784 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.5 -34.67 11.2 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.396 2.064 . . . . 0.0 112.246 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -59.32 -52.74 64.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.475 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.78 -45.65 92.98 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 23' ' ' LEU . 87.4 t -46.72 -31.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.71 86.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.267 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.57 67.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.82 -52.05 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.85 -29.25 70.05 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.911 0.386 . . . . 0.0 110.395 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.01 -25.58 62.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.528 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.02 51.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.767 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -61.56 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.828 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.3 Cg_exo -26.83 108.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.275 1.983 . . . . 0.0 113.992 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 14.5 mt -147.9 153.91 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.628 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -89.28 131.98 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.78 40.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.94 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 128.25 48.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.55 132.74 36.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -100.7 130.02 46.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -94.1 134.79 36.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' ASP . 7.5 t-105 -154.87 148.36 25.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.044 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -29.34 84.32 0.0 OUTLIER Glycine 0 C--N 1.336 0.557 0 O-C-N 123.375 0.422 . . . . 0.0 113.781 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' TRP . 27.8 t70 73.93 -37.23 0.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.406 0.282 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.749 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.3 tm-20 -73.44 128.04 34.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.992 0.425 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -131.1 125.0 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.786 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -136.49 127.43 27.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.355 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.3 p90 -133.28 145.39 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.61 146.62 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.581 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.82 6.79 10.42 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 82.57 -7.89 1.24 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.3 p -84.66 114.42 24.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.94 94.87 5.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 60' ' ' VAL . 6.1 p -132.47 106.74 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.143 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -124.12 134.64 53.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.027 0.441 . . . . 0.0 111.621 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -146.86 165.34 30.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.267 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 3.7 pm0 -102.02 92.4 4.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.048 0.451 . . . . 0.0 111.245 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.13 156.16 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.5 t-20 63.19 -81.48 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.706 0.289 . . . . 0.0 111.094 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.1 m 28.15 82.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.55 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.786 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.99 155.9 17.88 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.318 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -117.45 -7.01 11.18 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.7 p -127.03 144.43 37.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.623 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.548 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.5 m -158.47 163.19 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -108.65 143.22 38.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.036 0.446 . . . . 0.0 110.935 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -37.71 131.83 0.95 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.01 -31.52 6.47 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.711 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -83.25 156.83 22.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.247 0.546 . . . . 0.0 112.215 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 109' ' ' ARG . 23.1 t -114.95 152.43 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.997 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.94 149.33 32.0 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.313 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.481 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -106.73 123.78 48.64 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.268 179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.598 ' HA ' HG12 ' A' ' 104' ' ' VAL . 3.1 t90 -65.67 111.07 3.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -66.3 -68.31 0.76 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.69 80.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 121.914 1.743 . . . . 0.0 111.752 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.12 -9.41 3.29 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.607 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.04 32.29 17.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.096 0.448 . . . . 0.0 110.863 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.16 133.9 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.881 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.78 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.236 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 35.3 t -143.14 157.26 44.67 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -112.37 156.41 22.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.941 179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.9 m-85 -136.76 130.86 32.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 111.515 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.445 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.77 49.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.71 -82.22 0.12 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.268 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -138.94 -167.85 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.265 0.555 . . . . 0.0 111.748 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -155.4 -176.51 0.62 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.822 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 97.1 Cg_exo -45.18 -21.69 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.187 1.925 . . . . 0.0 112.997 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.677 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -147.51 65.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.463 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.575 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.5 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 99.41 9.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.065 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.881 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -68.95 -31.15 24.85 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.538 2.159 . . . . 0.0 112.564 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.665 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.99 -162.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -7.3 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.645 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.97 73.74 0.07 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.5 m -122.16 142.3 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.005 0.431 . . . . 0.0 111.774 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.511 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m120 -83.15 152.19 25.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.43 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.786 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.96 82.02 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.708 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -65.9 20.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 114.27 -149.51 18.74 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.871 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.873 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.6 mtt85 -156.23 163.6 39.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.182 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.615 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -90.07 116.3 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.242 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 86' ' ' LEU . 4.1 tp . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.583 0.23 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -20.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 117' ' ' LEU . . . -91.31 30.34 6.45 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.644 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.8 m -77.52 154.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.483 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 147.21 30.2 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.608 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 13.6 p-10 -53.81 112.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 112.01 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.25 100.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.565 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.412 ' OE2' ' HB ' ' A' ' 120' ' ' VAL . 5.5 pt-20 -152.82 148.37 27.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.68 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.324 0.583 . . . . 0.0 112.456 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 45' ' ' ALA . 40.1 t -158.13 127.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.258 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.8 m -125.22 107.29 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.0 111.228 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.21 128.72 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.573 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 pt-20 -152.45 129.07 10.77 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.751 0.31 . . . . 0.0 111.235 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.58 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.86 92.73 3.1 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.874 0.369 . . . . 0.0 110.735 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.724 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . 0.455 ' O ' ' HG2' ' A' ' 8' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.07 0.462 . . . . 0.0 111.266 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -131.92 145.45 51.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.12 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.37 162.44 15.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.649 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.46 142.79 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -138.91 102.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 109.704 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.34 156.15 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.589 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.2 m-85 -137.64 138.34 39.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -29.14 0.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -126.22 22.1 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.87 153.34 1.35 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.66 145.06 48.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.085 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.36 148.85 11.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.561 0.22 . . . . 0.0 111.432 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -117.93 156.68 28.05 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.22 135.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.047 0.451 . . . . 0.0 111.338 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -90.89 -178.39 5.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.409 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.781 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -149.76 146.68 27.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.982 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -121.56 146.14 47.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.858 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.73 -9.03 2.39 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -45.52 -28.25 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.603 0.24 . . . . 0.0 111.423 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.711 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -80.07 -56.24 4.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 116.23 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.824 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.89 -29.77 8.69 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.521 2.147 . . . . 0.0 112.505 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.31 -43.56 81.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.183 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.844 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -67.18 -46.26 74.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.781 HG13 ' CD2' ' A' ' 23' ' ' LEU . 31.0 t -45.98 -35.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -56.62 -37.76 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.01 -47.56 74.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.99 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.86 -49.78 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.585 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.46 -28.79 70.21 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.247 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -71.19 -25.65 62.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 110.481 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.88 51.29 1.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.962 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.968 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.06 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.434 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 29.9 Cg_exo -28.64 103.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.058 1.839 . . . . 0.0 114.086 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.8 mt -145.62 150.62 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.395 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -85.88 135.62 33.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.164 0.506 . . . . 0.0 111.914 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.06 148.6 32.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.232 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.008 0.432 . . . . 0.0 110.374 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.98 132.55 34.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -104.13 119.01 38.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.802 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -82.43 136.88 34.84 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 16.0 t-105 -148.44 148.56 30.43 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.588 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.177 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 26.4 t70 79.44 -41.31 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.712 0.405 . . . . 0.0 111.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.56 152.08 24.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.577 HG21 HD21 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -150.13 117.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.726 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.1 p90 -125.15 140.17 53.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.243 0.545 . . . . 0.0 112.169 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 4.3 p90 -140.25 145.33 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.581 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 145.58 24.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.672 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.17 6.6 11.25 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.7 mt-30 81.75 -7.78 1.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.9 p -85.14 115.63 27.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.25 94.74 6.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.002 0.429 . . . . 0.0 111.706 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.844 ' CG2' HG22 ' A' ' 31' ' ' THR . 7.6 p -130.13 106.75 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.511 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.94 131.77 33.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.939 0.399 . . . . 0.0 111.412 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 52.1 tttm -141.07 165.65 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.354 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -99.56 89.27 4.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 111.374 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.8 tt0 -170.14 157.82 6.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.67 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.0 t-20 63.5 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.405 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.9 m 29.95 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.534 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 156.29 17.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.327 179.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.92 -7.01 10.96 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.4 p -126.63 142.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.537 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.81 157.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.26 151.08 19.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.357 0.599 . . . . 0.0 111.57 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -46.42 125.84 7.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.171 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.41 -31.72 6.27 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.369 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.45 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -75.66 155.81 35.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.619 0.709 . . . . 0.0 112.078 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.5 t -113.09 152.54 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.027 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.03 145.92 28.68 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.343 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.446 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -101.54 121.37 41.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 179.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.562 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -64.83 114.48 4.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.821 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.711 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -70.74 -67.34 0.63 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.735 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 27.8 Cg_exo -61.23 75.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.856 1.704 . . . . 0.0 111.633 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 147.11 -10.94 1.37 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 30.61 12.38 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.234 0.517 . . . . 0.0 110.973 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.72 136.64 52.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 9.5 mt -88.53 147.81 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.8 m -142.77 132.1 23.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -89.55 157.73 17.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.025 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 7.7 m-85 -136.49 134.67 37.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 111.536 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -153.58 28.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.708 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 148.53 -149.59 21.64 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.584 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -39.75 169.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.79 -176.58 0.63 Allowed Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.639 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.2 Cg_exo -42.64 -25.49 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.087 1.858 . . . . 0.0 112.571 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -136.49 52.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.511 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.451 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.5 HG23 ' OG1' ' A' ' 91' ' ' THR . 66.1 mt . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.914 0.388 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.41 99.32 49.1 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.24 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 55.1 Cg_endo -68.25 -30.6 30.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 112.494 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.635 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -162.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.838 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -4.84 17.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.727 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.42 74.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 101' ' ' ALA . 20.8 m -122.7 141.98 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.544 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.3 m120 -82.15 152.77 26.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.624 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.667 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.6 90.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.781 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.93 19.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.263 -177.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.59 -149.24 18.65 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.572 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.765 ' HA ' HG23 ' A' ' 75' ' ' VAL . 13.6 mtt180 -151.52 164.18 37.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.003 0.43 . . . . 0.0 111.472 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.683 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -93.83 115.78 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.291 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.851 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp . . . . . 0 N--CA 1.463 0.21 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.63 -19.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.413 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -91.52 27.35 9.75 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.051 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.3 m -81.62 153.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.763 0.281 . . . . 0.0 111.527 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.57 148.59 35.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -53.8 105.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 0.0 112.047 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.06 109.94 0.12 Allowed Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.989 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.18 138.72 14.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.639 0.257 . . . . 0.0 110.794 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.8 152.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 111.901 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 45' ' ' ALA . 61.5 t -144.62 128.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.3 m -124.69 107.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.82 128.38 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.6 pt-20 -152.46 130.29 11.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 111.216 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.575 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.76 93.79 2.64 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.901 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpp . . . . . 0 CA--C 1.524 -0.039 0 CA-C-O 120.859 0.362 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.64 145.26 38.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 112.03 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.54 163.6 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.719 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.45 145.06 33.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -147.35 102.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -108.58 155.99 20.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.854 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CG ' HD11 ' A' ' 117' ' ' LEU . 2.7 m-85 -128.82 140.31 51.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.159 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.07 -28.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -122.24 23.19 9.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -176.28 155.05 1.43 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -117.1 152.66 34.24 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.229 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.08 151.47 17.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.92 0.39 . . . . 0.0 111.926 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -137.45 149.96 47.26 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.235 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.13 141.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.131 0.491 . . . . 0.0 111.842 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' OE2' HG13 ' A' ' 111' ' ' VAL . 2.0 mp0 -95.03 -178.1 4.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.234 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.797 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -154.79 142.33 19.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.05 146.92 48.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -55.32 -9.41 0.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.61 -28.59 1.0 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.186 -0.321 . . . . 0.0 111.219 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.2 t90 -79.78 -55.87 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.667 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 156.8 115.97 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.648 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 3.8 Cg_exo -46.22 -36.7 17.37 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -62.12 -48.54 79.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.365 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -62.38 -44.96 95.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.888 0.375 . . . . 0.0 110.353 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 ' CD2' ' A' ' 23' ' ' LEU . 43.7 t -51.31 -31.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -59.73 -36.06 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.48 -47.31 67.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.1 -51.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.68 -28.69 69.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.983 0.42 . . . . 0.0 110.42 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.03 -23.83 60.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.44 50.81 0.89 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.877 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.957 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.506 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 30.7 Cg_exo -28.88 106.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.164 1.909 . . . . 0.0 113.979 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.2 mt -147.63 149.3 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.403 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 136.59 33.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.09 149.25 33.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.35 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.82 127.89 48.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -87.16 136.27 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -108.83 123.56 49.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.235 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.713 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -80.85 138.17 36.19 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.5 t-105 -150.1 148.88 29.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.58 95.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.513 -0.375 . . . . 0.0 113.72 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.68 30.5 11.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.266 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.9 OUTLIER -145.63 146.03 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.326 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -140.51 121.45 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 19.3 p90 -129.61 129.78 44.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.112 0.482 . . . . 0.0 110.98 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.54 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.7 p90 -139.11 145.53 39.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.815 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 149.34 21.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.34 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.16 6.28 9.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 80.41 -6.21 1.71 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.799 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.1 p -86.54 116.01 28.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.834 0.35 . . . . 0.0 110.2 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.32 94.79 5.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.0 0.429 . . . . 0.0 111.769 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.847 HG22 HG22 ' A' ' 31' ' ' THR . 7.5 p -124.07 106.59 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.016 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.34 136.56 51.13 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 111.587 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 63' ' ' GLU . 8.9 ttmt -141.51 164.79 29.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.242 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -101.24 76.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.051 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -170.11 160.78 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.485 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 28.3 t-20 72.78 -82.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.6 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER 22.43 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.97 160.55 14.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.639 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' HG23 ' A' ' 69' ' ' VAL . 12.1 p30 -122.38 -4.3 8.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 68' ' ' ASP . 40.7 t -131.87 143.66 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.103 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.524 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.77 158.21 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.029 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.33 150.54 24.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.362 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp -52.08 124.79 13.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.963 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -32.19 6.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.017 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -67.55 166.05 15.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.104 0.452 . . . . 0.0 111.883 -179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 ' CD1' ' A' ' 110' ' ' ILE . 22.0 t -122.72 152.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.719 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 146.17 26.47 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.697 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.518 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -98.24 126.97 43.94 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.962 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.738 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.2 t90 -68.38 122.59 18.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.215 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -72.25 -68.53 0.41 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.453 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 38.8 Cg_exo -59.44 82.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.915 1.743 . . . . 0.0 111.837 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.53 -7.18 4.95 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.642 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.62 39.43 13.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 0.0 111.176 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -115.19 135.5 54.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.55 145.57 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.5 m -142.49 131.27 22.79 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.815 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -98.07 139.19 34.26 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.3 p90 -136.52 138.05 40.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.075 0.464 . . . . 0.0 110.967 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.9 50.68 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.491 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.03 -81.14 0.13 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -123.49 -170.26 2.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.387 0.613 . . . . 0.0 111.553 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -166.16 178.09 1.37 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.807 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.6 Cg_exo -36.25 -30.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.659 2.239 . . . . 0.0 112.657 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -142.11 69.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.348 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 111.205 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.4 mt . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 111.121 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -116.83 99.29 52.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.644 ' HA ' HG21 ' A' ' 91' ' ' THR . 40.0 Cg_endo -65.73 -31.43 49.02 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.552 2.168 . . . . 0.0 112.446 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.682 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.57 -159.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.62 -4.12 17.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.85 73.21 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.738 HG12 ' CD1' ' A' ' 78' ' ' TRP . 15.6 m -120.69 141.96 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.757 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.656 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 41.1 m-20 -80.71 151.03 29.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.687 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.44 85.48 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.719 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -68.17 19.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.945 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.33 -146.74 18.52 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.933 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 75' ' ' VAL . 10.5 mtt-85 -154.98 168.09 28.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.515 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.589 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.6 mt -93.58 118.85 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.458 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.8 tp . . . . . 0 N--CA 1.462 0.154 0 CA-C-O 120.638 0.256 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.1 OUTLIER -42.3 -24.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.416 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -91.32 35.04 4.05 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.057 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.7 m -70.91 154.79 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 122.61 0.364 . . . . 0.0 111.853 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.79 146.66 44.09 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 p30 -58.1 116.35 3.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.089 0.471 . . . . 0.0 112.238 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.93 102.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.973 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.37 150.98 25.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.792 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.4 t -52.1 167.45 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 112.229 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 89.2 t -157.7 128.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.21 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -127.84 108.23 17.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.02 129.01 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.7 pt-20 -152.05 128.22 10.48 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.607 0.242 . . . . 0.0 111.229 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.678 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.79 85.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.175 -0.916 . . . . 0.0 111.634 179.941 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttt . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.37 38.88 4.92 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.448 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -114.19 25.85 10.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 0.0 111.065 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 4' ' ' ARG . 0.0 OUTLIER -147.33 -152.15 0.42 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.325 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -173.73 -50.22 0.05 OUTLIER Glycine 0 C--N 1.338 0.688 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.554 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.694 HG23 ' CD1' ' A' ' 24' ' ' TYR . 13.7 p -90.05 53.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.258 0.551 . . . . 0.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -157.8 48.79 0.4 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.49 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.404 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -112.64 90.2 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.588 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -102.35 145.06 30.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 111.76 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.28 164.17 19.3 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.004 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.48 144.87 42.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.631 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.577 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.32 102.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.085 0.469 . . . . 0.0 109.779 179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -99.82 156.23 17.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.376 0.608 . . . . 0.0 111.893 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 17' ' ' ALA . 2.7 m-85 -135.88 138.87 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.495 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.07 0.48 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 36.6 p -125.98 21.83 7.45 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -176.53 153.32 1.14 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.91 146.58 37.61 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.339 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.16 149.01 10.17 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.168 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -113.29 155.66 24.74 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.66 0.267 . . . . 0.0 110.549 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.81 142.06 16.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.85 0.357 . . . . 0.0 111.223 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 7.4 mt-10 -100.58 -178.8 3.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.062 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.757 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.8 tp -150.92 149.36 29.54 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.067 0.46 . . . . 0.0 111.368 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.694 ' CD1' HG23 ' A' ' 6' ' ' VAL . 19.3 m-85 -126.36 148.01 49.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.732 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -58.18 -8.88 1.22 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -45.65 -27.73 0.85 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.621 0.248 . . . . 0.0 111.593 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.653 ' CZ2' HG21 ' A' ' 31' ' ' THR . 8.9 t90 -81.61 -56.27 4.12 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.89 114.87 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.438 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.452 178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -46.41 -35.23 15.73 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.555 2.17 . . . . 0.0 112.335 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.78 -53.5 57.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.539 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.69 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.51 -45.06 92.38 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.788 0.328 . . . . 0.0 110.521 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.757 HG13 ' CD2' ' A' ' 23' ' ' LEU . 61.4 t -47.43 -28.42 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.33 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 49.6 ttt-85 -61.21 -38.64 87.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.464 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.94 79.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.671 0.272 . . . . 0.0 111.116 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.09 -51.29 55.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.573 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.03 -27.8 69.66 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-O 120.948 0.404 . . . . 0.0 110.369 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -71.93 -25.31 61.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.877 0.37 . . . . 0.0 110.599 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.23 49.6 1.13 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.047 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.1 mt -61.91 -160.21 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.79 0 CA-C-O 118.381 -0.819 . . . . 0.0 109.58 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 32.3 Cg_exo -29.2 107.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 122.129 1.886 . . . . 0.0 114.021 -178.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.04 150.19 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.627 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -85.77 136.61 33.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.111 0.481 . . . . 0.0 111.745 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.599 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.33 149.1 33.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.497 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.78 125.59 48.48 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.0 0.429 . . . . 0.0 110.349 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.88 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.85 136.01 34.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.2 m-20 -108.26 125.8 52.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.073 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.644 ' HD3' ' O ' ' A' ' 120' ' ' VAL . 1.0 OUTLIER -85.39 135.37 33.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -150.91 148.97 29.08 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.902 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' O ' ' HD2' ' A' ' 90' ' ' LYS . . . -32.88 102.8 0.01 OUTLIER Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.505 -0.379 . . . . 0.0 113.729 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.22 30.87 0.49 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.3 OUTLIER -144.02 142.91 30.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.351 179.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.606 HD11 ' HG2' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -139.92 124.83 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.299 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 34.9 p90 -133.83 127.84 33.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.742 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.521 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.0 p90 -133.58 146.5 51.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.049 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.01 145.19 24.83 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.759 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.97 6.73 11.36 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.9 OUTLIER 82.95 -8.14 1.17 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -84.34 115.78 26.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.33 94.56 6.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.025 0.44 . . . . 0.0 112.053 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.69 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.3 p -123.21 106.61 17.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.081 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -132.41 136.39 46.74 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.041 0.448 . . . . 0.0 111.665 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -160.32 161.7 33.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.987 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -96.33 96.28 8.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.044 0.449 . . . . 0.0 110.975 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.0 tt0 -170.37 149.87 3.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.884 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 57.4 t-20 63.33 -81.74 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.727 0.299 . . . . 0.0 111.108 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.443 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.2 m 29.97 83.8 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.676 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.802 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.54 157.06 16.71 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.145 178.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.0 p30 -120.98 -4.16 9.6 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.5 p -127.56 141.2 47.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.403 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.552 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.75 157.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.599 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -95.62 150.77 19.99 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.401 0.619 . . . . 0.0 111.926 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 tp -44.85 126.49 5.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.98 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 112.41 -26.96 10.44 Favored Glycine 0 CA--C 1.523 0.531 0 C-N-CA 120.256 -0.973 . . . . 0.0 114.614 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.432 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.8 p30 -82.53 156.21 24.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.844 0.822 . . . . 0.0 111.894 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.874 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -113.48 151.59 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.393 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.689 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.06 153.34 33.78 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.946 0.403 . . . . 0.0 111.821 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' CD2' ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -103.98 131.69 50.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.308 179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.564 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.0 t90 -74.37 109.12 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.999 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.725 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -65.32 -69.17 0.61 Allowed Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.311 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.725 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 39.0 Cg_exo -58.85 80.36 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 121.886 1.724 . . . . 0.0 111.518 178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.46 -9.33 3.19 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 121.064 -0.589 . . . . 0.0 112.291 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.429 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 50.05 39.62 19.52 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.907 0.354 . . . . 0.0 111.121 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.02 136.38 54.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.873 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.53 147.05 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 1.5 m -143.12 135.89 27.71 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.778 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.07 160.82 19.18 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.519 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 57.1 m-85 -136.32 114.71 11.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.13 0.49 . . . . 0.0 111.984 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.683 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -150.23 31.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.082 179.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.54 -153.07 24.1 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.663 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -52.6 -173.64 0.0 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.522 0.677 . . . . 0.0 112.203 -179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.725 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.31 -175.85 0.55 Allowed Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.118 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.689 ' HB2' HD12 ' A' ' 93' ' ' ILE . 74.3 Cg_exo -42.6 -25.22 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.032 1.821 . . . . 0.0 112.888 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.689 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -142.02 72.12 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.483 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -60.6 -75.33 0.06 Allowed 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 110.415 179.168 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 61.26 -91.07 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.109 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -119.51 -30.69 4.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.4 mtmt -125.56 -161.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.319 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.641 HG23 ' OG1' ' A' ' 91' ' ' THR . 91.7 mt -118.69 110.3 29.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.89 0.376 . . . . 0.0 111.1 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.1 tpp180 -109.32 99.26 35.7 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.959 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.725 ' HA ' HG21 ' A' ' 91' ' ' THR . 60.0 Cg_endo -70.66 -31.27 16.83 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.526 2.151 . . . . 0.0 112.719 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.71 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.69 -162.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.803 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.22 -5.37 14.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.613 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.27 70.06 0.08 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.71 HG13 ' HB3' ' A' ' 101' ' ' ALA . 12.7 m -119.01 141.4 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.024 0.44 . . . . 0.0 111.805 179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.689 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.1 m120 -84.43 151.39 24.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.419 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.802 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.7 96.89 6.36 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.618 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.27 20.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.74 -149.75 18.62 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.55 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.874 ' HA ' HG23 ' A' ' 75' ' ' VAL . 30.6 mtp180 -156.75 168.03 28.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.965 0.412 . . . . 0.0 111.19 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.586 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.84 112.72 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.531 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.457 HG21 ' OE1' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -107.35 -86.63 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.547 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -67.57 74.35 0.16 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.873 0.368 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.81 -70.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.769 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 2.7 ttm 54.77 35.48 24.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.801 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -80.01 152.31 29.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.239 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -94.97 45.71 2.1 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.393 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.825 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.7 tt -42.45 -35.59 1.08 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.555 0.216 . . . . 0.0 111.5 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.683 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.78 -21.16 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.402 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -93.43 34.35 4.65 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.427 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 117' ' ' LEU . 7.1 m -71.58 154.83 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 122.161 0.184 . . . . 0.0 111.088 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.635 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -81.22 147.92 29.74 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.603 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.1 p-10 -56.16 118.0 4.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.177 0.513 . . . . 0.0 112.328 -178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 65.63 101.15 0.02 OUTLIER Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.008 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.635 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -149.8 155.55 40.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.935 0.398 . . . . 0.0 110.48 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.6 t -55.56 164.98 0.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.681 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.88 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.5 t -157.96 127.88 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.562 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.553 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.39 108.13 18.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.949 0.404 . . . . 0.0 111.314 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.759 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.68 128.89 38.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.407 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.7 pt-20 -153.41 129.18 10.13 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.66 0.267 . . . . 0.0 111.379 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.632 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.24 89.54 3.12 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.632 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.257 -0.878 . . . . 0.0 111.682 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.825 0.345 . . . . 0.0 111.203 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.52 137.46 5.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.503 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.61 21.13 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.582 0.229 . . . . 0.0 111.077 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 58.69 -84.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.979 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -164.66 27.85 0.2 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.452 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.602 HG12 ' H ' ' A' ' 25' ' ' GLU . 32.8 m -115.68 63.66 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.086 0.47 . . . . 0.0 111.348 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.96 38.92 0.18 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.95 110.47 22.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.95 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.8 OUTLIER -108.38 145.43 34.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.356 0.598 . . . . 0.0 112.319 -179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 163.92 18.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.62 178.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.82 144.87 31.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.816 0.341 . . . . 0.0 110.806 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.7 mt -148.04 99.31 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.551 HH11 HG21 ' A' ' 127' ' ' VAL . 4.6 ptm180 -104.98 156.06 18.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.877 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.7 m-85 -129.63 139.11 51.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.277 179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -28.53 0.43 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -121.34 22.97 10.63 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.76 151.46 1.14 Allowed 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -124.37 138.35 54.38 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.791 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.499 ' SG ' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -163.54 149.2 11.32 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.639 -179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.33 158.26 31.43 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.115 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.3 m -148.24 141.13 18.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.121 0.486 . . . . 0.0 111.374 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.657 ' OE2' HG21 ' A' ' 111' ' ' VAL . 4.2 mt-10 -96.86 -178.46 4.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.979 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.806 ' CD2' HG13 ' A' ' 32' ' ' VAL . 8.1 tp -154.15 144.57 22.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.148 0.499 . . . . 0.0 111.479 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.461 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 16.7 m-85 -127.14 146.73 50.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.638 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.602 ' H ' HG12 ' A' ' 6' ' ' VAL . 11.3 mt-10 -57.07 -9.29 0.83 Allowed 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -45.49 -28.29 0.89 Allowed 'General case' 0 N--CA 1.464 0.253 0 O-C-N 122.265 -0.272 . . . . 0.0 111.33 -179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.726 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.8 t90 -81.12 -56.18 4.26 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.41 115.47 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.463 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.597 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -46.17 -35.47 15.16 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.517 2.145 . . . . 0.0 112.341 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -59.15 -52.7 64.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.446 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.726 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -62.8 -45.15 94.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.859 0.361 . . . . 0.0 110.39 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.806 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.0 t -47.91 -30.04 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.307 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 -60.66 -38.31 84.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.399 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.05 -47.19 75.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.195 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.34 -52.29 32.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.9 -29.01 69.92 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-O 120.977 0.417 . . . . 0.0 110.445 179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -70.92 -25.44 62.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.42 50.82 1.07 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.968 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.951 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.92 -160.05 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.45 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 35.4 Cg_exo -29.59 105.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 122.106 1.871 . . . . 0.0 113.953 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.7 mt -147.94 149.29 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.566 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.89 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.09 0.471 . . . . 0.0 111.766 -178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.623 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.7 p -146.08 149.01 33.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.463 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.92 129.38 48.17 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.865 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -89.46 134.45 34.09 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -106.06 122.02 45.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.045 177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.807 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -81.79 136.73 35.4 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.525 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -154.45 148.34 25.59 Favored 'General case' 0 C--N 1.335 -0.06 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.47 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.452 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.83 86.45 0.01 OUTLIER Glycine 0 C--N 1.335 0.497 0 O-C-N 123.278 0.361 . . . . 0.0 113.838 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.4 t70 76.15 -36.29 0.27 Allowed 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.15 138.49 37.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 111.376 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -136.26 110.01 9.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.991 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 39.7 p90 -119.87 128.74 53.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.985 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.491 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.3 p90 -136.64 144.46 44.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.393 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.64 147.07 23.17 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.89 7.56 10.42 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 56' ' ' THR . 36.1 mt-30 81.02 -6.82 1.59 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.819 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -86.54 115.76 28.1 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.39 94.9 5.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.045 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.678 ' CG2' HG22 ' A' ' 31' ' ' THR . 2.9 p -125.33 106.66 16.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.961 179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.69 138.17 53.88 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-O 121.053 0.454 . . . . 0.0 111.623 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -152.99 164.5 37.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.335 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.12 87.2 3.02 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 110.78 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.0 tt0 -170.11 153.56 4.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.478 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 49.7 t-20 69.42 -80.27 0.04 OUTLIER 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.642 -0.254 . . . . 0.0 111.277 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.456 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 5.3 m 25.28 82.9 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.473 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.883 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.77 157.02 17.14 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.536 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 p30 -118.97 -8.13 10.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.0 p -124.89 143.04 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.296 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.9 m -159.08 157.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.78 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.49 151.59 21.31 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.406 0.622 . . . . 0.0 111.483 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.38 125.36 10.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.805 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.59 -32.18 6.0 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.268 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 1.9 p30 -73.61 156.49 37.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.578 0.689 . . . . 0.0 111.942 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.0 t -112.93 152.35 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.391 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.53 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.4 148.94 31.83 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.262 0.483 . . . . 0.0 112.294 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.56 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -103.91 123.08 46.49 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.816 179.14 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.686 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.0 t90 -64.62 119.98 11.53 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.809 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.772 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -70.64 -68.03 0.55 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.753 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.772 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.07 78.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 121.846 1.697 . . . . 0.0 111.696 179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 141.19 -9.24 2.71 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.737 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.412 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.02 36.23 14.72 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 117.0 0.4 . . . . 0.0 111.059 179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.85 134.75 54.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.723 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.8 mt -84.3 141.16 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.451 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.5 m -135.65 130.36 34.21 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.825 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.58 156.3 19.57 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.329 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.8 m-85 -136.79 129.67 30.76 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.626 0.25 . . . . 0.0 110.989 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -165.79 42.3 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.304 179.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.47 -84.09 0.1 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.327 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -130.57 -166.95 1.75 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.259 0.552 . . . . 0.0 111.902 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.872 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.56 -176.65 0.63 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.612 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.7 Cg_exo -47.32 -24.62 4.05 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 121.793 1.662 . . . . 0.0 111.786 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.526 HD12 ' HB2' ' A' ' 92' ' ' PRO . 1.9 mp -142.57 66.3 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.416 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -44.55 -33.33 1.72 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.779 0.323 . . . . 0.0 111.328 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.83 146.57 8.01 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 97' ' ' LYS . 9.8 m-20 60.63 52.24 4.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.483 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 66.08 163.32 0.17 Allowed 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.612 -179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.1 mt -60.37 108.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.102 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -103.47 99.21 14.46 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.872 ' HA ' HG21 ' A' ' 91' ' ' THR . 52.4 Cg_endo -68.33 -31.39 28.52 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.482 2.121 . . . . 0.0 112.537 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.605 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.41 -158.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.13 -6.93 14.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.697 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.01 73.12 0.09 Allowed 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.686 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.7 m -122.74 142.49 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 121.057 0.456 . . . . 0.0 111.826 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.522 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.5 m120 -83.58 152.0 25.07 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.854 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.883 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.73 99.84 9.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 177.457 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.571 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.66 21.33 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.09 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.79 -133.22 10.55 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.245 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.867 ' HA ' HG23 ' A' ' 75' ' ' VAL . 9.5 ptt85 -170.47 168.12 7.92 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 121.045 0.45 . . . . 0.0 111.484 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.607 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.0 mt -98.16 115.27 37.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.575 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.657 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -99.74 -85.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.504 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -75.73 -176.34 3.28 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.86 0.362 . . . . 0.0 111.074 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 57.9 m 62.06 162.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.3 tpp -57.88 129.43 41.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.941 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 1.3 mp0 -104.66 25.52 10.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.003 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -112.84 32.67 6.05 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.392 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.867 ' O ' HG13 ' A' ' 120' ' ' VAL . 6.2 tt -49.94 -31.87 13.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 111.146 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.479 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.95 -24.38 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.173 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.439 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.92 31.29 4.72 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.983 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.867 HG13 ' O ' ' A' ' 117' ' ' LEU . 10.6 m -75.09 153.98 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.562 0.22 . . . . 0.0 111.299 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.26 146.61 32.91 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.618 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -57.28 111.64 1.14 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.99 98.75 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.401 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -152.41 149.71 28.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.872 0.367 . . . . 0.0 110.826 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.68 166.22 0.09 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.281 0.562 . . . . 0.0 112.257 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.865 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.8 t -157.98 128.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.137 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.556 ' O ' HG23 ' A' ' 127' ' ' VAL . 27.5 m -129.46 109.14 17.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.95 0.405 . . . . 0.0 111.589 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.89 129.26 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.243 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 11.8 pt-20 -154.31 128.04 8.73 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.622 0.249 . . . . 0.0 111.293 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.596 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -72.81 87.59 1.29 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.812 0.339 . . . . 0.0 110.786 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.253 -0.879 . . . . 0.0 111.751 179.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.26 123.28 2.81 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.494 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.65 -41.71 1.18 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.62 0.247 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.33 -63.33 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.609 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.44 28.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 25' ' ' GLU . 32.3 m -113.53 63.14 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.961 0.41 . . . . 0.0 111.254 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -157.26 38.83 0.29 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.982 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.09 110.58 22.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -108.54 145.32 34.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.2 0.524 . . . . 0.0 112.329 -179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.48 163.96 17.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.682 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.59 145.68 38.72 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.796 0.332 . . . . 0.0 110.948 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.607 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.2 100.16 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 179.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -102.63 155.5 18.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.615 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.502 ' CE1' HG13 ' A' ' 126' ' ' VAL . 2.8 m-85 -131.2 138.05 49.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.441 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.53 -29.07 0.26 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.1 p -126.08 23.12 7.18 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.677 0.251 . . . . 0.0 111.677 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.06 152.44 3.49 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.78 143.5 49.36 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.676 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 148.6 13.27 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.75 0.31 . . . . 0.0 111.769 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -136.31 157.83 45.86 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.054 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.15 146.57 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.038 0.446 . . . . 0.0 111.648 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 6.6 mt-10 -98.16 -178.29 4.01 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.871 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.758 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.9 tp -153.71 144.2 22.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.479 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 16.0 m-85 -123.97 146.8 48.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.641 ' H ' HG12 ' A' ' 6' ' ' VAL . 12.9 mt-10 -55.45 -9.27 0.45 Allowed 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.61 -27.26 0.74 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 117.939 0.336 . . . . 0.0 111.443 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.655 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.5 t90 -81.28 -56.37 4.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 154.23 113.62 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.665 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.72 -29.62 8.08 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.35 -46.46 80.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.283 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.693 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -68.32 -46.2 70.88 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.728 0.299 . . . . 0.0 110.572 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.758 HG13 ' CD2' ' A' ' 23' ' ' LEU . 30.2 t -45.87 -29.82 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.339 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.55 -33.44 72.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.477 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.53 55.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.612 0.244 . . . . 0.0 111.044 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.3 -49.08 75.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.12 -28.62 69.89 Favored 'General case' 0 C--N 1.342 0.239 0 CA-C-O 120.979 0.418 . . . . 0.0 110.319 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -71.4 -25.38 62.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.376 . . . . 0.0 110.543 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.01 51.11 1.03 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.988 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.953 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -62.21 -159.93 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 118.347 -0.835 . . . . 0.0 109.594 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.953 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.4 Cg_exo -29.08 107.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.186 1.924 . . . . 0.0 114.059 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.9 mt -150.04 149.78 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.642 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.2 mtpt -85.84 136.85 33.14 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.041 0.448 . . . . 0.0 111.919 -179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.58 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -146.05 149.19 33.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.45 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.85 124.44 47.48 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.078 0.466 . . . . 0.0 110.538 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.894 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -84.93 133.58 34.28 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -103.4 124.98 49.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.251 -0.886 . . . . 0.0 108.931 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.865 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.52 135.88 33.27 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -177.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.6 t-105 -156.71 148.34 22.58 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.957 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.81 84.89 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.649 -0.31 . . . . 0.0 113.764 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 48' ' ' TRP . 30.5 t70 74.22 -36.64 0.34 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.3 tt0 -74.71 128.22 35.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.939 0.399 . . . . 0.0 111.346 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.6 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.7 OUTLIER -132.29 119.41 39.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.849 179.277 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.402 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 53.4 p90 -131.47 125.03 31.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.906 0.384 . . . . 0.0 111.319 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.0 p90 -129.87 145.8 51.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.774 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.05 144.12 25.76 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.751 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -118.89 6.4 11.42 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.6 mm-40 82.23 -7.44 1.33 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 ' O ' HG13 ' A' ' 58' ' ' VAL . 8.7 p -84.98 116.87 29.22 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.1 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.159 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -98.87 94.56 6.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.703 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.693 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.0 p -126.08 106.74 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.509 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -133.3 133.93 43.21 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.929 0.395 . . . . 0.0 111.311 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.5 161.14 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.083 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -95.73 93.97 7.41 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.215 0.531 . . . . 0.0 110.796 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -170.51 148.39 3.1 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.69 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 66' ' ' SER . 35.5 t-20 70.44 -76.87 0.06 Allowed 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.606 0.241 . . . . 0.0 111.165 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.474 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 11.0 t 21.41 83.93 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.887 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.58 161.51 13.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.361 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -124.28 1.04 8.43 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.417 ' O ' ' CG1' ' A' ' 70' ' ' VAL . 49.6 t -138.41 142.33 35.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.309 . . . . 0.0 111.018 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.483 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.99 157.55 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.887 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -92.79 152.2 19.59 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.495 0.664 . . . . 0.0 111.62 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.1 tp -48.29 125.91 10.26 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.933 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.07 6.08 Favored Glycine 0 C--N 1.336 0.558 0 C-N-CA 120.505 -0.855 . . . . 0.0 114.083 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -75.37 156.37 35.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.458 0.629 . . . . 0.0 111.984 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.847 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.9 t -113.05 152.25 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.375 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.08 149.39 29.47 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 118.151 0.432 . . . . 0.0 111.874 -179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.433 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -104.51 137.66 42.03 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.341 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.631 ' HA ' HG12 ' A' ' 104' ' ' VAL . 1.6 t90 -78.72 108.26 12.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.966 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.447 HG13 ' ND2' ' A' ' 105' ' ' ASN . 0.3 OUTLIER -63.94 -66.42 1.5 Allowed Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.634 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 21.1 Cg_endo -60.72 77.78 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.255 1.97 . . . . 0.0 111.6 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 142.91 -9.99 2.31 Favored Glycine 0 CA--C 1.522 0.499 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.324 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 54.47 33.6 19.14 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.965 0.382 . . . . 0.0 110.913 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -115.96 134.8 54.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.049 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 7.1 mt -87.37 150.11 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.216 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 24.8 t -143.52 156.09 44.52 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.087 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -113.66 157.76 21.75 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.943 179.139 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 5.5 m-85 -136.71 138.21 40.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 111.492 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -175.46 44.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.957 179.438 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.36 -91.14 0.1 OUTLIER Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.973 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -133.36 -167.76 1.98 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.424 0.63 . . . . 0.0 111.724 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.841 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -163.61 -173.94 0.38 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.01 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.628 ' CD ' HG22 ' A' ' 91' ' ' THR . 90.4 Cg_exo -45.48 -22.2 0.97 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 121.81 1.673 . . . . 0.0 112.736 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.522 HD12 ' HB2' ' A' ' 92' ' ' PRO . 2.7 mp -142.06 73.1 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.509 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -63.75 -13.2 41.54 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 179.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 94' ' ' SER . 3.7 t0 -26.1 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 41.47 31.94 0.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.058 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HA ' ' CE ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER 175.39 163.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.804 0.335 . . . . 0.0 110.758 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.27 102.32 13.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.877 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 34.6 mmm-85 -98.76 99.11 7.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.841 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.4 Cg_endo -68.87 -31.09 25.5 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.483 2.122 . . . . 0.0 112.561 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.77 -160.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.76 -0.43 14.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.599 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.474 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -171.42 68.25 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 78' ' ' TRP . 18.6 m -121.45 141.63 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 CA-C-O 121.132 0.492 . . . . 0.0 112.09 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.532 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.2 m120 -82.32 152.04 26.45 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.815 -178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.887 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -89.1 97.43 6.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.528 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -82.95 22.23 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.116 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.43 -144.65 17.9 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.079 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.847 ' HA ' HG23 ' A' ' 75' ' ' VAL . 5.0 mtt180 -156.79 168.1 28.46 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.012 0.434 . . . . 0.0 111.33 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mp -91.41 116.29 32.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.076 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.46 -87.07 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -120.15 126.0 49.61 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.85 0.357 . . . . 0.0 111.395 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 176.59 -67.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.633 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -169.17 -42.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.699 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.426 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 22.2 mt-10 57.48 35.32 25.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.024 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.07 28.19 2.5 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.449 -0.881 . . . . 0.0 112.877 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.087 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp -52.17 -34.06 43.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.782 0.325 . . . . 0.0 110.995 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.51 -26.29 0.11 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.94 -179.463 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.54 31.34 4.22 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.011 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.865 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.1 m -79.84 154.19 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.641 0.258 . . . . 0.0 111.202 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.96 146.55 32.01 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.578 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 16.0 p-10 -54.57 112.01 0.92 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.997 0.427 . . . . 0.0 111.593 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 69.61 100.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.869 -0.682 . . . . 0.0 113.179 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -151.82 148.88 28.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.878 0.371 . . . . 0.0 110.982 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.1 t -46.63 163.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.327 0.584 . . . . 0.0 112.233 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 45' ' ' ALA . 42.4 t -158.1 128.07 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.326 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.2 m -126.51 108.42 19.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.901 0.382 . . . . 0.0 111.547 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.751 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.05 128.53 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.289 179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.44 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.4 pt-20 -154.0 130.26 10.45 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.589 0.233 . . . . 0.0 111.43 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.603 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.19 89.53 3.09 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.81 0.338 . . . . 0.0 110.801 179.662 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.25 -0.881 . . . . 0.0 111.719 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.0 mtp . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.775 0.322 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.09 -27.87 2.0 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.501 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 60.91 -160.12 0.31 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.473 0.178 . . . . 0.0 110.724 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 60.26 19.26 8.72 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.656 0.265 . . . . 0.0 111.069 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.09 -32.01 0.12 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.747 HG12 ' H ' ' A' ' 25' ' ' GLU . 26.5 m -112.11 61.78 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.031 0.443 . . . . 0.0 111.274 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -158.51 36.52 0.23 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.071 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 114.5 28.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -111.27 145.32 38.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.168 0.509 . . . . 0.0 112.099 -179.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.39 164.57 14.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.796 178.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.35 143.82 36.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 0.0 111.159 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.45 100.99 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.344 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -102.48 156.26 17.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.597 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.553 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.1 m-85 -136.27 137.91 41.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.524 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.5 -29.18 0.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.5 p -123.88 22.81 8.8 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.54 151.86 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -126.68 141.5 51.83 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.83 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.61 148.94 11.05 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.717 0.294 . . . . 0.0 111.498 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.5 160.11 31.51 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.308 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -151.86 144.98 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.122 0.487 . . . . 0.0 111.571 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 8.3 mt-10 -96.21 -178.52 4.34 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.13 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.849 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.0 tp -151.02 147.02 26.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.029 0.442 . . . . 0.0 111.15 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 19.4 m-85 -128.5 146.88 50.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.722 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.747 ' H ' HG12 ' A' ' 6' ' ' VAL . 20.5 mt-10 -59.06 -9.03 1.7 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -45.4 -29.56 1.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.647 0.26 . . . . 0.0 111.336 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -79.9 -56.38 4.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 158.24 117.2 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.649 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -45.99 -35.36 14.21 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.523 2.149 . . . . 0.0 112.208 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.67 -49.63 76.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.708 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.539 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.91 -44.22 93.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.859 0.362 . . . . 0.0 110.514 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.849 HG13 ' CD2' ' A' ' 23' ' ' LEU . 63.7 t -47.68 -34.66 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.204 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -60.07 -36.98 78.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.3 -47.39 70.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.161 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.457 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -54.95 -51.76 50.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.612 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.42 -28.7 69.98 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-O 121.028 0.442 . . . . 0.0 110.399 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -70.74 -26.16 63.25 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.452 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.0 51.48 1.12 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.778 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.964 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.7 -159.71 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.883 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.591 179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.964 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.6 Cg_exo -28.92 105.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 121.996 1.798 . . . . 0.0 113.989 -178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 39' ' ' LEU . 21.0 mt -146.64 150.71 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.63 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.76 135.66 33.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.036 0.446 . . . . 0.0 111.82 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.608 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.9 p -144.05 148.97 35.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.453 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.89 126.95 48.91 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.918 0.389 . . . . 0.0 110.291 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.933 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -88.84 132.75 34.52 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -102.63 122.3 44.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.712 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.925 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.66 136.18 33.18 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.575 ' O ' ' N ' ' A' ' 50' ' ' ASP . 0.9 OUTLIER -155.74 148.26 23.9 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.81 178.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -32.07 85.47 0.01 OUTLIER Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.271 -0.49 . . . . 0.0 113.178 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.1 t70 76.0 -39.28 0.37 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.879 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.9 tt0 -71.09 120.26 16.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.829 0.347 . . . . 0.0 111.504 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.869 HG21 HD21 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -128.36 121.54 55.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.742 178.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -135.23 127.91 30.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.844 0.354 . . . . 0.0 111.296 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.7 p90 -133.4 145.76 50.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.013 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.15 146.19 24.05 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.639 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.63 6.31 10.53 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER 83.07 -8.08 1.16 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.2 p -85.76 115.02 26.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.38 94.7 5.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.975 0.417 . . . . 0.0 112.052 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.8 p -129.66 106.78 14.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.124 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -122.64 134.75 54.49 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-O 121.027 0.441 . . . . 0.0 111.641 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.26 167.26 22.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.065 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -109.03 88.78 2.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.972 0.415 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.33 160.79 7.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.757 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.8 t-20 63.42 -81.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.14 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.49 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 3.3 m 28.5 83.6 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.368 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.841 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.19 155.45 17.75 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.398 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.655 ' OD1' HG23 ' A' ' 69' ' ' VAL . 1.5 p30 -120.41 2.11 10.74 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.655 HG23 ' OD1' ' A' ' 68' ' ' ASP . 51.0 t -137.28 141.18 40.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.827 0.346 . . . . 0.0 111.132 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -158.12 157.21 3.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.715 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -98.26 148.73 23.32 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.389 0.614 . . . . 0.0 111.439 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.61 129.42 4.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.948 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.51 -32.06 6.08 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.134 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' HA ' ' HG2' ' A' ' 109' ' ' ARG . 2.5 p30 -81.15 157.93 25.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.327 0.564 . . . . 0.0 111.929 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.87 HG23 ' HA ' ' A' ' 109' ' ' ARG . 38.4 t -116.21 152.53 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.48 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.649 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 151.32 32.54 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 118.305 0.502 . . . . 0.0 112.341 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.434 ' CZ ' ' HA ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER -107.36 137.28 45.7 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.547 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.553 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -76.22 111.95 12.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.3 OUTLIER -64.04 -67.37 1.08 Allowed Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 32.2 Cg_endo -63.5 76.28 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.23 1.954 . . . . 0.0 111.785 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.83 -10.84 1.65 Allowed Glycine 0 CA--C 1.523 0.54 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.545 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.38 28.72 11.9 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 117.147 0.474 . . . . 0.0 110.944 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.12 130.9 55.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.676 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.6 mt -89.74 147.66 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.197 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.1 t -141.06 156.83 45.94 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.482 0.658 . . . . 0.0 112.769 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.922 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.75 161.76 15.11 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.069 179.216 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 10.5 m-85 -136.55 138.94 41.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.774 0.321 . . . . 0.0 111.185 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.429 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -177.68 49.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.418 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.71 -78.54 0.19 Allowed Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.21 -0.995 . . . . 0.0 113.619 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -141.47 -161.51 1.23 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.109 0.481 . . . . 0.0 111.976 -179.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.879 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -166.33 177.87 1.41 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.009 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.1 Cg_endo -41.79 -23.67 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.473 2.115 . . . . 0.0 112.921 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.431 HD11 ' HB3' ' A' ' 99' ' ' ARG . 10.0 pt -141.19 64.59 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.462 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -54.53 -71.12 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.115 0.483 . . . . 0.0 110.662 179.077 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 64.0 -102.69 0.1 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.646 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.7 -12.17 10.9 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.717 0.294 . . . . 0.0 110.908 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.97 -159.7 0.98 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.019 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.3 mt -123.1 100.93 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.749 0.309 . . . . 0.0 110.948 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -100.09 99.06 8.53 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.767 ' HA ' HG21 ' A' ' 91' ' ' THR . 46.9 Cg_endo -68.16 -29.68 32.59 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.384 2.056 . . . . 0.0 112.215 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.668 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.39 -162.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.661 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.8 -2.97 15.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.654 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -172.16 70.1 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.4 m -120.03 141.64 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 120.956 0.408 . . . . 0.0 111.8 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.612 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.8 m120 -83.83 153.1 24.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.285 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.841 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.84 89.66 3.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.121 178.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.649 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.87 23.64 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -178.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 114.71 -150.46 18.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.807 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.87 ' HA ' HG23 ' A' ' 75' ' ' VAL . 27.2 mtp180 -156.94 168.16 28.32 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 111.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.2 mt -98.05 114.59 35.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.568 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.99 -86.67 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.737 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.3 p-10 -66.98 170.28 6.99 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.973 0.416 . . . . 0.0 111.164 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.1 p 59.66 168.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 36.4 mmm -58.28 149.64 23.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' CB ' HG21 ' A' ' 110' ' ' ILE . 3.5 pm0 -131.29 36.17 3.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.845 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -116.89 45.31 1.3 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.755 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.922 HD22 HD13 ' A' ' 86' ' ' LEU . 1.5 tp -49.58 -34.7 18.48 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.41 -26.43 0.11 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.282 -179.365 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.03 29.83 4.54 Favored Glycine 0 CA--C 1.522 0.492 0 C-N-CA 120.657 -0.783 . . . . 0.0 113.39 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.925 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.3 m -84.32 153.89 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.832 0.316 . . . . 0.0 111.381 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -79.67 147.18 32.08 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.475 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 5.2 p-10 -56.31 117.72 4.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.047 0.451 . . . . 0.0 111.735 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.52 100.55 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.108 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -154.29 149.63 27.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.781 0.324 . . . . 0.0 111.137 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.2 t -48.6 164.92 0.05 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.301 0.572 . . . . 0.0 112.061 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.933 HG21 ' HB2' ' A' ' 45' ' ' ALA . 48.0 t -158.02 128.82 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.315 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.578 HG23 ' OE2' ' A' ' 129' ' ' GLU . 17.4 m -125.83 108.44 19.5 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.948 0.404 . . . . 0.0 111.453 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.0 128.79 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.225 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.578 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -154.43 131.66 11.1 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.799 0.333 . . . . 0.0 111.542 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.534 ' CB ' HD22 ' A' ' 39' ' ' LEU . 3.1 tmm_? -74.25 92.85 2.28 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.679 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.417 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.867 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.795 0.331 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.405 ' O ' HG23 ' A' ' 6' ' ' VAL . . . 123.2 170.24 13.42 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.525 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -147.27 -160.18 1.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.582 0.229 . . . . 0.0 110.65 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 3.0 mmm-85 60.63 19.11 9.08 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.134 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.4 -28.12 0.16 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.61 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.698 HG12 ' H ' ' A' ' 25' ' ' GLU . 27.0 m -112.94 62.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.979 0.419 . . . . 0.0 111.241 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -156.59 43.47 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.113 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.14 112.11 24.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.89 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -109.15 145.42 35.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.141 0.496 . . . . 0.0 112.156 -179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.11 163.27 17.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.7 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.98 144.86 32.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.885 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.604 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.9 OUTLIER -145.89 101.21 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.125 0.488 . . . . 0.0 109.749 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -100.09 156.12 17.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.71 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.67 138.03 44.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.431 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -43.43 -28.91 0.39 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 35.6 t -125.56 22.37 7.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.14 150.26 1.53 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.415 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -131.92 139.23 48.67 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.188 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.97 149.2 8.92 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.7 0.286 . . . . 0.0 111.339 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -116.41 156.92 25.95 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.41 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -146.79 138.04 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.084 0.469 . . . . 0.0 111.3 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.689 ' OE2' HG13 ' A' ' 111' ' ' VAL . 3.2 mt-10 -92.96 -178.3 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.325 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.836 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -155.43 145.87 21.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.016 0.436 . . . . 0.0 110.866 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.439 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 20.6 m-85 -126.65 146.71 50.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.875 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.698 ' H ' HG12 ' A' ' 6' ' ' VAL . 29.6 mt-10 -56.59 -9.13 0.67 Allowed 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -45.67 -27.4 0.79 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 122.212 -0.305 . . . . 0.0 111.383 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.776 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.6 t90 -80.56 -55.96 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.49 109.7 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.48 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.738 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 88.4 Cg_exo -40.9 -29.71 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.789 2.326 . . . . 0.0 112.967 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -67.97 -42.04 81.47 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.321 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.776 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -68.74 -45.03 72.53 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.784 0.326 . . . . 0.0 110.477 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 ' CD2' ' A' ' 23' ' ' LEU . 35.5 t -48.85 -33.64 5.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.244 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -58.03 -37.25 74.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.227 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.44 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -66.5 -48.44 69.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.45 -51.23 43.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.04 -29.03 70.01 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-O 120.967 0.413 . . . . 0.0 110.331 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -71.7 -24.76 61.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.62 51.47 0.93 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.983 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.959 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.762 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.522 179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.959 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 33.6 Cg_exo -29.49 105.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.071 1.848 . . . . 0.0 113.969 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.8 mt -147.23 150.79 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.569 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.9 136.85 33.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.106 0.479 . . . . 0.0 111.69 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.612 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.0 p -145.23 148.88 34.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.504 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 123.65 46.09 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.068 0.461 . . . . 0.0 110.263 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.928 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.49 135.04 34.81 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -107.26 126.43 52.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.679 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -89.43 137.4 32.36 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 14.4 t-105 -149.47 148.37 29.34 Favored 'General case' 0 N--CA 1.46 0.057 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.431 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.519 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.17 92.99 0.01 OUTLIER Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.053 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 27.9 t70 78.87 -41.36 0.28 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.724 0.41 . . . . 0.0 111.649 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.92 152.55 24.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.095 0.474 . . . . 0.0 111.425 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 120' ' ' VAL . 0.5 OUTLIER -153.0 117.34 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.627 179.626 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.501 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 26.2 p90 -124.06 141.68 51.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.345 0.593 . . . . 0.0 112.226 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.458 ' CD2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -140.45 145.39 36.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.33 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.57 149.5 21.32 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.697 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.89 5.23 8.71 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 2.2 mm-40 83.32 -8.08 1.12 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.764 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.2 p -85.02 116.7 28.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.33 94.95 5.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 0.0 112.187 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.614 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.0 p -124.55 106.62 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.874 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -128.71 136.44 50.6 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-O 121.026 0.441 . . . . 0.0 111.708 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -156.86 164.62 37.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.233 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.79 91.02 6.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.859 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.7 tt0 -170.12 152.04 4.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.7 t-20 68.5 -79.96 0.04 OUTLIER 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.638 0.256 . . . . 0.0 110.96 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.492 ' OG ' HD12 ' A' ' 79' ' ' ILE . 4.4 m 23.8 80.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.624 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 158.67 16.05 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.558 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -120.64 -5.88 9.71 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.442 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.9 p -128.83 142.87 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.392 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.54 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 29.5 m -158.68 157.9 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.119 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -88.23 151.45 22.66 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.343 0.592 . . . . 0.0 111.412 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -50.43 126.2 14.58 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.143 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.53 -32.22 6.19 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.939 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.4 p-10 -68.98 162.49 26.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.074 0.464 . . . . 0.0 112.101 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.854 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -121.73 152.47 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.948 179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.798 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.61 146.24 25.68 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.495 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.99 130.98 44.24 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.817 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.748 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.9 t90 -71.03 122.66 20.45 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.99 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -68.09 -67.84 0.75 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.903 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.493 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 47.1 Cg_endo -68.05 80.56 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.246 1.964 . . . . 0.0 112.181 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.46 -11.94 2.48 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.433 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 53.76 30.56 11.41 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 117.11 0.455 . . . . 0.0 110.749 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -109.65 135.07 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.63 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 30.5 mt -85.96 144.24 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.441 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.8 m -137.66 130.7 30.39 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.889 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -87.36 156.86 19.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.09 178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.7 m-85 -136.5 130.13 32.05 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.859 0.361 . . . . 0.0 111.346 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.538 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 2.6 m-85 -152.51 28.19 0.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.636 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 151.07 -151.78 23.7 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.518 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -40.73 169.98 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.619 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -151.2 -174.62 0.42 Allowed Pre-proline 0 N--CA 1.455 -0.198 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.647 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.6 Cg_exo -46.18 -24.19 2.31 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 121.748 1.632 . . . . 0.0 112.297 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -139.94 55.54 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.201 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -48.99 -78.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 49.25 58.46 5.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.702 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 62.2 11.41 4.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.441 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 94' ' ' SER . 2.7 mmpt? -149.02 177.68 9.36 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 ' OG1' ' A' ' 91' ' ' THR . 67.8 mt -123.53 129.11 74.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.08 0.467 . . . . 0.0 111.849 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.7 mtt85 -136.33 99.2 10.93 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.556 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.452 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 54.0 Cg_endo -68.21 -31.66 28.67 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.44 2.093 . . . . 0.0 112.331 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.726 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.0 -161.61 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.748 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.16 -7.68 15.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.53 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.39 71.24 0.09 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.748 HG12 ' CD1' ' A' ' 78' ' ' TRP . 14.5 m -118.36 141.92 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 120.855 0.36 . . . . 0.0 111.472 178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.685 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 31.7 m-20 -82.15 150.94 27.17 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.624 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.51 92.61 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.223 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.798 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -79.17 19.67 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.423 -178.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 112.11 -148.24 18.21 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.087 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.854 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.5 mtt180 -155.93 167.87 29.03 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.964 0.411 . . . . 0.0 111.518 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.625 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -94.15 114.8 31.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.689 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -54.09 -77.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.954 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -75.67 75.84 2.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.846 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.6 p -73.07 64.83 0.75 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.839 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -147.5 30.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.923 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -120.35 7.28 10.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.418 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' C ' ' O ' ' A' ' 115' ' ' GLU . . . 21.3 46.39 0.01 OUTLIER Glycine 0 C--N 1.339 0.723 0 N-CA-C 114.389 0.516 . . . . 0.0 114.389 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.4 tt -42.5 -35.2 0.99 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.539 0.209 . . . . 0.0 111.421 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.538 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.9 -24.54 0.07 Allowed 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.727 179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.46 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -87.34 32.54 4.11 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.739 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.91 HG13 ' O ' ' A' ' 117' ' ' LEU . 12.1 m -74.94 154.54 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.272 0.229 . . . . 0.0 110.825 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.45 144.53 46.25 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.536 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 12.2 p-10 -58.02 112.91 1.67 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.423 . . . . 0.0 111.866 -179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.2 103.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.522 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -158.16 151.49 23.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.878 0.37 . . . . 0.0 110.934 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.11 164.54 0.11 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.307 0.575 . . . . 0.0 112.196 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.928 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.07 128.99 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.37 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.534 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.4 m -126.51 108.39 18.96 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.879 0.371 . . . . 0.0 111.356 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.697 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.01 128.84 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.444 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.7 pt-20 -153.26 129.64 10.58 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-O 120.672 0.273 . . . . 0.0 111.274 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.628 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.81 89.96 2.34 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.787 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.798 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.8 0.333 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 169.57 43.69 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.533 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.65 -158.7 0.67 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.571 0.224 . . . . 0.0 110.725 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 62.39 -82.52 0.02 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.616 0.246 . . . . 0.0 110.943 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.09 -41.55 0.19 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.586 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 6' ' ' VAL . 32.6 m -120.19 65.28 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.898 0.38 . . . . 0.0 111.372 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -159.89 44.22 0.22 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.956 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.59 109.33 21.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.833 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.7 OUTLIER -106.66 145.32 32.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.205 0.526 . . . . 0.0 112.29 -179.379 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.97 164.72 15.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.66 178.512 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.52 147.29 36.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.787 0.327 . . . . 0.0 111.11 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -142.88 102.92 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.41 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 0.1 OUTLIER -102.37 156.24 17.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.481 -179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.822 ' CE1' HG22 ' A' ' 126' ' ' VAL . 43.9 m-85 -139.01 138.59 37.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.743 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.71 -28.87 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.104 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 m -125.7 22.97 7.45 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.449 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -175.38 154.67 1.72 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.46 147.04 50.3 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.683 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.96 149.79 14.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.776 0.322 . . . . 0.0 111.533 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.19 156.94 47.46 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.142 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -155.33 149.87 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.032 0.444 . . . . 0.0 111.631 -179.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 13.5 mt-10 -102.23 -178.64 3.76 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.974 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 4.1 tp -153.29 149.52 27.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.11 0.481 . . . . 0.0 111.402 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.428 ' H ' HD12 ' A' ' 23' ' ' LEU . 22.7 m-85 -127.24 148.87 50.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.743 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' H ' HG12 ' A' ' 6' ' ' VAL . 39.0 mt-10 -56.2 -8.97 0.55 Allowed 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -45.61 -27.49 0.79 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 117.967 0.349 . . . . 0.0 111.533 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.641 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -82.42 -56.53 3.83 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.42 116.16 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.416 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -45.89 -34.41 12.34 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.478 2.119 . . . . 0.0 112.383 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mp0 -61.63 -49.99 74.37 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.424 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.498 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.38 -44.85 93.57 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.606 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.9 t -49.15 -31.48 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.16 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -61.97 -38.16 87.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -46.63 80.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.03 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.455 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.23 -51.31 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.02 -28.09 69.34 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 121.087 0.47 . . . . 0.0 110.445 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.85 -23.5 59.63 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.82 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.62 51.37 0.84 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.661 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.976 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.5 mt -61.95 -159.9 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.281 -0.866 . . . . 0.0 109.692 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.976 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.0 Cg_exo -27.66 105.23 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.65 0 C-N-CA 122.167 1.911 . . . . 0.0 114.156 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 23.8 mt -147.18 150.71 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.395 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.81 135.42 33.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.114 0.483 . . . . 0.0 111.748 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.619 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.5 p -146.06 149.13 33.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.391 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.74 132.03 47.69 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.11 136.07 33.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' ND2' ' CE1' ' A' ' 53' ' ' TYR . 1.2 m-20 -100.79 117.55 35.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.271 -0.877 . . . . 0.0 108.914 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.601 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -86.11 133.0 33.91 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -178.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.558 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.4 t-105 -154.21 148.81 26.33 Favored 'General case' 0 C--O 1.229 0.017 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -30.72 85.61 0.01 OUTLIER Glycine 0 C--N 1.338 0.64 0 C-N-CA 121.625 -0.321 . . . . 0.0 113.282 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 48' ' ' TRP . 33.0 t70 73.31 -37.8 0.39 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.542 0.337 . . . . 0.0 111.521 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.583 ' CD ' HG22 ' A' ' 91' ' ' THR . 6.1 tt0 -72.08 129.29 38.15 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.855 0.359 . . . . 0.0 110.837 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.602 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -133.26 124.63 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.129 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.41 ' CE1' ' ND2' ' A' ' 46' ' ' ASN . 55.0 p90 -135.7 133.15 37.78 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.944 0.402 . . . . 0.0 111.644 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.3 p90 -138.83 145.44 40.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.022 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -93.6 148.52 22.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.162 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.679 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.99 5.87 9.3 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 83.38 -8.18 1.11 Allowed 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.0 p -85.89 114.15 25.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.124 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.31 98.47 8.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 112.055 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.1 p -134.42 106.81 8.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.173 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -126.64 133.93 50.87 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-O 121.054 0.454 . . . . 0.0 111.555 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 31.8 tttt -140.07 164.77 29.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.292 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -99.23 86.94 3.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.778 0.323 . . . . 0.0 110.85 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.455 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.7 tt0 -170.18 160.61 8.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.797 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.455 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.4 t-20 63.31 -82.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.857 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.456 ' HB3' ' HB1' ' A' ' 103' ' ' ALA . 5.4 m 26.48 81.21 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.87 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.65 161.08 13.84 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.834 -0.346 . . . . 0.0 110.349 179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -122.62 -7.44 8.57 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.3 p -126.7 141.6 45.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.531 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.484 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.4 m -159.27 146.9 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -89.14 152.76 21.44 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.193 0.521 . . . . 0.0 110.953 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.2 tp -41.23 124.01 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.465 -0.788 . . . . 0.0 112.348 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -32.31 6.04 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.681 -0.771 . . . . 0.0 114.058 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -70.99 127.05 31.28 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.818 0.309 . . . . 0.0 111.505 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 11.9 t -94.8 150.62 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.626 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -145.65 153.04 40.58 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.516 0.598 . . . . 0.0 112.474 -179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -110.53 122.63 48.21 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.091 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.753 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.3 t90 -61.84 127.22 30.37 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.087 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.47 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -75.13 -64.19 0.63 Allowed Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.893 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.47 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 46.3 Cg_endo -67.8 85.55 0.39 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.283 1.988 . . . . 0.0 112.025 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.43 -6.75 5.3 Favored Glycine 0 CA--C 1.521 0.449 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.38 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.16 36.88 13.28 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.96 0.409 . . . . 0.0 111.069 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.95 134.19 51.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.356 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.0 mt -91.37 149.42 4.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.504 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 34.7 t -143.16 156.53 44.8 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.265 0.555 . . . . 0.0 112.492 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.653 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.99 158.59 18.09 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.415 179.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 12.9 m-85 -136.67 127.11 26.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.5 OUTLIER -168.62 51.66 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.677 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.403 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 162.74 -80.78 0.13 Allowed Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.44 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -155.89 176.92 12.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.036 0.446 . . . . 0.0 111.926 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.773 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -143.52 -174.32 0.4 Allowed Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.603 ' CD ' HG22 ' A' ' 91' ' ' THR . 97.0 Cg_exo -45.02 -22.81 0.79 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.131 1.887 . . . . 0.0 112.934 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 99' ' ' ARG . 1.6 mp -132.44 76.07 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.856 0.36 . . . . 0.0 111.872 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -89.41 20.72 3.71 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.178 179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -45.78 -84.58 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.573 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -109.0 -9.14 15.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.281 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.3 mtmm -155.36 -172.58 4.21 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.833 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.544 HG23 ' OG1' ' A' ' 91' ' ' THR . 14.4 mt -103.9 106.4 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.804 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' HB2' HD13 ' A' ' 93' ' ' ILE . 27.9 mmm-85 -99.89 99.35 8.91 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.773 ' HA ' HG21 ' A' ' 91' ' ' THR . 64.1 Cg_endo -71.24 -32.14 13.31 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.513 2.142 . . . . 0.0 112.579 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.63 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.62 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.816 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.69 -5.38 13.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 66' ' ' SER . . . -169.96 71.65 0.07 Allowed 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.753 HG12 ' CD1' ' A' ' 78' ' ' TRP . 16.6 m -121.34 142.04 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 120.696 0.284 . . . . 0.0 111.222 178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.626 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.7 m-20 -85.86 153.0 22.55 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.87 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -88.14 101.99 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.607 HG12 HD13 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -87.51 22.24 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 117.4 -148.6 18.74 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.196 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.8 mtt180 -154.84 163.0 40.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.843 0.354 . . . . 0.0 110.947 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.12 113.8 28.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.292 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.37 -86.59 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -73.56 63.95 0.85 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 111.267 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 170.71 41.79 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.938 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 5.9 ttt -69.15 70.52 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.781 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.05 -166.04 1.25 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.137 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -127.46 45.4 1.15 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.393 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.802 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.2 tp -43.13 -38.64 2.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.706 0.289 . . . . 0.0 111.366 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.78 0.09 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.062 -179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.44 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.27 34.98 3.8 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.423 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.802 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.3 m -81.5 153.75 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.7 147.31 43.73 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.379 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.508 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 2.4 p30 -53.35 135.86 38.28 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.501 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 55.32 99.4 0.01 OUTLIER Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.311 -0.859 . . . . 0.0 114.243 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -145.01 153.29 41.32 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.008 0.432 . . . . 0.0 111.145 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.92 157.74 24.05 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.482 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.892 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.5 t -148.54 129.05 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.023 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 24.9 m -124.27 107.13 17.96 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.37 128.97 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.739 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.497 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.2 OUTLIER -150.96 128.23 11.27 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 120.714 0.292 . . . . 0.0 111.147 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.716 ' HB3' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.05 90.91 3.05 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.798 0.332 . . . . 0.0 110.824 179.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.297 -0.858 . . . . 0.0 111.688 179.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.86 0.362 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.66 -84.74 0.3 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.492 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.703 ' OE2' HG23 ' A' ' 6' ' ' VAL . 4.0 mm-40 -107.92 -62.34 1.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.861 0.362 . . . . 0.0 110.994 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 58.45 20.77 7.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.152 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.62 -32.08 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.719 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.703 HG23 ' OE2' ' A' ' 3' ' ' GLU . 32.8 m -118.34 65.9 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.045 0.45 . . . . 0.0 111.207 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.26 47.26 1.14 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.01 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.6 115.37 29.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -114.79 145.22 42.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.249 0.547 . . . . 0.0 112.346 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.23 163.67 19.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.507 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.47 144.62 31.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.92 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.0 OUTLIER -145.89 100.01 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -108.77 156.21 19.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.832 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.9 m-85 -126.49 143.7 51.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.154 179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -28.67 0.23 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.0 t -121.69 23.07 10.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.76 154.57 1.97 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.185 -0.606 . . . . 0.0 112.631 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -127.53 142.79 51.29 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.16 149.49 12.2 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.676 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -121.9 158.16 29.59 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.349 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -154.59 142.84 13.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.001 0.429 . . . . 0.0 111.372 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -92.78 -178.27 4.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.498 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.846 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -152.72 140.39 19.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.963 0.411 . . . . 0.0 110.95 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.13 143.14 49.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.82 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.618 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -60.61 -8.49 2.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.02 -29.63 0.89 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.696 0.284 . . . . 0.0 111.118 -179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.678 ' NE1' HG21 ' A' ' 31' ' ' THR . 0.5 OUTLIER -76.77 -54.14 7.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 178.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.782 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 162.59 116.24 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.414 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.804 178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.4 Cg_endo -47.4 -34.61 19.52 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.578 2.185 . . . . 0.0 112.504 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -68.51 -37.51 80.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.353 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.782 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -68.72 -43.95 74.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.926 0.393 . . . . 0.0 110.28 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.846 HG13 ' CD2' ' A' ' 23' ' ' LEU . 65.3 t -50.04 -38.88 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.716 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -56.87 -35.13 68.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.24 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.72 -47.06 70.41 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.799 0.333 . . . . 0.0 111.011 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.54 -49.24 78.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.601 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.1 -29.63 70.95 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 121.144 0.497 . . . . 0.0 110.284 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -70.43 -25.76 63.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 0.0 110.554 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.39 52.79 0.94 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.849 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.68 -159.91 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.692 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 27.9 Cg_exo -28.04 106.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.18 1.92 . . . . 0.0 114.099 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.6 mt -148.18 150.25 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.514 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -85.87 136.88 33.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.177 0.513 . . . . 0.0 111.759 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -146.05 149.12 33.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.361 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.72 130.42 48.11 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.912 0.387 . . . . 0.0 110.15 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.88 133.12 35.95 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -103.39 128.38 50.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.004 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.873 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.6 138.21 31.63 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.3 t-105 -155.1 148.98 25.61 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.453 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -37.31 97.16 0.01 OUTLIER Glycine 0 C--N 1.336 0.574 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.492 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 t0 53.27 24.6 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.753 0.311 . . . . 0.0 111.356 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.73 136.93 39.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.489 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -138.4 129.42 36.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 52.6 p90 -137.92 122.11 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.371 . . . . 0.0 110.84 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.504 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.9 p90 -131.29 146.36 52.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.912 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.89 148.9 21.63 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.7 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.73 6.33 8.8 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.973 0.361 . . . . 0.0 111.973 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.4 OUTLIER 82.89 -8.01 1.19 Allowed 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -86.05 114.82 26.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.258 179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.48 96.04 6.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.046 0.45 . . . . 0.0 111.855 -179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.64 ' CG2' HG22 ' A' ' 31' ' ' THR . 5.9 p -133.14 106.81 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.253 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -130.87 133.5 45.96 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.937 0.399 . . . . 0.0 111.535 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.422 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 40.5 tttm -145.08 165.55 27.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.372 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -99.09 90.06 4.47 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 4.5 tt0 -170.21 158.49 6.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.804 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.471 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 35.8 t-20 63.21 -82.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.85 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 65' ' ' ASN . 19.9 m 25.63 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.326 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.766 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -104.13 162.03 13.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.852 179.498 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -120.94 -12.16 8.82 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.4 p -121.27 143.25 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.439 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.574 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 36.0 m -158.31 157.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -86.71 150.15 24.38 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.338 0.59 . . . . 0.0 111.053 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.63 125.01 15.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.939 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.98 -31.43 6.53 Favored Glycine 0 C--N 1.337 0.597 0 C-N-CA 120.471 -0.871 . . . . 0.0 114.223 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.467 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.2 p-10 -69.24 165.72 19.95 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 117.16 0.48 . . . . 0.0 111.825 -179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.802 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.9 t -119.99 152.36 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.251 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.683 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.44 148.92 30.01 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.442 0.565 . . . . 0.0 112.381 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE2' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -104.57 135.42 46.02 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.161 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.694 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -76.6 108.7 9.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.457 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.527 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -56.73 -70.65 0.32 Allowed Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.145 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.527 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -58.64 87.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.266 1.977 . . . . 0.0 112.347 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.39 -6.03 5.61 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.774 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.8 32.42 9.62 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.959 0.38 . . . . 0.0 110.582 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.66 131.68 54.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.764 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 11.4 mt -87.76 150.6 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.087 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 18.6 t -143.34 156.35 44.67 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.948 HD13 HD22 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -121.37 137.8 54.54 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.144 178.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.9 p90 -136.65 139.76 42.26 Favored 'General case' 0 C--O 1.232 0.132 0 O-C-N 122.029 -0.419 . . . . 0.0 111.491 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.454 ' CZ ' ' HB2' ' A' ' 115' ' ' GLU . 0.2 OUTLIER -149.55 53.44 0.94 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.048 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 147.22 -135.03 5.47 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -57.35 -173.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 117.676 0.738 . . . . 0.0 111.2 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -167.93 -174.14 0.33 Allowed Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.133 -0.94 . . . . 0.0 108.932 179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 88.2 Cg_exo -45.83 -21.4 0.95 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 121.816 1.677 . . . . 0.0 112.59 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 8.2 mt -143.36 60.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -49.52 -75.4 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 110.761 179.224 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 61.62 -103.43 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.97 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.84 -8.46 11.34 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.725 0.298 . . . . 0.0 111.042 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.01 -158.08 0.83 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.125 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.53 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.2 mt -123.13 117.61 52.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.965 0.412 . . . . 0.0 111.275 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.64 99.42 52.81 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.998 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.717 ' HA ' HG21 ' A' ' 91' ' ' THR . 33.2 Cg_endo -62.61 -29.69 78.24 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.472 2.115 . . . . 0.0 112.604 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.603 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.37 -162.05 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.798 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.59 -5.92 22.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.536 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -176.31 77.54 0.02 OUTLIER 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 78' ' ' TRP . 24.5 m -125.35 141.5 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.94 0.4 . . . . 0.0 111.611 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m-20 -81.88 153.91 26.11 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.261 -178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.766 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.23 81.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.683 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -64.86 19.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -178.253 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 117.51 -138.07 13.81 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.849 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.802 ' HA ' HG23 ' A' ' 75' ' ' VAL . 4.2 ptt180 -170.51 162.19 8.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.89 0.376 . . . . 0.0 111.225 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.622 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -88.49 115.75 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.537 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.16 -83.26 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.217 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -153.62 135.98 14.97 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.057 0.455 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 173.91 -58.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.481 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.2 tpt 179.01 77.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.407 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 88' ' ' PHE . 10.4 pt-20 -70.31 63.02 0.24 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.09 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.18 13.62 3.05 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.906 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.948 HD22 HD13 ' A' ' 86' ' ' LEU . 3.8 tp -56.87 -43.22 81.0 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.909 0.355 . . . . 0.0 111.104 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.19 -25.26 0.07 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.04 30.21 6.01 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.559 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.873 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.7 m -71.02 154.47 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 122.334 0.254 . . . . 0.0 111.56 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.623 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -79.18 148.57 32.24 Favored 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.595 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 7.7 p-10 -57.0 109.85 0.72 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.069 0.462 . . . . 0.0 111.947 -178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.04 101.54 0.2 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.792 -0.64 . . . . 0.0 113.93 178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.623 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -154.02 154.46 33.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.969 0.414 . . . . 0.0 110.845 178.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.405 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.1 OUTLIER -56.66 167.24 0.77 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.964 -179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 58.6 t -158.01 129.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.414 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.4 m -127.78 108.05 17.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-O 120.901 0.381 . . . . 0.0 111.311 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.7 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.31 128.79 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.334 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 5.2 pt-20 -153.75 131.62 11.64 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.685 0.278 . . . . 0.0 111.29 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.55 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.11 89.89 3.06 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.85 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.456 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.206 -0.902 . . . . 0.0 111.748 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 120.83 0.348 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 145.32 108.45 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.478 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -59.34 -38.4 80.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.819 0.343 . . . . 0.0 110.889 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.66 -71.91 0.22 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.755 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.31 89.89 0.08 OUTLIER Glycine 0 CA--C 1.517 0.218 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.354 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 6' ' ' VAL . 28.9 m -140.12 77.53 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.062 0.458 . . . . 0.0 111.232 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -173.98 33.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.856 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.28 105.95 14.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.053 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -116.9 145.39 43.63 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.173 0.511 . . . . 0.0 112.125 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.35 163.6 15.79 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.621 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 147.24 31.37 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.99 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.4 OUTLIER -143.93 102.49 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.603 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' CG ' HG23 ' A' ' 127' ' ' VAL . 8.2 ptm180 -100.5 156.36 17.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.446 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.519 ' CE2' HG22 ' A' ' 126' ' ' VAL . 6.8 m-85 -139.71 134.9 32.57 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.598 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.72 -29.14 0.28 Allowed 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -125.02 22.45 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.7 153.09 1.37 Allowed 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 120.409 -0.516 . . . . 0.0 112.377 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -128.87 142.79 50.85 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.866 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.81 149.32 12.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.767 0.318 . . . . 0.0 111.475 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -128.77 158.9 37.36 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.056 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -152.1 144.16 15.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.028 0.442 . . . . 0.0 111.657 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.0 mt-10 -97.47 -178.5 4.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.906 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.772 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.1 tp -153.52 148.1 26.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.121 0.486 . . . . 0.0 111.407 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -125.37 148.14 48.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.692 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -57.54 -8.97 0.96 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.37 -28.3 0.83 Allowed 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.259 -0.276 . . . . 0.0 111.512 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.65 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.77 -56.5 3.95 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.65 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.66 117.22 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.58 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.77 -34.76 12.41 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.449 2.1 . . . . 0.0 112.223 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -60.52 -52.0 67.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.401 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.616 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -61.01 -45.44 94.8 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.833 0.349 . . . . 0.0 110.349 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.772 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -49.83 -30.41 5.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.207 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -28.72 70.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.268 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.2 -45.52 39.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.715 0.293 . . . . 0.0 110.979 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.464 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.36 -51.46 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.562 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.08 -28.64 69.75 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.362 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -72.44 -24.6 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 110.672 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.59 51.49 0.93 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.769 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -61.71 -160.09 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.756 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.622 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 24.6 Cg_exo -27.66 107.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.708 0 C-N-CA 122.297 1.998 . . . . 0.0 114.085 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.0 mt -149.62 151.06 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.513 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.89 136.37 33.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 111.884 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.05 148.99 33.25 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.483 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.98 129.5 48.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 0.0 110.199 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.937 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -92.79 130.76 38.3 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -178.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -97.81 133.12 42.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.506 177.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.949 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.2 OUTLIER -100.05 133.02 45.05 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.437 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 50' ' ' ASP . 1.9 t90 -157.22 148.32 21.77 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 48' ' ' TRP . . . -25.6 87.29 0.01 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.203 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 48' ' ' TRP . 13.0 t70 69.12 -40.94 0.46 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 49' ' ' GLY . 15.6 tt0 -62.72 118.99 8.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.895 0.378 . . . . 0.0 111.25 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -129.01 114.68 33.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.763 179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 50.8 p90 -126.37 126.96 44.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.445 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 2.6 p90 -135.31 145.99 48.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.769 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.66 149.75 21.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.056 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.671 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.71 4.48 8.86 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 -179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.421 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.5 OUTLIER 83.2 -8.09 1.14 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.798 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.13 114.97 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.08 94.78 5.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.011 0.434 . . . . 0.0 111.94 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.616 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.6 p -127.62 106.71 15.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.901 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HG2' HG22 ' A' ' 79' ' ' ILE . 1.8 mt-10 -127.92 134.37 49.33 Favored 'General case' 0 CA--C 1.527 0.093 0 CA-C-O 120.966 0.412 . . . . 0.0 111.898 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 13.8 tttp -142.14 165.74 26.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.209 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -103.63 88.65 3.12 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.058 0.456 . . . . 0.0 111.33 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.1 tt0 -170.2 161.38 8.36 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.2 t-20 63.9 -83.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.953 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.469 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 13.2 m 30.8 81.99 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.732 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.901 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.58 157.41 16.47 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.209 178.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -118.29 -7.24 10.76 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 p -129.2 144.27 38.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.67 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.3 m -157.86 156.84 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -99.65 149.03 23.71 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.371 0.605 . . . . 0.0 111.651 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -41.03 126.87 2.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.094 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.49 -32.01 6.1 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 120.491 -0.861 . . . . 0.0 114.197 178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.479 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.86 157.38 28.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 117.457 0.629 . . . . 0.0 111.945 -179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.869 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -116.32 152.61 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.252 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.562 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.69 150.94 34.06 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -110.62 132.43 54.19 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.687 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.747 ' HD1' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -73.62 143.71 46.24 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.189 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.646 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -94.13 -54.26 0.24 Allowed Pre-proline 0 N--CA 1.463 0.223 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.7 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 8.6 Cg_exo -72.3 72.36 2.87 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.529 2.153 . . . . 0.0 111.649 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.408 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 143.05 -7.65 2.13 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.513 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 52.57 34.64 16.07 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.977 0.388 . . . . 0.0 110.867 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.84 131.13 55.29 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.319 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.3 mt -89.3 150.68 3.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.278 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.643 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -141.28 155.73 45.96 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.27 0.557 . . . . 0.0 112.259 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.083 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.01 161.59 15.02 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.482 179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.529 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 28.2 m-85 -136.48 141.12 43.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.835 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER 175.34 43.29 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.988 -179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.9 -82.81 0.11 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.271 -0.966 . . . . 0.0 113.154 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -144.37 -168.75 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.886 0.374 . . . . 0.0 111.469 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.57 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -162.45 -177.96 0.78 Allowed Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.712 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 80.8 Cg_exo -42.5 -27.53 0.8 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.324 2.016 . . . . 0.0 112.81 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.3 mp -131.31 75.14 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.951 0.405 . . . . 0.0 111.179 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -97.13 26.68 4.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.904 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -58.03 -82.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.229 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -88.71 -45.37 9.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.889 0.376 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -141.64 170.44 15.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.774 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.57 HG23 ' OG1' ' A' ' 91' ' ' THR . 43.8 mt -75.9 98.73 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.436 ' HB2' ' HB ' ' A' ' 93' ' ' ILE . 12.9 mmm-85 -100.15 99.15 8.78 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.529 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 56.3 Cg_endo -69.63 -31.69 20.59 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.565 2.177 . . . . 0.0 112.655 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.653 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.29 -162.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.962 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.93 -9.4 15.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.537 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -165.31 72.76 0.19 Allowed 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.747 HG12 ' HD1' ' A' ' 78' ' ' TRP . 19.7 m -121.36 141.43 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.815 0.341 . . . . 0.0 111.406 178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.517 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 30.4 m-20 -85.35 151.47 24.0 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.901 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -87.67 98.17 7.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.593 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -84.43 23.79 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 109.53 -159.94 13.74 Favored Glycine 0 C--O 1.228 -0.245 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.663 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.869 ' HA ' HG23 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -143.26 168.19 20.37 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.99 0.424 . . . . 0.0 111.717 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.582 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -91.94 115.42 30.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.601 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.56 -85.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 116.638 -0.255 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -85.03 -173.49 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.888 0.375 . . . . 0.0 111.102 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.4 m 62.23 160.03 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.794 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -54.98 108.66 0.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.406 ' O ' ' CD1' ' A' ' 88' ' ' PHE . 4.6 pm0 -90.75 17.16 7.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.371 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.39 43.31 1.75 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.333 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.083 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -49.41 -30.31 7.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.12 -27.2 0.12 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.917 -179.457 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -84.99 30.01 4.06 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.4 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.949 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.9 m -81.81 154.33 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.943 0.371 . . . . 0.0 111.246 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.33 147.21 34.3 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 11.2 p-10 -55.35 116.46 2.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.072 0.463 . . . . 0.0 112.14 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.59 103.56 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.626 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -154.95 149.57 26.44 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 111.026 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.71 165.68 0.07 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.189 0.519 . . . . 0.0 112.173 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.937 HG21 ' HB2' ' A' ' 45' ' ' ALA . 43.9 t -158.09 128.02 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.61 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 127' ' ' VAL . 16.6 m -124.54 107.89 19.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-O 120.928 0.394 . . . . 0.0 111.233 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.671 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.99 128.6 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.521 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.451 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 3.3 pt-20 -152.12 130.46 12.08 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.667 0.27 . . . . 0.0 111.261 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.627 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -77.46 95.16 4.4 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.846 0.355 . . . . 0.0 110.735 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.785 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.733 0.301 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.97 -107.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.53 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -99.73 19.84 15.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 111.194 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.31 19.77 6.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.151 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.412 ' O ' ' CD1' ' A' ' 24' ' ' TYR . . . 179.13 86.83 0.07 OUTLIER Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.566 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.593 ' O ' HG13 ' A' ' 6' ' ' VAL . 7.3 p -152.49 92.21 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.984 0.421 . . . . 0.0 110.778 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.595 ' HG2' HG11 ' A' ' 32' ' ' VAL . 4.8 tp10 -92.0 -126.55 0.09 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.546 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 40.7 tpp -125.19 143.16 51.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.927 0.394 . . . . 0.0 111.142 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.518 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -86.04 145.36 27.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.578 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.63 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -116.09 156.69 25.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.965 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.51 141.63 36.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.066 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -141.73 100.9 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.02 156.11 17.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.028 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.446 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -133.17 138.58 46.65 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.322 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.08 -28.83 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 p -123.49 23.0 9.07 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -174.8 150.48 1.29 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -133.63 140.64 47.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.207 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.53 149.38 9.79 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.626 0.251 . . . . 0.0 111.288 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -116.46 157.23 25.5 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.514 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.2 141.1 16.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.951 0.405 . . . . 0.0 111.132 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 12.6 mt-10 -98.75 -178.43 3.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.057 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.769 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.5 tp -151.89 144.43 24.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.091 0.472 . . . . 0.0 111.09 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' GLY . 15.8 m-85 -120.76 146.46 46.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.553 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -56.44 -9.46 0.71 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -45.93 -27.58 0.93 Allowed 'General case' 0 CA--C 1.533 0.3 0 O-C-N 122.197 -0.315 . . . . 0.0 111.363 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.668 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.6 t90 -80.23 -56.35 4.27 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 152.48 115.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.534 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.665 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -45.55 -36.19 13.53 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.386 2.057 . . . . 0.0 112.302 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.05 -52.85 63.62 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.168 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.723 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -60.76 -45.66 93.49 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.819 0.342 . . . . 0.0 110.356 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.769 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.8 t -48.9 -29.55 2.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.31 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 47.4 ttt-85 -59.58 -38.54 81.45 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.319 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.02 -47.63 73.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.671 0.272 . . . . 0.0 111.204 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.444 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.1 OUTLIER -53.66 -51.78 40.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.569 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.29 -28.67 69.89 Favored 'General case' 0 C--N 1.341 0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 110.31 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -71.65 -25.02 61.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.882 0.373 . . . . 0.0 110.641 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.54 50.96 0.99 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.977 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.955 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.3 mt -62.42 -160.15 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.241 -0.885 . . . . 0.0 109.528 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.955 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 34.0 Cg_exo -29.35 106.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.625 0 C-N-CA 122.191 1.927 . . . . 0.0 113.934 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 39' ' ' LEU . 28.5 mt -149.99 149.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.635 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.82 136.78 33.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.097 0.475 . . . . 0.0 111.86 -179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.589 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.5 p -145.79 149.1 33.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.439 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.72 122.43 43.91 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.053 0.454 . . . . 0.0 110.285 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.893 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -81.14 132.44 35.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -104.33 123.84 48.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.141 -0.936 . . . . 0.0 108.597 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.913 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.93 137.33 32.46 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -177.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.4 t-105 -149.54 148.54 29.49 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.348 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.445 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.18 91.84 0.01 OUTLIER Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.241 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 48' ' ' TRP . 35.7 t70 78.64 -42.0 0.31 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.536 0.334 . . . . 0.0 111.578 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG3' HG22 ' A' ' 91' ' ' THR . 4.6 mt-10 -80.5 150.87 29.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.2 0.524 . . . . 0.0 111.643 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.498 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -149.73 115.88 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.574 179.312 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.7 p90 -123.4 136.45 54.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.227 0.537 . . . . 0.0 111.969 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CD2' HG11 ' A' ' 126' ' ' VAL . 5.1 p90 -136.46 145.34 45.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.522 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.32 146.73 23.83 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.712 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.92 6.96 9.82 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.8 mt-30 82.07 -7.36 1.36 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.722 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.6 p -86.21 115.6 27.68 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.066 0 CA-C-O 120.79 0.328 . . . . 0.0 110.289 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.68 96.06 6.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.0 0.429 . . . . 0.0 111.64 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.723 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.8 p -123.85 106.66 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.133 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -125.51 133.36 52.39 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.959 0.409 . . . . 0.0 111.515 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -147.61 164.48 33.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.261 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -100.54 83.46 2.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 0.0 110.757 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.21 154.71 5.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.895 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 21.2 t-20 71.67 -78.97 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.487 ' OG ' ' HB1' ' A' ' 103' ' ' ALA . 9.0 t 18.69 81.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.82 164.06 11.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.813 179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 69' ' ' VAL . 11.9 p30 -125.61 -5.6 7.0 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.551 HG23 ' OD1' ' A' ' 68' ' ' ASP . 39.6 t -131.8 141.92 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 120.832 0.349 . . . . 0.0 111.198 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.516 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.31 157.97 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -89.59 152.06 21.6 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.308 0.575 . . . . 0.0 111.39 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.36 127.1 16.6 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.245 -0.888 . . . . 0.0 112.124 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 113.62 -32.33 6.11 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.486 -0.864 . . . . 0.0 113.819 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.439 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.7 p-10 -69.64 162.06 28.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.114 0.483 . . . . 0.0 111.927 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.827 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -122.54 152.45 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.911 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.795 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.15 147.14 26.68 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -97.7 121.57 39.77 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.954 178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 80' ' ' PRO . 2.5 t90 -64.21 117.77 7.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.037 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -69.07 -69.5 0.44 Allowed Pre-proline 0 CA--C 1.533 0.302 0 N-CA-C 110.064 -0.346 . . . . 0.0 110.064 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 42.6 Cg_exo -54.73 85.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.796 1.664 . . . . 0.0 111.968 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 128.8 -6.74 6.51 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.647 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 49.99 37.68 14.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 117.035 0.417 . . . . 0.0 110.959 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 78' ' ' TRP . . . -113.11 137.0 52.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.678 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 4.6 mt -86.29 148.04 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.39 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 42.7 t -143.15 155.33 44.54 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.31 0.576 . . . . 0.0 112.444 -179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.808 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -111.89 156.21 22.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.949 179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 3.9 m-85 -136.91 127.42 26.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.8 0.333 . . . . 0.0 111.656 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.592 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.7 m-85 -147.57 29.44 0.94 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.343 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 150.47 -150.29 22.29 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.64 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -38.67 170.03 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.41 -176.44 0.61 Allowed Pre-proline 0 N--CA 1.454 -0.258 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.578 ' HB2' HD12 ' A' ' 93' ' ' ILE . 94.3 Cg_exo -43.82 -25.86 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.989 1.792 . . . . 0.0 112.283 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.578 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.0 mp -138.31 54.95 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.925 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.425 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -50.27 -40.62 48.67 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.234 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -47.22 -62.04 1.61 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.96 56.98 2.06 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.606 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.9 164.72 0.15 Allowed 'General case' 0 C--O 1.231 0.105 0 CA-C-O 120.72 0.295 . . . . 0.0 110.62 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.1 mt -63.76 103.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.913 0.387 . . . . 0.0 110.911 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 -107.58 99.48 29.18 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.917 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.535 ' HA ' HG21 ' A' ' 91' ' ' THR . 37.5 Cg_endo -64.57 -29.6 61.19 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.491 2.127 . . . . 0.0 112.6 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 177.71 -164.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.09 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.67 -6.16 23.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.497 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.487 ' HB1' ' OG ' ' A' ' 66' ' ' SER . . . -178.06 80.38 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.785 HG13 ' HB3' ' A' ' 101' ' ' ALA . 7.1 m -125.96 142.39 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.703 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 15.1 m-20 -83.19 151.85 25.5 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.485 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.594 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.04 87.68 2.04 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.795 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -72.76 16.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.366 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.01 -149.68 18.76 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.405 -0.902 . . . . 0.0 112.648 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.827 ' HA ' HG23 ' A' ' 75' ' ' VAL . 7.3 mtp-105 -156.84 168.08 28.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.854 0.359 . . . . 0.0 111.327 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.593 HG13 HG21 ' A' ' 75' ' ' VAL . 6.1 mt -100.28 114.82 40.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.357 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.61 -87.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.626 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -70.79 143.73 51.08 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.958 0.409 . . . . 0.0 111.079 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.53 28.14 15.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.214 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.6 ttt -66.87 152.67 45.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -160.67 173.68 15.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.062 0.458 . . . . 0.0 111.43 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -91.65 46.21 2.75 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.313 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.892 ' O ' HG13 ' A' ' 120' ' ' VAL . 7.2 tt -42.25 -31.98 0.45 Allowed 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.592 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.69 -27.22 0.16 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.573 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.0 32.31 3.53 Favored Glycine 0 C--N 1.335 0.495 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.983 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.913 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.6 m -73.11 154.57 7.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.676 0.274 . . . . 0.0 111.198 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.605 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -75.91 147.47 38.96 Favored 'General case' 0 C--N 1.334 -0.081 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.537 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 15.2 p-10 -58.55 108.61 0.66 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.072 0.463 . . . . 0.0 111.684 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 77.49 103.45 0.17 Allowed Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.928 -0.653 . . . . 0.0 113.464 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.605 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -154.46 154.59 33.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.786 0.327 . . . . 0.0 110.743 178.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t -53.26 164.16 0.49 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.181 0.515 . . . . 0.0 111.748 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.893 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.9 t -158.02 128.66 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.577 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.548 ' O ' HG23 ' A' ' 127' ' ' VAL . 31.3 m -126.66 108.11 18.37 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-O 120.898 0.38 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.712 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.94 128.74 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.337 179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.7 pt-20 -153.54 130.73 11.17 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.672 0.272 . . . . 0.0 111.532 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.598 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -76.09 88.24 3.0 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 120.797 0.332 . . . . 0.0 110.826 179.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.196 -0.906 . . . . 0.0 111.655 179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttt . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.79 0.328 . . . . 0.0 111.17 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 105.37 155.5 22.29 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.414 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -77.34 -32.63 55.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 67.94 -69.94 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.972 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 164.23 -28.8 0.22 Allowed Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.352 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 6' ' ' VAL . 33.7 m -123.82 67.87 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.952 0.406 . . . . 0.0 111.228 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -153.9 40.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.223 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -105.03 111.38 24.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.696 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.48 145.44 40.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.541 . . . . 0.0 112.219 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.401 HD23 ' N ' ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.18 164.16 15.21 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.559 178.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.54 35.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.07 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -144.22 103.35 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -102.21 156.36 17.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.501 -179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.576 ' CE2' HG22 ' A' ' 126' ' ' VAL . 13.7 m-85 -138.18 137.71 37.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.763 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -44.44 -28.92 0.62 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.179 -0.464 . . . . 0.0 112.06 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.8 p -125.96 22.66 7.33 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.43 154.38 1.66 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.47 0.544 . . . . 0.0 112.47 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -131.43 144.44 51.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.851 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -163.22 149.2 11.87 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.543 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -126.62 157.11 39.77 Favored 'General case' 0 N--CA 1.461 0.09 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.159 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -152.06 138.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.991 0.424 . . . . 0.0 111.381 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mp0 -92.45 -178.53 4.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.296 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.767 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.0 tp -152.74 146.63 25.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.07 0.462 . . . . 0.0 111.286 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.456 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 14.8 m-85 -123.33 146.53 47.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.717 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.551 ' H ' HG12 ' A' ' 6' ' ' VAL . 65.6 mt-10 -57.17 -9.16 0.84 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -45.81 -25.79 0.57 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 122.259 -0.276 . . . . 0.0 111.551 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.651 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.9 t90 -81.14 -56.17 4.26 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 153.19 116.03 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.586 178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -46.77 -27.78 5.98 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.488 2.126 . . . . 0.0 112.467 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -68.05 -43.35 78.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.306 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.718 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -70.25 -46.04 65.22 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.773 0.321 . . . . 0.0 110.65 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.767 HG13 ' CD2' ' A' ' 23' ' ' LEU . 24.4 t -47.53 -29.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.242 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -60.36 -38.59 84.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.207 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.62 -47.44 75.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.723 0.296 . . . . 0.0 111.01 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -50.1 68.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.48 -27.23 69.13 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 120.96 0.41 . . . . 0.0 110.39 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.838 0.351 . . . . 0.0 110.721 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.06 49.46 1.01 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.892 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.961 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.8 mt -61.82 -159.94 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 118.289 -0.862 . . . . 0.0 109.592 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.961 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.3 Cg_exo -28.52 106.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.158 1.905 . . . . 0.0 114.081 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 39' ' ' LEU . 27.8 mt -149.28 149.66 14.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.507 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -85.91 134.09 33.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.07 0.462 . . . . 0.0 111.965 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.615 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -145.32 149.57 35.06 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.542 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.61 132.7 47.14 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.929 0.395 . . . . 0.0 110.181 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.953 ' HB1' ' NH2' ' A' ' 47' ' ' ARG . . . -90.66 137.32 32.45 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -106.8 120.11 41.15 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.277 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.953 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -84.69 127.25 34.0 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -178.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.452 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.7 t-105 -146.71 148.43 31.99 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -34.41 93.02 0.01 OUTLIER Glycine 0 C--N 1.339 0.714 0 C-N-CA 121.337 -0.459 . . . . 0.0 113.196 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 25.3 t70 72.03 -38.29 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 122.306 0.242 . . . . 0.0 111.585 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.2 OUTLIER -78.94 139.38 38.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.052 0.453 . . . . 0.0 110.875 -179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.57 HG12 ' NH2' ' A' ' 47' ' ' ARG . 0.4 OUTLIER -144.64 112.47 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.668 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 40.6 p90 -123.78 139.68 53.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.286 0.565 . . . . 0.0 111.996 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.5 p90 -141.3 142.85 33.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.447 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 43' ' ' SER . 0.2 OUTLIER -91.38 145.94 24.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.258 179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.695 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.92 4.96 10.92 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.408 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 82.63 -7.38 1.27 Allowed 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 179.696 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.8 p -85.56 116.08 28.18 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.209 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.59 94.87 6.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.988 0.423 . . . . 0.0 111.707 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.718 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.3 p -124.88 106.58 16.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.327 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -133.57 132.33 40.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.962 0.41 . . . . 0.0 111.442 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 163.76 37.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.08 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -93.47 88.15 5.82 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.878 0.37 . . . . 0.0 110.753 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -170.14 148.01 3.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.872 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.527 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 28.9 t-20 72.04 -83.18 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.126 0 CA-C-O 120.463 0.173 . . . . 0.0 110.981 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.659 ' OG ' HD12 ' A' ' 79' ' ' ILE . 2.1 m 23.16 82.11 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.791 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -99.68 162.66 12.88 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.282 178.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.662 ' OD1' HG23 ' A' ' 69' ' ' VAL . 7.1 p30 -122.5 -0.09 9.3 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.662 HG23 ' OD1' ' A' ' 68' ' ' ASP . 47.2 t -138.53 145.36 28.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.101 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.75 158.58 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.835 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -94.05 150.81 20.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.467 0.651 . . . . 0.0 111.426 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.3 tp -47.16 124.96 7.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.976 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.35 -29.73 7.44 Favored Glycine 0 C--N 1.336 0.55 0 C-N-CA 120.364 -0.922 . . . . 0.0 114.703 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 109' ' ' ARG . 2.8 p30 -78.57 156.98 28.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.593 0.697 . . . . 0.0 111.921 -178.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.864 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.6 t -111.06 152.33 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.462 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.553 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -149.3 150.34 32.37 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.977 0.417 . . . . 0.0 111.658 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.506 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.2 OUTLIER -105.46 131.65 52.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.404 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.684 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -71.99 113.07 8.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.8 OUTLIER -68.25 -66.16 1.17 Allowed Pre-proline 0 CA--C 1.534 0.357 0 C-N-CA 121.033 -0.267 . . . . 0.0 110.621 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.68 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 24.6 Cg_exo -62.39 80.28 0.1 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.932 1.755 . . . . 0.0 111.663 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.48 -8.13 3.13 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.596 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 51.18 37.2 17.72 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.857 0.361 . . . . 0.0 111.126 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.45 137.51 52.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.79 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 3.7 mt -87.58 147.64 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.43 179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 3.3 m -142.86 131.53 22.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.02 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.99 159.78 18.87 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.373 179.106 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 35.0 m-85 -136.63 132.51 35.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.21 0.529 . . . . 0.0 111.878 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.47 ' CB ' ' HG2' ' A' ' 118' ' ' LYS . 1.4 m-85 -165.21 33.32 0.06 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.057 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.22 -150.53 21.08 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.388 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.19 -172.7 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.458 0.647 . . . . 0.0 112.131 -179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.707 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -159.83 -176.11 0.57 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.522 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 66.2 Cg_exo -41.81 -25.29 0.33 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.273 1.982 . . . . 0.0 113.042 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -146.65 67.67 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-O 120.902 0.382 . . . . 0.0 111.678 179.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.506 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -50.98 -75.79 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.166 0.508 . . . . 0.0 110.483 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 64.47 -97.72 0.06 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.032 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.1 p30 -115.41 -27.34 7.22 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.81 0.338 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 mttp -128.43 -163.28 1.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.517 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.411 HG23 ' OG1' ' A' ' 91' ' ' THR . 78.2 mt -116.73 116.69 53.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.874 0.368 . . . . 0.0 110.962 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB2' HD11 ' A' ' 93' ' ' ILE . 1.8 mtt85 -117.74 99.54 52.25 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.035 178.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.707 ' HA ' HG21 ' A' ' 91' ' ' THR . 58.7 Cg_endo -69.73 -31.31 20.89 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.6 2.2 . . . . 0.0 112.564 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.569 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.11 -160.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.807 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -5.23 14.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.565 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -168.43 73.98 0.11 Allowed 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.684 HG12 ' HA ' ' A' ' 78' ' ' TRP . 21.2 m -124.02 140.46 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 111.477 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.527 ' HB3' ' ND2' ' A' ' 65' ' ' ASN . 6.0 m-20 -84.66 150.37 25.18 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.791 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.59 100.35 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.099 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.553 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -85.02 21.38 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -178.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 115.2 -129.46 8.61 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.192 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.864 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 ptt180 -170.4 167.19 8.37 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.04 0.448 . . . . 0.0 111.484 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -93.06 116.37 34.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.667 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -71.81 -81.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.038 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -157.3 141.04 15.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.951 0.405 . . . . 0.0 111.131 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.408 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 1.1 m 173.95 -36.97 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.626 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -168.57 -45.72 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.539 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 45.2 mt-10 58.76 20.46 7.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.353 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.39 31.97 2.2 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.988 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.02 HD22 HD13 ' A' ' 86' ' ' LEU . 4.5 tp -58.32 -42.72 87.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.973 0.387 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.47 ' HG2' ' CB ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.6 -21.32 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -89.92 30.68 5.69 Favored Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.705 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.6 m -81.28 153.65 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 122.232 0.213 . . . . 0.0 111.34 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.63 143.47 46.3 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 4.6 p-10 -51.07 131.98 27.5 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 59.07 100.32 0.01 OUTLIER Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.347 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -148.1 154.25 39.96 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.746 0.308 . . . . 0.0 110.662 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.3 t -63.13 168.34 4.26 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.436 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.84 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 48.3 t -157.97 128.92 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.955 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.557 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -125.27 106.59 16.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.004 0.43 . . . . 0.0 110.718 179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.695 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.85 129.07 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.822 -179.437 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 3.5 pt-20 -151.41 126.94 10.08 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.663 0.268 . . . . 0.0 111.327 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.699 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.36 92.16 2.27 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.817 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.276 -0.868 . . . . 0.0 111.743 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.844 0.354 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.57 27.17 5.34 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.393 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -81.26 -159.1 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.455 0.169 . . . . 0.0 110.782 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.9 mmm-85 63.84 19.34 11.69 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.54 -40.68 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.617 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 24' ' ' TYR . 14.6 p -90.38 54.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.327 0.584 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.38 36.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.888 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.416 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -99.17 90.1 4.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 0.0 111.037 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.536 ' C ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -84.09 145.47 28.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.754 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -118.76 164.05 15.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.104 179.008 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 144.09 33.13 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.803 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.11 100.39 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.018 0.437 . . . . 0.0 109.963 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.39 156.04 17.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.376 0.608 . . . . 0.0 111.965 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.0 m-85 -134.6 142.64 46.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.025 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.3 -29.75 0.44 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 49.7 m -126.2 20.89 7.44 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -179.13 155.92 0.75 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.125 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -149.37 148.89 30.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.9 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.65 150.05 11.77 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.923 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -107.46 156.54 18.85 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.842 0.353 . . . . 0.0 110.759 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -147.22 140.19 19.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.911 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.7 mt-10 -90.91 -178.48 5.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.657 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.818 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.2 tp -147.73 136.26 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.077 0.465 . . . . 0.0 111.136 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.596 ' HA ' HG23 ' A' ' 6' ' ' VAL . 9.6 m-85 -118.84 141.0 49.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.619 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -59.6 -8.95 2.2 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -45.38 -29.0 0.96 Allowed 'General case' 0 N--CA 1.463 0.222 0 O-C-N 122.295 -0.253 . . . . 0.0 111.31 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.649 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -78.3 -56.69 4.26 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 178.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.57 118.54 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.451 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.775 178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.42 -33.31 12.44 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.436 2.091 . . . . 0.0 112.338 179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.38 -52.27 66.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.848 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.484 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -66.31 -44.12 84.3 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.82 0.343 . . . . 0.0 110.419 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.818 HG13 ' CD2' ' A' ' 23' ' ' LEU . 75.8 t -44.62 -31.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.347 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.3 ttt180 -64.45 -38.32 90.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.978 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 58' ' ' VAL . . . -63.93 -47.65 79.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.061 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -55.77 -52.04 52.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.543 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.58 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.15 -27.48 69.4 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-O 120.977 0.418 . . . . 0.0 110.43 179.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -72.26 -25.39 61.6 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.669 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.57 50.71 1.06 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.797 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.963 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -61.73 -160.04 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.37 -0.824 . . . . 0.0 109.612 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.963 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 31.5 Cg_exo -28.95 103.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.116 1.877 . . . . 0.0 113.887 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 39' ' ' LEU . 18.5 mt -145.74 151.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.567 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.71 136.69 33.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.089 0.471 . . . . 0.0 111.604 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.625 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.2 p -145.1 148.91 34.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.295 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.94 127.19 48.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.037 0.446 . . . . 0.0 110.313 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.913 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -87.03 136.13 33.03 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 -108.34 122.97 48.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.101 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -81.39 138.27 35.62 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.399 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 10.9 t-105 -153.87 148.95 26.83 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.862 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.03 94.51 0.01 OUTLIER Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.524 -0.37 . . . . 0.0 113.781 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.503 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 3.7 m-20 51.85 25.42 2.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.896 0.379 . . . . 0.0 111.578 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.4 OUTLIER -136.2 138.91 42.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.149 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -137.29 119.93 20.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.041 0.448 . . . . 0.0 111.225 -179.455 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.2 p90 -128.5 126.94 41.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.921 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.512 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.8 p90 -135.49 145.93 47.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.955 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.94 149.65 21.8 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.727 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.22 7.9 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.211 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.417 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.41 -8.77 1.08 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.722 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.8 p -86.31 114.0 25.13 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.19 94.99 5.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 31' ' ' THR . 3.2 p -122.79 106.78 18.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.879 178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -112.95 125.26 54.2 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -140.83 165.32 27.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.202 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.3 pm0 -113.84 91.34 3.6 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.043 0.449 . . . . 0.0 111.023 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 2.5 tt0 -170.38 157.07 5.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.503 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 34.8 t-20 64.21 -81.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.772 0.32 . . . . 0.0 111.081 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.46 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 1.5 m 31.88 82.08 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.212 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.764 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.43 154.9 18.41 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.589 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -119.78 -4.75 10.19 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -126.32 140.45 48.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.528 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 32.8 m -158.39 157.13 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.594 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -96.03 149.7 21.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.485 0.66 . . . . 0.0 111.732 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 tp -43.26 126.76 4.26 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.002 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.19 -30.08 7.27 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.366 -0.921 . . . . 0.0 114.636 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.445 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.1 p30 -80.64 156.64 26.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.533 0.666 . . . . 0.0 112.032 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.824 HG23 ' HA ' ' A' ' 109' ' ' ARG . 24.0 t -116.34 152.4 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.283 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.691 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -152.01 151.1 30.72 Favored 'General case' 0 C--N 1.341 0.212 0 O-C-N 121.971 -0.455 . . . . 0.0 111.696 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HB3' ' HB ' ' A' ' 107' ' ' ILE . 0.0 OUTLIER -106.9 132.58 52.69 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.679 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.582 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.3 t90 -68.49 120.81 15.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.648 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.491 HD11 ' OD1' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -70.07 -68.44 0.53 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.049 -179.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 79' ' ' ILE . 33.9 Cg_endo -63.62 75.8 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.165 1.91 . . . . 0.0 111.979 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.67 -9.98 1.88 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.71 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 53.0 32.23 12.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.061 0.43 . . . . 0.0 111.161 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.97 131.04 55.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.221 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 10.0 mt -88.16 144.24 9.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.55 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -136.98 134.53 36.77 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -178.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.867 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.43 158.8 19.52 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.224 -0.443 . . . . 0.0 109.896 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.542 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 36.1 m-85 -136.62 117.11 13.75 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.546 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.9 OUTLIER -163.7 52.09 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.692 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.18 -78.72 0.17 Allowed Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.24 -0.981 . . . . 0.0 113.721 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.503 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -147.26 -169.47 3.32 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.479 0.657 . . . . 0.0 111.93 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.901 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -154.44 174.89 3.43 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.035 179.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 91' ' ' THR . 5.5 Cg_exo -39.1 -25.42 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.696 2.264 . . . . 0.0 113.129 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.42 ' N ' ' O ' ' A' ' 91' ' ' THR . 2.1 mp -137.69 62.71 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.421 ' CB ' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -52.84 -64.05 0.95 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.162 0.506 . . . . 0.0 110.375 178.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.9 t70 48.59 -92.72 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.474 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -113.66 -46.03 3.07 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.8 0.333 . . . . 0.0 110.771 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -119.68 159.55 24.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.753 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 73.2 mt -78.93 103.65 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.803 0.335 . . . . 0.0 111.146 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.07 99.22 8.85 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.022 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.901 ' HA ' HG21 ' A' ' 91' ' ' THR . 55.4 Cg_endo -69.33 -31.12 23.12 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.515 2.144 . . . . 0.0 112.584 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.655 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 176.33 -161.26 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.12 -6.99 16.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.611 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.83 71.11 0.04 OUTLIER 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.655 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.6 m -117.69 141.49 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.84 0.352 . . . . 0.0 111.555 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.691 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.9 m120 -81.88 150.29 27.85 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.278 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.764 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.97 82.01 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 177.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.688 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -68.7 18.87 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -178.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 119.12 -153.21 16.98 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.944 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.824 ' HA ' HG23 ' A' ' 75' ' ' VAL . 33.3 mtp180 -156.23 167.17 31.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.58 HG13 HG21 ' A' ' 75' ' ' VAL . 5.0 mt -98.83 114.96 38.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.36 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.28 -85.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.398 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -82.23 152.71 26.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.997 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.6 t 62.67 33.61 15.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.025 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.42 ' HA ' ' CG2' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -49.33 -70.98 0.07 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.993 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 61.31 -174.88 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.054 0.454 . . . . 0.0 111.314 179.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -115.91 46.25 1.18 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.36 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.883 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.7 tt -42.06 -35.62 0.95 Allowed 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.546 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.88 -22.45 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 179.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.405 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -92.24 36.1 3.79 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 117' ' ' LEU . 6.4 m -69.19 154.87 8.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 122.513 0.325 . . . . 0.0 111.535 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.95 145.93 44.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.3 p-10 -57.88 121.24 10.04 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.122 0.487 . . . . 0.0 111.921 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.93 101.46 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.46 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -154.35 150.78 28.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.883 0.373 . . . . 0.0 110.888 178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.14 165.32 0.23 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.222 0.535 . . . . 0.0 111.904 -179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.913 HG21 ' HB2' ' A' ' 45' ' ' ALA . 46.5 t -157.74 128.91 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.312 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.549 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.5 m -127.3 108.49 18.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-O 120.978 0.418 . . . . 0.0 111.46 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.727 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.9 129.17 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.356 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.0 pt-20 -153.82 129.06 9.73 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.576 0.227 . . . . 0.0 111.344 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.548 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.5 89.45 1.68 Allowed 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.89 0.376 . . . . 0.0 110.785 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.649 179.8 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.85 0.357 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.72 153.4 6.55 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.452 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -98.86 27.03 5.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.842 0.353 . . . . 0.0 111.103 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -146.91 0.54 Allowed 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.682 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -171.41 33.21 0.14 Allowed Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.442 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.6 m -112.87 62.36 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 121.057 0.456 . . . . 0.0 111.274 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.67 39.18 1.68 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.078 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -109.57 115.65 30.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.043 -179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.06 145.43 43.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.131 0.491 . . . . 0.0 112.135 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.8 163.5 17.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.851 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.06 146.47 29.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.739 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.4 mt -147.32 100.11 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.131 0.491 . . . . 0.0 109.787 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -104.79 156.0 18.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.635 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.0 m-85 -130.76 138.55 50.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.448 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -41.77 -29.01 0.17 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -178.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -124.22 23.04 8.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.42 154.18 1.63 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -114.81 151.86 33.13 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.389 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.68 151.14 16.31 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.866 0.365 . . . . 0.0 111.779 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -137.53 150.4 47.48 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.168 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -153.87 143.76 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-O 121.138 0.494 . . . . 0.0 112.012 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.456 ' OE2' HG21 ' A' ' 111' ' ' VAL . 6.7 mt-10 -95.48 -178.38 4.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.199 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.856 ' CD2' HG13 ' A' ' 32' ' ' VAL . 7.6 tp -150.07 134.73 17.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.973 0.416 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.441 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 6.9 m-85 -116.73 139.25 50.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.566 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.56 ' H ' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -60.76 -8.46 3.02 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -179.169 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -44.66 -29.49 0.76 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.07 -179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.754 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -76.54 -56.01 5.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 163.2 116.05 0.01 OUTLIER Pre-proline 0 N--CA 1.467 0.38 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.739 178.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -46.58 -36.99 19.6 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.375 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.99 -49.59 76.83 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.458 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.59 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -61.2 -44.5 97.19 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.757 0.313 . . . . 0.0 110.27 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.856 HG13 ' CD2' ' A' ' 23' ' ' LEU . 90.9 t -46.74 -37.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.693 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -33.35 71.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.009 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.41 -47.43 64.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.741 0.305 . . . . 0.0 110.97 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.99 -50.31 70.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.591 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.75 -29.39 70.65 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.261 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -70.55 -25.74 63.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.936 0.398 . . . . 0.0 110.523 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.12 51.96 1.04 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.919 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.989 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -61.25 -159.77 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.62 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.989 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 26.4 Cg_exo -27.8 105.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.636 0 C-N-CA 122.083 1.855 . . . . 0.0 114.085 -178.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.7 mt -145.16 149.11 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.366 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -85.9 133.64 33.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 111.887 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.64 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.9 p -142.33 149.02 38.91 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.299 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.77 131.33 48.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.354 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -92.05 135.54 33.89 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.1 m-20 -106.92 122.88 47.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.061 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.837 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -83.18 137.04 34.21 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' HB3' ' A' ' 51' ' ' GLU . 12.7 t-105 -152.26 149.13 28.36 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 115.531 -0.758 . . . . 0.0 109.866 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.444 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -34.54 92.82 0.01 OUTLIER Glycine 0 CA--C 1.522 0.512 0 C-N-CA 121.377 -0.44 . . . . 0.0 113.666 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 48' ' ' TRP . 0.7 OUTLIER 53.27 25.98 4.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 0.0 111.815 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB3' ' CD1' ' A' ' 48' ' ' TRP . 8.5 tp10 -136.77 139.36 41.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.952 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.612 HG21 HD21 ' A' ' 117' ' ' LEU . 0.7 OUTLIER -139.18 122.71 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.905 0.383 . . . . 0.0 111.593 -179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.417 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 50.8 p90 -130.04 123.37 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.789 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 3.7 p90 -133.15 145.38 50.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.143 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.52 146.48 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.698 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -117.85 5.61 12.22 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.225 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.3 mt-30 82.34 -8.2 1.26 Allowed 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.0 p -87.23 115.43 27.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -102.61 94.79 5.82 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.993 0.425 . . . . 0.0 111.911 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.583 ' CG2' HG22 ' A' ' 31' ' ' THR . 3.5 p -131.53 106.73 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.299 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -130.16 133.18 46.42 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.926 0.393 . . . . 0.0 111.587 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.416 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 53.4 tttt -140.8 164.77 29.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.291 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -99.14 90.87 4.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.999 0.428 . . . . 0.0 110.966 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 5.9 tt0 -170.16 157.88 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.599 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 24.7 t-20 62.74 -82.5 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.906 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m 31.99 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.297 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.825 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -101.95 158.06 16.42 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 120.746 -0.382 . . . . 0.0 110.282 179.111 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -124.11 0.38 8.45 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' O ' HG13 ' A' ' 70' ' ' VAL . 3.3 p -126.71 138.16 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 111.616 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.528 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.6 m -160.56 164.8 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.784 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -123.84 158.8 31.01 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.086 0.47 . . . . 0.0 110.769 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -38.56 129.67 1.41 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.347 -179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.24 -31.31 6.52 Favored Glycine 0 C--N 1.336 0.541 0 C-N-CA 120.519 -0.848 . . . . 0.0 114.059 178.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.449 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.2 p30 -88.73 156.36 19.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.219 0.533 . . . . 0.0 112.327 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.875 HG23 ' HA ' ' A' ' 109' ' ' ARG . 25.7 t -119.13 152.55 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.078 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.725 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.06 150.14 34.47 Favored 'General case' 0 C--N 1.343 0.304 0 O-C-N 121.807 -0.558 . . . . 0.0 112.472 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -109.58 126.78 53.96 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.168 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.713 ' HD1' HG12 ' A' ' 104' ' ' VAL . 3.6 t90 -67.2 112.65 4.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.816 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.754 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.4 OUTLIER -67.19 -61.1 5.06 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.786 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 14.8 Cg_exo -67.98 66.27 0.95 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.232 1.955 . . . . 0.0 111.807 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 156.68 -11.45 0.3 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.896 -0.669 . . . . 0.0 113.034 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.62 27.49 12.56 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 117.306 0.553 . . . . 0.0 110.957 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.48 131.92 55.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.522 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 7.8 mt -88.05 143.38 11.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.331 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -135.7 132.39 36.85 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.807 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.89 161.07 18.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.168 178.863 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 20.8 m-85 -136.25 125.78 25.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.754 0.311 . . . . 0.0 110.765 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -163.88 54.54 0.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.209 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 149.06 -75.1 0.27 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.111 -1.043 . . . . 0.0 113.372 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -158.83 174.02 15.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.828 0.347 . . . . 0.0 111.796 -179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.645 HG22 ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -134.77 -175.11 0.45 Allowed Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.645 ' CD ' HG22 ' A' ' 91' ' ' THR . 84.4 Cg_exo -47.93 -22.46 3.42 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.017 1.811 . . . . 0.0 112.724 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.69 68.01 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.862 0.363 . . . . 0.0 111.722 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -63.98 -74.96 0.09 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 120.94 0.4 . . . . 0.0 110.398 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 50.23 52.78 14.07 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.711 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.54 4.13 4.54 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.609 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -142.67 178.65 7.48 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 93.8 mt -123.56 92.99 2.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 111.552 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -98.44 99.86 8.17 Favored Pre-proline 0 C--N 1.328 -0.335 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.554 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 69.1 Cg_endo -70.57 -32.48 15.13 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.668 2.245 . . . . 0.0 112.969 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.05 -154.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.697 0.284 . . . . 0.0 110.879 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.03 -5.04 10.55 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.552 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.96 67.06 0.08 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.713 HG12 ' HD1' ' A' ' 78' ' ' TRP . 14.9 m -118.14 142.42 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 120.777 0.322 . . . . 0.0 111.552 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.509 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.4 m120 -84.28 152.99 23.81 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.825 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -85.57 86.56 2.41 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.096 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.725 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -71.55 23.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -177.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 112.97 -149.57 18.51 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.996 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.875 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.2 mtt85 -155.31 166.42 33.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 111.072 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 75' ' ' VAL . 4.2 mt -99.85 114.43 38.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.672 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.456 HG21 ' OE2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.24 -86.93 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.475 179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -67.99 174.27 3.9 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.83 0.348 . . . . 0.0 110.816 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.0 t 61.61 161.83 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.789 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.7 130.58 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.949 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.418 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 4.2 pm0 -109.09 29.7 7.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.005 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -111.07 45.02 1.38 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.547 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.807 HD22 HD13 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -53.41 -38.91 63.87 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.797 0.332 . . . . 0.0 111.171 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.4 -25.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.433 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -85.88 28.97 4.76 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.492 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.837 HG23 ' HD2' ' A' ' 47' ' ' ARG . 12.5 m -83.16 154.26 3.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.937 0.368 . . . . 0.0 111.534 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.646 ' HB3' ' OE1' ' A' ' 124' ' ' GLU . . . -80.53 148.76 30.26 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.619 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.1 p-10 -58.06 112.02 1.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.12 0.486 . . . . 0.0 111.994 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 75.76 100.89 0.12 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.791 -0.641 . . . . 0.0 113.728 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.646 ' OE1' ' HB3' ' A' ' 121' ' ' ALA . 0.1 OUTLIER -155.28 153.84 31.21 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.831 0.348 . . . . 0.0 110.847 178.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 11.6 t -56.96 168.38 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.222 0.535 . . . . 0.0 111.894 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.884 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 47.0 t -157.88 128.84 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.06 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.541 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.9 m -127.59 108.63 18.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.41 . . . . 0.0 111.473 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.21 129.04 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.4 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -152.92 130.16 11.24 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.709 0.29 . . . . 0.0 111.204 -179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.577 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.41 88.99 2.1 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.862 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.689 179.906 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.8 0.333 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 149.3 -136.85 5.97 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.476 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.31 -56.75 2.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.805 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.411 ' NH2' ' CB ' ' A' ' 7' ' ' GLU . 0.5 OUTLIER 62.91 -80.21 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.031 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -166.82 -61.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.755 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 6' ' ' VAL . 34.2 m -126.82 68.66 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.929 0.395 . . . . 0.0 111.466 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' CB ' ' NH2' ' A' ' 4' ' ' ARG . 52.1 mm-40 -159.96 44.46 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.022 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 109.32 21.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.052 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -108.68 145.3 35.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.154 0.502 . . . . 0.0 112.106 -179.535 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.35 163.75 16.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.703 178.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 144.89 34.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.86 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.581 ' O ' HG22 ' A' ' 12' ' ' ILE . 1.3 mt -145.89 100.4 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -100.8 156.13 17.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.387 0.613 . . . . 0.0 112.122 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -131.83 141.28 49.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.204 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.47 -28.89 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -126.05 22.96 7.23 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -173.23 151.3 2.03 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.21 142.12 45.97 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.26 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -164.74 149.24 9.33 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.439 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -115.28 157.82 23.22 Favored 'General case' 0 N--CA 1.461 0.089 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.87 137.53 12.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.044 0.449 . . . . 0.0 111.439 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 14.6 mt-10 -92.51 -178.65 4.96 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.268 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.834 ' CD2' HG13 ' A' ' 32' ' ' VAL . 3.3 tp -153.22 150.42 28.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.924 0.392 . . . . 0.0 111.129 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.465 ' H ' HD12 ' A' ' 23' ' ' LEU . 21.8 m-85 -129.23 147.95 51.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.027 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -58.21 -8.63 1.16 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.35 -29.2 0.99 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.85 0.296 . . . . 0.0 111.355 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.633 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.3 OUTLIER -80.92 -56.32 4.2 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.633 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 160.3 117.09 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.467 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.474 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -46.76 -35.86 18.37 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.504 2.136 . . . . 0.0 112.422 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.6 -47.7 82.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 28' ' ' ALA . 0.0 OUTLIER -62.95 -44.37 96.25 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.78 0.324 . . . . 0.0 110.397 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.834 HG13 ' CD2' ' A' ' 23' ' ' LEU . 46.3 t -50.05 -34.64 10.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.109 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -59.44 -37.01 77.0 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.033 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.79 76.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.04 -51.54 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.582 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.46 -28.71 70.0 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.009 0.433 . . . . 0.0 110.342 179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.65 -25.37 62.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.58 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.76 51.79 0.98 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.784 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.984 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.4 mt -61.58 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 118.434 -0.793 . . . . 0.0 109.539 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.984 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 25.6 Cg_exo -27.8 104.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 122.275 1.983 . . . . 0.0 114.033 -178.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 39' ' ' LEU . 19.5 mt -145.57 151.05 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.309 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -85.72 136.57 33.29 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.064 0.459 . . . . 0.0 111.871 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.639 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 3.4 p -146.0 148.86 33.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.41 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -102.02 130.48 48.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -90.44 135.84 33.44 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -108.12 125.2 51.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.182 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.706 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -82.45 138.42 34.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -178.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 14.8 t-105 -154.17 148.95 26.53 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.069 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.13 99.86 0.01 OUTLIER Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.538 -0.363 . . . . 0.0 113.768 -179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 45.62 30.15 0.75 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.868 0.366 . . . . 0.0 111.382 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -141.78 143.35 33.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.118 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 ' HG2' ' A' ' 47' ' ' ARG . 1.0 OUTLIER -139.49 123.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.864 0.364 . . . . 0.0 111.461 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 23.4 p90 -130.64 132.36 45.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.498 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.6 p90 -140.87 146.11 37.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.986 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.69 149.45 22.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.158 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.799 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.18 5.92 9.17 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.363 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' HG3' ' C ' ' A' ' 56' ' ' THR . 12.1 mt-30 80.94 -7.07 1.58 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.716 179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.5 p -87.22 114.95 27.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.109 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.76 94.89 5.44 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.083 0.468 . . . . 0.0 112.12 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.563 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.7 p -127.06 106.69 15.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.724 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.561 ' HG2' HG22 ' A' ' 79' ' ' ILE . 2.5 mt-10 -125.28 134.98 52.07 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 121.082 0.467 . . . . 0.0 111.929 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 6.9 ttmt -144.55 165.62 27.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.165 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.68 90.74 3.59 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.021 0.438 . . . . 0.0 110.947 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.4 160.22 7.45 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.77 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 31.7 t-20 64.03 -83.29 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.096 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.459 ' N ' ' OD1' ' A' ' 105' ' ' ASN . 2.1 m 30.49 81.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.608 -0.723 . . . . 0.0 112.646 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.976 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -100.47 156.71 17.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 178.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -117.73 -7.81 10.95 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.38 142.95 42.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.386 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -157.74 156.23 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.108 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.36 151.04 21.63 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.354 0.597 . . . . 0.0 111.368 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -48.16 126.39 10.85 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.214 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.05 -31.99 6.21 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.545 -0.836 . . . . 0.0 114.093 178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.484 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p-10 -70.04 163.17 26.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.958 0.409 . . . . 0.0 112.085 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.743 HG23 ' HA ' ' A' ' 109' ' ' ARG . 16.0 t -121.41 152.02 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.074 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.615 ' HB3' ' HE2' ' A' ' 87' ' ' PHE . . . -149.58 152.36 35.36 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 118.463 0.574 . . . . 0.0 112.125 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' CE1' ' O ' ' A' ' 78' ' ' TRP . 0.0 OUTLIER -111.04 131.28 55.19 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.449 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.763 ' CD1' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -73.03 146.62 45.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.003 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.602 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.7 OUTLIER -96.3 -53.14 0.22 Allowed Pre-proline 0 N--CA 1.463 0.203 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.522 -179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.652 ' HD2' ' CD1' ' A' ' 78' ' ' TRP . 6.9 Cg_exo -73.86 70.74 4.3 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.696 2.264 . . . . 0.0 111.623 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.409 ' O ' ' HD2' ' A' ' 82' ' ' LYS . . . 144.38 -8.33 1.86 Allowed Glycine 0 CA--C 1.523 0.554 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.556 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.409 ' HD2' ' O ' ' A' ' 81' ' ' GLY . 0.0 OUTLIER 53.1 34.1 16.52 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.857 0.361 . . . . 0.0 110.827 179.728 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.76 130.85 55.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.167 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 6.4 mt -85.83 151.51 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.476 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER -140.0 135.15 32.42 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.284 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.817 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.25 161.74 18.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.029 179.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' ALA . 54.1 m-85 -136.25 118.61 15.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.499 . . . . 0.0 111.782 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.6 m-85 -157.43 30.35 0.28 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.851 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 160.55 -152.74 23.53 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.36 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -54.0 -173.26 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.507 0.67 . . . . 0.0 112.086 -179.565 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.703 ' OG1' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -157.47 -173.54 0.38 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.81 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 72.9 Cg_exo -42.15 -23.63 0.28 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 121.859 1.706 . . . . 0.0 112.976 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.1 OUTLIER -146.38 87.63 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.88 0.371 . . . . 0.0 111.817 179.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.534 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -82.16 27.93 0.46 Allowed 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.391 179.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -60.69 78.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 94' ' ' SER . 0.1 OUTLIER 71.23 -10.78 0.75 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 112.082 179.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.4 OUTLIER -146.41 -175.58 4.83 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.703 HG23 ' OG1' ' A' ' 91' ' ' THR . 87.2 mt -114.17 97.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.845 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.439 ' CB ' HG12 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -101.73 99.21 11.22 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.635 ' HA ' HG21 ' A' ' 91' ' ' THR . 57.9 Cg_endo -70.44 -31.22 17.87 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.508 2.139 . . . . 0.0 112.645 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.662 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -163.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.884 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.9 -10.5 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.407 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.42 ' O ' HG13 ' A' ' 79' ' ' ILE . . . -164.81 72.1 0.2 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.763 HG12 ' CD1' ' A' ' 78' ' ' TRP . 22.2 m -119.13 140.15 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.844 0.354 . . . . 0.0 111.337 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.471 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 37.2 m-20 -84.91 148.14 26.4 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.976 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -84.18 97.82 5.29 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.064 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.637 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -82.96 21.84 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -178.312 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 117.31 -149.18 18.71 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.477 -0.868 . . . . 0.0 113.206 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HG23 ' A' ' 75' ' ' VAL . 1.9 mtt180 -152.92 167.67 28.36 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.061 0.458 . . . . 0.0 111.362 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.672 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -100.44 114.3 38.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.342 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -98.27 -85.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.689 -0.232 . . . . 0.0 111.593 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.03 109.81 14.83 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.809 0.338 . . . . 0.0 111.128 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.4 p -178.58 -80.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.007 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.0 mtm 53.33 50.5 17.41 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.856 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 117' ' ' LEU . 3.6 mp0 -119.15 30.79 6.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.32 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 115' ' ' GLU . . . 21.29 46.52 0.01 OUTLIER Glycine 0 C--N 1.338 0.69 0 O-C-N 123.613 0.57 . . . . 0.0 114.123 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.95 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.2 tt -42.38 -36.3 1.25 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.491 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.34 -26.94 0.12 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -90.28 38.35 3.23 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.566 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.95 HG13 ' O ' ' A' ' 117' ' ' LEU . 8.6 m -74.4 154.74 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 122.393 0.277 . . . . 0.0 111.465 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.98 146.09 44.11 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.706 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 6.1 p-10 -59.59 115.35 3.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.045 0.45 . . . . 0.0 111.901 -179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.32 100.49 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.65 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -154.27 150.75 28.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.881 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.401 ' C ' HG23 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -52.79 166.43 0.21 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.189 0.519 . . . . 0.0 112.035 -179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 52.4 t -157.81 129.07 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.433 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 127' ' ' VAL . 17.6 m -128.14 108.47 17.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 121.005 0.431 . . . . 0.0 111.355 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.799 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -81.62 128.93 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.27 179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 4.5 pt-20 -152.9 130.88 11.79 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.636 0.255 . . . . 0.0 111.339 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.565 ' CB ' HD22 ' A' ' 39' ' ' LEU . 5.9 tmm_? -75.22 92.91 2.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.686 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.317 -0.849 . . . . 0.0 111.832 179.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 mtt . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.789 0.328 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.26 -55.84 1.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.522 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -141.17 -159.36 0.95 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.297 -0.26 . . . . 0.0 110.297 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.27 -73.47 0.21 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.727 0.298 . . . . 0.0 110.726 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.84 -176.85 42.37 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.547 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.452 HG22 ' CD ' ' A' ' 25' ' ' GLU . 26.0 t -102.55 58.9 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.959 0.409 . . . . 0.0 110.696 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.17 51.62 0.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.815 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.78 116.55 32.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.063 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -110.1 145.47 37.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.147 0.499 . . . . 0.0 112.314 -179.46 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.93 164.78 15.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.792 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 145.96 35.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.926 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.7 OUTLIER -145.03 100.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -102.29 156.12 17.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.511 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.545 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 3.6 m-85 -134.71 137.79 43.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.384 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.44 -29.05 0.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.95 23.07 7.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -172.77 151.45 2.29 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -125.65 141.34 52.07 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.963 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.6 149.13 11.19 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.601 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -128.53 159.27 36.02 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.146 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.1 m -151.83 140.5 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.057 0.456 . . . . 0.0 111.747 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 2.5 mt-10 -94.28 -178.61 4.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.983 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.792 ' CD2' HG13 ' A' ' 32' ' ' VAL . 5.3 tp -153.98 148.27 25.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.087 0.47 . . . . 0.0 111.284 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -126.06 148.45 49.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.635 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.452 ' CD ' HG22 ' A' ' 6' ' ' VAL . 46.5 mt-10 -58.27 -9.01 1.29 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.61 -27.68 0.82 Allowed 'General case' 0 N--CA 1.464 0.245 0 O-C-N 122.249 -0.282 . . . . 0.0 111.533 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.651 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.2 OUTLIER -81.07 -56.62 3.97 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.07 110.9 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.469 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 178.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -40.48 -30.0 0.45 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.64 2.226 . . . . 0.0 112.817 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -62.78 -49.84 73.38 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.447 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.531 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -65.42 -45.66 83.05 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.768 0.318 . . . . 0.0 110.39 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.792 HG13 ' CD2' ' A' ' 23' ' ' LEU . 23.4 t -47.87 -29.01 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.32 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.1 ttt85 -65.35 -38.64 90.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.218 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.18 -46.09 74.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.919 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.448 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.21 -51.38 55.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.598 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.54 -29.53 70.64 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.363 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -71.16 -25.48 62.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.976 0.417 . . . . 0.0 110.611 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.57 51.92 1.0 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.75 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.986 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.2 mt -61.22 -159.74 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 118.312 -0.852 . . . . 0.0 109.682 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.986 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.4 Cg_exo -27.58 105.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.216 1.944 . . . . 0.0 114.006 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 39' ' ' LEU . 22.5 mt -146.5 150.25 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.498 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -86.27 134.12 33.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.87 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.606 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.7 p -142.06 149.1 39.48 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.557 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.75 128.24 48.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.935 0.398 . . . . 0.0 110.319 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.934 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.0 131.94 36.29 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -100.86 122.63 43.78 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.725 177.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.917 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -86.81 136.53 32.95 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -177.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 50' ' ' ASP . 5.6 t-105 -155.01 148.62 25.36 Favored 'General case' 0 N--CA 1.458 -0.04 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.833 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -33.22 86.92 0.01 OUTLIER Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.294 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 48' ' ' TRP . 18.1 t0 72.68 -35.61 0.33 Allowed 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 122.47 0.308 . . . . 0.0 111.512 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG3' HG22 ' A' ' 91' ' ' THR . 6.0 tm-20 -73.86 133.57 43.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.81 0.338 . . . . 0.0 111.011 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.672 HG21 HD21 ' A' ' 117' ' ' LEU . 0.6 OUTLIER -138.87 125.98 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.203 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -137.14 128.79 28.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.832 0.349 . . . . 0.0 111.374 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE2' HG11 ' A' ' 126' ' ' VAL . 2.6 p90 -135.51 145.97 47.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.854 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.59 147.89 22.52 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.607 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.63 7.91 10.04 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.96 0.355 . . . . 0.0 111.96 -179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.406 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.3 mt-30 80.07 -6.34 1.75 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.654 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -88.53 115.13 28.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 CA-C-O 120.708 0.29 . . . . 0.0 110.317 179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.7 94.91 5.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.089 0.471 . . . . 0.0 111.761 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.1 p -129.98 106.55 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.202 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.88 133.93 48.1 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-O 121.014 0.435 . . . . 0.0 111.667 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.5 159.22 42.65 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.149 179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.0 OUTLIER -92.81 88.8 6.35 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.386 0.612 . . . . 0.0 111.127 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.6 tt0 -170.33 159.66 7.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.828 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.475 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 37.3 t-20 64.07 -82.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 65' ' ' ASN . 4.3 t 27.82 82.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.325 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.908 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.65 17.22 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.37 179.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.764 ' OD1' HG23 ' A' ' 69' ' ' VAL . 2.8 p30 -117.33 -6.53 11.26 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.764 HG23 ' OD1' ' A' ' 68' ' ' ASP . 27.3 t -131.99 144.91 35.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.806 0.336 . . . . 0.0 111.204 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.542 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.9 m -158.06 157.85 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.814 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -94.72 151.12 19.53 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.357 0.599 . . . . 0.0 111.638 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.4 tp -45.95 125.75 6.62 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.979 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.4 -31.41 6.43 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.487 -0.863 . . . . 0.0 114.525 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.471 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.8 p30 -75.91 156.56 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.464 0.632 . . . . 0.0 112.188 -178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG23 ' HA ' ' A' ' 109' ' ' ARG . 18.2 t -114.23 152.59 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.187 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.61 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.97 149.69 31.6 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -103.44 129.02 50.48 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.993 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.645 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.0 t90 -69.5 117.89 11.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.986 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.549 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.4 OUTLIER -65.66 -72.07 0.3 Allowed Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.733 -0.212 . . . . 0.0 110.735 -179.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.549 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 34.1 Cg_endo -63.43 80.45 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.081 1.854 . . . . 0.0 112.12 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.82 -11.17 2.38 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.732 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 52.98 31.46 11.02 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 117.066 0.433 . . . . 0.0 110.902 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -108.92 133.56 52.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.462 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.59 145.94 6.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.434 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 17.4 t -139.12 156.27 47.27 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.258 0.551 . . . . 0.0 112.389 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.023 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -109.47 156.03 20.6 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.263 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 8.6 m-85 -136.69 127.24 26.9 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.788 0.328 . . . . 0.0 111.23 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.521 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -167.98 49.72 0.05 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.918 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.4 ' C ' ' HD2' ' A' ' 90' ' ' LYS . . . 165.18 -82.35 0.11 Allowed Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.1 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.611 ' N ' ' CD ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -154.14 176.39 12.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.119 0.485 . . . . 0.0 111.69 -179.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.681 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -144.15 -174.26 0.4 Allowed Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.238 179.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.58 ' CD ' HG22 ' A' ' 91' ' ' THR . 99.6 Cg_exo -45.17 -22.74 0.89 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.012 1.808 . . . . 0.0 112.598 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.3 mp -131.4 77.18 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -90.5 29.19 1.32 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.042 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -69.07 75.37 0.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.757 0.313 . . . . 0.0 111.658 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 78.6 -9.32 1.52 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.233 -0.44 . . . . 0.0 112.176 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -145.61 -170.05 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.414 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 65.7 mt -123.16 105.12 15.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.859 0.361 . . . . 0.0 111.26 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.32 99.36 8.19 Favored Pre-proline 0 C--N 1.327 -0.404 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.681 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.8 Cg_endo -69.3 -31.14 23.18 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.467 2.112 . . . . 0.0 112.638 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.598 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.01 -163.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.792 0.329 . . . . 0.0 110.896 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.06 -3.4 20.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.669 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -175.58 77.4 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.645 HG12 ' HA ' ' A' ' 78' ' ' TRP . 19.3 m -127.52 142.04 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-O 120.722 0.296 . . . . 0.0 111.68 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.531 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m-20 -86.31 153.66 21.81 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.908 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.62 99.48 7.58 Favored 'Isoleucine or valine' 0 C--O 1.231 0.113 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.654 HG12 HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -85.47 22.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -178.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 116.36 -147.77 18.9 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.526 -0.845 . . . . 0.0 113.07 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.877 ' HA ' HG23 ' A' ' 75' ' ' VAL . 6.5 mtt180 -156.52 168.13 28.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.057 0.456 . . . . 0.0 111.416 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.489 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.5 mt -100.4 114.94 40.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.165 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.68 -85.79 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.593 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.39 -176.87 4.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.806 0.336 . . . . 0.0 111.01 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.1 m 63.61 163.29 0.11 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.57 111.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.023 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 88' ' ' PHE . 25.4 pt-20 -96.21 42.51 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -135.08 45.03 1.13 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.555 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.023 HD22 HD13 ' A' ' 86' ' ' LEU . 0.8 OUTLIER -49.44 -30.35 7.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.784 0.326 . . . . 0.0 110.967 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.45 -22.8 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -179.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.421 ' N ' ' CE ' ' A' ' 118' ' ' LYS . . . -88.21 27.78 6.63 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.29 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.917 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.4 m -79.18 153.95 4.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.765 0.283 . . . . 0.0 111.247 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.64 146.99 29.77 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.53 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.2 p-10 -53.75 117.81 3.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.977 0.418 . . . . 0.0 111.641 -179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 62.34 98.64 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.838 -0.619 . . . . 0.0 113.007 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -150.61 146.4 26.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.993 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.2 164.53 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.257 0.551 . . . . 0.0 112.268 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 45' ' ' ALA . 44.9 t -158.14 128.45 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.073 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 127' ' ' VAL . 22.7 m -125.34 108.35 19.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 0.0 111.402 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.607 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.04 128.7 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.407 179.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.446 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.3 pt-20 -152.86 130.74 11.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.666 0.27 . . . . 0.0 111.336 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.582 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -76.38 91.43 3.28 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.858 0.361 . . . . 0.0 110.809 179.649 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.423 ' HB3' ' NH2' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.1 mtp . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.732 0.301 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.4 31.63 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.535 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -143.88 -55.63 0.37 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.748 0.309 . . . . 0.0 111.057 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.41 -78.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.861 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.0 31.04 0.31 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 6' ' ' VAL . 25.6 t -101.23 58.29 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.982 0.42 . . . . 0.0 110.795 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.04 38.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.766 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.48 117.45 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.114 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -112.71 145.31 40.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.153 0.501 . . . . 0.0 111.926 -179.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.9 163.9 15.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.932 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.24 143.63 38.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.825 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.603 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -142.72 100.46 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -99.98 156.32 17.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.78 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.569 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 2.8 m-85 -136.82 137.99 40.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.697 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.13 -28.79 0.53 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 22.19 7.33 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.803 0.297 . . . . 0.0 111.803 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.79 151.37 1.41 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -133.63 143.43 48.6 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.179 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.84 149.01 10.68 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.308 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -119.25 156.05 30.63 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.437 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.71 144.41 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.039 0.447 . . . . 0.0 111.083 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.487 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 5.9 mt-10 -99.18 -178.27 3.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.297 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.813 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -151.37 144.4 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.078 0.466 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -125.24 145.99 49.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.594 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.32 -9.04 3.01 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.867 0.692 . . . . 0.0 112.867 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -45.66 -28.08 0.92 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.639 0.257 . . . . 0.0 111.399 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.743 ' CZ2' HG21 ' A' ' 31' ' ' THR . 7.2 t90 -80.03 -56.08 4.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 157.14 115.88 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.675 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 2.9 Cg_endo -46.76 -34.82 16.42 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 112.49 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -60.78 -50.85 71.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.394 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.743 HG21 ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -63.02 -45.42 92.42 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.813 HG13 ' CD2' ' A' ' 23' ' ' LEU . 84.2 t -46.65 -32.66 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.429 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -58.99 -38.7 79.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.482 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.53 -46.9 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.78 0.324 . . . . 0.0 111.14 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -54.66 -51.55 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.587 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.11 -27.92 69.71 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-O 120.915 0.388 . . . . 0.0 110.211 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -71.74 -25.57 62.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.946 0.403 . . . . 0.0 110.562 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.25 49.95 1.15 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.063 -179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.9 mt -62.42 -160.08 0.0 OUTLIER Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.312 -0.851 . . . . 0.0 109.527 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 38.9 Cg_exo -29.85 107.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.125 1.883 . . . . 0.0 113.85 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.5 mt -150.02 148.54 15.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.638 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.92 136.07 33.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.101 0.477 . . . . 0.0 111.953 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 5.2 p -146.03 148.65 32.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.334 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.24 125.82 49.05 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.162 0.506 . . . . 0.0 110.376 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.904 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -85.55 132.46 34.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.46 -0.791 . . . . 0.0 113.042 -178.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -100.39 128.19 46.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.56 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.957 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -90.26 135.15 33.85 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -177.741 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.546 ' O ' ' N ' ' A' ' 50' ' ' ASP . 10.1 t-105 -154.5 148.43 25.64 Favored 'General case' 0 N--CA 1.458 -0.075 0 CA-C-N 115.419 -0.809 . . . . 0.0 108.888 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -30.47 85.75 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 121.609 -0.329 . . . . 0.0 113.632 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 48' ' ' TRP . 36.6 t70 74.09 -38.25 0.39 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.882 0.326 . . . . 0.0 111.882 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.4 124.19 24.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.945 0.402 . . . . 0.0 111.114 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -126.74 111.02 24.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.163 0.506 . . . . 0.0 110.179 179.377 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 43.7 p90 -122.48 134.06 54.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.068 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.483 ' CE2' HG11 ' A' ' 126' ' ' VAL . 5.2 p90 -140.15 145.61 37.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.599 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.33 147.58 22.8 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.739 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -122.38 6.48 9.6 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER 83.45 -8.13 1.1 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.4 p -85.1 115.43 26.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.136 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -107.01 94.82 5.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.064 0.459 . . . . 0.0 112.029 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.684 ' CG2' HG22 ' A' ' 31' ' ' THR . 4.4 p -120.66 106.68 19.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.139 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -120.2 136.43 54.64 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.964 0.412 . . . . 0.0 111.441 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.25 163.4 39.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.205 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -104.62 87.02 2.59 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.816 0.341 . . . . 0.0 110.93 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -170.13 149.69 3.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.791 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.413 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.4 t-20 72.03 -82.66 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.523 0.202 . . . . 0.0 111.273 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.431 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.7 m 27.46 82.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.647 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.77 156.18 17.49 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.457 179.022 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -121.25 -3.25 9.49 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.1 p -127.65 140.01 50.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.513 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.535 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.1 m -158.7 157.55 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.544 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -95.2 150.67 19.97 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.49 0.662 . . . . 0.0 111.719 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -45.0 126.09 5.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.964 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -30.77 6.82 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 120.379 -0.915 . . . . 0.0 114.599 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.452 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -78.01 157.06 29.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 117.528 0.664 . . . . 0.0 111.978 -178.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.821 HG23 ' HA ' ' A' ' 109' ' ' ARG . 17.8 t -115.96 152.35 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.297 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.756 ' HB1' ' O ' ' A' ' 105' ' ' ASN . . . -151.52 151.23 31.31 Favored 'General case' 0 C--N 1.344 0.348 0 O-C-N 121.86 -0.525 . . . . 0.0 112.41 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.588 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -102.19 123.99 47.0 Favored 'General case' 0 C--O 1.231 0.089 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.075 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.674 ' CD1' HG12 ' A' ' 104' ' ' VAL . 4.1 t90 -66.57 119.02 10.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.901 -179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.765 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.2 OUTLIER -69.53 -71.01 0.3 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.601 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.765 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.48 83.32 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.628 1.552 . . . . 0.0 111.705 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 133.6 -8.35 4.95 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.416 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.427 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.66 39.79 14.29 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 120.841 0.353 . . . . 0.0 111.24 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -116.15 135.17 54.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.77 -179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 36.8 mt -84.35 145.3 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.647 -0.251 . . . . 0.0 110.42 179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.6 m -140.69 132.42 27.34 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.724 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -86.63 158.0 19.57 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.1 179.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 23.7 m-85 -136.67 115.17 11.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.871 0.367 . . . . 0.0 111.369 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.563 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -156.53 39.53 0.34 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.904 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.41 ' O ' HD11 ' A' ' 98' ' ' ILE . . . 172.07 -89.16 0.08 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.934 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.491 ' HD2' ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -136.47 -169.08 2.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.221 0.534 . . . . 0.0 111.499 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.899 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -152.29 -177.68 0.74 Allowed Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.558 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.611 ' CD ' HG22 ' A' ' 91' ' ' THR . 87.9 Cg_exo -47.49 -16.9 0.5 Allowed 'Trans proline' 0 CA--C 1.531 0.337 0 C-N-CA 121.968 1.779 . . . . 0.0 112.896 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 ' HB3' ' A' ' 99' ' ' ARG . 6.0 pt -145.75 62.38 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.449 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -52.99 -71.79 0.06 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.041 0.448 . . . . 0.0 110.622 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 62.95 -95.07 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.039 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.56 -5.1 9.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.865 0.364 . . . . 0.0 111.238 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -150.38 -162.16 1.49 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.315 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.41 HD11 ' O ' ' A' ' 89' ' ' GLY . 78.6 mt -118.69 101.31 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.802 0.334 . . . . 0.0 111.197 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.433 ' HB3' HD11 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -99.35 99.16 7.81 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.72 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.899 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -69.16 -31.21 23.68 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.473 2.115 . . . . 0.0 112.491 -179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.736 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.66 -158.88 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.776 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.09 -6.96 14.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.779 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -167.48 69.26 0.09 Allowed 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' A' ' 101' ' ' ALA . 6.2 m -116.8 142.83 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.827 0.346 . . . . 0.0 111.65 178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.756 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -83.18 151.31 25.75 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.595 -178.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.647 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -87.08 86.95 2.65 Favored 'Isoleucine or valine' 0 C--O 1.231 0.096 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.69 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -72.03 18.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.509 -178.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.487 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.94 -150.91 18.52 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.678 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.821 ' HA ' HG23 ' A' ' 75' ' ' VAL . 32.4 mtp180 -156.37 168.19 28.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.187 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.53 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.9 mt -95.27 113.61 30.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.463 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.91 -86.83 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.418 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -69.02 149.61 48.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.782 0.325 . . . . 0.0 110.828 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.23 34.18 8.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.31 115.24 2.83 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.2 176.45 6.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.035 0.445 . . . . 0.0 111.402 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -105.55 45.99 1.23 Allowed Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.444 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.753 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.4 tt -42.25 -36.26 1.18 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.617 0.246 . . . . 0.0 111.424 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.53 -24.85 0.07 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.461 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -94.59 37.69 3.34 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.841 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.957 HG23 ' HD2' ' A' ' 47' ' ' ARG . 3.5 m -79.01 154.47 4.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.728 0.299 . . . . 0.0 111.728 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -78.74 148.48 33.01 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.307 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.641 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.2 p-10 -50.72 110.84 0.46 Allowed 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.37 111.62 0.04 OUTLIER Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.775 -0.648 . . . . 0.0 114.314 178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.46 139.05 15.98 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.561 0.219 . . . . 0.0 110.701 178.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.9 t -40.75 161.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.111 0.482 . . . . 0.0 112.0 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 45' ' ' ALA . 41.8 t -154.17 128.29 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.803 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.4 m -126.57 108.09 18.39 Favored 'Isoleucine or valine' 0 C--O 1.231 0.103 0 CA-C-O 120.86 0.362 . . . . 0.0 111.145 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.739 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -83.8 128.76 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.473 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 1.2 pt-20 -153.28 129.64 10.57 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-O 120.766 0.317 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.622 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.64 88.75 2.21 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.695 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.187 -0.911 . . . . 0.0 111.703 179.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.83 117.79 3.94 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.514 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -117.49 32.76 5.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.806 0.336 . . . . 0.0 110.938 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.84 19.18 9.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -165.81 45.67 0.28 Allowed Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.514 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.9 m -124.77 72.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.181 0.515 . . . . 0.0 111.2 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -174.93 36.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.667 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.0 106.96 17.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.971 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.87 145.42 38.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.161 0.505 . . . . 0.0 111.851 -179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -117.73 162.31 18.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.828 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.56 142.95 34.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.824 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -145.26 101.75 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.148 0.499 . . . . 0.0 109.824 179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.2 mtt-85 -102.03 156.77 17.33 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.778 0.799 . . . . 0.0 112.501 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -134.56 137.45 43.78 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.499 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -28.94 0.51 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.6 p -124.79 22.24 8.19 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -175.09 150.76 1.22 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -134.28 144.05 48.12 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.127 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.57 148.31 7.73 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.444 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -115.56 155.96 26.63 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 120.675 0.274 . . . . 0.0 110.315 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.2 138.57 15.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.972 0.415 . . . . 0.0 111.258 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.479 ' O ' ' HA3' ' A' ' 108' ' ' GLY . 1.3 mt-10 -95.1 -178.39 4.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.304 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.786 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.3 tp -154.34 146.37 23.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.942 0.401 . . . . 0.0 110.949 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.442 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 22.9 m-85 -126.76 147.71 49.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.853 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 16.8 mt-10 -56.28 -9.27 0.63 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -45.55 -28.78 1.01 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.857 0.298 . . . . 0.0 111.296 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.643 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 7.9 t90 -80.81 -56.27 4.25 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 155.6 113.89 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.538 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.688 178.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -46.65 -35.9 17.97 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.456 2.104 . . . . 0.0 112.577 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.96 -51.94 67.51 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.193 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.712 HG22 HG21 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -63.18 -45.81 90.06 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.835 0.35 . . . . 0.0 110.503 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.786 HG13 ' CD2' ' A' ' 23' ' ' LEU . 59.3 t -46.16 -30.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.226 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -60.14 -38.95 84.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.101 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.91 -47.15 84.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.5 -49.29 78.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.195 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -64.27 -27.17 68.86 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.249 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -73.13 -24.49 60.61 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.631 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.19 49.39 1.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.0 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.941 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.16 -159.97 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 CA-C-O 118.356 -0.831 . . . . 0.0 109.592 179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.941 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 39.0 Cg_exo -29.87 106.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.132 1.888 . . . . 0.0 114.085 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 39' ' ' LEU . 30.0 mt -150.11 149.44 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.621 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -85.92 134.95 33.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.003 0.43 . . . . 0.0 111.669 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.573 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 6.0 p -143.6 149.27 37.1 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.696 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.76 121.27 41.75 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.037 0.446 . . . . 0.0 110.212 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -80.42 131.26 35.57 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -102.68 123.83 47.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.593 177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.926 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -88.19 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.463 ' O ' ' N ' ' A' ' 50' ' ' ASP . 8.9 t-105 -151.5 148.51 28.13 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.236 178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.498 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -35.08 91.67 0.01 OUTLIER Glycine 0 C--N 1.336 0.556 0 C-N-CA 121.184 -0.531 . . . . 0.0 113.029 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 29.3 t70 75.94 -41.15 0.42 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.683 0.393 . . . . 0.0 111.309 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.833 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.06 143.1 41.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.0 0.429 . . . . 0.0 111.438 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -146.81 114.9 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.529 179.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -126.27 133.34 51.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.144 0.497 . . . . 0.0 112.038 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' CD2' HG11 ' A' ' 126' ' ' VAL . 4.5 p90 -131.63 143.84 50.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.369 179.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.68 142.91 26.84 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.665 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.82 8.48 11.14 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' HG3' ' C ' ' A' ' 56' ' ' THR . 39.7 mt-30 80.74 -6.33 1.66 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.754 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.4 p -83.94 115.5 26.23 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-O 120.842 0.353 . . . . 0.0 110.238 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.4 106.59 17.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.747 -179.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.712 HG21 HG22 ' A' ' 31' ' ' THR . 3.6 p -137.08 106.73 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.395 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -124.73 133.65 53.1 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.91 0.386 . . . . 0.0 111.254 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -153.92 165.09 37.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.335 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -102.16 88.35 3.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.828 0.347 . . . . 0.0 110.922 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -170.08 149.13 3.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 66' ' ' SER . 47.0 t-20 69.24 -81.46 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.522 0.201 . . . . 0.0 111.162 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 65' ' ' ASN . 2.3 m 24.73 82.36 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.72 156.53 17.29 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.518 179.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -120.72 -3.6 9.76 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 70' ' ' VAL . 4.2 p -127.83 140.11 50.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.841 -0.343 . . . . 0.0 111.494 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.531 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 30.5 m -159.02 157.89 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.759 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -93.84 152.06 19.16 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.424 0.63 . . . . 0.0 111.684 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.0 tp -47.64 126.49 10.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.89 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.11 -28.86 8.07 Favored Glycine 0 C--N 1.337 0.602 0 C-N-CA 120.131 -1.033 . . . . 0.0 114.63 178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.422 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 2.0 p30 -80.14 156.11 27.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.641 0.72 . . . . 0.0 111.988 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.842 HG23 ' HA ' ' A' ' 109' ' ' ARG . 22.3 t -114.03 152.16 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.29 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.789 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -152.25 145.4 24.61 Favored 'General case' 0 C--N 1.342 0.249 0 O-C-N 121.9 -0.5 . . . . 0.0 112.169 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.595 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -96.84 137.26 36.19 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.167 179.155 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -79.47 121.97 25.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.622 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.524 ' HB ' ' CD ' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -72.89 -70.19 0.28 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -179.148 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.524 ' CD ' ' HB ' ' A' ' 79' ' ' ILE . 79.3 Cg_exo -33.14 -62.96 0.15 Allowed 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.155 2.57 . . . . 0.0 113.845 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.68 -1.46 90.01 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.262 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 54.77 26.97 8.2 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.983 0.42 . . . . 0.0 110.485 -179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -108.99 137.76 46.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.638 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.4 mt -82.63 148.51 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.604 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 40.1 t -143.26 155.24 44.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.285 0.564 . . . . 0.0 112.486 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.877 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -107.07 158.76 16.81 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.98 179.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 35.5 m-85 -136.53 115.39 12.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.873 0.368 . . . . 0.0 111.676 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.545 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.4 OUTLIER -139.33 25.46 2.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.759 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 152.63 -153.7 25.04 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.051 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HD2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -39.43 171.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.833 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -153.21 176.99 2.12 Favored Pre-proline 0 N--CA 1.454 -0.226 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.522 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 5.8 Cg_exo -39.01 -27.66 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.568 2.179 . . . . 0.0 112.714 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 93' ' ' ILE . 3.7 mp -130.44 52.57 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.675 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -55.46 -77.68 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.167 0 CA-C-O 120.99 0.424 . . . . 0.0 110.644 179.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 28.0 t0 56.06 -93.62 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.117 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -123.96 -7.15 7.82 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.598 0.237 . . . . 0.0 111.445 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -139.82 -175.29 4.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.759 0.314 . . . . 0.0 110.47 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 94.9 mt -116.53 116.86 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.985 0.421 . . . . 0.0 111.312 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -121.53 99.46 45.24 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.998 179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.518 ' HA ' HG21 ' A' ' 91' ' ' THR . 61.4 Cg_endo -70.66 -31.6 16.24 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.466 2.111 . . . . 0.0 112.587 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.805 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . -178.39 -160.7 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.926 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -6.39 13.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.404 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -171.72 69.35 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.805 HG13 ' HB3' ' A' ' 101' ' ' ALA . 11.9 m -116.02 141.78 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.047 0.451 . . . . 0.0 111.783 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.758 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 3.0 m120 -82.49 150.96 26.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.618 -178.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.613 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.02 86.53 2.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 177.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.789 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -71.77 16.57 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.527 -178.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.41 -147.79 18.6 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.749 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.842 ' HA ' HG23 ' A' ' 75' ' ' VAL . 11.5 mtp-105 -155.94 167.61 29.88 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.007 0.432 . . . . 0.0 111.357 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.595 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -92.77 114.85 30.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.646 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -51.69 -78.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.804 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -70.54 99.21 1.59 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.636 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -20.41 64.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.262 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -55.5 -23.75 27.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.73 0.3 . . . . 0.0 111.268 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 51.1 mm-40 -68.49 98.41 0.86 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.934 0.397 . . . . 0.0 111.028 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -93.06 45.87 2.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.557 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.877 HD22 HD13 ' A' ' 86' ' ' LEU . 7.2 tt -42.61 -33.56 0.73 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.626 0.25 . . . . 0.0 111.621 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -25.35 0.08 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.423 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -89.82 34.29 4.12 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.91 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.926 HG23 ' HD2' ' A' ' 47' ' ' ARG . 4.8 m -74.73 154.05 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.474 0.178 . . . . 0.0 111.302 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -76.89 145.8 38.06 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -56.54 110.16 0.74 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.058 0.456 . . . . 0.0 111.593 -179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.31 102.7 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.305 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -153.63 150.03 28.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.0 110.854 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.71 162.63 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.142 0.496 . . . . 0.0 112.154 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.91 HG21 ' HB2' ' A' ' 45' ' ' ALA . 51.7 t -158.06 128.67 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.483 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.552 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.9 m -126.2 107.43 17.44 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 111.153 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.46 128.68 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.472 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.508 ' OE2' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -153.48 127.9 9.25 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.597 0.237 . . . . 0.0 111.319 -179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.6 89.97 2.77 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.789 0.328 . . . . 0.0 110.779 179.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.467 ' HB3' ' HE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.766 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.924 0.392 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.24 -73.05 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.44 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -78.42 -61.05 2.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 -72.46 0.21 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.718 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.434 ' O ' ' HG2' ' A' ' 25' ' ' GLU . . . -175.69 32.05 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.474 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.3 m -127.93 69.52 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.972 0.415 . . . . 0.0 111.421 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -145.99 32.51 1.02 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.034 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.54 116.37 31.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 0.0 111.028 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 145.3 46.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.071 0.462 . . . . 0.0 111.949 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 10' ' ' LEU . 0.0 OUTLIER -114.86 163.68 15.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.92 178.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.92 145.58 38.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.828 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.3 OUTLIER -142.25 102.95 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.455 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.408 ' HG3' ' CG2' ' A' ' 127' ' ' VAL . 14.7 ptm180 -102.4 156.22 17.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.582 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.904 ' CE2' HG22 ' A' ' 126' ' ' VAL . 32.3 m-85 -140.69 139.54 34.78 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.915 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -28.84 0.89 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.064 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -125.79 22.44 7.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.416 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.9 154.38 1.49 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.389 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.97 144.29 47.32 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.877 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.12 150.09 12.73 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.743 0.306 . . . . 0.0 111.492 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.5 158.6 34.08 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.339 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -153.02 143.56 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.021 0.439 . . . . 0.0 111.212 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -90.96 -178.29 5.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.305 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.793 HD21 HG22 ' A' ' 32' ' ' VAL . 2.6 tp -151.04 130.43 12.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.048 0.452 . . . . 0.0 111.525 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.457 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 6.0 m-85 -113.54 136.46 52.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.38 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.524 ' OE1' HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -57.84 -8.83 1.05 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -45.0 -28.39 0.67 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.652 0.263 . . . . 0.0 111.009 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.633 ' CZ2' HG21 ' A' ' 31' ' ' THR . 6.4 t90 -75.94 -53.16 8.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.731 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 159.72 114.05 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.482 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.806 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 25' ' ' GLU . 3.3 Cg_exo -47.2 -37.76 24.34 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.567 2.178 . . . . 0.0 112.547 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.9 mp0 -62.43 -46.76 87.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.44 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.793 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -64.05 -44.7 91.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 110.261 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.793 HG22 HD21 ' A' ' 23' ' ' LEU . 58.5 t -47.02 -36.27 3.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.005 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -56.47 -39.0 72.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.528 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.05 -46.73 80.02 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.655 0.264 . . . . 0.0 111.261 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.48 -49.98 69.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.66 -26.83 68.85 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -73.6 -24.1 60.01 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.636 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.96 49.19 1.01 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.967 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.946 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mt -62.04 -159.78 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.303 -0.856 . . . . 0.0 109.697 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.946 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 36.2 Cg_exo -29.46 107.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.709 0 C-N-CA 122.063 1.842 . . . . 0.0 114.049 -178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' LEU . 33.5 mt -150.13 149.87 14.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.6 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -85.94 133.88 33.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.927 0.394 . . . . 0.0 111.866 -179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.595 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 2.8 p -145.91 149.5 34.34 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.517 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.53 133.39 46.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.895 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -91.96 136.59 33.05 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.04 120.15 39.96 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.755 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.631 ' NH2' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -87.88 133.39 33.92 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -177.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.481 ' O ' ' N ' ' A' ' 50' ' ' ASP . 9.3 t-105 -155.65 148.7 24.5 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.369 179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -33.69 89.76 0.01 OUTLIER Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.415 -0.422 . . . . 0.0 113.391 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 48' ' ' TRP . 28.9 t70 72.99 -36.82 0.37 Allowed 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.82 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -75.87 132.08 40.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.932 0.396 . . . . 0.0 111.092 -179.588 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.8 OUTLIER -138.86 121.3 17.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.768 179.506 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -134.01 131.59 39.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.916 0.389 . . . . 0.0 111.613 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.2 p90 -136.61 145.13 44.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.809 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.66 144.28 25.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.175 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.7 5.79 11.0 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.0 OUTLIER 83.26 -7.77 1.15 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.898 0.332 . . . . 0.0 111.898 179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.5 p -84.1 115.52 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.119 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.207 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -97.37 94.8 7.27 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.001 0.429 . . . . 0.0 111.716 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.793 ' CG2' HG22 ' A' ' 31' ' ' THR . 6.7 p -129.17 106.79 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.493 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -138.94 132.7 30.77 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-O 120.872 0.368 . . . . 0.0 111.328 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -148.74 164.33 34.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.426 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' A' ' 63' ' ' GLU . 0.2 OUTLIER -94.32 87.91 5.37 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.455 0.645 . . . . 0.0 111.262 -179.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -170.23 148.79 3.35 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' ND2' ' HB3' ' A' ' 105' ' ' ASN . 43.2 t-20 71.85 -83.21 0.03 OUTLIER 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.578 0.228 . . . . 0.0 111.165 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 8.1 m 27.4 81.4 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.856 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -100.41 156.03 17.48 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.225 178.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -117.83 -6.75 11.02 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.9 p -127.48 143.0 42.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.631 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.572 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 33.3 m -158.56 157.6 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.777 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -94.56 150.51 20.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.373 0.606 . . . . 0.0 111.576 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.5 tp -46.28 126.67 8.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.956 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.37 -30.64 6.87 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.385 -0.912 . . . . 0.0 114.535 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' A' ' 109' ' ' ARG . 2.4 p30 -79.21 156.39 28.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.49 0.645 . . . . 0.0 111.957 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.899 HG23 ' HA ' ' A' ' 109' ' ' ARG . 19.7 t -111.16 152.16 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.257 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.605 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -151.11 150.22 30.42 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 118.086 0.403 . . . . 0.0 111.882 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.473 ' CE2' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -106.32 137.91 43.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.442 179.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.62 ' HA ' HG12 ' A' ' 104' ' ' VAL . 4.3 t90 -79.1 108.46 12.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.639 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.6 OUTLIER -63.94 -65.84 1.82 Allowed Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 121.005 -0.278 . . . . 0.0 110.82 -179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.99 81.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 121.823 1.682 . . . . 0.0 111.714 179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 136.56 -6.89 3.91 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.651 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HA ' ' HE1' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 52.36 36.82 20.83 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.002 0.401 . . . . 0.0 110.931 179.868 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -116.24 134.84 54.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.044 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -88.38 151.2 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.401 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 16.9 t -143.47 157.06 44.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.849 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -110.2 159.68 17.17 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.353 179.459 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' ALA . 33.7 m-85 -136.78 134.56 37.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 111.792 179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.583 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -169.47 35.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.853 179.345 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.14 -153.53 24.76 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.323 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.568 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -53.4 -171.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.515 0.674 . . . . 0.0 112.097 -179.614 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.82 HG22 ' HG3' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -163.79 -174.34 0.4 Allowed Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.858 -1.064 . . . . 0.0 108.934 179.74 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.68 ' HB2' HD12 ' A' ' 93' ' ' ILE . 93.9 Cg_exo -44.89 -24.32 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 121.877 1.718 . . . . 0.0 112.519 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.6 mp -142.25 69.96 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.568 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -59.51 -76.82 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.089 0.471 . . . . 0.0 110.365 179.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.2 t70 60.09 -95.9 0.06 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.906 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -122.08 -5.38 8.97 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.586 0.232 . . . . 0.0 111.214 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.35 -169.75 3.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.569 HG23 ' OG1' ' A' ' 91' ' ' THR . 97.3 mt -116.59 104.24 16.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.818 0.342 . . . . 0.0 111.024 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -103.55 99.25 14.79 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.813 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.702 ' HA ' HG21 ' A' ' 91' ' ' THR . 59.7 Cg_endo -70.39 -31.51 17.61 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.505 2.137 . . . . 0.0 112.69 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.659 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 178.42 -161.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.784 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.62 -8.76 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.665 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -166.56 71.83 0.13 Allowed 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.659 HG13 ' HB3' ' A' ' 101' ' ' ALA . 18.4 m -119.08 141.24 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.004 0.431 . . . . 0.0 111.872 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.448 ' ND2' ' H ' ' A' ' 66' ' ' SER . 1.9 m120 -83.88 150.24 25.85 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.713 -178.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.856 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -85.28 94.12 3.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.605 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.2 OUTLIER -80.28 24.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 109.81 -149.98 17.38 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.41 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.899 ' HA ' HG23 ' A' ' 75' ' ' VAL . 26.2 mtp180 -157.01 168.06 28.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.454 . . . . 0.0 111.216 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.618 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -95.15 113.86 30.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.425 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -100.5 -85.73 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.4 ' H ' HG23 ' A' ' 111' ' ' VAL . 11.9 p-10 -78.28 60.1 2.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.014 0.435 . . . . 0.0 111.212 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 170.9 39.63 0.0 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 9.4 ptm -72.72 65.4 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.015 0.436 . . . . 0.0 110.689 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.403 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 0.4 OUTLIER -90.82 -168.81 2.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.164 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -118.64 45.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.316 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.849 HD22 HD13 ' A' ' 86' ' ' LEU . 2.0 tt -42.57 -36.73 1.45 Allowed 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.586 0.232 . . . . 0.0 111.601 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.583 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.43 -26.85 0.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.31 33.94 3.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.928 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 117' ' ' LEU . 2.4 m -80.39 154.03 4.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.627 0.251 . . . . 0.0 111.473 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.452 ' O ' ' HD3' ' A' ' 47' ' ' ARG . . . -73.53 146.81 44.53 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.465 ' HA ' ' CG ' ' A' ' 47' ' ' ARG . 12.8 p-10 -53.6 134.61 41.23 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.519 ' H ' ' HD2' ' A' ' 47' ' ' ARG . . . 56.86 99.16 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 CA-C-N 115.363 -0.835 . . . . 0.0 114.282 178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -144.61 153.34 41.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.893 0.378 . . . . 0.0 110.98 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.3 t -65.09 158.17 26.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.542 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.904 HG22 ' CE2' ' A' ' 14' ' ' PHE . 40.8 t -148.06 129.18 5.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.087 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.572 ' O ' HG23 ' A' ' 127' ' ' VAL . 28.0 m -124.55 106.1 16.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.89 0.376 . . . . 0.0 110.595 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.675 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.17 128.9 38.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.813 -179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 6.3 pt-20 -153.2 125.04 7.82 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.665 0.269 . . . . 0.0 111.25 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.698 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.14 94.74 1.98 Allowed 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.839 0.352 . . . . 0.0 110.813 179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HB3' ' NE ' ' A' ' 130' ' ' ARG . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.145 -0.931 . . . . 0.0 111.8 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.58 -108.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.55 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -135.58 -73.94 0.45 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.715 0.293 . . . . 0.0 110.967 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.58 17.91 1.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.184 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.55 90.08 0.08 OUTLIER Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.403 -0.904 . . . . 0.0 112.59 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 6' ' ' VAL . 25.4 m -146.49 79.53 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.944 0.402 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -159.03 28.45 0.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.051 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.75 106.89 16.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.989 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -114.77 145.29 42.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.483 . . . . 0.0 112.113 -179.687 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.26 163.61 16.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.951 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.64 147.37 33.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.783 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -144.33 101.91 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HE ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.12 156.17 17.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.555 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.558 ' CZ ' HG22 ' A' ' 126' ' ' VAL . 4.7 m-85 -138.25 136.47 36.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.1 -29.44 0.23 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.13 22.49 7.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -174.35 152.96 1.85 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.39 145.6 50.76 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.871 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.418 ' HA ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -163.43 148.46 11.13 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.658 0.266 . . . . 0.0 111.607 -179.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.6 158.88 41.1 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.163 179.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.23 148.08 12.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.107 0.48 . . . . 0.0 111.644 -179.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 1.2 mt-10 -94.57 -178.29 4.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.021 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 32' ' ' VAL . 7.0 tp -147.46 133.19 18.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.148 0.499 . . . . 0.0 111.4 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.415 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 11.6 m-85 -112.12 139.49 47.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.436 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -57.11 -8.92 0.76 Allowed 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -45.29 -27.98 0.74 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.62 0.248 . . . . 0.0 111.427 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 0.4 OUTLIER -79.26 -56.61 4.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.9 115.98 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.784 178.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -45.5 -34.67 11.2 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.396 2.064 . . . . 0.0 112.246 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -59.32 -52.74 64.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.443 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.475 HG21 ' NE1' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -61.78 -45.65 92.98 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.037 HG22 HD21 ' A' ' 23' ' ' LEU . 87.4 t -46.72 -31.69 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.19 -37.71 86.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.267 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.08 -47.57 67.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.215 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.82 -52.05 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.59 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.85 -29.25 70.05 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-O 120.911 0.386 . . . . 0.0 110.395 179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.01 -25.58 62.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.528 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.02 51.53 1.04 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.767 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.985 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.7 mt -61.56 -160.0 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.828 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.985 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 22.3 Cg_exo -26.83 108.24 0.03 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 122.275 1.983 . . . . 0.0 113.992 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 127' ' ' VAL . 14.5 mt -147.9 153.91 11.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.628 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.2 mtmp? -89.28 131.98 35.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.97 0.414 . . . . 0.0 111.074 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.78 40.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.94 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.32 128.25 48.96 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.836 0.351 . . . . 0.0 110.44 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.914 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -91.55 132.74 36.08 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -100.7 130.02 46.69 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -94.1 134.79 36.15 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 -177.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.557 ' O ' ' N ' ' A' ' 50' ' ' ASP . 7.5 t-105 -154.87 148.36 25.2 Favored 'General case' 0 CA--C 1.527 0.076 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.044 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -29.34 84.32 0.0 OUTLIER Glycine 0 C--N 1.336 0.557 0 O-C-N 123.375 0.422 . . . . 0.0 113.781 -179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 48' ' ' TRP . 27.8 t70 73.93 -37.23 0.36 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 122.406 0.282 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.749 ' HG3' HG22 ' A' ' 91' ' ' THR . 1.3 tm-20 -73.44 128.04 34.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.992 0.425 . . . . 0.0 111.335 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -131.1 125.0 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.786 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -136.49 127.43 27.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.355 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.469 ' CE2' HG11 ' A' ' 126' ' ' VAL . 4.3 p90 -133.28 145.39 50.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.776 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.61 146.62 23.63 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.581 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -120.82 6.79 10.42 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.412 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER 82.57 -7.89 1.24 Allowed 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.492 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.3 p -84.66 114.42 24.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -105.94 94.87 5.41 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 60' ' ' VAL . 6.1 p -132.47 106.74 11.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.143 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -124.12 134.64 53.3 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.027 0.441 . . . . 0.0 111.621 -179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ttmt -146.86 165.34 30.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.267 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 3.7 pm0 -102.02 92.4 4.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.048 0.451 . . . . 0.0 111.245 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.451 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.9 tt0 -170.13 156.16 5.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.762 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.451 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 30.5 t-20 63.19 -81.48 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.706 0.289 . . . . 0.0 111.094 179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.448 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.1 m 28.15 82.94 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.55 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.786 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.99 155.9 17.88 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.318 178.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -117.45 -7.01 11.18 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.7 p -127.03 144.43 37.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.623 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.548 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 27.5 m -158.47 163.19 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.394 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -108.65 143.22 38.01 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.036 0.446 . . . . 0.0 110.935 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -37.71 131.83 0.95 Allowed 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.475 -0.784 . . . . 0.0 112.039 -178.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.01 -31.52 6.47 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.711 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -83.25 156.83 22.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.247 0.546 . . . . 0.0 112.215 -178.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.873 HG23 ' HA ' ' A' ' 109' ' ' ARG . 23.1 t -114.95 152.43 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.997 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.708 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -147.94 149.33 32.0 Favored 'General case' 0 C--N 1.342 0.242 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.313 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.481 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -106.73 123.78 48.64 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.268 179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.598 ' HA ' HG12 ' A' ' 104' ' ' VAL . 3.1 t90 -65.67 111.07 3.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.802 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.705 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 0.3 OUTLIER -66.3 -68.31 0.76 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.787 -0.188 . . . . 0.0 110.708 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.705 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 31.4 Cg_exo -57.69 80.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 121.914 1.743 . . . . 0.0 111.752 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 139.12 -9.41 3.29 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.607 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.04 32.29 17.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 117.096 0.448 . . . . 0.0 110.863 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.16 133.9 54.02 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.881 -179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.2 mt -90.78 148.98 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.236 179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.561 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 35.3 t -143.14 157.26 44.67 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.037 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -112.37 156.41 22.53 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.184 -0.917 . . . . 0.0 109.941 179.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.466 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 4.9 m-85 -136.76 130.86 32.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.661 0.267 . . . . 0.0 111.515 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 115' ' ' GLU . 0.3 OUTLIER -167.77 49.37 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 179.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.71 -82.22 0.12 Allowed Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.389 -0.91 . . . . 0.0 113.268 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -138.94 -167.85 2.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.265 0.555 . . . . 0.0 111.748 -179.513 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.881 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -155.4 -176.51 0.62 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.822 179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 91' ' ' THR . 97.1 Cg_exo -45.18 -21.69 0.67 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.187 1.925 . . . . 0.0 112.997 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.677 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -147.51 65.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -49.85 -73.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.013 0.435 . . . . 0.0 110.575 179.117 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.16 -90.54 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.165 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -119.32 -30.58 4.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.894 0.378 . . . . 0.0 111.018 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm -127.7 -164.5 1.37 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.519 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 86.5 mt -115.99 105.6 18.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.789 0.328 . . . . 0.0 111.034 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 99.41 9.36 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.065 179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.881 ' HA ' HG21 ' A' ' 91' ' ' THR . 56.6 Cg_endo -68.95 -31.15 24.85 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.538 2.159 . . . . 0.0 112.564 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.665 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 175.99 -162.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.928 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.24 -7.3 16.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.645 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -169.97 73.74 0.07 Allowed 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 101' ' ' ALA . 17.5 m -122.16 142.3 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-O 121.005 0.431 . . . . 0.0 111.774 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.511 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.6 m120 -83.15 152.19 25.38 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.43 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.786 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.96 82.02 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.708 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -65.9 20.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -178.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 106' ' ' VAL . . . 114.27 -149.51 18.74 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.871 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.873 ' HA ' HG23 ' A' ' 75' ' ' VAL . 2.6 mtt85 -156.23 163.6 39.36 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.878 0.371 . . . . 0.0 111.182 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.615 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.8 mp -90.07 116.3 31.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.242 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -86.23 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -121.3 138.05 54.42 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.982 0.42 . . . . 0.0 111.517 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 19' ' ' CYS . 0.3 OUTLIER 167.44 -73.02 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.582 179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.48 -44.41 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.504 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.458 ' HB3' ' CZ ' ' A' ' 88' ' ' PHE . 17.0 mt-10 61.1 38.61 16.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.022 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.26 25.47 2.63 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.928 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.037 HD22 HD13 ' A' ' 86' ' ' LEU . 4.1 tp -54.67 -37.5 65.82 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.768 0.284 . . . . 0.0 111.097 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.445 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.42 -20.45 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -179.204 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 117' ' ' LEU . . . -91.31 30.34 6.45 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.644 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 2.8 m -77.52 154.27 5.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.597 0.237 . . . . 0.0 111.483 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 147.21 30.2 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.608 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 13.6 p-10 -53.81 112.06 0.86 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.161 0.505 . . . . 0.0 112.01 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.25 100.65 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 113.565 179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.412 ' OE2' ' HB ' ' A' ' 120' ' ' VAL . 5.5 pt-20 -152.82 148.37 27.12 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.029 0.442 . . . . 0.0 110.752 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.68 165.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.324 0.583 . . . . 0.0 112.456 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.914 HG21 ' HB2' ' A' ' 45' ' ' ALA . 40.1 t -158.13 127.82 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.258 179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 127' ' ' VAL . 29.8 m -125.22 107.29 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.021 0.439 . . . . 0.0 111.228 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.581 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.21 128.72 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.573 -179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.432 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 pt-20 -152.45 129.07 10.77 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.751 0.31 . . . . 0.0 111.235 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.58 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -75.86 92.73 3.1 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.874 0.369 . . . . 0.0 110.735 179.702 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.724 179.915 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.1 mmt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.834 0.349 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.21 163.81 12.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.506 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -103.04 -35.12 8.65 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.716 0.294 . . . . 0.0 110.807 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.46 -74.12 0.2 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.654 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -175.02 25.74 0.07 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.789 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 6' ' ' VAL . 31.5 m -130.01 70.5 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.033 0.444 . . . . 0.0 111.41 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -154.14 25.79 0.48 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.73 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . 0.455 ' O ' ' HG2' ' A' ' 8' ' ' MET . 0.0 OUTLIER -101.74 126.51 48.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.266 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' NH1' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -131.92 145.45 51.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.12 -179.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -112.37 162.44 15.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.649 178.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.46 142.79 33.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.857 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -138.91 102.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.194 0.521 . . . . 0.0 109.704 179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.402 ' CG ' ' CG2' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -101.34 156.15 17.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.589 -179.031 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' N ' ' O ' ' A' ' 17' ' ' ALA . 3.2 m-85 -137.64 138.34 39.37 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.525 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.27 -29.14 0.38 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.9 m -126.22 22.1 7.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 14' ' ' PHE . . . -175.87 153.34 1.35 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.66 145.06 48.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.085 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -163.36 148.85 11.41 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.561 0.22 . . . . 0.0 111.432 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -117.93 156.68 28.05 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.535 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -152.22 135.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.047 0.451 . . . . 0.0 111.338 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 9' ' ' ARG . 0.6 OUTLIER -90.89 -178.39 5.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.409 179.492 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.781 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.6 tp -149.76 146.68 27.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.872 0.368 . . . . 0.0 110.982 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.451 ' CD1' ' HB ' ' A' ' 6' ' ' VAL . 13.6 m-85 -121.56 146.14 47.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.858 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 5' ' ' GLY . 33.3 mt-10 -59.73 -9.03 2.39 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -45.52 -28.25 0.89 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.603 0.24 . . . . 0.0 111.423 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.711 ' CH2' HD11 ' A' ' 79' ' ' ILE . 0.4 OUTLIER -80.07 -56.24 4.38 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 27' ' ' TRP . . . 156.8 116.23 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.824 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -46.89 -29.77 8.69 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.521 2.147 . . . . 0.0 112.505 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -67.31 -43.56 81.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.183 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.844 HG22 ' CG2' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -67.18 -46.26 74.49 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.772 0.32 . . . . 0.0 110.35 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.781 HG13 ' CD2' ' A' ' 23' ' ' LEU . 31.0 t -45.98 -35.2 2.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.4 ttt85 -56.62 -37.76 71.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.262 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.01 -47.56 74.04 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.532 -0.303 . . . . 0.0 110.99 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -55.86 -49.78 72.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.32 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.585 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -63.46 -28.79 70.21 Favored 'General case' 0 C--N 1.34 0.183 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.247 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -71.19 -25.65 62.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.928 0.394 . . . . 0.0 110.481 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -97.88 51.29 1.05 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.962 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.968 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 9.0 mt -62.06 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.855 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.434 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.968 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 29.9 Cg_exo -28.64 103.39 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.69 0 C-N-CA 122.058 1.839 . . . . 0.0 114.086 -178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 39' ' ' LEU . 20.8 mt -145.62 150.62 15.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.395 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 mtpt -85.88 135.62 33.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.164 0.506 . . . . 0.0 111.914 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.588 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.6 p -146.06 148.6 32.84 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.232 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 125.44 48.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.008 0.432 . . . . 0.0 110.374 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.902 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -83.98 132.55 34.74 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -104.13 119.01 38.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.802 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.966 ' HD2' HG23 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -82.43 136.88 34.84 Favored 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.438 ' O ' ' N ' ' A' ' 50' ' ' ASP . 16.0 t-105 -148.44 148.56 30.43 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.588 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.522 ' O ' ' HB3' ' A' ' 50' ' ' ASP . . . -38.61 92.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.419 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.177 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 49' ' ' GLY . 26.4 t70 79.44 -41.31 0.25 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 122.712 0.405 . . . . 0.0 111.778 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.56 152.08 24.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.183 0.516 . . . . 0.0 111.59 -179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.577 HG21 HD21 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -150.13 117.03 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.726 179.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 84' ' ' ILE . 37.1 p90 -125.15 140.17 53.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.243 0.545 . . . . 0.0 112.169 -179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 4.3 p90 -140.25 145.33 37.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.581 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 145.58 24.41 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.672 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -119.17 6.6 11.25 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.403 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.7 mt-30 81.75 -7.78 1.38 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.698 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.486 ' O ' HG13 ' A' ' 58' ' ' VAL . 10.9 p -85.14 115.63 27.22 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.25 94.74 6.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.002 0.429 . . . . 0.0 111.706 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.844 ' CG2' HG22 ' A' ' 31' ' ' THR . 7.6 p -130.13 106.75 13.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.511 179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.94 131.77 33.49 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.939 0.399 . . . . 0.0 111.412 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 27' ' ' TRP . 52.1 tttm -141.07 165.65 26.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.354 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.1 pm0 -99.56 89.27 4.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.057 0.456 . . . . 0.0 111.374 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 3.8 tt0 -170.14 157.82 6.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.67 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.452 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 27.0 t-20 63.5 -82.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.405 ' H ' ' ND2' ' A' ' 105' ' ' ASN . 2.9 m 29.95 84.0 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.534 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.667 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -102.47 156.29 17.7 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.327 179.015 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.92 -7.01 10.96 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 70' ' ' VAL . 5.4 p -126.63 142.16 43.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.537 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.576 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 35.6 m -157.81 157.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -94.26 151.08 19.71 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.357 0.599 . . . . 0.0 111.57 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.2 tp -46.42 125.84 7.34 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.171 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.41 -31.72 6.27 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 120.421 -0.895 . . . . 0.0 114.369 178.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.45 ' CG ' ' HB ' ' A' ' 70' ' ' VAL . 1.9 p30 -75.66 155.81 35.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.619 0.709 . . . . 0.0 112.078 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.765 HG23 ' HA ' ' A' ' 109' ' ' ARG . 21.5 t -113.09 152.54 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.027 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.781 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -148.03 145.92 28.68 Favored 'General case' 0 C--N 1.341 0.204 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.343 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.446 ' CZ ' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -101.54 121.37 41.85 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.337 179.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.562 ' HA ' HG12 ' A' ' 104' ' ' VAL . 2.8 t90 -64.83 114.48 4.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.821 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.711 HD11 ' CH2' ' A' ' 27' ' ' TRP . 0.5 OUTLIER -70.74 -67.34 0.63 Allowed Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.109 -0.237 . . . . 0.0 110.735 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 27.8 Cg_exo -61.23 75.89 0.08 OUTLIER 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.856 1.704 . . . . 0.0 111.633 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 79' ' ' ILE . . . 147.11 -10.94 1.37 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.13 30.61 12.38 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.234 0.517 . . . . 0.0 110.973 179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -114.72 136.64 52.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' TYR . 9.5 mt -88.53 147.81 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.8 m -142.77 132.1 23.46 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.025 HD13 HD22 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -89.55 157.73 17.95 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.025 178.449 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 100' ' ' PRO . 7.7 m-85 -136.49 134.67 37.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.361 . . . . 0.0 111.536 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.568 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -153.58 28.82 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.708 179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 90' ' ' LYS . . . 148.53 -149.59 21.64 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.584 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.451 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -39.75 169.57 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -179.171 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.566 ' HB ' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -155.79 -176.58 0.63 Allowed Pre-proline 0 N--CA 1.454 -0.233 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.639 ' HB2' HD12 ' A' ' 93' ' ' ILE . 79.2 Cg_exo -42.64 -25.49 0.5 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.087 1.858 . . . . 0.0 112.571 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.639 HD12 ' HB2' ' A' ' 92' ' ' PRO . 3.7 mp -136.49 52.86 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.511 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.451 ' HB3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -53.07 -75.98 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.032 0.444 . . . . 0.0 110.717 179.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 53.57 -91.27 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.312 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.91 3.68 6.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.702 0.287 . . . . 0.0 111.222 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.4 mtmt -149.81 -170.25 3.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.453 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.5 HG23 ' OG1' ' A' ' 91' ' ' THR . 66.1 mt -123.15 110.53 26.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.914 0.388 . . . . 0.0 111.17 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.41 99.32 49.1 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.24 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.422 ' HB3' ' CE1' ' A' ' 87' ' ' PHE . 55.1 Cg_endo -68.25 -30.6 30.54 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.51 2.14 . . . . 0.0 112.494 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.635 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 179.2 -162.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.838 -179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.41 -4.84 17.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.727 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -174.42 74.71 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.635 HG13 ' HB3' ' A' ' 101' ' ' ALA . 20.8 m -122.7 141.98 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.997 0.427 . . . . 0.0 111.891 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.544 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 1.3 m120 -82.15 152.77 26.35 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.624 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.667 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -83.6 90.07 2.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.781 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -75.93 19.68 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.263 -177.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 113.59 -149.24 18.65 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.572 178.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.765 ' HA ' HG23 ' A' ' 75' ' ' VAL . 13.6 mtt180 -151.52 164.18 37.38 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.003 0.43 . . . . 0.0 111.472 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.683 ' CD1' HG22 ' A' ' 75' ' ' VAL . 2.7 mp -93.83 115.78 33.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.598 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -58.18 -79.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.851 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -169.31 -167.56 0.72 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.08 90.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.09 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.55 45.59 24.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.049 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.409 ' O ' ' CE1' ' A' ' 88' ' ' PHE . 13.1 pt-20 -75.37 -6.69 51.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.265 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -88.19 45.64 3.31 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.83 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 1.025 HD22 HD13 ' A' ' 86' ' ' LEU . 1.2 tp -42.77 -31.71 0.51 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.72 0.295 . . . . 0.0 111.228 -179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.568 ' HG2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -42.63 -19.39 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.398 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.413 ' N ' ' HE2' ' A' ' 118' ' ' LYS . . . -91.52 27.35 9.75 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.051 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.966 HG23 ' HD2' ' A' ' 47' ' ' ARG . 5.3 m -81.62 153.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.763 0.281 . . . . 0.0 111.527 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.57 148.59 35.12 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.474 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 8.3 p-10 -53.8 105.17 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.122 0.487 . . . . 0.0 112.047 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.06 109.94 0.12 Allowed Glycine 0 CA--C 1.521 0.469 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.989 178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.18 138.72 14.97 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.639 0.257 . . . . 0.0 110.794 178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -39.8 152.68 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.028 0.442 . . . . 0.0 111.901 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.902 HG21 ' HB2' ' A' ' 45' ' ' ALA . 61.5 t -144.62 128.23 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.85 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.3 m -124.69 107.14 17.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -82.82 128.38 38.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.637 -179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 7.6 pt-20 -152.46 130.29 11.69 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.652 0.263 . . . . 0.0 111.216 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.575 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -74.76 93.79 2.64 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.901 179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.499 ' HB2' ' NH1' ' A' ' 9' ' ' ARG . . . . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.151 -0.928 . . . . 0.0 111.948 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.252 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.31 -147.73 16.35 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.476 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -141.29 -47.93 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.871 0.367 . . . . 0.0 111.009 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.67 -146.67 0.55 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -159.95 -40.38 0.02 OUTLIER Glycine 0 C--N 1.336 0.532 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.71 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 25' ' ' GLU . 24.4 m -108.58 60.35 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 121.015 0.436 . . . . 0.0 111.305 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -156.95 44.31 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.03 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' MET . . . . . . . . . . . . . 2.2 tpp -109.63 115.68 30.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -110.64 145.26 38.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.206 0.527 . . . . 0.0 112.03 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.54 163.6 16.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.719 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.45 145.06 33.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.886 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 12' ' ' ILE . 0.8 OUTLIER -147.35 102.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -108.58 155.99 20.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.321 0.581 . . . . 0.0 111.854 -178.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.472 ' CG ' HD11 ' A' ' 117' ' ' LEU . 2.7 m-85 -128.82 140.31 51.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.159 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.07 -28.84 0.2 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 p -122.24 23.19 9.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' HD12 ' A' ' 117' ' ' LEU . . . -176.28 155.05 1.43 Allowed 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -117.1 152.66 34.24 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.229 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.08 151.47 17.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.92 0.39 . . . . 0.0 111.926 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -137.45 149.96 47.26 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.235 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -155.13 141.37 11.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.131 0.491 . . . . 0.0 111.842 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' OE2' HG13 ' A' ' 111' ' ' VAL . 2.0 mp0 -95.03 -178.1 4.37 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.234 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.797 ' CD2' HG13 ' A' ' 32' ' ' VAL . 6.4 tp -154.79 142.33 19.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.875 0.369 . . . . 0.0 111.072 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -124.05 146.92 48.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.662 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.689 ' H ' HG12 ' A' ' 6' ' ' VAL . 39.7 mt-10 -55.32 -9.41 0.44 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -45.61 -28.59 1.0 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 122.186 -0.321 . . . . 0.0 111.219 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.645 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 6.2 t90 -79.78 -55.87 4.68 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.667 ' HB3' ' OG1' ' A' ' 31' ' ' THR . . . 156.8 115.97 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.465 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.648 178.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 28' ' ' ALA . 3.8 Cg_exo -46.22 -36.7 17.37 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.521 2.147 . . . . 0.0 112.407 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -62.12 -48.54 79.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.365 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.847 HG22 HG22 ' A' ' 60' ' ' VAL . 0.0 OUTLIER -62.38 -44.96 95.23 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.888 0.375 . . . . 0.0 110.353 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.797 HG13 ' CD2' ' A' ' 23' ' ' LEU . 43.7 t -51.31 -31.39 11.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -59.73 -36.06 75.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.356 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -68.48 -47.31 67.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -53.1 -51.39 39.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.54 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -61.68 -28.69 69.58 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 120.983 0.42 . . . . 0.0 110.42 179.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -73.03 -23.83 60.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.859 0.361 . . . . 0.0 110.671 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.44 50.81 0.89 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.877 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.957 ' HB3' ' HD2' ' A' ' 40' ' ' PRO . 8.4 mt -62.26 -159.96 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 118.33 -0.843 . . . . 0.0 109.506 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.957 ' HD2' ' HB3' ' A' ' 39' ' ' LEU . 30.7 Cg_exo -28.88 106.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.164 1.909 . . . . 0.0 113.979 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 39' ' ' LEU . 24.2 mt -147.63 149.3 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.403 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.99 136.59 33.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.116 0.484 . . . . 0.0 111.863 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.614 ' OG ' ' HB ' ' A' ' 126' ' ' VAL . 4.4 p -146.09 149.25 33.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.35 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.82 127.89 48.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 110.177 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.89 ' HB2' ' CG2' ' A' ' 126' ' ' VAL . . . -87.16 136.27 32.99 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -108.83 123.56 49.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.235 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.713 ' HG3' ' HA ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER -80.85 138.17 36.19 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.414 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' N ' ' A' ' 49' ' ' GLY . 9.5 t-105 -150.1 148.88 29.52 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.189 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' N ' ' CD1' ' A' ' 48' ' ' TRP . . . -36.58 95.55 0.01 OUTLIER Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.513 -0.375 . . . . 0.0 113.72 -179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.68 30.5 11.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.832 0.349 . . . . 0.0 111.266 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 91' ' ' THR . 0.9 OUTLIER -145.63 146.03 31.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.326 179.8 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.548 ' O ' ' HA ' ' A' ' 85' ' ' CYS . 0.9 OUTLIER -140.51 121.45 14.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.862 0.363 . . . . 0.0 111.267 -179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 53' ' ' TYR . 19.3 p90 -129.61 129.78 44.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.112 0.482 . . . . 0.0 110.98 179.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.54 ' CE2' HG11 ' A' ' 126' ' ' VAL . 6.7 p90 -139.11 145.53 39.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.815 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.36 149.34 21.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.34 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.812 HG21 HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -123.16 6.28 9.17 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 80.41 -6.21 1.71 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.799 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 58' ' ' VAL . 11.1 p -86.54 116.01 28.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.834 0.35 . . . . 0.0 110.2 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -103.32 94.79 5.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.0 0.429 . . . . 0.0 111.769 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.847 HG22 HG22 ' A' ' 31' ' ' THR . 7.5 p -124.07 106.59 17.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.016 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -128.34 136.56 51.13 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-O 121.051 0.453 . . . . 0.0 111.587 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.417 ' HG2' ' N ' ' A' ' 63' ' ' GLU . 8.9 ttmt -141.51 164.79 29.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.242 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 63' ' ' GLU . 1.0 OUTLIER -101.24 76.42 1.71 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.835 0.35 . . . . 0.0 111.051 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.485 ' HG3' ' N ' ' A' ' 65' ' ' ASN . 0.4 OUTLIER -170.11 160.78 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.979 179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.485 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 28.3 t-20 72.78 -82.65 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.6 ' OG ' HD12 ' A' ' 79' ' ' ILE . 0.4 OUTLIER 22.43 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -101.97 160.55 14.39 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.639 179.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' OD1' HG23 ' A' ' 69' ' ' VAL . 12.1 p30 -122.38 -4.3 8.86 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' OD1' ' A' ' 68' ' ' ASP . 40.7 t -131.87 143.66 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.733 0.301 . . . . 0.0 111.103 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.524 HG11 ' NZ ' ' A' ' 67' ' ' LYS . 26.8 m -158.77 158.21 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 112.029 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -85.33 150.54 24.69 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.312 0.577 . . . . 0.0 111.362 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.7 tp -52.08 124.79 13.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.963 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 114.28 -32.19 6.05 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.541 -0.837 . . . . 0.0 114.017 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.458 ' O ' ' CE1' ' A' ' 87' ' ' PHE . 1.0 OUTLIER -67.55 166.05 15.63 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.104 0.452 . . . . 0.0 111.883 -179.054 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.589 HG22 ' CD1' ' A' ' 110' ' ' ILE . 22.0 t -122.72 152.36 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.719 ' HA ' ' H ' ' A' ' 107' ' ' ILE . . . -150.47 146.17 26.47 Favored 'General case' 0 C--N 1.344 0.338 0 C-N-CA 119.963 -0.695 . . . . 0.0 112.697 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.518 ' CE1' ' CZ2' ' A' ' 27' ' ' TRP . 0.0 OUTLIER -98.24 126.97 43.94 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.962 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.738 ' CD1' HG12 ' A' ' 104' ' ' VAL . 3.2 t90 -68.38 122.59 18.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.215 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.723 ' HB ' ' HD3' ' A' ' 80' ' ' PRO . 1.0 OUTLIER -72.25 -68.53 0.41 Allowed Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.453 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.723 ' HD3' ' HB ' ' A' ' 79' ' ' ILE . 38.8 Cg_exo -59.44 82.62 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.915 1.743 . . . . 0.0 111.837 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.53 -7.18 4.95 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.642 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' HA ' ' CE2' ' A' ' 77' ' ' TYR . 0.0 OUTLIER 48.62 39.43 13.38 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.865 0.364 . . . . 0.0 111.176 179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' A' ' 78' ' ' TRP . . . -115.19 135.5 54.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.574 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.55 145.57 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 2.5 m -142.49 131.27 22.79 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -179.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.815 HD13 ' CD2' ' A' ' 117' ' ' LEU . 0.1 OUTLIER -98.07 139.19 34.26 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.458 ' CE1' ' O ' ' A' ' 74' ' ' ASP . 14.3 p90 -136.52 138.05 40.93 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.075 0.464 . . . . 0.0 110.967 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.9 50.68 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.491 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.03 -81.14 0.13 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.456 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -123.49 -170.26 2.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.387 0.613 . . . . 0.0 111.553 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -166.16 178.09 1.37 Allowed Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.014 -0.994 . . . . 0.0 108.807 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 91' ' ' THR . 2.6 Cg_exo -36.25 -30.17 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.659 2.239 . . . . 0.0 112.657 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.689 ' N ' HD13 ' A' ' 93' ' ' ILE . 0.2 OUTLIER -142.11 69.62 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.348 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.456 ' HB3' ' HB2' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -44.88 -40.43 6.25 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.864 0.364 . . . . 0.0 111.205 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -47.84 151.74 0.86 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.0 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 58.28 52.21 7.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.405 -179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.09 161.83 0.11 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.283 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 79.4 mt -57.78 120.74 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 120.984 0.421 . . . . 0.0 111.121 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 100' ' ' PRO . 0.0 OUTLIER -116.83 99.29 52.81 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.644 ' HA ' HG21 ' A' ' 91' ' ' THR . 40.0 Cg_endo -65.73 -31.43 49.02 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.552 2.168 . . . . 0.0 112.446 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.682 ' HB3' HG13 ' A' ' 104' ' ' VAL . . . 173.57 -159.5 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.757 0.313 . . . . 0.0 110.663 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.62 -4.12 17.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.552 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -173.85 73.21 0.03 OUTLIER 'General case' 0 C--O 1.232 0.17 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.738 HG12 ' CD1' ' A' ' 78' ' ' TRP . 15.6 m -120.69 141.96 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-O 120.979 0.418 . . . . 0.0 111.757 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.656 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 41.1 m-20 -80.71 151.03 29.1 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.687 -178.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -84.44 85.48 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.111 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.441 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.719 ' H ' ' HA ' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -68.17 19.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.945 -178.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . 113.33 -146.74 18.52 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.933 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 75' ' ' VAL . 10.5 mtt-85 -154.98 168.09 28.14 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.098 0.475 . . . . 0.0 111.515 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.589 ' CD1' HG22 ' A' ' 75' ' ' VAL . 3.6 mt -93.58 118.85 40.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.432 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.458 HG13 ' OE2' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -62.85 -74.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.037 -179.821 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.9 t30 -166.15 -31.32 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.445 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 m -40.56 -32.79 0.22 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.755 0.312 . . . . 0.0 111.669 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.489 ' HB3' HG21 ' A' ' 110' ' ' ILE . 1.2 tmt? -87.5 155.37 20.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.705 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -125.66 -76.68 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.81 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -140.18 45.38 1.0 Allowed Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.573 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 120' ' ' VAL . 5.8 tp -45.76 -40.7 9.84 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.638 0.256 . . . . 0.0 111.076 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 119' ' ' GLY . 0.1 OUTLIER -42.3 -24.59 0.05 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.847 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.416 ' N ' ' HD3' ' A' ' 118' ' ' LYS . . . -91.32 35.04 4.05 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.057 179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.906 HG13 ' O ' ' A' ' 117' ' ' LEU . 3.7 m -70.91 154.79 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 122.61 0.364 . . . . 0.0 111.853 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.79 146.66 44.09 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.713 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 3.8 p30 -58.1 116.35 3.48 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.089 0.471 . . . . 0.0 112.238 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.93 102.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.973 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -156.37 150.98 25.77 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.879 0.371 . . . . 0.0 110.792 178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.4 t -52.1 167.45 0.12 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.265 0.555 . . . . 0.0 112.229 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.89 ' CG2' ' HB2' ' A' ' 45' ' ' ALA . 89.2 t -157.7 128.09 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.21 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.545 ' O ' HG23 ' A' ' 127' ' ' VAL . 30.6 m -127.84 108.23 17.7 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 CA-C-O 120.862 0.363 . . . . 0.0 111.352 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.812 HG21 HG21 ' A' ' 56' ' ' THR . 0.2 OUTLIER -84.02 129.01 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.388 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.443 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 4.7 pt-20 -152.05 128.22 10.48 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.607 0.242 . . . . 0.0 111.229 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.678 ' CB ' HD22 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -73.79 85.37 1.68 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.634 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.175 -0.916 . . . . 0.0 111.634 179.941 . . . . . . . . 0 0 . 1 stop_ save_